Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
COQ8B	positive	HAGHL	ENSG00000103253	COQ8B	1	COQ8B	1	0.00054096779254198	WBGene00012459	WBGene00012459(0)			GO:0046872;GO:0016787;GO:0004416;GO:0019243	metal ion binding;hydrolase activity;hydroxyacylglutathione hydrolase activity;methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione	Alternative splicing;Hydrolase;Metal-binding;Reference proteome;Zinc		
COQ8B	positive	ZDHHC24	ENSG00000174165	COQ8B	1	COQ8B	1	0.00054096779254198	WBGene00008606;WBGene00019344				GO:0016020;GO:0016021;GO:0016740;GO:0016746;GO:0016409;GO:0019706;GO:0005515;GO:0005783;GO:0005794;GO:0006612;GO:0018230	membrane;integral component of membrane;transferase activity;transferase activity, transferring acyl groups;palmitoyltransferase activity;protein-cysteine S-palmitoyltransferase activity;protein binding;endoplasmic reticulum;Golgi apparatus;protein targeting to membrane;peptidyl-L-cysteine S-palmitoylation	Acyltransferase;Lipoprotein;Membrane;Palmitate;Reference proteome;Transferase;Transmembrane;Transmembrane helix		
COQ8B	positive	ISOC2	ENSG00000063241	COQ8B	1	COQ8B	1	0.000859415086071791	WBGene00009436	WBGene00009436(0)			GO:0005737;GO:0005634;GO:0003824;GO:0005515;GO:0031648	catalytic activity;cytoplasm;nucleus;protein binding;protein destabilization	Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome		
COQ8B	positive	SREBF1	ENSG00000072310	COQ8B	1	COQ8B	1	0.000859415086071791	WBGene00004735		ACLY;FAS;LDLR;NR0B2;PCSK9;SCD5		GO:0046983;GO:0045944;GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0003677;GO:0005794;GO:0006629;GO:0008202;GO:0030522;GO:0000139;GO:0031410;GO:0008203;GO:0003700;GO:0005515;GO:0000978;GO:0000122;GO:0000981;GO:0000790;GO:0012507;GO:0005654;GO:0005829;GO:1903146;GO:1903214;GO:0005635;GO:0007623;GO:0006357;GO:0045540;GO:0000977;GO:0031647;GO:0010867;GO:0033993;GO:0008610;GO:0001228;GO:0003682;GO:0004879;GO:0019901;GO:0032810;GO:0043565;GO:0044877;GO:0003062;GO:0006355;GO:0007568;GO:0008286;GO:0009267;GO:0009749;GO:0014070;GO:0019217;GO:0030324;GO:0031065;GO:0032094;GO:0032526;GO:0032570;GO:0032869;GO:0033762;GO:0042493;GO:0042789;GO:0043434;GO:0045444;GO:0045542;GO:0045893;GO:0046676;GO:0050796;GO:0051591;GO:0070542;GO:0071398;GO:1902895;GO:0032991;GO:0043231	protein dimerization activity;positive regulation of transcription by RNA polymerase II;nucleus;cytoplasm;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;DNA binding;Golgi apparatus;lipid metabolic process;steroid metabolic process;protein binding;intracellular receptor signaling pathway;cytoplasmic vesicle;Golgi membrane;cholesterol metabolic process;DNA-binding transcription factor activity;RNA polymerase II cis-regulatory region sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;ER to Golgi transport vesicle membrane;nucleoplasm;cytosol;regulation of autophagy of mitochondrion;regulation of protein targeting to mitochondrion;nuclear envelope;circadian rhythm;regulation of transcription by RNA polymerase II;regulation of cholesterol biosynthetic process;RNA polymerase II regulatory region sequence-specific DNA binding;regulation of protein stability;response to lipid;positive regulation of triglyceride biosynthetic process;lipid biosynthetic process;nuclear receptor activity;sterol response element binding;cellular response to starvation;SREBP signaling pathway;positive regulation of pri-miRNA transcription by RNA polymerase II;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;protein kinase binding;sequence-specific DNA binding;protein-containing complex binding;regulation of heart rate by chemical signal;regulation of transcription, DNA-templated;aging;insulin receptor signaling pathway;response to glucose;response to organic cyclic compound;regulation of fatty acid metabolic process;lung development;positive regulation of histone deacetylation;response to food;response to retinoic acid;response to progesterone;cellular response to insulin stimulus;response to glucagon;response to drug;mRNA transcription by RNA polymerase II;response to peptide hormone;fat cell differentiation;positive regulation of cholesterol biosynthetic process;positive regulation of transcription, DNA-templated;negative regulation of insulin secretion;regulation of insulin secretion;response to cAMP;response to fatty acid;cellular response to fatty acid;protein-containing complex;intracellular membrane-bounded organelle	3D-structure;Activator;Alternative splicing;Cholesterol metabolism;Cytoplasmic vesicle;DNA-binding;Direct protein sequencing;Endoplasmic reticulum;Golgi apparatus;Lipid metabolism;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Steroid metabolism;Sterol metabolism;Transcription;Transcription regulation;Transmembrane;Transmembrane helix	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9614085;R-HSA-9615017;R-HSA-400253;R-HSA-1368082	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Circadian Clock;RORA activates gene expression
COQ8B	positive	CEP131	ENSG00000141577	COQ8B	1	COQ8B	1	0.000859415086071791					GO:0005737;GO:0043231;GO:0045171;GO:0042803;GO:0015630;GO:0005856;GO:0042995;GO:0005515;GO:0007049;GO:0007275;GO:0005815;GO:0031410;GO:0030154;GO:0007283;GO:0005813;GO:0036064;GO:0005829;GO:0030030;GO:0060271;GO:0034451;GO:0001669;GO:0000086;GO:0010389;GO:0097711;GO:0035735;GO:0008284;GO:0035869;GO:0044877;GO:0090316;GO:0010824;GO:0071539;GO:0005929	intraciliary transport involved in cilium assembly;cytoplasm;intracellular membrane-bounded organelle;intercellular bridge;cytoskeleton;protein homodimerization activity;microtubule cytoskeleton;cell projection;protein binding;cell cycle;multicellular organism development;centriolar satellite;cytoplasmic vesicle;cell differentiation;spermatogenesis;centrosome;microtubule organizing center;ciliary basal body;cytosol;cell projection organization;cilium assembly;acrosomal vesicle;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;positive regulation of cell population proliferation;ciliary transition zone;protein-containing complex binding;positive regulation of intracellular protein transport;regulation of centrosome duplication;protein localization to centrosome;cilium	Alternative splicing;Cell cycle;Cell projection;Cilium biogenesis/degradation;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Developmental protein;Differentiation;Phosphoprotein;Polymorphism;Reference proteome;Spermatogenesis;Transport;Ubl conjugation	R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518	Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2
COQ8B	positive	TRPT1	ENSG00000149743	COQ8B	1	COQ8B	1	0.000859415086071791	WBGene00019724;WBGene00019825				GO:0016740;GO:0008033;GO:0016772;GO:0006388;GO:0003674;GO:0008150;GO:0000215;GO:0045859	transferase activity, transferring phosphorus-containing groups;tRNA splicing, via endonucleolytic cleavage and ligation;transferase activity;tRNA processing;molecular_function;biological_process;tRNA 2'-phosphotransferase activity;regulation of protein kinase activity	Acetylation;Alternative splicing;NAD;Phosphoprotein;Polymorphism;Reference proteome;Transferase;tRNA processing		
COQ8B	positive	TRAPPC2L	ENSG00000167515	COQ8B	1	COQ8B	1	0.000859415086071791	WBGene00044604	WBGene00044604(0)		ENCEPHALOPATHY PROGRESSIVE EARLY-ONSET WITH EPISODICRHABDOMYOLYSIS	GO:0006888;GO:0005737;GO:0005622;GO:0043231;GO:0005829;GO:0005783;GO:0005794;GO:0005515;GO:0048471;GO:0016192;GO:0000139;GO:0051259;GO:0048208;GO:0030008	endoplasmic reticulum to Golgi vesicle-mediated transport;cytoplasm;intracellular membrane-bounded organelle;cytosol;endoplasmic reticulum;Golgi apparatus;protein binding;perinuclear region of cytoplasm;vesicle-mediated transport;Golgi membrane;TRAPP complex;COPII vesicle coating	Alternative splicing;Cytoplasm;Disease mutation;ER-Golgi transport;Endoplasmic reticulum;Epilepsy;Golgi apparatus;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-446203;R-HSA-199977;R-HSA-948021;R-HSA-204005	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport
COQ8B	positive	MLST8	ENSG00000167965	COQ8B	1	COQ8B	1	0.000859415086071791	WBGene00015697	WBGene00015697(0)			GO:0031929;GO:0031931;GO:0031932;GO:0005515;GO:0032008;GO:0005737;GO:0071902;GO:0005654;GO:0005829;GO:0032956;GO:1900034;GO:0032148;GO:0007050;GO:0016241;GO:0038202;GO:0043539	protein binding;TOR signaling;TORC1 complex;TORC2 complex;cytoplasm;positive regulation of protein serine/threonine kinase activity;nucleoplasm;cytosol;regulation of actin cytoskeleton organization;regulation of cellular response to heat;positive regulation of TOR signaling;activation of protein kinase B activity;cell cycle arrest;regulation of macroautophagy;TORC1 signaling;protein serine/threonine kinase activator activity;positive regulation of actin filament polymerization;regulation of GTPase activity;positive regulation of peptidyl-tyrosine phosphorylation	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Phosphoprotein;Reference proteome;Repeat;WD repeat	R-HSA-1280218;R-HSA-168256;R-HSA-388841;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-9612973;R-HSA-1257604;R-HSA-2262752;R-HSA-5663202;R-HSA-6807070;R-HSA-8953897;R-HSA-9006925;R-HSA-9006934;R-HSA-3371556;R-HSA-2219528;R-HSA-5674400;R-HSA-5633007;R-HSA-6804757;R-HSA-6806003;R-HSA-8943724;R-HSA-165159;R-HSA-166208;R-HSA-194138;R-HSA-389356;R-HSA-389357;R-HSA-4420097;R-HSA-5628897;R-HSA-5218920;R-HSA-1632852;R-HSA-380972;R-HSA-3371571	Adaptive Immune System;Immune System;Costimulation by the CD28 family;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;Autophagy;PIP3 activates AKT signaling;Cellular responses to stress;Diseases of signal transduction;PTEN Regulation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Cellular response to heat stress;PI3K/AKT Signaling in Cancer;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Regulation of PTEN gene transcription;mTOR signalling;mTORC1-mediated signalling;Signaling by VEGF;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;VEGFA-VEGFR2 Pathway;TP53 Regulates Metabolic Genes;VEGFR2 mediated vascular permeability;Macroautophagy;Energy dependent regulation of mTOR by LKB1-AMPK;HSF1-dependent transactivation
COQ8B	positive	DEAF1	ENSG00000177030	COQ8B	1	COQ8B	1	0.000859415086071791				Autosomal dominant non-syndromic intellectual disability;Intellectual disability-epilepsy-extrapyramidal syndrome;SMITH-MAGENIS SYNDROME;Autism intellectual disability basal ganglia dysfunction and epilepsy;Mental retardation autosomal dominant 24;DYSKINESIA SEIZURES AND INTELLECTUAL DEVELOPMENTAL DISORDER;Mental retardation autosomal dominant 24	GO:0003677;GO:0005634;GO:0005737;GO:0046872;GO:0001650;GO:0005515;GO:0005576;GO:0007275;GO:0048706;GO:0045893;GO:0003700;GO:0007399;GO:0006357;GO:0000981;GO:0000790;GO:0001227;GO:0000122;GO:0045892;GO:0006366;GO:0009653;GO:0000977;GO:0001843;GO:0001662;GO:0007281;GO:0008542;GO:0033599;GO:0005667	DNA binding;nucleus;cytoplasm;metal ion binding;nucleoplasm;fibrillar center;protein binding;extracellular region;multicellular organism development;embryonic skeletal system development;positive regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nervous system development;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;transcription by RNA polymerase II;anatomical structure morphogenesis;RNA polymerase II regulatory region sequence-specific DNA binding;neural tube closure;behavioral fear response;germ cell development;visual learning;regulation of mammary gland epithelial cell proliferation;transcription factor complex	3D-structure;Alternative splicing;Cytoplasm;DNA-binding;Developmental protein;Disease mutation;Epilepsy;Mental retardation;Metal-binding;Neurogenesis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Secreted;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ8B	positive	PIGQ	ENSG00000007541	COQ8B	1	COQ8B	1	0.00134284195658874	WBGene00008504	WBGene00008504(0)		Early infantile epileptic encephalopathy;SEVERE EARLY-ONSET EPILEPSY	GO:0016021;GO:0006506;GO:0017176;GO:0016020;GO:0016740;GO:0016757;GO:0005789;GO:0005975;GO:0016254;GO:0000506	integral component of membrane;GPI anchor biosynthetic process;phosphatidylinositol N-acetylglucosaminyltransferase activity;membrane;transferase activity;transferase activity, transferring glycosyl groups;endoplasmic reticulum membrane;carbohydrate metabolic process;preassembly of GPI anchor in ER membrane;glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex	Alternative splicing;Direct protein sequencing;Disease mutation;Epilepsy;GPI-anchor biosynthesis;Glycosyltransferase;Membrane;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix		
COQ8B	positive	PRICKLE3	ENSG00000012211	COQ8B	1	COQ8B	1	0.00134284195658874	WBGene00022727;WBGene00006407	WBGene00022727(1)			GO:0005737;GO:0016020;GO:0008270;GO:0046872;GO:0005634;GO:0005813;GO:0005886;GO:0005515;GO:0007275;GO:0008150;GO:0030030	zinc ion binding;cytoplasm;membrane;metal ion binding;plasma membrane;protein binding;multicellular organism development;biological_process;cell projection organization	Alternative splicing;Cell membrane;Cilium biogenesis/degradation;Cytoplasm;Developmental protein;LIM domain;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Zinc		
COQ8B	positive	CROCC	ENSG00000058453	COQ8B	1	COQ8B	1	0.00134284195658874	WBGene00022500;WBGene00012121				GO:0005737;GO:0005813;GO:0005829;GO:0005886;GO:0015629;GO:0005856;GO:0042995;GO:0007049;GO:0007098;GO:0005815;GO:0005515;GO:0005929;GO:0070062;GO:0030030;GO:0005814;GO:0008104;GO:0019894;GO:0005198;GO:0045724;GO:1903566;GO:0035253;GO:0033365;GO:0010457;GO:0003779;GO:0005200;GO:0010669;GO:0032053;GO:0045494;GO:0051656;GO:0001917	centrosome cycle;ciliary rootlet;cytoplasm;cytosol;plasma membrane;cytoskeleton;centrosome;actin cytoskeleton;cell projection;cell cycle;microtubule organizing center;protein binding;cilium;extracellular exosome;cell projection organization;centriole;protein localization;kinesin binding;structural molecule activity;positive regulation of cilium assembly;positive regulation of protein localization to cilium;protein localization to organelle;centriole-centriole cohesion;actin binding;structural constituent of cytoskeleton;epithelial structure maintenance;ciliary basal body organization;photoreceptor cell maintenance;establishment of organelle localization;photoreceptor inner segment	Alternative splicing;Cell cycle;Cell projection;Cilium;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	ZNF446	ENSG00000083838	COQ8B	1	COQ8B	1	0.00134284195658874		WBGene00003033(0);WBGene00001824(0);WBGene00012385(0)			GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003700;GO:0005622;GO:0003677;GO:0005615;GO:0006357;GO:0000981;GO:0000790;GO:0005515	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleic acid binding;nucleus;metal ion binding;DNA binding;extracellular space;protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin	Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ8B	positive	NAT14	ENSG00000090971	COQ8B	1	COQ8B	1	0.00134284195658874					GO:0005634;GO:0016020;GO:0016021;GO:0016740;GO:0003677;GO:0016746;GO:0008080;GO:0045893;GO:0006352	N-acetyltransferase activity;nucleus;membrane;integral component of membrane;transferase activity;DNA binding;transferase activity, transferring acyl groups;positive regulation of transcription, DNA-templated;DNA-templated transcription, initiation	Activator;Acyltransferase;DNA-binding;Membrane;Reference proteome;Transcription;Transcription regulation;Transferase;Transmembrane;Transmembrane helix		
COQ8B	positive	R3HCC1	ENSG00000104679	COQ8B	1	COQ8B	1	0.00134284195658874		WBGene00008622(0)			GO:0003676;GO:0035145	nucleic acid binding;exon-exon junction complex	Alternative splicing;Coiled coil;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	NUMBL	ENSG00000105245	COQ8B	1	COQ8B	1	0.00134284195658874	WBGene00003830	WBGene00001116(0);WBGene00002176(0);WBGene00000894(0);WBGene00003830(0);WBGene00009930(0)			GO:0005737;GO:0005515;GO:0007275;GO:0007399;GO:0050769;GO:0045296;GO:0019221;GO:0021670;GO:0021849;GO:0019538;GO:0007405;GO:0007409;GO:0030900;GO:0034332	protein binding;cytoplasm;multicellular organism development;positive regulation of neurogenesis;nervous system development;cadherin binding;cytokine-mediated signaling pathway;lateral ventricle development;neuroblast division in subventricular zone;protein metabolic process;neuroblast proliferation;axonogenesis;forebrain development;adherens junction organization	3D-structure;Cytoplasm;Developmental protein;Neurogenesis;Phosphoprotein;Reference proteome;Ubl conjugation pathway		
COQ8B	positive	DDX49	ENSG00000105671	COQ8B	1	COQ8B	1	0.00134284195658874	WBGene00019219	WBGene00019219(0)			GO:0003676;GO:0003723;GO:0000166;GO:0005524;GO:0016787;GO:0004386;GO:0003724;GO:0005634;GO:0005654;GO:0006364	ATP binding;nucleic acid binding;RNA binding;nucleotide binding;hydrolase activity;helicase activity;RNA helicase activity;nucleus;nucleoplasm;rRNA processing;positive regulation of cell growth;regulation of rRNA stability	ATP-binding;Alternative splicing;Helicase;Hydrolase;Nucleotide-binding;Polymorphism;RNA-binding;Reference proteome	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ8B	positive	SGSM2	ENSG00000141258	COQ8B	1	COQ8B	1	0.00134284195658874	WBGene00008018				GO:0005737;GO:0005096;GO:0042470;GO:0017137;GO:0006886;GO:0090630;GO:0043547;GO:0034499	GTPase activator activity;cytoplasm;melanosome;Rab GTPase binding;intracellular protein transport;activation of GTPase activity;positive regulation of GTPase activity;late endosome to Golgi transport	Alternative splicing;Cytoplasm;GTPase activation;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	SCRN2	ENSG00000141295	COQ8B	1	COQ8B	1	0.00134284195658874					GO:0005515;GO:0006508;GO:0016805;GO:0070062;GO:0003674;GO:0008150	proteolysis;dipeptidase activity;protein binding;extracellular exosome;molecular_function;biological_process	Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	SIRT3	ENSG00000142082	COQ8B	1	COQ8B	1	0.00134284195658874					GO:0008270;GO:0046872;GO:0016787;GO:0016575;GO:0005739;GO:0005759;GO:0070403;GO:0034979;GO:0006476;GO:0017136;GO:0005515;GO:0043565;GO:0005634;GO:0005737;GO:0005654;GO:0032991;GO:0007005;GO:0006471;GO:0003950;GO:0009060;GO:0034983;GO:2000304;GO:0019899;GO:0007568;GO:0032024;GO:0070373;GO:2000378	zinc ion binding;NAD+ binding;NAD-dependent histone deacetylase activity;metal ion binding;transferase activity;mitochondrion;mitochondrial matrix;NAD-dependent protein deacetylase activity;protein deacetylation;histone deacetylation;protein binding;sequence-specific DNA binding;nucleus;cytoplasm;nucleoplasm;protein-containing complex;mitochondrion organization;protein ADP-ribosylation;NAD+ ADP-ribosyltransferase activity;aerobic respiration;peptidyl-lysine deacetylation;positive regulation of ceramide biosynthetic process;enzyme binding;aging;positive regulation of insulin secretion;negative regulation of ERK1 and ERK2 cascade;positive regulation of superoxide dismutase activity;positive regulation of catalase activity;negative regulation of reactive oxygen species metabolic process	3D-structure;Alternative splicing;Metal-binding;Mitochondrion;NAD;Polymorphism;Reference proteome;Transferase;Transit peptide;Zinc	R-HSA-1852241;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9614085;R-HSA-9615017;R-HSA-1592230;R-HSA-2151201;R-HSA-9617629	Organelle biogenesis and maintenance;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;Regulation of FOXO transcriptional activity by acetylation
COQ8B	positive	CCDC24	ENSG00000159214	COQ8B	1	COQ8B	1	0.00134284195658874					GO:0005515;GO:0001835	protein binding;blastocyst hatching	Alternative splicing;Coiled coil;Reference proteome		
COQ8B	positive	MFSD3	ENSG00000167700	COQ8B	1	COQ8B	1	0.00134284195658874					GO:0016020;GO:0016021;GO:0055085;GO:0005887;GO:1902600;GO:0015295	membrane;transmembrane transport;integral component of membrane;proton transmembrane transport;solute:proton symporter activity	Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ8B	positive	PC	ENSG00000173599	COQ8B	1	COQ8B	1	0.00134284195658874	WBGene00004258;WBGene00009319;WBGene00017864	WBGene00004258(0)		Pyruvate carboxylase deficiency benign type;Pyruvate carboxylase deficiency infantile type;Pyruvate carboxylase deficiency severe neonatal type;PYRUVATE CARBOXYLASE DEFICIENCY;PYRUVATE CARBOXYLASE DEFICIENCY	GO:0046872;GO:0000166;GO:0005524;GO:0005739;GO:0003824;GO:0005759;GO:0006629;GO:0016874;GO:0005515;GO:0008152;GO:0004736;GO:0009374;GO:0006090;GO:0006094;GO:0042802;GO:0005737;GO:0005829;GO:0010629;GO:0044794;GO:0006768;GO:0019074;GO:0044791	metal ion binding;ATP binding;catalytic activity;gluconeogenesis;pyruvate carboxylase activity;biotin binding;pyruvate metabolic process;nucleotide binding;mitochondrion;mitochondrial matrix;lipid metabolic process;ligase activity;protein binding;metabolic process;identical protein binding;cytoplasm;cytosol;negative regulation of gene expression;positive regulation by host of viral process;biotin metabolic process;viral RNA genome packaging;positive regulation by host of viral release from host cell	3D-structure;ATP-binding;Acetylation;Alternative splicing;Biotin;Disease mutation;Gluconeogenesis;Ligase;Lipid biosynthesis;Lipid metabolism;Manganese;Metal-binding;Mitochondrion;Multifunctional enzyme;Nucleotide-binding;Phosphoprotein;Polymorphism;Pyruvate;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-1643685;R-HSA-70326;R-HSA-71387;R-HSA-196854;R-HSA-70263;R-HSA-196780;R-HSA-196849;R-HSA-3296482;R-HSA-5668914;R-HSA-3323169;R-HSA-3371599	Metabolism;Disease;Glucose metabolism;Metabolism of carbohydrates;Metabolism of vitamins and cofactors;Gluconeogenesis;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Defects in vitamin and cofactor metabolism;Diseases of metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency
COQ8B	positive	SLC35C1	ENSG00000181830	COQ8B	1	COQ8B	1	0.00134284195658874	WBGene00008237;WBGene00011882	WBGene00011882(1);WBGene00008237(1)		Leukocyte adhesion deficiency type II;Congenital disorder of glycosylation type 2C;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIc	GO:0016020;GO:0016021;GO:0005794;GO:0000139;GO:0008643;GO:0005457;GO:0036085;GO:0015297;GO:0036066;GO:0022857;GO:0030259;GO:0045746	Golgi apparatus;GDP-fucose transmembrane transporter activity;GDP-fucose import into Golgi lumen;membrane;integral component of membrane;Golgi membrane;carbohydrate transport;antiporter activity;transmembrane transporter activity;protein O-linked fucosylation;lipid glycosylation;negative regulation of Notch signaling pathway	Alternative splicing;Congenital disorder of glycosylation;Disease mutation;Golgi apparatus;Membrane;Polymorphism;Reference proteome;Sugar transport;Transmembrane;Transmembrane helix;Transport	R-HSA-392499;R-HSA-597592;R-HSA-382551;R-HSA-425407;R-HSA-446193;R-HSA-446203;R-HSA-446219;R-HSA-6787639;R-HSA-1643685;R-HSA-5619115;R-HSA-5619102;R-HSA-425397;R-HSA-727802;R-HSA-5619078	Metabolism of proteins;Post-translational protein modification;Transport of small molecules;SLC-mediated transmembrane transport;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;GDP-fucose biosynthesis;Disease;Disorders of transmembrane transporters;SLC transporter disorders;Transport of vitamins, nucleosides, and related molecules;Transport of nucleotide sugars;Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)
COQ8B	positive	C17orf97	ENSG00000187624	COQ8B	1	COQ8B	1	0.00134284195658874					GO:0016598	protein arginylation	Alternative splicing;Polymorphism;Reference proteome;Repeat		
COQ8B	positive	NTHL1	ENSG00000065057	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00011201	WBGene00011201(1)		NTHL1-related attenuated familial adenomatous polyposis;FAMILIAL ADENOMATOUS POLYPOSIS 3	GO:0005634;GO:0003677;GO:0003824;GO:0006281;GO:0003906;GO:0006284;GO:0051539;GO:0019104;GO:0006285;GO:0046872;GO:0016787;GO:0016829;GO:0005739;GO:0008152;GO:0016798;GO:0006974;GO:0004519;GO:0051536;GO:0140078;GO:0005515;GO:0005654;GO:0003690;GO:0000703;GO:0006296;GO:0008534;GO:0045008	DNA binding;nucleus;catalytic activity;DNA-(apurinic or apyrimidinic site) endonuclease activity;DNA repair;4 iron, 4 sulfur cluster binding;base-excision repair;DNA N-glycosylase activity;base-excision repair, AP site formation;metal ion binding;hydrolase activity;lyase activity;mitochondrion;metabolic process;hydrolase activity, acting on glycosyl bonds;cellular response to DNA damage stimulus;endonuclease activity;iron-sulfur cluster binding;protein binding;class I DNA-(apurinic or apyrimidinic site) endonuclease activity;nucleoplasm;double-stranded DNA binding;oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity;nucleotide-excision repair, DNA incision, 5'-to lesion;oxidized purine nucleobase lesion DNA N-glycosylase activity;depyrimidination;nuclear chromatin	4Fe-4S;Alternative initiation;DNA damage;DNA repair;Direct protein sequencing;Glycosidase;Hydrolase;Iron;Iron-sulfur;Lyase;Metal-binding;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1643685;R-HSA-73894;R-HSA-110328;R-HSA-110329;R-HSA-110357;R-HSA-73884;R-HSA-73928;R-HSA-73929;R-HSA-73933;R-HSA-9605308;R-HSA-9616333;R-HSA-9630221;R-HSA-9630222	Disease;DNA Repair;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Displacement of DNA glycosylase by APEX1;Base Excision Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Diseases of Base Excision Repair;Defective Base Excision Repair Associated with NTHL1;Defective NTHL1 substrate processing;Defective NTHL1 substrate binding
COQ8B	positive	WDR18	ENSG00000065268	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00004185	WBGene00004185(0)			GO:0005634;GO:0005737;GO:0005515;GO:0007275;GO:0005654;GO:0005730;GO:0006364;GO:0005656;GO:0030174;GO:0097344	protein binding;nucleus;cytoplasm;nucleoplasm;multicellular organism development;nucleolus;rRNA processing;nuclear pre-replicative complex;regulation of DNA-dependent DNA replication initiation;Rix1 complex	Cytoplasm;Developmental protein;Nucleus;Polymorphism;Reference proteome;Repeat;WD repeat	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
COQ8B	positive	PLEKHH3	ENSG00000068137	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00003143				GO:0007165;GO:0005615;GO:0005856	signal transduction;extracellular space;cytoskeleton	Alternative splicing;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Signal		
COQ8B	positive	JMJD4	ENSG00000081692	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00011563	WBGene00011563(0)			GO:0005737;GO:0046872;GO:0016491;GO:0055114;GO:0005515;GO:0051213;GO:0016706;GO:0045905;GO:0018126	cytoplasm;metal ion binding;oxidoreductase activity;oxidation-reduction process;protein binding;dioxygenase activity;2-oxoglutarate-dependent dioxygenase activity;positive regulation of translational termination;protein hydroxylation	Alternative splicing;Cytoplasm;Dioxygenase;Iron;Metal-binding;Oxidoreductase;Polymorphism;Reference proteome		
COQ8B	positive	RAB3A	ENSG00000105649	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00004267				GO:0005737;GO:0016020;GO:0015031;GO:0000166;GO:0003924;GO:0005525;GO:0005829;GO:0006887;GO:0005886;GO:0005515;GO:0048471;GO:0031410;GO:0032781;GO:0001671;GO:0008022;GO:0030742;GO:0051021;GO:0051117;GO:0003016;GO:0007005;GO:0007274;GO:0007409;GO:0009791;GO:0010807;GO:0016079;GO:0016188;GO:0017156;GO:0017157;GO:0030324;GO:0031630;GO:0036465;GO:0048172;GO:0048489;GO:0048790;GO:0050975;GO:0051602;GO:0061670;GO:0097091;GO:2000300;GO:0001669;GO:0005768;GO:0008021;GO:0030141;GO:0030424;GO:0032991;GO:0043195;GO:0043229;GO:0048786;GO:0098993;GO:0005764;GO:0006886;GO:0032482;GO:0009306;GO:0043687;GO:0043312;GO:0031489;GO:0030667;GO:0014047;GO:1903561;GO:0030133;GO:0072659;GO:0007269;GO:0060478;GO:0031982;GO:0001778;GO:0045055;GO:0032418;GO:0006904;GO:1903307;GO:0061202;GO:0045054;GO:0045921;GO:1905684;GO:0060201;GO:0060203;GO:0070083	GTP binding;GTPase activity;cell;cytoplasm;membrane;protein transport;nucleotide binding;cytosol;exocytosis;plasma membrane;protein binding;perinuclear region of cytoplasm;cytoplasmic vesicle;positive regulation of ATPase activity;ATPase activator activity;protein C-terminus binding;GTP-dependent protein binding;GDP-dissociation inhibitor binding;ATPase binding;respiratory system process;mitochondrion organization;neuromuscular synaptic transmission;axonogenesis;post-embryonic development;regulation of synaptic vesicle priming;regulation of dopamine secretion;synaptic vesicle exocytosis;synaptic vesicle maturation;calcium-ion regulated exocytosis;regulation of exocytosis;lung development;regulation of synaptic vesicle fusion to presynaptic active zone membrane;synaptic vesicle recycling;regulation of short-term neuronal synaptic plasticity;synaptic vesicle transport;maintenance of presynaptic active zone structure;sensory perception of touch;response to electrical stimulus;evoked neurotransmitter secretion;synaptic vesicle clustering;regulation of synaptic vesicle exocytosis;acrosomal vesicle;endosome;synaptic vesicle;secretory granule;axon;protein-containing complex;terminal bouton;intracellular organelle;presynaptic active zone;anchored component of synaptic vesicle membrane;lysosome;intracellular protein transport;Rab protein signal transduction;endomembrane system;protein secretion;post-translational protein modification;vesicle;neutrophil degranulation;myosin V binding;secretory granule membrane;glutamate secretion;extracellular vesicle;transport vesicle;protein localization to plasma membrane;neurotransmitter secretion;acrosomal vesicle exocytosis;plasma membrane repair;regulated exocytosis;lysosome localization;vesicle docking involved in exocytosis;positive regulation of regulated secretory pathway;clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane;constitutive secretory pathway;positive regulation of exocytosis;regulation of plasma membrane repair;clathrin-sculpted acetylcholine transport vesicle membrane;clathrin-sculpted glutamate transport vesicle membrane;clathrin-sculpted monoamine transport vesicle membrane	Cell membrane;Cytoplasm;Cytoplasmic vesicle;Exocytosis;GTP-binding;Lipoprotein;Lysosome;Membrane;Methylation;Nucleotide-binding;Phosphoprotein;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-168249;R-HSA-168256;R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-8873719;R-HSA-112315;R-HSA-112316;R-HSA-6798695;R-HSA-112310;R-HSA-210500;R-HSA-181429;R-HSA-181430;R-HSA-212676;R-HSA-264642;R-HSA-888590	Innate Immune System;Immune System;Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;RAB geranylgeranylation;Transmission across Chemical Synapses;Neuronal System;Neutrophil degranulation;Neurotransmitter release cycle;Glutamate Neurotransmitter Release Cycle;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;GABA synthesis, release, reuptake and degradation
COQ8B	positive	PEX16	ENSG00000121680	COQ8B	1	COQ8B	1	0.00206380347814339				Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;Zellweger Syndrome;PEROXISOME BIOGENESIS DISORDER COMPLEMENTATION GROUP 9;Zellweger Syndrome;PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER);PEROXISOME BIOGENESIS DISORDER 8B	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005515;GO:0005777;GO:0005778;GO:0008022;GO:0007031;GO:0006625;GO:0005779;GO:0016558;GO:0022615;GO:0045046;GO:0016557;GO:0032581;GO:0106101	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;peroxisome;peroxisomal membrane;protein C-terminus binding;peroxisome organization;protein targeting to peroxisome;integral component of peroxisomal membrane;protein import into peroxisome matrix;protein to membrane docking;protein import into peroxisome membrane;peroxisome membrane biogenesis;ER-dependent peroxisome organization;ER-dependent peroxisome localization	Alternative splicing;Disease mutation;Membrane;Peroxisome;Peroxisome biogenesis;Peroxisome biogenesis disorder;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Zellweger syndrome	R-HSA-9609507;R-HSA-9603798	Protein localization;Class I peroxisomal membrane protein import
COQ8B	positive	ZNF205	ENSG00000122386	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00044651				GO:0005739;GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0008270;GO:0003677;GO:0005515;GO:0000981;GO:0000122;GO:0010729;GO:1901030;GO:0005622;GO:0000977;GO:0001227	regulation of transcription, DNA-templated;nucleic acid binding;mitochondrion;nucleus;metal ion binding;zinc ion binding;DNA binding;protein binding;negative regulation of transcription by RNA polymerase II;positive regulation of hydrogen peroxide biosynthetic process;positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific	DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ8B	positive	BCL2L12	ENSG00000126453	COQ8B	1	COQ8B	1	0.00206380347814339					GO:0016020;GO:0042981;GO:0006915;GO:0045944;GO:0005634;GO:1990001;GO:0002039;GO:1902166;GO:2000773	regulation of apoptotic process;membrane;apoptotic process;positive regulation of transcription by RNA polymerase II;nucleus;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;p53 binding;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;negative regulation of cellular senescence	Alternative splicing;Apoptosis;Methylation;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	TRAP1	ENSG00000126602	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00020110	WBGene00020110(0)			GO:0005524;GO:0006457;GO:0051082;GO:0003723;GO:0016020;GO:0000166;GO:0005654;GO:0005739;GO:0005743;GO:0005164;GO:0005759;GO:0005515;GO:0019901;GO:1903751;GO:0005758;GO:1903427;GO:0009386;GO:0061077;GO:1901856	ATP binding;protein folding;unfolded protein binding;RNA binding;membrane;nucleotide binding;nucleoplasm;mitochondrion;mitochondrial inner membrane;tumor necrosis factor receptor binding;mitochondrial matrix;protein binding;protein kinase binding;negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide;mitochondrial intermembrane space;negative regulation of reactive oxygen species biosynthetic process;translational attenuation;chaperone-mediated protein folding;negative regulation of cellular respiration	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chaperone;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-1428517;R-HSA-163200;R-HSA-611105	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
COQ8B	positive	AAMP	ENSG00000127837	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00013735	WBGene00013735(1)			GO:0005737;GO:0016020;GO:0005829;GO:0045171;GO:0005886;GO:0015630;GO:0005515;GO:0007275;GO:0030154;GO:0009986;GO:0001525;GO:0008201;GO:0010595;GO:0014909	protein binding;cytoplasm;membrane;cytosol;intercellular bridge;plasma membrane;microtubule cytoskeleton;multicellular organism development;cell differentiation;cell surface;angiogenesis;heparin binding;positive regulation of endothelial cell migration;smooth muscle cell migration	Angiogenesis;Cell membrane;Cytoplasm;Developmental protein;Differentiation;Direct protein sequencing;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat		
COQ8B	positive	SLC27A1	ENSG00000130304	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00009218;WBGene00017012	WBGene00008669(0);WBGene00016108(0);WBGene00022849(0);WBGene00007082(0);WBGene00009218(0);WBGene00019920(0);WBGene00011173(0)			GO:0016021;GO:0003824;GO:0004467;GO:0031957;GO:0001676;GO:0015245;GO:0015908;GO:0005737;GO:0016020;GO:0000166;GO:0005829;GO:0005739;GO:0005886;GO:0006629;GO:0006631;GO:0016874;GO:0006646;GO:0006869;GO:0006655;GO:0005515;GO:0005743;GO:0012505;GO:0006656;GO:0006661;GO:0044539;GO:0005324;GO:0006654;GO:0006659;GO:0019216;GO:0032049;GO:0010867;GO:0009409;GO:0015909;GO:0032868;GO:0001579;GO:0042803;GO:0031652;GO:0033211;GO:0071072;GO:0071902;GO:0005783;GO:0005887	integral component of membrane;catalytic activity;long-chain fatty acid-CoA ligase activity;very long-chain fatty acid-CoA ligase activity;long-chain fatty acid metabolic process;fatty acid transmembrane transporter activity;fatty acid transport;cytoplasm;membrane;nucleotide binding;lipid metabolic process;fatty acid metabolic process;plasma membrane;ligase activity;phosphatidylethanolamine biosynthetic process;lipid transport;phosphatidylglycerol biosynthetic process;protein binding;mitochondrion;mitochondrial inner membrane;endomembrane system;phosphatidylcholine biosynthetic process;phosphatidylinositol biosynthetic process;long-chain fatty acid import into cell;long-chain fatty acid transporter activity;phosphatidic acid biosynthetic process;phosphatidylserine biosynthetic process;regulation of lipid metabolic process;cardiolipin biosynthetic process;positive regulation of triglyceride biosynthetic process;response to cold;long-chain fatty acid transport;response to insulin;medium-chain fatty acid transport;positive regulation of heat generation;adiponectin-activated signaling pathway;negative regulation of phospholipid biosynthetic process;positive regulation of protein serine/threonine kinase activity;endoplasmic reticulum;integral component of plasma membrane	Alternative splicing;Cell membrane;Cytoplasm;Fatty acid metabolism;Ligase;Lipid metabolism;Lipid transport;Membrane;Nucleotide-binding;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-400206;R-HSA-382551;R-HSA-425407;R-HSA-425397;R-HSA-804914	Metabolism;Metabolism of lipids;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Transport of small molecules;SLC-mediated transmembrane transport;Transport of vitamins, nucleosides, and related molecules;Transport of fatty acids
COQ8B	positive	WRAP53	ENSG00000141499	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00013669	WBGene00013669(0)		Dyskeratosis congenita;DYSKERATOSIS CONGENITA AUTOSOMAL RECESSIVE 3;DYSKERATOSIS CONGENITA AUTOSOMAL RECESSIVE 3	GO:0003723;GO:0005634;GO:0005829;GO:0005654;GO:0005694;GO:0005515;GO:0006281;GO:0006974;GO:0016604;GO:0042802;GO:0000781;GO:0045739;GO:2001034;GO:0035861;GO:0031625;GO:0042393;GO:0051973;GO:0051087;GO:0070034;GO:0007004;GO:0005697;GO:0015030;GO:0090666;GO:1904851;GO:0030576;GO:1905168;GO:0044877;GO:2000781;GO:0032203;GO:0034337;GO:0090671;GO:1904867	protein binding;RNA binding;nucleus;nucleoplasm;cytosol;chromosome;DNA repair;cellular response to DNA damage stimulus;nuclear body;identical protein binding;chromosome, telomeric region;Cajal body;positive regulation of DNA repair;positive regulation of double-strand break repair via nonhomologous end joining;site of double-strand break;viral process;ubiquitin protein ligase binding;histone binding;positive regulation of telomerase activity;chaperone binding;telomerase RNA binding;telomere maintenance via telomerase;telomerase holoenzyme complex;scaRNA localization to Cajal body;positive regulation of establishment of protein localization to telomere;Cajal body organization;positive regulation of double-strand break repair via homologous recombination;protein-containing complex binding;positive regulation of double-strand break repair;telomere formation via telomerase;RNA folding;telomerase RNA localization to Cajal body;protein localization to Cajal body	Chaperone;Chromosome;DNA damage;DNA repair;Disease mutation;Dyskeratosis congenita;Host-virus interaction;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Repeat;Telomere;WD repeat	R-HSA-392499;R-HSA-1640170;R-HSA-390466;R-HSA-391251;R-HSA-73886;R-HSA-390471;R-HSA-157579;R-HSA-171319;R-HSA-180786	Metabolism of proteins;Cell Cycle;Chaperonin-mediated protein folding;Protein folding;Chromosome Maintenance;Association of TriC/CCT with target proteins during biosynthesis;Telomere Maintenance;Telomere Extension By Telomerase;Extension of Telomeres
COQ8B	positive	CAPN10	ENSG00000142330	COQ8B	1	COQ8B	1	0.00206380347814339		WBGene00006606(0);WBGene00010417(0);WBGene00013184(0);WBGene00012233(0);WBGene00009695(0);WBGene00000546(0);WBGene00000544(0);WBGene00000547(0);WBGene00000542(0)		Autosomal Recessive Mental Retardation;DIABETES MELLITUS NONINSULIN-DEPENDENT 1	GO:0046326;GO:0032869;GO:0016787;GO:0008233;GO:0008234;GO:0006508;GO:0004198;GO:0005737;GO:0005829;GO:0005886;GO:0032024;GO:0031532;GO:0005739;GO:0008092;GO:0097050;GO:0000149;GO:0006921;GO:0032388;GO:2000676;GO:0005622	proteolysis;calcium-dependent cysteine-type endopeptidase activity;cellular response to insulin stimulus;positive regulation of glucose import;hydrolase activity;peptidase activity;cysteine-type peptidase activity;cytoplasm;cytosol;plasma membrane;positive regulation of insulin secretion;actin cytoskeleton reorganization;mitochondrion;cytoskeletal protein binding;type B pancreatic cell apoptotic process;SNARE binding;cellular component disassembly involved in execution phase of apoptosis;positive regulation of intracellular transport;positive regulation of type B pancreatic cell apoptotic process	Alternative splicing;Diabetes mellitus;Hydrolase;Polymorphism;Protease;Reference proteome;Repeat;Thiol protease	R-HSA-1474228;R-HSA-1474244	Degradation of the extracellular matrix;Extracellular matrix organization
COQ8B	positive	SYTL1	ENSG00000142765	COQ8B	1	COQ8B	1	0.00206380347814339					GO:0005623;GO:0006886;GO:0006887;GO:0017137;GO:0016020;GO:0005886;GO:0042470;GO:0005515;GO:0070062;GO:0070382;GO:0019897;GO:0042043;GO:0031528	intracellular protein transport;exocytosis;Rab GTPase binding;membrane;plasma membrane;melanosome;protein binding;extracellular exosome;exocytic vesicle;extrinsic component of plasma membrane;neurexin family protein binding;microvillus membrane	Alternative splicing;Cell membrane;Exocytosis;Membrane;Phosphoprotein;Reference proteome;Repeat	R-HSA-5653656;R-HSA-199991;R-HSA-9007101;R-HSA-8854214	Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;TBC/RABGAPs
COQ8B	positive	TARS2	ENSG00000143374	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00006617			Combined oxidative phosphorylation defect type 21;Combined oxidative phosphorylation deficiency 21	GO:0005575;GO:0005737;GO:0006412;GO:0000166;GO:0005524;GO:0005739;GO:0005759;GO:0042803;GO:0016874;GO:0004812;GO:0006418;GO:0106074;GO:0043039;GO:0004829;GO:0006435;GO:0002161;GO:0070159	ATP binding;cytoplasm;aminoacyl-tRNA ligase activity;tRNA aminoacylation for protein translation;nucleotide binding;threonine-tRNA ligase activity;threonyl-tRNA aminoacylation;cellular_component;translation;mitochondrion;mitochondrial matrix;protein homodimerization activity;ligase activity;aminoacyl-tRNA metabolism involved in translational fidelity;tRNA aminoacylation;aminoacyl-tRNA editing activity;mitochondrial threonyl-tRNA aminoacylation	ATP-binding;Alternative splicing;Aminoacyl-tRNA synthetase;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Phosphoprotein;Primary mitochondrial disease;Protein biosynthesis;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-379724;R-HSA-379726	Metabolism of proteins;Translation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation
COQ8B	positive	RHPN1	ENSG00000158106	COQ8B	1	COQ8B	1	0.00206380347814339		WBGene00001215(0)			GO:0007165;GO:0005515;GO:0005829	protein binding;signal transduction;cytosol	Coiled coil;Phosphoprotein;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-195258;R-HSA-5666185	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Rhotekin and Rhophilins
COQ8B	positive	ALDH16A1	ENSG00000161618	COQ8B	1	COQ8B	1	0.00206380347814339		WBGene00000107(0);WBGene00000108(0);WBGene00000109(0)			GO:0016020;GO:0055114;GO:0016491;GO:0016620	oxidation-reduction process;oxidoreductase activity;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;membrane	Alternative splicing;Polymorphism;Reference proteome		
COQ8B	positive	JOSD2	ENSG00000161677	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00022190	WBGene00022190(1)			GO:0005737;GO:0004843;GO:0016579;GO:0016787;GO:0005829;GO:0005515;GO:0008233;GO:0006508;GO:0036459	protein deubiquitination;thiol-dependent ubiquitin-specific protease activity;cytoplasm;hydrolase activity;cytosol;protein binding;peptidase activity;proteolysis;thiol-dependent ubiquitinyl hydrolase activity	3D-structure;Alternative splicing;Cytoplasm;Hydrolase;Protease;Reference proteome;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689877	Metabolism of proteins;Post-translational protein modification;Deubiquitination;Josephin domain DUBs
COQ8B	positive	REEP4	ENSG00000168476	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00020562	WBGene00012180(0);WBGene00022127(0);WBGene00020562(0);WBGene00011401(0);WBGene00018930(0)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0051301;GO:0007049;GO:0005874;GO:0008017;GO:0006998;GO:0007084	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;cell division;cell cycle;microtubule;microtubule binding;nuclear envelope organization;mitotic nuclear envelope reassembly	Alternative splicing;Cell cycle;Cell division;Endoplasmic reticulum;Membrane;Microtubule;Mitosis;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-381753;R-HSA-418555	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Olfactory Signaling Pathway;G alpha (s) signalling events
COQ8B	positive	ZNHIT2	ENSG00000174276	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00009648	WBGene00009648(0)			GO:0046872;GO:0005515	metal ion binding;protein binding	3D-structure;Acetylation;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Zinc;Zinc-finger		
COQ8B	positive	ASPHD1	ENSG00000174939	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00010703	WBGene00010703(0)			GO:0018193;GO:0016020;GO:0016021;GO:0016491;GO:0055114;GO:0051213	peptidyl-amino acid modification;membrane;integral component of membrane;oxidoreductase activity;oxidation-reduction process;dioxygenase activity	Dioxygenase;Membrane;Oxidoreductase;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix		
COQ8B	positive	IFT140	ENSG00000187535	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00000490	WBGene00000490(0)		Jeune syndrome;Leber congenital amaurosis;Retinitis pigmentosa;Saldino-Mainzer syndrome;Mainzer-Saldino Syndrome;RETINITIS PIGMENTOSA 80;SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY	GO:0005737;GO:0005856;GO:0042995;GO:0005813;GO:0005815;GO:0005515;GO:0005929;GO:0036064;GO:0035735;GO:0060271;GO:0061512;GO:0097542;GO:0003674;GO:0030030;GO:1902017;GO:0005930;GO:0060041;GO:0042073;GO:0072001;GO:0048705;GO:0035721;GO:0030991;GO:0007368;GO:0007507;GO:0008589;GO:0021532;GO:0031076;GO:0035108;GO:0035845;GO:0042733;GO:0048701;GO:1905515;GO:1990403;GO:0001750;GO:0032391;GO:0097730	cytoplasm;cytoskeleton;cell projection;centrosome;microtubule organizing center;protein binding;cilium;ciliary basal body;intraciliary transport involved in cilium assembly;cilium assembly;protein localization to cilium;ciliary tip;molecular_function;cell projection organization;regulation of cilium assembly;axoneme;intraciliary transport;intraciliary retrograde transport;intraciliary transport particle A;determination of left/right symmetry;heart development;regulation of smoothened signaling pathway;neural tube patterning;embryonic camera-type eye development;limb morphogenesis;photoreceptor cell outer segment organization;embryonic digit morphogenesis;embryonic cranial skeleton morphogenesis;non-motile cilium assembly;embryonic brain development;photoreceptor outer segment;centriole;photoreceptor connecting cilium;non-motile cilium	Alternative splicing;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Disease mutation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Retinitis pigmentosa;TPR repeat;WD repeat	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-162582;R-HSA-5358351;R-HSA-5610787	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
COQ8B	positive	QTRT1	ENSG00000213339	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00006566	WBGene00006566(1)			GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0008033;GO:0016757;GO:0005739;GO:0042803;GO:0006400;GO:0005741;GO:0016763;GO:0032991;GO:0046982;GO:0008479;GO:0101030;GO:0005634	transferase activity, transferring pentosyl groups;tRNA modification;queuine tRNA-ribosyltransferase activity;tRNA-guanine transglycosylation;cytoplasm;membrane;metal ion binding;transferase activity;tRNA processing;transferase activity, transferring glycosyl groups;mitochondrion;protein homodimerization activity;mitochondrial outer membrane;protein-containing complex;protein heterodimerization activity;nucleus	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Glycosyltransferase;Membrane;Metal-binding;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Reference proteome;Transferase;Zinc;tRNA processing	R-HSA-6782315;R-HSA-72306;R-HSA-8953854	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
COQ8B	positive	MRM1	ENSG00000278619	COQ8B	1	COQ8B	1	0.00206380347814339	WBGene00012864	WBGene00012864(0)			GO:0003723;GO:0006396;GO:0016740;GO:0008168;GO:0032259;GO:0005739;GO:0005515;GO:0008173;GO:0006364;GO:0005759;GO:0070039;GO:0000451;GO:0001510	RNA binding;RNA processing;methyltransferase activity;RNA methyltransferase activity;transferase activity;methylation;mitochondrion;protein binding;rRNA processing;mitochondrial matrix;rRNA (guanosine-2'-O-)-methyltransferase activity;rRNA 2'-O-methylation;RNA methylation	Alternative splicing;Methyltransferase;Mitochondrion;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase;Transit peptide;rRNA processing	R-HSA-8953854;R-HSA-72312;R-HSA-8868766;R-HSA-6793080	Metabolism of RNA;rRNA processing;rRNA processing in the mitochondrion;rRNA modification in the mitochondrion
COQ8B	positive	BAIAP3	ENSG00000007516	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00018837	WBGene00018837(0)			GO:0005737;GO:0016020;GO:0098793;GO:0005794;GO:0005829;GO:0006887;GO:0005886;GO:0005509;GO:0005768;GO:0031902;GO:0005515;GO:0000149;GO:0001956;GO:0042147;GO:0055038;GO:0019905;GO:0005543;GO:0035774;GO:0007186;GO:0032588;GO:0032228;GO:1905413;GO:1990502	cytoplasm;membrane;endosome;Golgi apparatus;cytosol;exocytosis;plasma membrane;calcium ion binding;protein binding;presynapse;late endosome membrane;phospholipid binding;SNARE binding;positive regulation of neurotransmitter secretion;retrograde transport, endosome to Golgi;recycling endosome membrane;syntaxin binding;positive regulation of insulin secretion involved in cellular response to glucose stimulus;G protein-coupled receptor signaling pathway;trans-Golgi network membrane;regulation of synaptic transmission, GABAergic;regulation of dense core granule exocytosis;dense core granule maturation	Alternative splicing;Calcium;Cell membrane;Cytoplasm;Endosome;Exocytosis;Golgi apparatus;Membrane;Metal-binding;Polymorphism;Reference proteome;Repeat;Transport		
COQ8B	positive	PPP1R3F	ENSG00000049769	COQ8B	1	COQ8B	1	0.00312008935018515		WBGene00019211(0)			GO:0016020;GO:0016021;GO:0019903;GO:2001069;GO:0005979;GO:2000465;GO:0005515	membrane;integral component of membrane;protein phosphatase binding;glycogen binding;regulation of glycogen biosynthetic process;regulation of glycogen (starch) synthase activity;protein binding	Alternative splicing;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	positive	SPHK2	ENSG00000063176	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00007918	WBGene00020398(0);WBGene00007918(0)			GO:0005634;GO:0005737;GO:0016020;GO:0043231;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0043066;GO:0005783;GO:0005743;GO:0005739;GO:0005765;GO:0003951;GO:0000786;GO:0005829;GO:0046834;GO:0005764;GO:0003376;GO:0005515;GO:0008283;GO:0043065;GO:0030308;GO:0030148;GO:0090280;GO:0043122;GO:0045815;GO:0038036;GO:1903426;GO:0090037;GO:1990774;GO:0043306;GO:2001169;GO:1901726;GO:0072604;GO:0017016;GO:2000617;GO:1904628;GO:0046512;GO:0031064;GO:0006670;GO:1904959;GO:0031493;GO:0008481;GO:0017050;GO:0002374;GO:0006669;GO:0033008;GO:0043977;GO:0043980;GO:0072611;GO:2000304;GO:0001568;GO:0007420;GO:0007565;GO:0008284	kinase activity;NAD+ kinase activity;nucleus;cytoplasm;membrane;intracellular membrane-bounded organelle;nucleotide binding;ATP binding;transferase activity;phosphorylation;endoplasmic reticulum;mitochondrial inner membrane;mitochondrion;lysosomal membrane;nucleosome;cytosol;lipid phosphorylation;lysosome;protein binding;sphingosine-1-phosphate receptor signaling pathway;positive regulation of apoptotic process;negative regulation of cell growth;sphingosine metabolic process;sphingolipid biosynthetic process;positive regulation of calcium ion import;regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of gene expression, epigenetic;sphingosine-1-phosphate receptor activity;regulation of reactive oxygen species biosynthetic process;positive regulation of protein kinase C signaling;tumor necrosis factor secretion;positive regulation of mast cell degranulation;regulation of ATP biosynthetic process;negative regulation of histone deacetylase activity;interleukin-6 secretion;Ras GTPase binding;positive regulation of histone H3-K9 acetylation;cellular response to phorbol 13-acetate 12-myristate;sphingosine biosynthetic process;negative regulation of histone deacetylation;regulation of cytochrome-c oxidase activity;nucleosomal histone binding;sphinganine kinase activity;D-erythro-sphingosine kinase activity;cytokine secretion involved in immune response;sphinganine-1-phosphate biosynthetic process;positive regulation of mast cell activation involved in immune response;histone H2A-K5 acetylation;histone H2B-K12 acetylation;interleukin-13 secretion;positive regulation of ceramide biosynthetic process;blood vessel development;brain development;female pregnancy;positive regulation of cell population proliferation	ATP-binding;Alternative splicing;Cytoplasm;Endoplasmic reticulum;Kinase;Lysosome;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-1430728;R-HSA-428157;R-HSA-556833;R-HSA-1660661	Metabolism;Sphingolipid metabolism;Metabolism of lipids;Sphingolipid de novo biosynthesis
COQ8B	positive	TFAP4	ENSG00000090447	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00001955	WBGene00001955(0)	CDKN1A;SALL2		GO:0005634;GO:0046983;GO:0005739;GO:0003677;GO:0042803;GO:0005515;GO:0045893;GO:0043565;GO:0003700;GO:0006357;GO:0000981;GO:0000790;GO:0008285;GO:0071157;GO:0043065;GO:0044212;GO:0045736;GO:0045892;GO:0070888;GO:0065003;GO:1901990;GO:0042826;GO:0017053;GO:0006978;GO:0043392;GO:0043922;GO:0043923;GO:0000978;GO:0001228;GO:0010629;GO:0045944;GO:0071549;GO:2001269	protein dimerization activity;nucleus;nucleoplasm;mitochondrion;DNA binding;protein homodimerization activity;protein binding;positive regulation of transcription, DNA-templated;sequence-specific DNA binding;DNA-binding transcription factor activity;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;negative regulation of cell population proliferation;negative regulation of cell cycle arrest;positive regulation of apoptotic process;transcription regulatory region DNA binding;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of transcription, DNA-templated;E-box binding;protein-containing complex assembly;regulation of mitotic cell cycle phase transition;histone deacetylase binding;transcriptional repressor complex;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of DNA binding;negative regulation by host of viral transcription;positive regulation by host of viral transcription;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;negative regulation of gene expression;positive regulation of transcription by RNA polymerase II;cellular response to dexamethasone stimulus;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	Activator;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation		
COQ8B	positive	TRMT2A	ENSG00000099899	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00019241	WBGene00019241(1)			GO:0003676;GO:0003723;GO:0006396;GO:0016740;GO:0008168;GO:0032259;GO:0008173;GO:0001510	RNA processing;nucleic acid binding;RNA methyltransferase activity;RNA binding;transferase activity;methyltransferase activity;methylation;RNA methylation	Alternative splicing;Coiled coil;Methyltransferase;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase		
COQ8B	positive	KLHL22	ENSG00000099910	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0005634;GO:0005737;GO:0016567;GO:0051301;GO:0005829;GO:0005856;GO:0005515;GO:0007049;GO:0031463;GO:0005764;GO:0005813;GO:0005815;GO:0005819;GO:0072686;GO:0043687;GO:0006513;GO:0007094;GO:0005827;GO:0043161;GO:0030307;GO:0071889;GO:0000070;GO:0010507;GO:0071233;GO:1904263;GO:0071230	protein binding;cell division;Cul3-RING ubiquitin ligase complex;protein monoubiquitination;nucleus;cytoplasm;Golgi apparatus;protein ubiquitination;intercellular bridge;cytoskeleton;cytosol;microtubule cytoskeleton;cell cycle;mitotic spindle;lysosome;centrosome;microtubule organizing center;spindle;post-translational protein modification;mitotic spindle assembly checkpoint;polar microtubule;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of cell growth;14-3-3 protein binding;mitotic sister chromatid segregation;negative regulation of autophagy;positive regulation of TORC1 signaling;cellular response to leucine	Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Disease mutation;Kelch repeat;Lysosome;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-983168;R-HSA-983169;R-HSA-8951664	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
COQ8B	positive	CABIN1	ENSG00000099991	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0006336;GO:0005515;GO:0005634;GO:0005829;GO:0005654;GO:0006325;GO:0016235;GO:0032515;GO:0004864;GO:0031491;GO:0007166	protein binding;DNA replication-independent nucleosome assembly;nucleus;nucleoplasm;cytosol;chromatin organization;aggresome;negative regulation of phosphoprotein phosphatase activity;protein phosphatase inhibitor activity;cell surface receptor signaling pathway	3D-structure;Alternative splicing;Chromatin regulator;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;TPR repeat;Ubl conjugation	R-HSA-2262752;R-HSA-8953897;R-HSA-2559583;R-HSA-2559586;R-HSA-2559584	Cellular responses to stress;Cellular responses to external stimuli;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
COQ8B	positive	PICK1	ENSG00000100151	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00013317	WBGene00013317(1)		Male infertility due to globozoospermia	GO:0005737;GO:0016020;GO:0046872;GO:0005829;GO:0005739;GO:0003779;GO:0005794;GO:0005886;GO:0019904;GO:0005856;GO:0005515;GO:0016235;GO:0048471;GO:0030054;GO:0045202;GO:0045211;GO:0006886;GO:0043113;GO:0043005;GO:0051015;GO:0006890;GO:0014069;GO:0008022;GO:0005543;GO:0008021;GO:0005102;GO:0019899;GO:0006468;GO:0030666;GO:0042734;GO:0007205;GO:0032588;GO:0042149;GO:0005080;GO:0001664;GO:0043046;GO:0002092;GO:0098842;GO:0034316;GO:0021782;GO:0015844;GO:0060292;GO:0097061;GO:0071933;GO:0036294;GO:0042802;GO:0043045;GO:0045161;GO:0097062	protein binding;protein domain specific binding;cytoplasm;membrane;metal ion binding;cytosol;mitochondrion;actin binding;Golgi apparatus;cytoskeleton;plasma membrane;aggresome;perinuclear region of cytoplasm;cell junction;synapse;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;intracellular protein transport;receptor clustering;neuron projection;actin filament binding;postsynaptic density;protein C-terminus binding;phospholipid binding;synaptic vesicle;signaling receptor binding;enzyme binding;protein phosphorylation;endocytic vesicle membrane;presynaptic membrane;protein kinase C-activating G protein-coupled receptor signaling pathway;trans-Golgi network membrane;cellular response to glucose starvation;protein kinase C binding;G protein-coupled receptor binding;DNA methylation involved in gamete generation;Arp2/3 complex binding;positive regulation of receptor internalization;postsynaptic early endosome;negative regulation of Arp2/3 complex-mediated actin nucleation;glial cell development;membrane curvature sensor activity;regulation of Arp2/3 complex-mediated actin nucleation;monoamine transport;long-term synaptic depression;dendritic spine organization;cellular response to decreased oxygen levels;identical protein binding;DNA methylation involved in embryo development;neuronal ion channel clustering;regulation of insulin secretion;dendritic spine maintenance	3D-structure;Actin-binding;Alternative splicing;Calcium;Cell junction;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Metal-binding;Palmitate;Phosphoprotein;Reference proteome;Synapse;Synaptosome;Zinc	R-HSA-109582;R-HSA-202733;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-399719;R-HSA-399721;R-HSA-416993	Hemostasis;Cell surface interactions at the vascular wall;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
COQ8B	positive	MCAT	ENSG00000100294	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00016812	WBGene00016812(1)			GO:0003723;GO:0016740;GO:0005739;GO:0006629;GO:0006631;GO:0006633;GO:0005759;GO:0006635;GO:0004312;GO:0004314;GO:0016419	transferase activity;RNA binding;mitochondrion;lipid metabolic process;fatty acid metabolic process;fatty acid biosynthetic process;mitochondrial matrix;fatty acid beta-oxidation;fatty acid synthase activity;[acyl-carrier-protein] S-malonyltransferase activity;S-malonyltransferase activity	3D-structure;Alternative splicing;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Mitochondrion;Polymorphism;Reference proteome;Transferase;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation
COQ8B	positive	PORCN	ENSG00000102312	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00003394	WBGene00003394(0)		FOCAL DERMAL HYPOPLASIA;FOCAL DERMAL HYPOPLASIA;FOCAL DERMAL HYPOPLASIA	GO:0016020;GO:0016021;GO:0016740;GO:0005783;GO:0005789;GO:0016746;GO:0016055;GO:0006497;GO:1990698;GO:0045234;GO:0017147;GO:0009100;GO:0060070;GO:0099072;GO:0030176;GO:0032281;GO:0098978	membrane;integral component of membrane;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;transferase activity, transferring acyl groups;Wnt signaling pathway;protein lipidation;palmitoleoyltransferase activity;protein palmitoleylation;Wnt-protein binding;glycoprotein metabolic process;canonical Wnt signaling pathway;regulation of postsynaptic membrane neurotransmitter receptor levels;integral component of endoplasmic reticulum membrane;AMPA glutamate receptor complex;glutamatergic synapse	Acyltransferase;Alternative splicing;Disease mutation;Endoplasmic reticulum;Lipoprotein;Membrane;Palmitate;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Wnt signaling pathway	R-HSA-162582;R-HSA-1643685;R-HSA-195721;R-HSA-5663202;R-HSA-3238698;R-HSA-4791275;R-HSA-5340573	Signal Transduction;Disease;Signaling by WNT;Diseases of signal transduction;WNT ligand biogenesis and trafficking;Signaling by WNT in cancer;WNT ligand secretion is abrogated by the PORCN inhibitor LGK974
COQ8B	positive	TSNAXIP1	ENSG00000102904	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0005737;GO:0007275;GO:0048471;GO:0030154;GO:0007283;GO:0003674;GO:0008150;GO:0005575	cytoplasm;multicellular organism development;perinuclear region of cytoplasm;cell differentiation;spermatogenesis;molecular_function;biological_process;cellular_component	Alternative splicing;Coiled coil;Cytoplasm;Developmental protein;Differentiation;Reference proteome;Spermatogenesis		
COQ8B	positive	PEX11G	ENSG00000104883	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00004196	WBGene00004196(0)			GO:0016020;GO:0016021;GO:0005779;GO:0016559;GO:0005777;GO:0005778;GO:0005515;GO:0032991;GO:0044375;GO:0031231	integral component of peroxisomal membrane;peroxisome fission;membrane;integral component of membrane;peroxisome;peroxisomal membrane;protein binding;protein-containing complex;regulation of peroxisome size;intrinsic component of peroxisomal membrane	Alternative splicing;Membrane;Peroxisome;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	positive	CADM4	ENSG00000105767	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0016020;GO:0016021;GO:0007155;GO:0031252;GO:0042127;GO:0001933;GO:0001932;GO:0035020;GO:2000145;GO:0030948;GO:0044291;GO:1900747;GO:0061041;GO:0043184;GO:0010801;GO:0050732;GO:0019903;GO:0030971;GO:0043183	membrane;integral component of membrane;cell adhesion;cell leading edge;regulation of cell population proliferation;negative regulation of protein phosphorylation;regulation of protein phosphorylation;regulation of Rac protein signal transduction;regulation of cell motility;negative regulation of vascular endothelial growth factor receptor signaling pathway;cell-cell contact zone;negative regulation of vascular endothelial growth factor signaling pathway;regulation of wound healing;vascular endothelial growth factor receptor 2 binding;negative regulation of peptidyl-threonine phosphorylation;negative regulation of peptidyl-tyrosine phosphorylation;protein phosphatase binding;receptor tyrosine kinase binding;vascular endothelial growth factor receptor 1 binding	Cell adhesion;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix;Tumor suppressor		
COQ8B	positive	SLC22A18	ENSG00000110628	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00008273	WBGene00008273(0)		embryonal rhabdomyosarcoma;Hereditary breast cancer;Breast Cancer;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED;RHABDOMYOSARCOMA EMBRYONAL 1	GO:0005737;GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005887;GO:0015293;GO:0006811;GO:0005886;GO:0031625;GO:0016324;GO:1990961;GO:0005635;GO:0015695;GO:0007588;GO:0042908;GO:0005215	transmembrane transporter activity;transmembrane transport;cytoplasm;membrane;integral component of membrane;symporter activity;ion transport;plasma membrane;ubiquitin protein ligase binding;apical plasma membrane;xenobiotic detoxification by transmembrane export across the plasma membrane;nuclear envelope;organic cation transport;excretion;xenobiotic transport	Cell membrane;Disease mutation;Ion transport;Membrane;Polymorphism;Reference proteome;Symport;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-425407;R-HSA-1643685;R-HSA-5619115;R-HSA-5619102;R-HSA-425366;R-HSA-549127;R-HSA-549132;R-HSA-5619066	Transport of small molecules;SLC-mediated transmembrane transport;Disease;Disorders of transmembrane transporters;SLC transporter disorders;Transport of bile salts and organic acids, metal ions and amine compounds;Organic cation transport;Organic cation/anion/zwitterion transport;Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)
COQ8B	positive	PIGT	ENSG00000124155	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00008918	WBGene00008918(0)		Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome;MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3;MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0006506;GO:0005515;GO:0016255;GO:0042765;GO:0003923;GO:0030176;GO:0030182;GO:0051402;GO:0005737;GO:0031410	attachment of GPI anchor to protein;GPI-anchor transamidase complex;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;GPI anchor biosynthetic process;GPI-anchor transamidase activity;integral component of endoplasmic reticulum membrane;neuron differentiation;neuron apoptotic process;cytoplasm;cytoplasmic vesicle	Alternative splicing;Direct protein sequencing;Disease mutation;Disulfide bond;Endoplasmic reticulum;Epilepsy;GPI-anchor biosynthesis;Glycoprotein;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-163125;R-HSA-162791	Metabolism of proteins;Post-translational protein modification;Post-translational modification: synthesis of GPI-anchored proteins;Attachment of GPI anchor to uPAR
COQ8B	positive	PLD2	ENSG00000129219	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00004040	WBGene00004040(0)			GO:0016020;GO:0016787;GO:0098793;GO:0003824;GO:0006629;GO:0016042;GO:0005515;GO:0035091;GO:0038096;GO:0005886;GO:0005794;GO:0005789;GO:0007264;GO:0036465;GO:0004630;GO:0070290;GO:0006654;GO:0007010;GO:0048017;GO:0048870	catalytic activity;phosphatidylinositol binding;phospholipase D activity;phosphatidic acid biosynthetic process;inositol lipid-mediated signaling;membrane;hydrolase activity;lipid metabolic process;lipid catabolic process;protein binding;Fc-gamma receptor signaling pathway involved in phagocytosis;plasma membrane;presynapse;Golgi apparatus;endoplasmic reticulum membrane;small GTPase mediated signal transduction;synaptic vesicle recycling;N-acylphosphatidylethanolamine-specific phospholipase D activity;cytoskeleton organization;cell motility	Alternative splicing;Hydrolase;Lipid degradation;Lipid metabolism;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029485;R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1483148;R-HSA-1483166	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PG;Synthesis of PA
COQ8B	positive	FAM98C	ENSG00000130244	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00044326	WBGene00044326(0)			GO:0072669	tRNA-splicing ligase complex	Alternative splicing;Polymorphism;Reference proteome		
COQ8B	positive	CPLANE2	ENSG00000132881	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0005737;GO:0015031;GO:0000166;GO:0005654;GO:0003924;GO:0005525;GO:0006887;GO:0005856;GO:0042995;GO:0005515;GO:0005929;GO:0036064;GO:0060271;GO:0030030;GO:0034613;GO:0017157;GO:0031338	GTP binding;GTPase activity;cytoplasm;protein transport;nucleotide binding;nucleoplasm;cytoskeleton;exocytosis;cell projection;protein binding;cilium;ciliary basal body;cilium assembly;cell projection organization;cellular protein localization;regulation of exocytosis;regulation of vesicle fusion	Cell projection;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Exocytosis;GTP-binding;Nucleotide-binding;Polymorphism;Protein transport;Reference proteome;Transport		
COQ8B	positive	TCF25	ENSG00000141002	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00010620	WBGene00010620(0)			GO:0005634;GO:0003677;GO:0003700;GO:0005515;GO:0000122;GO:0007507	nucleus;DNA binding;DNA-binding transcription factor activity;protein binding;negative regulation of transcription by RNA polymerase II;heart development	DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ8B	positive	CBX8	ENSG00000141570	COQ8B	1	COQ8B	1	0.00312008935018515		WBGene00007615(0);WBGene00001995(0)			GO:0005634;GO:0005654;GO:0006325;GO:0000790;GO:0050790;GO:0005515;GO:0000122;GO:0031519;GO:0035102;GO:0035064;GO:0003727;GO:0097027;GO:0008284;GO:0016574;GO:0032967;GO:0045739;GO:0070301;GO:0000151;GO:0000792	nucleus;nucleoplasm;chromatin organization;nuclear chromatin;regulation of catalytic activity;protein binding;negative regulation of transcription by RNA polymerase II;PcG protein complex;PRC1 complex;methylated histone binding;single-stranded RNA binding;ubiquitin-protein transferase activator activity;positive regulation of cell population proliferation;histone ubiquitination;positive regulation of collagen biosynthetic process;positive regulation of DNA repair;cellular response to hydrogen peroxide;ubiquitin ligase complex;heterochromatin	3D-structure;Chromatin regulator;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1257604;R-HSA-2262752;R-HSA-6807070;R-HSA-8878171;R-HSA-8953897;R-HSA-9006925;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-4551638;R-HSA-4570464;R-HSA-2559580;R-HSA-2559583;R-HSA-3899300;R-HSA-4655427;R-HSA-8939243;R-HSA-8943724	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;PIP3 activates AKT signaling;Cellular responses to stress;PTEN Regulation;Transcriptional regulation by RUNX1;Cellular responses to external stimuli;Intracellular signaling by second messengers;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation of transcription cofactors;SUMOylation of DNA methylation proteins;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription
COQ8B	positive	MVB12A	ENSG00000141971	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00015508	WBGene00015508(0)			GO:0005794;GO:0005654;GO:0000813;GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0005829;GO:0005856;GO:0008289;GO:0005813;GO:0005815;GO:0005768;GO:0031902;GO:0005515;GO:0070062;GO:0016197;GO:0016236;GO:0019058;GO:0036258;GO:0039702;GO:0075733;GO:0010008;GO:0043657;GO:0017124;GO:0043130;GO:0031982;GO:0043162;GO:0042058;GO:0032801;GO:0046755;GO:0019075;GO:0032510	ESCRT I complex;Golgi apparatus;nucleoplasm;nucleus;cytoplasm;membrane;protein transport;endosome;cytoskeleton;cytosol;lipid binding;centrosome;microtubule organizing center;protein binding;late endosome membrane;extracellular exosome;endosomal transport;macroautophagy;viral life cycle;multivesicular body assembly;viral budding via host ESCRT complex;intracellular transport of virus;endosome membrane;host cell;SH3 domain binding;ubiquitin binding;vesicle;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;regulation of epidermal growth factor receptor signaling pathway;receptor catabolic process;viral budding;virus maturation;endosome to lysosome transport via multivesicular body sorting pathway	Alternative splicing;Cytoplasm;Cytoskeleton;Endosome;Membrane;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;SH3-binding;Transport	R-HSA-5653656;R-HSA-199991;R-HSA-1643685;R-HSA-162587;R-HSA-162588;R-HSA-162599;R-HSA-162906;R-HSA-174490;R-HSA-174495;R-HSA-175474;R-HSA-5663205;R-HSA-917729;R-HSA-9612973;R-HSA-9615710	Vesicle-mediated transport;Membrane Trafficking;Disease;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);Autophagy;Late endosomal microautophagy
COQ8B	positive	ST14	ENSG00000149418	COQ8B	1	COQ8B	1	0.00312008935018515				Ichthyosis-hypotrichosis syndrome;ichthyosis autosomal recessive with hypotrichosis;ICHTHYOSIS CONGENITAL AUTOSOMAL RECESSIVE 11	GO:0016020;GO:0016021;GO:0016787;GO:0008233;GO:0006508;GO:0004252;GO:0008236;GO:0005886;GO:0005887;GO:0030216;GO:0070268;GO:0001843;GO:0060672;GO:0005576;GO:0005615;GO:0016323;GO:0019897;GO:0005515	protein binding;membrane;proteolysis;serine-type endopeptidase activity;integral component of membrane;hydrolase activity;peptidase activity;serine-type peptidase activity;plasma membrane;integral component of plasma membrane;keratinocyte differentiation;cornification;neural tube closure;epithelial cell morphogenesis involved in placental branching;extracellular region;extracellular space;basolateral plasma membrane;extrinsic component of plasma membrane	3D-structure;Disease mutation;Disulfide bond;Glycoprotein;Hydrolase;Hypotrichosis;Ichthyosis;Membrane;Polymorphism;Protease;Reference proteome;Repeat;Serine protease;Signal-anchor;Transmembrane;Transmembrane helix	R-HSA-1266738;R-HSA-6805567;R-HSA-6809371	Developmental Biology;Keratinization;Formation of the cornified envelope
COQ8B	positive	NMRAL1	ENSG00000153406	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0005634;GO:0005737;GO:0005515;GO:0048471;GO:0042802;GO:0005829;GO:0000050	nucleus;cytoplasm;nucleoplasm;protein binding;perinuclear region of cytoplasm;identical protein binding;cytosol;urea cycle	3D-structure;Cytoplasm;NADP;Nucleus;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-71291;R-HSA-70635	Metabolism;Metabolism of amino acids and derivatives;Urea cycle
COQ8B	positive	RECQL4	ENSG00000160957	COQ8B	1	COQ8B	1	0.00312008935018515				Baller-Gerold syndrome;RAPADILINO SYNDROME;Rothmund-Thomson syndrome type 2;Baller-Gerold syndrome;RAPADILINO SYNDROME;ROTHMUND-THOMSON SYNDROME;Baller-Gerold syndrome;RAPADILINO SYNDROME;ROTHMUND-THOMSON SYNDROME	GO:0003676;GO:0005524;GO:0004386;GO:0006310;GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0016787;GO:0005515;GO:0006260;GO:0003678;GO:0006281;GO:0032508;GO:0007275;GO:0000781;GO:0000724;GO:0000723;GO:0000405;GO:0009378;GO:0032357;GO:0036310;GO:0043138;GO:0061821;GO:0000733;GO:0006268;GO:0061820;GO:0005694	ATP binding;nucleic acid binding;DNA recombination;helicase activity;nucleus;cytoplasm;membrane;nucleotide binding;hydrolase activity;protein binding;DNA replication;DNA helicase activity;DNA repair;multicellular organism development;chromosome, telomeric region;double-strand break repair via homologous recombination;telomere maintenance;DNA duplex unwinding;bubble DNA binding;four-way junction helicase activity;oxidized purine DNA binding;annealing helicase activity;3'-5' DNA helicase activity;telomeric D-loop binding;DNA strand renaturation;DNA unwinding involved in DNA replication;telomeric D-loop disassembly;chromosome	3D-structure;ATP-binding;Cataract;Craniosynostosis;Cytoplasm;Disease mutation;Dwarfism;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	CDK5	ENSG00000164885	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00000407;WBGene00000405	WBGene00019362(0)		LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA	GO:1904646;GO:0005737;GO:0051966;GO:0005634;GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0005886;GO:0051301;GO:0030054;GO:0042995;GO:0005515;GO:0007049;GO:0048511;GO:0006915;GO:0045202;GO:0045211;GO:0030425;GO:0007399;GO:0002039;GO:0004693;GO:0005176;GO:0008092;GO:0019901;GO:0030549;GO:0043125;GO:0046875;GO:0050321;GO:0051879;GO:0099635;GO:0001764;GO:0001934;GO:0001963;GO:0006886;GO:0006887;GO:0006913;GO:0007005;GO:0007160;GO:0007409;GO:0007416;GO:0007519;GO:0008045;GO:0008306;GO:0008542;GO:0009611;GO:0014044;GO:0016477;GO:0016572;GO:0018105;GO:0018107;GO:0019233;GO:0021537;GO:0021549;GO:0021695;GO:0021697;GO:0021766;GO:0021819;GO:0021954;GO:0021987;GO:0022038;GO:0030182;GO:0030334;GO:0030517;GO:0030866;GO:0030900;GO:0031175;GO:0031397;GO:0031914;GO:0032092;GO:0032801;GO:0034352;GO:0035249;GO:0035418;GO:0042220;GO:0042501;GO:0043113;GO:0043525;GO:0045055;GO:0045786;GO:0045860;GO:0045956;GO:0046777;GO:0046826;GO:0048148;GO:0048167;GO:0048488;GO:0048812;GO:0048813;GO:0051402;GO:0060078;GO:0060079;GO:0061001;GO:0070509;GO:0090314;GO:0098883;GO:0099533;GO:0099601;GO:0099703;GO:1901216;GO:1901387;GO:1903076;GO:0005856;GO:0005874;GO:0014069;GO:0016533;GO:0030027;GO:0030175;GO:0030424;GO:0030426;GO:0031594;GO:0043005;GO:0043025;GO:0098685;GO:0098793;GO:0098794;GO:0098978;GO:0005654;GO:0043204;GO:0007268;GO:0000226;GO:0042981;GO:1901796;GO:0048156;GO:0016241;GO:1901215;GO:0048489;GO:0016079;GO:2000251;GO:0048675;GO:0048709;GO:0071156;GO:1903421;GO:0045861;GO:0045892	ATP binding;protein phosphorylation;protein kinase activity;cellular response to amyloid-beta;cytoplasm;regulation of synaptic transmission, glutamatergic;cell;nucleus;membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;plasma membrane;cell division;cell projection;protein binding;cell cycle;rhythmic process;apoptotic process;cell junction;synapse;dendrite;nervous system development;p53 binding;cyclin-dependent protein serine/threonine kinase activity;ErbB-2 class receptor binding;cytoskeletal protein binding;protein kinase binding;acetylcholine receptor activator activity;ErbB-3 class receptor binding;ephrin receptor binding;tau-protein kinase activity;Hsp90 protein binding;voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels;neuron migration;positive regulation of protein phosphorylation;synaptic transmission, dopaminergic;intracellular protein transport;exocytosis;nucleocytoplasmic transport;mitochondrion organization;cell-matrix adhesion;axonogenesis;synapse assembly;skeletal muscle tissue development;motor neuron axon guidance;associative learning;visual learning;response to wounding;Schwann cell development;cell migration;histone phosphorylation;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;sensory perception of pain;telencephalon development;cerebellum development;cerebellar cortex development;cerebellar cortex formation;hippocampus development;layer formation in cerebral cortex;central nervous system neuron development;cerebral cortex development;corpus callosum development;neuron differentiation;regulation of cell migration;negative regulation of axon extension;cortical actin cytoskeleton organization;forebrain development;neuron projection development;negative regulation of protein ubiquitination;negative regulation of synaptic plasticity;positive regulation of protein binding;receptor catabolic process;positive regulation of glial cell apoptotic process;synaptic transmission, glutamatergic;protein localization to synapse;response to cocaine;serine phosphorylation of STAT protein;receptor clustering;positive regulation of neuron apoptotic process;regulated exocytosis;negative regulation of cell cycle;positive regulation of protein kinase activity;positive regulation of calcium ion-dependent exocytosis;protein autophosphorylation;negative regulation of protein export from nucleus;behavioral response to cocaine;regulation of synaptic plasticity;synaptic vesicle endocytosis;neuron projection morphogenesis;dendrite morphogenesis;neuron apoptotic process;regulation of postsynaptic membrane potential;excitatory postsynaptic potential;regulation of dendritic spine morphogenesis;calcium ion import;positive regulation of protein targeting to membrane;synapse pruning;positive regulation of presynaptic cytosolic calcium concentration;regulation of neurotransmitter receptor activity;induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration;positive regulation of neuron death;positive regulation of voltage-gated calcium channel activity;regulation of protein localization to plasma membrane;cytosol;cytoskeleton;microtubule;postsynaptic density;protein kinase 5 complex;lamellipodium;filopodium;axon;growth cone;neuromuscular junction;neuron projection;neuronal cell body;Schaffer collateral - CA1 synapse;presynapse;postsynapse;glutamatergic synapse;perikaryon;chemical synaptic transmission;microtubule cytoskeleton organization;regulation of apoptotic process;regulation of signal transduction by p53 class mediator;tau protein binding;regulation of macroautophagy;negative regulation of neuron death;synaptic vesicle transport;synaptic vesicle exocytosis;oligodendrocyte differentiation;positive regulation of actin cytoskeleton reorganization;axon extension;regulation of cell cycle arrest;regulation of synaptic vesicle recycling;negative regulation of proteolysis;negative regulation of transcription, DNA-templated	3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Biological rhythms;Cell cycle;Cell division;Cell junction;Cell membrane;Cell projection;Cytoplasm;Kinase;Lissencephaly;Membrane;Neurodegeneration;Neurogenesis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Synapse;Transferase	R-HSA-109582;R-HSA-1266738;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-422475;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-1643685;R-HSA-418594;R-HSA-983231;R-HSA-9006934;R-HSA-111885;R-HSA-5633007;R-HSA-6804756;R-HSA-166520;R-HSA-373755;R-HSA-399956;R-HSA-8862803;R-HSA-8863678;R-HSA-9006115;R-HSA-180024;R-HSA-9032845	Hemostasis;Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Axon guidance;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Disease;G alpha (i) signalling events;Factors involved in megakaryocyte development and platelet production;Signaling by Receptor Tyrosine Kinases;Opioid Signalling;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Signaling by NTRKs;Semaphorin interactions;CRMPs in Sema3A signaling;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Signaling by NTRK2 (TRKB);DARPP-32 events;Activated NTRK2 signals through CDK5
COQ8B	positive	HSD11B1L	ENSG00000167733	COQ8B	1	COQ8B	1	0.00312008935018515		WBGene00000993(0);WBGene00219274(0);WBGene00000975(0);WBGene00011424(0);WBGene00000981(0);WBGene00000970(0);WBGene00008986(0);WBGene00008985(0);WBGene00022809(0)			GO:0043231;GO:0005654;GO:0016491;GO:0055114;GO:0005576	oxidoreductase activity;intracellular membrane-bounded organelle;nucleoplasm;oxidation-reduction process;extracellular region	Alternative splicing;NADP;Oxidoreductase;Reference proteome;Secreted;Signal		
COQ8B	positive	APEX2	ENSG00000169188	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00001372				GO:0005634;GO:0005737;GO:0043231;GO:0008270;GO:0046872;GO:0016787;GO:0003677;GO:0016829;GO:0005739;GO:0001650;GO:0004519;GO:0006281;GO:0090305;GO:0006310;GO:0006974;GO:0007049;GO:0004518;GO:0004527;GO:0140078;GO:0006284;GO:0003906;GO:0004528;GO:0008311;GO:0005622	DNA binding;zinc ion binding;DNA repair;endonuclease activity;nuclease activity;nucleus;cytoplasm;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;fibrillar center;hydrolase activity;lyase activity;mitochondrion;nucleic acid phosphodiester bond hydrolysis;DNA recombination;cellular response to DNA damage stimulus;cell cycle;exonuclease activity;class I DNA-(apurinic or apyrimidinic site) endonuclease activity;base-excision repair;DNA-(apurinic or apyrimidinic site) endonuclease activity;phosphodiesterase I activity;double-stranded DNA 3'-5' exodeoxyribonuclease activity	Cell cycle;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Endonuclease;Exonuclease;Hydrolase;Lyase;Magnesium;Metal-binding;Mitochondrion;Nuclease;Nucleus;Polymorphism;Reference proteome;Zinc;Zinc-finger		
COQ8B	positive	LRRC45	ENSG00000169683	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0005737;GO:0005813;GO:0005829;GO:0005654;GO:0005886;GO:0005856;GO:0005515;GO:0005815	protein binding;cytoplasm;nucleoplasm;cytosol;plasma membrane;cytoskeleton;centrosome;microtubule organizing center	Coiled coil;Cytoplasm;Cytoskeleton;Leucine-rich repeat;Phosphoprotein;Reference proteome;Repeat		
COQ8B	positive	TSEN34	ENSG00000170892	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00019535	WBGene00019535(0)		Pontocerebellar hypoplasia type 2;Pontocerebellar Hypoplasia Type 2 and Type 4;PONTOCEREBELLAR HYPOPLASIA TYPE 2C	GO:0005634;GO:0000213;GO:0090501;GO:0090502;GO:0000214;GO:0000379;GO:0003676;GO:0090305;GO:0004518;GO:0006388;GO:0006397;GO:0008033;GO:0016829;GO:0004519;GO:0005730;GO:0005654	tRNA-intron endonuclease activity;tRNA-intron endonuclease complex;tRNA-type intron splice site recognition and cleavage;nucleoplasm;RNA phosphodiester bond hydrolysis;RNA phosphodiester bond hydrolysis, endonucleolytic;nucleic acid binding;nuclease activity;tRNA splicing, via endonucleolytic cleavage and ligation;nucleic acid phosphodiester bond hydrolysis;mRNA processing;nucleus;tRNA processing;lyase activity;endonuclease activity;nucleolus	Disease mutation;Lyase;Neurodegeneration;Nucleus;Polymorphism;Pontocerebellar hypoplasia;Reference proteome;mRNA processing;tRNA processing	R-HSA-72306;R-HSA-8953854;R-HSA-6784531	tRNA processing;Metabolism of RNA;tRNA processing in the nucleus
COQ8B	positive	ADCK5	ENSG00000173137	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00008410				GO:0016020;GO:0016021;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0006468;GO:0005515	membrane;integral component of membrane;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;protein phosphorylation;protein binding	Kinase;Membrane;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Transmembrane;Transmembrane helix		
COQ8B	positive	SPTBN2	ENSG00000173898	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00006803;WBGene00004855;WBGene00004951			Spectrin-associated autosomal recessive cerebellar ataxia;Spinocerebellar ataxia type 5;Infantile ataxia with oculomotor and pyramidal signs;SCA14;SPINOCEREBELLAR ATAXIA 5;Spinocerebellar ataxia autosomal recessive 14	GO:0005737;GO:0005829;GO:0003779;GO:0005615;GO:0051693;GO:0030054;GO:0005856;GO:0005200;GO:0007010;GO:0005543;GO:0008091;GO:0016192;GO:0045296;GO:0005938;GO:0000165;GO:0019886;GO:0007411;GO:0006888;GO:0098918;GO:0007416;GO:0021692;GO:0030534;GO:0035264;GO:0099173;GO:0016324;GO:0043025;GO:0098688;GO:0098793;GO:0098978;GO:0099189;GO:0005515	protein binding;phospholipid binding;actin binding;structural constituent of cytoskeleton;spectrin;cytoplasm;cytosol;cytoskeleton;extracellular space;cell junction;cytoskeleton organization;vesicle-mediated transport;actin filament capping;cadherin binding;cell cortex;MAPK cascade;antigen processing and presentation of exogenous peptide antigen via MHC class II;axon guidance;endoplasmic reticulum to Golgi vesicle-mediated transport;structural constituent of synapse;synapse assembly;cerebellar Purkinje cell layer morphogenesis;adult behavior;multicellular organism growth;postsynapse organization;apical plasma membrane;neuronal cell body;parallel fiber to Purkinje cell synapse;presynapse;glutamatergic synapse;postsynaptic spectrin-associated cytoskeleton	3D-structure;Acetylation;Actin capping;Actin-binding;Alternative splicing;Cytoplasm;Cytoskeleton;Disease mutation;Neurodegeneration;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Spinocerebellar ataxia	R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-373760;R-HSA-422475;R-HSA-162582;R-HSA-199991;R-HSA-446203;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-199977;R-HSA-2132295;R-HSA-6807878;R-HSA-948021;R-HSA-375165;R-HSA-445095	Adaptive Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;Metabolism of proteins;Post-translational protein modification;L1CAM interactions;Axon guidance;Signal Transduction;Membrane Trafficking;Asparagine N-linked glycosylation;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;ER to Golgi Anterograde Transport;MHC class II antigen presentation;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;NCAM signaling for neurite out-growth;Interaction between L1 and Ankyrins
COQ8B	positive	MICOS13	ENSG00000174917	COQ8B	1	COQ8B	1	0.00312008935018515				3-Methylglutaconic aciduria type 3;Combined oxidative phosphorylation deficiency 37	GO:0005654;GO:0005739;GO:0005743;GO:0061617;GO:0016020;GO:0016021;GO:0042407;GO:0044284	nucleoplasm;mitochondrion;mitochondrial inner membrane;MICOS complex;membrane;integral component of membrane;inner mitochondrial membrane organization;SAM complex;MIB complex;cristae formation;mitochondrial crista junction	Membrane;Mitochondrion;Mitochondrion inner membrane;Primary mitochondrial disease;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1852241;R-HSA-1592230;R-HSA-8949613	Organelle biogenesis and maintenance;Mitochondrial biogenesis;Cristae formation
COQ8B	positive	CCDC57	ENSG00000176155	COQ8B	1	COQ8B	1	0.00312008935018515		WBGene00015188(0)			GO:0005515	protein binding	Alternative splicing;Coiled coil;Polymorphism;Reference proteome		
COQ8B	positive	MYPOP	ENSG00000176182	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0005634;GO:0003677;GO:0000978;GO:0000981;GO:0001227;GO:0003700;GO:0042803;GO:0000122;GO:0006357	nucleus;DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;identical protein binding;negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II	DNA-binding;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ8B	positive	RABEP2	ENSG00000177548	COQ8B	1	COQ8B	1	0.00312008935018515		WBGene00017161(0)			GO:0005737;GO:0015031;GO:0043231;GO:0005829;GO:0006897;GO:0008083;GO:0007165;GO:0005096;GO:0043547;GO:0005856;GO:0042995;GO:0005813;GO:0005815;GO:0005768;GO:0005769;GO:0005515;GO:0036064;GO:0030030;GO:1902017	growth factor activity;GTPase activator activity;endocytosis;cytoplasm;protein transport;intracellular membrane-bounded organelle;cytosol;endosome;signal transduction;cytoskeleton;positive regulation of GTPase activity;cell projection;protein binding;centrosome;microtubule organizing center;early endosome;ciliary basal body;cell projection organization;regulation of cilium assembly	Acetylation;Alternative splicing;Cell projection;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Endocytosis;Endosome;Phosphoprotein;Protein transport;Reference proteome;Transport		
COQ8B	positive	CHID1	ENSG00000177830	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00016642;WBGene00019980	WBGene00019980(0)			GO:0005975;GO:0005634;GO:0016020;GO:0005615;GO:0005576;GO:0008061;GO:0002376;GO:0045087;GO:0005764;GO:0005515;GO:0070062;GO:0005802;GO:0005770;GO:0002576;GO:0043202;GO:1900016;GO:0070492	carbohydrate metabolic process;chitin binding;nucleus;membrane;extracellular space;extracellular region;immune system process;innate immune response;lysosome;protein binding;extracellular exosome;trans-Golgi network;late endosome;platelet degranulation;lysosomal lumen;negative regulation of cytokine production involved in inflammatory response;oligosaccharide binding	3D-structure;Alternative splicing;Immunity;Innate immunity;Lysosome;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-109582;R-HSA-76002;R-HSA-76005;R-HSA-114608	Hemostasis;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation 
COQ8B	positive	HIST3H2A	ENSG00000181218	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00001909;WBGene00001931;WBGene00001877;WBGene00001881;WBGene00001886;WBGene00001890;WBGene00001893;WBGene00001895;WBGene00001904;WBGene00001907;WBGene00001917;WBGene00001921;WBGene00001925;WBGene00001927;WBGene00001935;WBGene00001939;WBGene00001942;WBGene00014240				GO:0005634;GO:0003677;GO:0046982;GO:0000786;GO:0005694;GO:0005515;GO:0000790;GO:0006325;GO:0070062;GO:0006337;GO:0000788;GO:0070914	DNA binding;nucleosome;protein heterodimerization activity;nucleus;chromosome;protein binding;nuclear chromatin;chromatin organization;chromatin silencing;extracellular exosome;nucleosome disassembly;nuclear nucleosome;UV-damage excision repair	Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Isopeptide bond;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-3214815;R-HSA-3247509;R-HSA-4839726;R-HSA-5689901;R-HSA-3214858;R-HSA-3214847	Metabolism of proteins;Post-translational protein modification;Deubiquitination;UCH proteinases;Ub-specific processing proteases;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;Metalloprotease DUBs;RMTs methylate histone arginines;HATs acetylate histones
COQ8B	positive	FAAP100	ENSG00000185504	COQ8B	1	COQ8B	1	0.00312008935018515					GO:0036297;GO:0043240;GO:0005634;GO:0005829;GO:0005654;GO:0003677;GO:0045111;GO:0005515;GO:0006281;GO:0006974	interstrand cross-link repair;Fanconi anaemia nuclear complex;nucleus;nucleoplasm;DNA binding;protein binding;DNA repair;cellular response to DNA damage stimulus	Alternative splicing;DNA damage;DNA repair;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-6783310;R-HSA-73894	Fanconi Anemia Pathway;DNA Repair
COQ8B	positive	CCDC151	ENSG00000198003	COQ8B	1	COQ8B	1	0.00312008935018515				Primary ciliary dyskinesia;Primary cillary dyskineasia;Ciliary dyskinesia primary 30	GO:0005737;GO:0005856;GO:0042995;GO:0005515;GO:0005929;GO:0070286;GO:0003341;GO:0036064;GO:0030030;GO:0005814;GO:0007368;GO:0036158;GO:1902017;GO:0005930	cilium movement;cilium;axonemal dynein complex assembly;cytoplasm;cytoskeleton;cell projection;protein binding;ciliary basal body;cell projection organization;centriole;determination of left/right symmetry;outer dynein arm assembly;regulation of cilium assembly;axoneme	Alternative splicing;Cell projection;Ciliopathy;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Kartagener syndrome;Polymorphism;Primary ciliary dyskinesia;Reference proteome		
COQ8B	positive	DENND6B	ENSG00000205593	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00018777	WBGene00018777(1)			GO:0005737;GO:0005085;GO:0005768;GO:0017112;GO:0005829;GO:0055037	Rab guanyl-nucleotide exchange factor activity;cytoplasm;endosome;guanyl-nucleotide exchange factor activity;cytosol;recycling endosome	Cytoplasm;Endosome;Guanine-nucleotide releasing factor;Reference proteome	R-HSA-5653656;R-HSA-199991;R-HSA-8876198;R-HSA-9007101	Vesicle-mediated transport;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
COQ8B	positive	MPV17L2	ENSG00000254858	COQ8B	1	COQ8B	1	0.00312008935018515	WBGene00022744	WBGene00022744(1)			GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0005737;GO:0005762;GO:0070131;GO:0061668	integral component of membrane;membrane;mitochondrial inner membrane;mitochondrion;cytoplasm;mitochondrial large ribosomal subunit;positive regulation of mitochondrial translation;mitochondrial ribosome assembly	Alternative splicing;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	positive	PNKP	ENSG00000039650	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00009010	WBGene00009010(1)		Ataxia-oculomotor apraxia type 4;Early infantile epileptic encephalopathy;ATAXIA-OCULOMOTOR APRAXIA 4;Epileptic encephalopathy early infantile 10;ATAXIA-OCULOMOTOR APRAXIA 4;MICROCEPHALY SEIZURES AND DEVELOPMENTAL DELAY	GO:0005634;GO:0005730;GO:0006281;GO:0016310;GO:0046403;GO:0046404;GO:0098504;GO:0098506;GO:0005515;GO:0016020;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016787;GO:0090305;GO:0003824;GO:0008152;GO:0006974;GO:0004519;GO:0046940;GO:0005654;GO:0016311;GO:0003690;GO:0051734;GO:0006979;GO:0006261;GO:0032212;GO:0051973;GO:1904355;GO:0003684;GO:0009314;GO:0042769;GO:0010836;GO:0050145;GO:0017076;GO:0000718;GO:0046939;GO:0005739	protein binding;DNA repair;polynucleotide 3'-phosphatase activity;ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity;obsolete DNA 3' dephosphorylation involved in DNA repair;nucleoplasm;nucleolus;phosphorylation;polynucleotide 3' dephosphorylation;nucleus;membrane;nucleotide binding;ATP binding;kinase activity;transferase activity;hydrolase activity;nucleic acid phosphodiester bond hydrolysis;catalytic activity;metabolic process;cellular response to DNA damage stimulus;endonuclease activity;nucleoside monophosphate phosphorylation;dephosphorylation;double-stranded DNA binding;ATP-dependent polynucleotide kinase activity;response to oxidative stress;DNA-dependent DNA replication;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;positive regulation of telomere capping;damaged DNA binding;response to radiation;DNA damage response, detection of DNA damage;negative regulation of protein ADP-ribosylation;nucleoside monophosphate kinase activity;purine nucleotide binding;nucleotide-excision repair, DNA damage removal;nucleotide phosphorylation;positive regulation of double-strand break repair via nonhomologous end joining;mitochondrion	3D-structure;ATP-binding;Acetylation;Alternative splicing;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Epilepsy;Hydrolase;Kinase;Mental retardation;Multifunctional enzyme;Neurodegeneration;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Primary microcephaly;Reference proteome;Transferase	R-HSA-73894;R-HSA-5649702;R-HSA-73884;R-HSA-73933	DNA Repair;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;Base Excision Repair;Resolution of Abasic Sites (AP sites)
COQ8B	positive	FLYWCH1	ENSG00000059122	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0005634;GO:0046872;GO:0005829;GO:0005654;GO:0003677;GO:0016604	nucleus;metal ion binding;nucleoplasm;cytosol;DNA binding;nuclear body	3D-structure;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger		
COQ8B	positive	NLE1	ENSG00000073536	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00021074	WBGene00021074(1)			GO:0005634;GO:0005730;GO:0007219;GO:0000027;GO:0005515;GO:0001756;GO:0001822;GO:0001826;GO:0042273;GO:0045930;GO:0048705;GO:0061484;GO:0090263;GO:2001268	protein binding;nucleus;nucleoplasm;nucleolus;Notch signaling pathway;ribosomal large subunit assembly;somitogenesis;kidney development;inner cell mass cell differentiation;ribosomal large subunit biogenesis;negative regulation of mitotic cell cycle;skeletal system morphogenesis;hematopoietic stem cell homeostasis;positive regulation of canonical Wnt signaling pathway;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	Acetylation;Alternative splicing;Direct protein sequencing;Notch signaling pathway;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat		
COQ8B	positive	MRPL28	ENSG00000086504	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00020796	WBGene00020796(1)			GO:0003723;GO:0006412;GO:0005829;GO:0005739;GO:0003735;GO:0005840;GO:0005515;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005761	structural constituent of ribosome;RNA binding;translation;cytosol;mitochondrion;ribosome;protein binding;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome	3D-structure;Mitochondrion;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ8B	positive	OCEL1	ENSG00000099330	COQ8B	1	COQ8B	1	0.00464042313833413		WBGene00021281(0)			GO:0016020;GO:0016021	membrane;integral component of membrane	Polymorphism;Reference proteome		
COQ8B	positive	TXN2	ENSG00000100348	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00007099;WBGene00015062;WBGene00021548;WBGene00021933	WBGene00007099(1)		Combined oxidative phosphorylation defect type 29;Combined oxidative phosphorylation deficiency 29	GO:0005730;GO:0055114;GO:0005739;GO:0045454;GO:0005515;GO:0015035;GO:0005759;GO:0006662;GO:0000098;GO:0008113;GO:0033743;GO:0044877;GO:0001666;GO:0006979;GO:0009725;GO:0009749;GO:0014070;GO:0031669;GO:0042493;GO:0048678;GO:0030425;GO:0043025;GO:0005623	protein disulfide oxidoreductase activity;cell redox homeostasis;glycerol ether metabolic process;cell;nucleolus;oxidation-reduction process;mitochondrion;protein binding;mitochondrial matrix;sulfur amino acid catabolic process;peptide-methionine (S)-S-oxide reductase activity;peptide-methionine (R)-S-oxide reductase activity;protein-containing complex binding;response to hypoxia;response to oxidative stress;response to hormone;response to glucose;response to organic cyclic compound;cellular response to nutrient levels;response to drug;response to axon injury;dendrite;neuronal cell body	3D-structure;Acetylation;Direct protein sequencing;Disulfide bond;Electron transport;Mitochondrion;Neurodegeneration;Primary mitochondrial disease;Redox-active center;Reference proteome;Transit peptide;Transport	R-HSA-1430728;R-HSA-71291;R-HSA-2262752;R-HSA-8953897;R-HSA-3299685;R-HSA-1614558;R-HSA-1614635	Metabolism;Metabolism of amino acids and derivatives;Cellular responses to stress;Cellular responses to external stimuli;Detoxification of Reactive Oxygen Species;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism
COQ8B	positive	ZNF500	ENSG00000103199	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00013970;WBGene00000483				GO:0003676;GO:0005634;GO:0046872;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005622	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;cytosol;DNA binding	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ8B	positive	CIAO3	ENSG00000103245	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00021902				GO:0046872;GO:0051536;GO:0051539;GO:0016226;GO:0005515;GO:0097361;GO:0010468;GO:0001666;GO:0032364;GO:0002244	metal ion binding;iron-sulfur cluster binding;4 iron, 4 sulfur cluster binding;iron-sulfur cluster assembly;protein binding;CIA complex;regulation of gene expression;response to hypoxia;oxygen homeostasis;hematopoietic progenitor cell differentiation	4Fe-4S;Acetylation;Alternative splicing;Iron;Iron-sulfur;Metal-binding;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-2564830	Metabolism;Cytosolic iron-sulfur cluster assembly
COQ8B	positive	METRN	ENSG00000103260	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0007165;GO:0005576;GO:0007275;GO:0030154;GO:0005615;GO:0007399;GO:0005179;GO:0010001;GO:0050772	glial cell differentiation;positive regulation of axonogenesis;signal transduction;extracellular region;multicellular organism development;cell differentiation;extracellular space;nervous system development;hormone activity	Developmental protein;Differentiation;Disulfide bond;Neurogenesis;Reference proteome;Secreted;Signal		
COQ8B	positive	ERCC2	ENSG00000104884	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00021752;WBGene00021759	WBGene00021752(1)	BAX;CDKN1A;TP53	COFS syndrome;Trichothiodystrophy;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;CEREBRO-OCULO-FACIO-SKELETAL SYNDROME TYPE 2;TRICHOTHIODYSTROPHY PHOTOSENSITIVE;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP D;CEREBROOCULOFACIOSKELETAL SYNDROME 2;TRICHOTHIODYSTROPHY 1 PHOTOSENSITIVE;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP D	GO:0005634;GO:0003676;GO:0005737;GO:0046872;GO:0000166;GO:0005524;GO:0005829;GO:0005654;GO:0016787;GO:0003677;GO:0006468;GO:0005856;GO:0005515;GO:0003678;GO:0006281;GO:0006974;GO:0006915;GO:0004386;GO:0006289;GO:0051536;GO:0051539;GO:0005675;GO:0045893;GO:0005819;GO:0006139;GO:0007059;GO:0016818;GO:0045944;GO:0006366;GO:0016032;GO:0008022;GO:0047485;GO:0006979;GO:0030674;GO:0006368;GO:0006370;GO:0006367;GO:0004672;GO:0006361;GO:0006362;GO:0006363;GO:1901990;GO:0008094;GO:0006283;GO:0003684;GO:0071817;GO:0008353;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0070911;GO:0000717;GO:0006294;GO:0043139;GO:0000019;GO:0000462;GO:0001666;GO:0001701;GO:0007568;GO:0008283;GO:0009411;GO:0009650;GO:0009791;GO:0021510;GO:0022405;GO:0030198;GO:0030282;GO:0032289;GO:0035264;GO:0035315;GO:0040016;GO:0042274;GO:0043249;GO:0043388;GO:0043588;GO:0045951;GO:0048568;GO:0048820;GO:0060218;GO:0000439;GO:0005669;GO:0070516;GO:0032508	DNA binding;nucleus;ATP binding;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;DNA helicase activity;nucleotide-excision repair;nucleic acid binding;nucleobase-containing compound metabolic process;helicase activity;cytoplasm;metal ion binding;nucleotide binding;nucleoplasm;cytosol;hydrolase activity;protein phosphorylation;cytoskeleton;protein binding;DNA repair;cellular response to DNA damage stimulus;apoptotic process;iron-sulfur cluster binding;4 iron, 4 sulfur cluster binding;transcription factor TFIIH holo complex;positive regulation of transcription, DNA-templated;spindle;chromosome segregation;positive regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;viral process;protein C-terminus binding;protein N-terminus binding;response to oxidative stress;protein binding, bridging;transcription elongation from RNA polymerase II promoter;7-methylguanosine mRNA capping;transcription initiation from RNA polymerase II promoter;protein kinase activity;DNA-dependent ATPase activity;transcription initiation from RNA polymerase I promoter;transcription elongation from RNA polymerase I promoter;termination of RNA polymerase I transcription;regulation of mitotic cell cycle phase transition;transcription-coupled nucleotide-excision repair;damaged DNA binding;MMXD complex;RNA polymerase II CTD heptapeptide repeat kinase activity;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;global genome nucleotide-excision repair;nucleotide-excision repair, DNA duplex unwinding;nucleotide-excision repair, preincision complex assembly;5'-3' DNA helicase activity;regulation of mitotic recombination;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);response to hypoxia;in utero embryonic development;aging;cell population proliferation;response to UV;UV protection;post-embryonic development;spinal cord development;hair cycle process;extracellular matrix organization;bone mineralization;central nervous system myelin formation;multicellular organism growth;hair cell differentiation;embryonic cleavage;ribosomal small subunit biogenesis;erythrocyte maturation;positive regulation of DNA binding;skin development;positive regulation of mitotic recombination;embryonic organ development;hair follicle maturation;hematopoietic stem cell differentiation;transcription factor TFIIH core complex;transcription factor TFIID complex;CAK-ERCC2 complex;DNA duplex unwinding	3D-structure;4Fe-4S;ATP-binding;Alternative splicing;Cataract;Chromosome partition;Cockayne syndrome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA-binding;Deafness;Disease mutation;Dwarfism;Helicase;Host-virus interaction;Hydrolase;Ichthyosis;Iron;Iron-sulfur;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Xeroderma pigmentosum	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-8953854;R-HSA-1643685;R-HSA-73894;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-112382;R-HSA-167152;R-HSA-167169;R-HSA-167172;R-HSA-167200;R-HSA-167246;R-HSA-674695;R-HSA-6796648;R-HSA-75955;R-HSA-113418;R-HSA-167158;R-HSA-167160;R-HSA-72086;R-HSA-77075;R-HSA-167161;R-HSA-167162;R-HSA-73776;R-HSA-73779;R-HSA-75953;R-HSA-76042;R-HSA-212165;R-HSA-427413;R-HSA-5250941;R-HSA-73762;R-HSA-73772;R-HSA-73854;R-HSA-73863;R-HSA-73864;R-HSA-5696398;R-HSA-6781823;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-2564830;R-HSA-5696395;R-HSA-5696399;R-HSA-5696400	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of RNA;Disease;DNA Repair;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Formation of RNA Pol II elongation complex ;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription Elongation;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;mRNA Capping;RNA Pol II CTD phosphorylation and interaction with CE;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Cytosolic iron-sulfur cluster assembly;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER
COQ8B	positive	FZR1	ENSG00000105325	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00001510;WBGene00001511	WBGene00001510(0)			GO:0005634;GO:0005737;GO:0005654;GO:0016567;GO:0031965;GO:0051301;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0005829;GO:0031145;GO:1901990;GO:0010997;GO:0097027;GO:1904668;GO:0006511;GO:0070979;GO:0005680;GO:0072425;GO:0045732;GO:0008284;GO:0040020;GO:0070306;GO:0090344	protein binding;anaphase-promoting complex binding;ubiquitin-protein transferase activator activity;positive regulation of ubiquitin protein ligase activity;nucleus;cytoplasm;nucleoplasm;protein ubiquitination;nuclear membrane;cell division;DNA repair;cellular response to DNA damage stimulus;cell cycle;cytosol;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;ubiquitin-dependent protein catabolic process;protein K11-linked ubiquitination;anaphase-promoting complex;signal transduction involved in G2 DNA damage checkpoint;positive regulation of protein catabolic process;positive regulation of cell population proliferation;regulation of meiotic nuclear division;lens fiber cell differentiation;negative regulation of cell aging	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;DNA damage;DNA repair;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation pathway;WD repeat	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169;R-HSA-1640170;R-HSA-174113;R-HSA-174143;R-HSA-174178;R-HSA-176408;R-HSA-2262752;R-HSA-453276;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-8953897;R-HSA-174084;R-HSA-69656;R-HSA-2559583;R-HSA-176407;R-HSA-2559582;R-HSA-176417	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Cell Cycle;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Regulation of APC/C activators between G1/S and early anaphase;Cellular responses to stress;Regulation of mitotic cell cycle;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Cellular responses to external stimuli;Autodegradation of Cdh1 by Cdh1:APC/C;Cyclin A:Cdk2-associated events at S phase entry;Cellular Senescence;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Senescence-Associated Secretory Phenotype (SASP);Phosphorylation of Emi1
COQ8B	positive	CAPS	ENSG00000105519	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0005737;GO:0046872;GO:0005509;GO:0031982;GO:0035556	calcium ion binding;cytoplasm;metal ion binding;vesicle;intracellular signal transduction	3D-structure;Alternative splicing;Calcium;Cytoplasm;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ8B	positive	MIIP	ENSG00000116691	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0005515;GO:0010972;GO:0030336	negative regulation of G2/M transition of mitotic cell cycle;negative regulation of cell migration;protein binding	Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	ZBTB45	ENSG00000119574	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00012317				GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0000122;GO:0007399;GO:0000977;GO:0001227;GO:0005515	protein binding;nucleic acid binding;nucleus;metal ion binding;DNA binding;negative regulation of transcription by RNA polymerase II;nervous system development;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific	DNA-binding;Metal-binding;Neurogenesis;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ8B	positive	ZNF576	ENSG00000124444	COQ8B	1	COQ8B	1	0.00464042313833413		WBGene00001824(0);WBGene00012385(0)			GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0005515	nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding	DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ8B	positive	TMEM53	ENSG00000126106	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00020402;WBGene00015623;WBGene00012002	WBGene00012002(0);WBGene00015623(0);WBGene00020402(0);WBGene00020401(0)			GO:0016020;GO:0016021;GO:0005634	membrane;integral component of membrane;nucleus	Alternative splicing;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	positive	ABHD8	ENSG00000127220	COQ8B	1	COQ8B	1	0.00464042313833413		WBGene00022260(0);WBGene00022259(0);WBGene00010628(0);WBGene00018077(0);WBGene00007854(0);WBGene00022258(0);WBGene00019525(0);WBGene00017335(0)			GO:0016787;GO:0003824;GO:0070062	catalytic activity;hydrolase activity;extracellular exosome	Hydrolase;Reference proteome		
COQ8B	positive	WDR24	ENSG00000127580	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00021316				GO:0016020;GO:0005765;GO:0005515;GO:0006914;GO:0005764;GO:0032008;GO:0010506;GO:0034198;GO:0061700	protein binding;positive regulation of TOR signaling;membrane;intracellular membrane-bounded organelle;cytosol;lysosomal membrane;autophagy;lysosome;regulation of autophagy;cellular response to amino acid starvation;GATOR2 complex	Autophagy;Lysosome;Membrane;Phosphoprotein;Reference proteome;Repeat;WD repeat		
COQ8B	positive	MRPS12	ENSG00000128626	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00011391	WBGene00011391(1)			GO:0003723;GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0015935;GO:0005515;GO:0032543;GO:0005743;GO:0070125;GO:0070126;GO:0005761;GO:0005763	structural constituent of ribosome;translation;ribosome;small ribosomal subunit;RNA binding;mitochondrion;protein binding;mitochondrial translation;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome;mitochondrial small ribosomal subunit	3D-structure;Mitochondrion;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ8B	positive	PODNL1	ENSG00000132000	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0005515;GO:0005576;GO:0062023	protein binding;extracellular region;extracellular space;collagen-containing extracellular matrix	Alternative splicing;Extracellular matrix;Glycoprotein;Leucine-rich repeat;Polymorphism;Reference proteome;Repeat;Secreted;Signal		
COQ8B	positive	RFX1	ENSG00000132005	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00000914	WBGene00000914(0)	COL1A2		GO:0005634;GO:0043231;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005515;GO:0006357;GO:0000978;GO:0000981;GO:0000790;GO:0006955	DNA binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;intracellular membrane-bounded organelle;nucleoplasm;protein binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;immune response	3D-structure;Activator;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation		
COQ8B	positive	KMT5C	ENSG00000133247	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00016313				GO:0005634;GO:0016740;GO:0005654;GO:0008168;GO:0032259;GO:0006325;GO:0005694;GO:0005515;GO:0018024;GO:0042799;GO:0034773;GO:0005721;GO:0016571;GO:0000780;GO:0005720	protein binding;histone methyltransferase activity (H4-K20 specific);histone H4-K20 trimethylation;nucleus;metal ion binding;transferase activity;nucleoplasm;methyltransferase activity;methylation;chromatin organization;chromosome;DNA repair;chromatin binding;positive regulation of double-strand break repair via nonhomologous end joining;pericentric heterochromatin;positive regulation of isotype switching;S-adenosyl-L-methionine binding;histone binding;histone methylation;condensed nuclear chromosome, centromeric region;nuclear heterochromatin	3D-structure;Alternative splicing;Chromatin regulator;Chromosome;Metal-binding;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Zinc	R-HSA-3247509;R-HSA-4839726;R-HSA-3214841	Chromatin modifying enzymes;Chromatin organization;PKMTs methylate histone lysines
COQ8B	positive	RHOT2	ENSG00000140983	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00019544;WBGene00016737				GO:0016020;GO:0016021;GO:0046872;GO:0000166;GO:0005829;GO:0016787;GO:0005509;GO:0003924;GO:0005525;GO:0005739;GO:0005515;GO:0005741;GO:0007005;GO:0005886;GO:0010821;GO:0051056;GO:0007266;GO:0031307;GO:0019725;GO:0097345;GO:0047497	GTP binding;calcium ion binding;GTPase activity;mitochondrion organization;integral component of mitochondrial outer membrane;cell;membrane;integral component of membrane;metal ion binding;nucleotide binding;nucleoplasm;hydrolase activity;mitochondrion;protein binding;mitochondrial outer membrane;plasma membrane;regulation of mitochondrion organization;cytosol;regulation of small GTPase mediated signal transduction;Rho protein signal transduction;cellular homeostasis;mitochondrial outer membrane permeabilization;mitochondrion transport along microtubule	3D-structure;Alternative splicing;Calcium;GTP-binding;Hydrolase;Membrane;Metal-binding;Mitochondrion;Mitochondrion outer membrane;Nucleotide-binding;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-194315;R-HSA-194840	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
COQ8B	positive	PLPP2	ENSG00000141934	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00018756;WBGene00008749;WBGene00020895	WBGene00018756(0)			GO:0016020;GO:0016021;GO:0016787;GO:0008195;GO:0005515;GO:0006470;GO:0005886;GO:0005887;GO:0016791;GO:0042577;GO:0006644;GO:0046839;GO:0030148;GO:0004721;GO:0016311	phosphatidate phosphatase activity;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;endosome;lipid metabolic process;plasma membrane;protein binding;caveola;early endosome;signal transduction;integral component of plasma membrane;phosphatase activity;lipid phosphatase activity;phospholipid metabolic process;phospholipid dephosphorylation;early endosome membrane;sphingosine-1-phosphate phosphatase activity;ceramide-1-phosphate phosphatase activity;sphingosine metabolic process;ceramide metabolic process;sphingolipid biosynthetic process;regulation of cell cycle G1/S phase transition;dephosphorylation	Alternative splicing;Cell membrane;Endoplasmic reticulum;Endosome;Glycoprotein;Hydrolase;Lipid metabolism;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-428157;R-HSA-556833;R-HSA-1660661	Metabolism;Sphingolipid metabolism;Metabolism of lipids;Sphingolipid de novo biosynthesis
COQ8B	positive	DUS3L	ENSG00000141994	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00021377	WBGene00021377(1)			GO:0003723;GO:0046872;GO:0008033;GO:0016491;GO:0050660;GO:0055114;GO:0003824;GO:0017150;GO:0002943	flavin adenine dinucleotide binding;oxidation-reduction process;catalytic activity;tRNA dihydrouridine synthase activity;tRNA processing;RNA binding;metal ion binding;oxidoreductase activity;tRNA dihydrouridine synthesis	Acetylation;Alternative splicing;FMN;Flavoprotein;Isopeptide bond;Metal-binding;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger;tRNA processing		
COQ8B	positive	ZNF687	ENSG00000143373	COQ8B	1	COQ8B	1	0.00464042313833413				PAGET DISEASE OF BONE 6	GO:0003676;GO:0005634;GO:0005737;GO:0046872;GO:0005829;GO:0005654;GO:0003677;GO:0005515	nucleic acid binding;nucleus;cytoplasm;metal ion binding;nucleoplasm;cytosol;DNA binding;protein binding	Alternative splicing;Cytoplasm;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ8B	positive	ADAM15	ENSG00000143537	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00000074;WBGene00006804				GO:0016020;GO:0016021;GO:0046872;GO:0031514;GO:0016787;GO:0007155;GO:0042995;GO:0005515;GO:0008233;GO:0006508;GO:0030054;GO:0031410;GO:0004222;GO:0008237;GO:0009986;GO:0007229;GO:0045087;GO:0005886;GO:0005929;GO:0070062;GO:0001669;GO:0012505;GO:0005912;GO:0017124;GO:0001525;GO:0030308;GO:0005178;GO:0030198;GO:0022617;GO:0001953;GO:0030574;GO:0030336;GO:0007160;GO:1900121;GO:0002418;GO:1904628;GO:0008584;GO:0042246;GO:0060317;GO:1990910	membrane;integral component of membrane;metal ion binding;motile cilium;hydrolase activity;cell adhesion;cell projection;protein binding;peptidase activity;proteolysis;cell junction;cytoplasmic vesicle;metalloendopeptidase activity;metallopeptidase activity;cell surface;integrin-mediated signaling pathway;innate immune response;plasma membrane;cilium;extracellular exosome;acrosomal vesicle;endomembrane system;adherens junction;SH3 domain binding;angiogenesis;negative regulation of cell growth;integrin binding;extracellular matrix organization;extracellular matrix disassembly;negative regulation of cell-matrix adhesion;collagen catabolic process;negative regulation of cell migration;cell-matrix adhesion;negative regulation of receptor binding;immune response to tumor cell;cellular response to phorbol 13-acetate 12-myristate;male gonad development;tissue regeneration;cardiac epithelial to mesenchymal transition;response to hypobaric hypoxia	Alternative splicing;Angiogenesis;Cell adhesion;Cell junction;Cell projection;Cilium;Cleavage on pair of basic residues;Collagen degradation;Cytoplasmic vesicle;Disulfide bond;EGF-like domain;Flagellum;Glycoprotein;Hydrolase;Membrane;Metal-binding;Metalloprotease;Phosphoprotein;Polymorphism;Protease;Reference proteome;SH3-binding;Signal;Transmembrane;Transmembrane helix;Zinc;Zymogen	R-HSA-1474228;R-HSA-1474244;R-HSA-8941237	Degradation of the extracellular matrix;Extracellular matrix organization;Invadopodia formation
COQ8B	positive	TTC12	ENSG00000149292	COQ8B	1	COQ8B	1	0.00464042313833413		WBGene00006781(0);WBGene00019983(0)			GO:0005813;GO:0005515	protein binding;centrosome	Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome;Repeat;TPR repeat		
COQ8B	positive	CXXC1	ENSG00000154832	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00009924				GO:0005634;GO:0016607;GO:0008270;GO:0046872;GO:0005829;GO:0003677;GO:0005515;GO:0048188;GO:0045893;GO:0005654;GO:0006355;GO:0036498;GO:0051568;GO:0042800;GO:0035097;GO:0045322;GO:0000987;GO:0016363	DNA binding;zinc ion binding;Set1C/COMPASS complex;nucleus;nuclear speck;metal ion binding;nucleoplasm;cytosol;protein binding;positive regulation of transcription, DNA-templated;regulation of transcription, DNA-templated;IRE1-mediated unfolded protein response;methylated histone binding;histone H3-K4 methylation;histone methyltransferase activity (H3-K4 specific);histone methyltransferase complex;unmethylated CpG binding;cis-regulatory region sequence-specific DNA binding;nuclear matrix	3D-structure;Acetylation;Activator;Alternative splicing;Coiled coil;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-392499;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
COQ8B	positive	LRRC56	ENSG00000161328	COQ8B	1	COQ8B	1	0.00464042313833413				Primary ciliary dyskinesia;Mucociliary Clearance and Laterality Defects;CILIARY DYSKINESIA PRIMARY 39	GO:0042995;GO:0005515;GO:0005929;GO:0030030	protein binding;cell projection;cilium;cell projection organization	Cell projection;Ciliopathy;Cilium biogenesis/degradation;Disease mutation;Kartagener syndrome;Leucine-rich repeat;Polymorphism;Primary ciliary dyskinesia;Reference proteome;Repeat		
COQ8B	positive	FAAP20	ENSG00000162585	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0005634;GO:0046872;GO:0005654;GO:0005694;GO:0030054;GO:0005515;GO:0006281;GO:0006974;GO:0043130;GO:0016604;GO:0043240;GO:0036297;GO:0019985;GO:0140036;GO:0070530;GO:0031593	nucleus;metal ion binding;nucleoplasm;chromosome;cell junction;protein binding;DNA repair;cellular response to DNA damage stimulus;ubiquitin binding;nuclear body;Fanconi anaemia nuclear complex;interstrand cross-link repair;translesion synthesis;ubiquitin-dependent protein binding;K63-linked polyubiquitin modification-dependent protein binding;polyubiquitin modification-dependent protein binding	3D-structure;Alternative splicing;Chromosome;DNA damage;DNA repair;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Zinc;Zinc-finger	R-HSA-6783310;R-HSA-73894	Fanconi Anemia Pathway;DNA Repair
COQ8B	positive	ANKS3	ENSG00000168096	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00012704	WBGene00012704(0)		Situs inversus totalis	GO:0005737;GO:0042995;GO:0005515;GO:0005929	protein binding;cytoplasm;cell projection;cilium	3D-structure;ANK repeat;Alternative splicing;Cell projection;Coiled coil;Cytoplasm;Hydroxylation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation		
COQ8B	positive	HEXD	ENSG00000169660	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00012663;WBGene00015767;WBGene00013497;WBGene00021766	WBGene00015767(0);WBGene00012663(0);WBGene00013497(0);WBGene00021766(0)			GO:0005634;GO:0005737;GO:0016787;GO:0005975;GO:0008152;GO:0004553;GO:0016798;GO:0004563;GO:0102148;GO:0015929;GO:1903561	carbohydrate metabolic process;hydrolase activity, hydrolyzing O-glycosyl compounds;hexosaminidase activity;nucleus;cytoplasm;hydrolase activity;metabolic process;hydrolase activity, acting on glycosyl bonds;beta-N-acetylhexosaminidase activity;N-acetyl-beta-D-galactosaminidase activity;extracellular vesicle	Alternative splicing;Cytoplasm;Disulfide bond;Glycosidase;Hydrolase;Nucleus;Polymorphism;Reference proteome		
COQ8B	positive	TRABD	ENSG00000170638	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00018161	WBGene00018161(1)					Acetylation;Alternative splicing;Phosphoprotein;Reference proteome		
COQ8B	positive	LRFN4	ENSG00000173621	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00021353				GO:0005515;GO:0016020;GO:0016021;GO:0099151;GO:0099560;GO:1905606;GO:0009986;GO:0098978;GO:0098982;GO:0099061;GO:0005886	protein binding;membrane;integral component of membrane;regulation of postsynaptic density assembly;synaptic membrane adhesion;regulation of presynapse assembly;cell surface;glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic density membrane;plasma membrane	Disulfide bond;Glycoprotein;Immunoglobulin domain;Leucine-rich repeat;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-112316;R-HSA-6794362;R-HSA-8849932	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
COQ8B	positive	BRMS1	ENSG00000174744	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0009987;GO:0005634;GO:0005737;GO:0005515;GO:0006915;GO:0000122;GO:0005654;GO:0032088;GO:0042826;GO:0042981;GO:0045892;GO:0004407;GO:0051059;GO:0016575;GO:2000210;GO:0070822;GO:0090312	cellular process;nucleus;cytoplasm;protein binding;apoptotic process;negative regulation of transcription by RNA polymerase II;nucleoplasm;negative regulation of NF-kappaB transcription factor activity;histone deacetylase binding;regulation of apoptotic process;negative regulation of transcription, DNA-templated;histone deacetylase activity;NF-kappaB binding;histone deacetylation;positive regulation of anoikis;Sin3-type complex;positive regulation of protein deacetylation	3D-structure;Apoptosis;Coiled coil;Cytoplasm;Isopeptide bond;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation	R-HSA-3214815;R-HSA-3247509;R-HSA-4839726	HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization
COQ8B	positive	RIN1	ENSG00000174791	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00008183	WBGene00012644(0);WBGene00008183(0)			GO:0005737;GO:0016020;GO:0007165;GO:0043547;GO:0005856;GO:0005515;GO:0005096;GO:0017016;GO:0007613;GO:0008306;GO:0031914;GO:0030425;GO:0043025;GO:0005829;GO:0006897;GO:0005886	signal transduction;cytoplasm;membrane;cytoskeleton;positive regulation of GTPase activity;protein binding;GTPase activator activity;endocytosis;Ras GTPase binding;memory;associative learning;negative regulation of synaptic plasticity;dendrite;neuronal cell body;cytosol;plasma membrane	Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Endocytosis;GTPase activation;Membrane;Methylation;Phosphoprotein;Reference proteome;SH2 domain	R-HSA-5653656;R-HSA-199991;R-HSA-8876198;R-HSA-9007101	Vesicle-mediated transport;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
COQ8B	positive	RPS6KB2	ENSG00000175634	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00012929;WBGene00044281;WBGene00000102;WBGene00000103;WBGene00004789	WBGene00012929(0);WBGene00044281(0)			GO:0004672;GO:0005524;GO:0006468;GO:0005634;GO:0005737;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0007165;GO:0045948;GO:0035556;GO:0005654;GO:0006412;GO:0004711;GO:0031929;GO:0042277;GO:0043491	protein kinase activity;ATP binding;protein phosphorylation;signal transduction;protein serine/threonine kinase activity;nucleus;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;positive regulation of translational initiation;intracellular signal transduction;nucleoplasm;translation;ribosomal protein S6 kinase activity;TOR signaling;peptide binding;protein kinase B signaling	ATP-binding;Alternative splicing;Cytoplasm;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-162582;R-HSA-1643685;R-HSA-1257604;R-HSA-5663202;R-HSA-9006925;R-HSA-198693;R-HSA-2219528;R-HSA-5674400	Signal Transduction;Disease;PIP3 activates AKT signaling;Diseases of signal transduction;Intracellular signaling by second messengers;AKT phosphorylates targets in the nucleus;PI3K/AKT Signaling in Cancer;Constitutive Signaling by AKT1 E17K in Cancer
COQ8B	positive	BAIAP2	ENSG00000175866	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0032956;GO:0007009;GO:0008093;GO:0005829;GO:0005886;GO:0005515;GO:0005737;GO:0016020;GO:0005856;GO:0042995;GO:0038096;GO:0042802;GO:0030175;GO:0070062;GO:0005654;GO:0015629;GO:0030838;GO:0051017;GO:0008360;GO:0098641;GO:0098609;GO:0005913;GO:0001726;GO:0070064;GO:0048010;GO:0007409;GO:0009617;GO:0008022;GO:0008286;GO:0051764;GO:2000251;GO:0001221;GO:0030165;GO:0097110;GO:0007420;GO:0010976;GO:0016358;GO:0030182;GO:0035418;GO:0048167;GO:0050804;GO:0061003;GO:0071364;GO:0099564;GO:1905232;GO:1905274;GO:2000463;GO:0005791;GO:0005794;GO:0005874;GO:0014069;GO:0030141;GO:0043005;GO:0043025;GO:0043197;GO:0043198;GO:0044306;GO:0060076;GO:0061845;GO:0061846;GO:0097060;GO:0098685;GO:0098793;GO:0098794;GO:0098978;GO:0099092;GO:0099523;GO:0099524	protein binding;plasma membrane organization;cytoskeletal adaptor activity;regulation of actin cytoskeleton organization;cytoplasm;membrane;cytosol;plasma membrane;cytoskeleton;cell projection;Fc-gamma receptor signaling pathway involved in phagocytosis;identical protein binding;nucleoplasm;filopodium;extracellular exosome;positive regulation of actin filament polymerization;actin filament bundle assembly;regulation of cell shape;cadherin binding involved in cell-cell adhesion;cell-cell adhesion;adherens junction;ruffle;proline-rich region binding;vascular endothelial growth factor receptor signaling pathway;axonogenesis;actin cytoskeleton;response to bacterium;protein C-terminus binding;insulin receptor signaling pathway;actin crosslink formation;positive regulation of actin cytoskeleton reorganization;transcription cofactor binding;PDZ domain binding;scaffold protein binding;brain development;positive regulation of neuron projection development;dendrite development;neuron differentiation;protein localization to synapse;regulation of synaptic plasticity;modulation of chemical synaptic transmission;positive regulation of dendritic spine morphogenesis;cellular response to epidermal growth factor stimulus;modification of synaptic structure, modulating synaptic transmission;cellular response to L-glutamate;regulation of modification of postsynaptic actin cytoskeleton;positive regulation of excitatory postsynaptic potential;rough endoplasmic reticulum;Golgi apparatus;microtubule;postsynaptic density;secretory granule;neuron projection;neuronal cell body;dendritic spine;dendritic shaft;neuron projection terminus;excitatory synapse;neuron projection branch point;dendritic spine cytoplasm;synaptic membrane;Schaffer collateral - CA1 synapse;presynapse;postsynapse;glutamatergic synapse;postsynaptic density, intracellular component;presynaptic cytosol;postsynaptic cytosol	3D-structure;Alternative splicing;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Membrane;Phosphoprotein;Polymorphism;Reference proteome;SH3 domain	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029482;R-HSA-162582;R-HSA-194315;R-HSA-195258;R-HSA-5663213;R-HSA-9006934;R-HSA-194138;R-HSA-4420097	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Signaling by VEGF;VEGFA-VEGFR2 Pathway
COQ8B	positive	SOX12	ENSG00000177732	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00004771	WBGene00015716(0);WBGene00001182(0)			GO:0005634;GO:0005654;GO:0003713;GO:0006357;GO:0003677;GO:0000981;GO:0006355;GO:0030154;GO:0044798;GO:0000790;GO:0045944;GO:0000976;GO:0021510;GO:0001228;GO:0045165;GO:0065004;GO:0032993	regulation of transcription by RNA polymerase II;transcription coactivator activity;cell fate commitment;nucleus;nucleoplasm;DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;regulation of transcription, DNA-templated;anatomical structure morphogenesis;cell differentiation;nuclear transcription factor complex;nuclear chromatin;positive regulation of transcription by RNA polymerase II;transcription regulatory region sequence-specific DNA binding;spinal cord development;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of regulatory T cell differentiation;protein-DNA complex assembly;protein-DNA complex	Activator;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation		
COQ8B	positive	ZNF48	ENSG00000180035	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00021931;WBGene00004773;WBGene00001223;WBGene00013240	WBGene00013734(0)			GO:0003676;GO:0005634;GO:0046872;GO:0003677	nucleic acid binding;nucleus;metal ion binding;DNA binding	Acetylation;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ8B	positive	CRELD2	ENSG00000184164	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00008624	WBGene00022858(0);WBGene00019901(0);WBGene00018906(0);WBGene00000168(0);WBGene00012018(0);WBGene00013480(0);WBGene00013486(0);WBGene00013487(0)			GO:0016853;GO:0005783;GO:0005509;GO:0005515;GO:0003756;GO:0005615;GO:0005794	calcium ion binding;isomerase activity;endoplasmic reticulum;protein binding;protein disulfide isomerase activity;extracellular space;Golgi apparatus	Alternative splicing;Calcium;Direct protein sequencing;Disulfide bond;EGF-like domain;Endoplasmic reticulum;Glycoprotein;Isomerase;Polymorphism;Redox-active center;Reference proteome;Repeat;Signal		
COQ8B	positive	CYHR1	ENSG00000187954	COQ8B	1	COQ8B	1	0.00464042313833413					GO:0005737;GO:0008270;GO:0046872;GO:0005654;GO:0005515;GO:0048471;GO:0016020;GO:0016021	zinc ion binding;protein binding;cytoplasm;metal ion binding;nucleoplasm;perinuclear region of cytoplasm;membrane;integral component of membrane	Alternative splicing;Cytoplasm;Metal-binding;Reference proteome;Zinc;Zinc-finger		
COQ8B	positive	MROH6	ENSG00000204839	COQ8B	1	COQ8B	1	0.00464042313833413	WBGene00016418						Polymorphism;Reference proteome;Repeat		
COQ8B	positive	ALDH3B1	ENSG00000006534	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00000110;WBGene00000111	WBGene00000107(0);WBGene00000108(0);WBGene00000110(0);WBGene00000111(0);WBGene00000109(0)			GO:0016020;GO:0016491;GO:0055114;GO:0005886;GO:0005515;GO:0016620;GO:0006081;GO:0070062;GO:0043312;GO:0035579;GO:0030667;GO:0005737;GO:0031982;GO:0006629;GO:0030148;GO:0006066;GO:0006068;GO:0034599;GO:0004028;GO:0004030;GO:0018477;GO:0018479;GO:0046185;GO:0004029;GO:0005829	oxidation-reduction process;oxidoreductase activity;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;cellular aldehyde metabolic process;membrane;plasma membrane;protein binding;extracellular exosome;neutrophil degranulation;specific granule membrane;secretory granule membrane;cytoplasm;vesicle;lipid metabolic process;sphingolipid biosynthetic process;alcohol metabolic process;ethanol catabolic process;cellular response to oxidative stress;3-chloroallyl aldehyde dehydrogenase activity;aldehyde dehydrogenase [NAD(P)+] activity;benzaldehyde dehydrogenase (NADP+) activity;benzaldehyde dehydrogenase (NAD+) activity;aldehyde catabolic process;aldehyde dehydrogenase (NAD+) activity;cytosol	Acetylation;Alternative splicing;Cell membrane;Lipoprotein;Membrane;Methylation;NAD;Oxidoreductase;Palmitate;Prenylation;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-428157;R-HSA-556833;R-HSA-6798695;R-HSA-1660661	Innate Immune System;Immune System;Metabolism;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation;Sphingolipid de novo biosynthesis
COQ8B	positive	PPP5C	ENSG00000011485	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00012665	WBGene00012665(1)			GO:0005634;GO:0005737;GO:0016020;GO:0043231;GO:0046872;GO:0005829;GO:0016787;GO:0005886;GO:0001965;GO:0003723;GO:0004721;GO:0004722;GO:0008017;GO:0031072;GO:0001933;GO:0006470;GO:0010288;GO:0016576;GO:0043278;GO:0051259;GO:0051291;GO:0060548;GO:0070301;GO:0071276;GO:1901215;GO:1904550;GO:2000324;GO:0043005;GO:0043025;GO:0043204;GO:0071944;GO:1990635;GO:0005515;GO:0006281;GO:0006974;GO:0008289;GO:0042802;GO:0005654;GO:0000165;GO:0032991;GO:0043123;GO:0048156;GO:0000278;GO:0006351;GO:0101031;GO:0005524;GO:0043531;GO:0016791;GO:0051879;GO:0035970;GO:0070262	protein binding;hydrolase activity;protein dephosphorylation;phosphoprotein phosphatase activity;nucleus;cytoplasm;membrane;intracellular membrane-bounded organelle;metal ion binding;cytosol;plasma membrane;G-protein alpha-subunit binding;RNA binding;protein serine/threonine phosphatase activity;microtubule binding;heat shock protein binding;protein-containing complex binding;negative regulation of protein phosphorylation;response to lead ion;histone dephosphorylation;response to morphine;negative regulation of cell death;cellular response to hydrogen peroxide;cellular response to cadmium ion;negative regulation of neuron death;response to arachidonic acid;positive regulation of glucocorticoid receptor signaling pathway;neuron projection;neuronal cell body;perikaryon;cell periphery;proximal dendrite;DNA repair;cellular response to DNA damage stimulus;lipid binding;identical protein binding;nucleoplasm;MAPK cascade;protein-containing complex;positive regulation of I-kappaB kinase/NF-kappaB signaling;tau protein binding;mitotic cell cycle;transcription, DNA-templated;chaperone complex;peptidyl-serine dephosphorylation;ATP binding;ADP binding;phosphatase activity;Hsp90 protein binding;peptidyl-threonine dephosphorylation	3D-structure;Acetylation;Alzheimer disease;Amyloid;Amyloidosis;Cell membrane;Cytoplasm;DNA damage;DNA repair;Hydrolase;Lipid-binding;Magnesium;Manganese;Membrane;Metal-binding;Neurodegeneration;Nucleus;Protein phosphatase;Reference proteome;Repeat;TPR repeat	R-HSA-168256;R-HSA-162582;R-HSA-5693532;R-HSA-73894;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-8939211;R-HSA-9006931;R-HSA-5693565;R-HSA-5693606;R-HSA-5675221	Immune System;Signal Transduction;DNA Double-Strand Break Repair;DNA Repair;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;ESR-mediated signaling;Signaling by Nuclear Receptors;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Negative regulation of MAPK pathway
COQ8B	positive	PTPRU	ENSG00000060656	COQ8B	1	COQ8B	1	0.00679015613713607					GO:0016020;GO:0016021;GO:0016787;GO:0007155;GO:0005886;GO:0004721;GO:0006470;GO:0005515;GO:0004725;GO:0016311;GO:0035335;GO:0016791;GO:0030054;GO:0030154;GO:0005887;GO:0008285;GO:0090090;GO:0005911;GO:0034394;GO:0008013;GO:0030336;GO:2000049;GO:0005001;GO:0007185;GO:0031100;GO:0034109;GO:0051384	protein binding;membrane;phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;dephosphorylation;integral component of membrane;hydrolase activity;cell adhesion;plasma membrane;phosphoprotein phosphatase activity;peptidyl-tyrosine dephosphorylation;cell junction;cell differentiation;integral component of plasma membrane;negative regulation of cell population proliferation;negative regulation of canonical Wnt signaling pathway;cell-cell junction;protein localization to cell surface;beta-catenin binding;negative regulation of cell migration;positive regulation of cell-cell adhesion mediated by cadherin;transmembrane receptor protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase signaling pathway;animal organ regeneration;homotypic cell-cell adhesion;response to glucocorticoid	Alternative splicing;Cell adhesion;Cell junction;Cell membrane;Differentiation;Disulfide bond;Glycoprotein;Hydrolase;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Protein phosphatase;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-9006934;R-HSA-1433557	Signal Transduction;Signaling by Receptor Tyrosine Kinases;Signaling by SCF-KIT
COQ8B	positive	RFXANK	ENSG00000064490	COQ8B	1	COQ8B	1	0.00679015613713607				Immunodeficiency by defective expression of MHC class II;BARE LYMPHOCYTE SYNDROME TYPE II	GO:0005829;GO:0005654;GO:0005634;GO:0005737;GO:0003677;GO:0045171;GO:0042826;GO:0007265;GO:0045944;GO:0003700;GO:0003712;GO:0005515	nucleoplasm;cytosol;protein binding;nucleus;cytoplasm;DNA binding;intercellular bridge;histone deacetylase binding;Ras protein signal transduction;positive regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity;transcription coregulator activity	3D-structure;ANK repeat;Activator;Alternative splicing;Cytoplasm;DNA-binding;Direct protein sequencing;Disease mutation;Nucleus;Polymorphism;Reference proteome;Repeat;SCID;Transcription;Transcription regulation		
COQ8B	positive	MRPS34	ENSG00000074071	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00010905	WBGene00010905(0)		Leigh Syndrome with Instability of the Small Mitoribosomal Subunit;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32	GO:0005739;GO:0003735;GO:0032543;GO:0005840;GO:0005763;GO:0005743;GO:0070125;GO:0070126	structural constituent of ribosome;mitochondrion;mitochondrial translation;ribosome;mitochondrial small ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination	3D-structure;Disease mutation;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome;Ribonucleoprotein;Ribosomal protein	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
COQ8B	positive	LIPE	ENSG00000079435	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00016704	WBGene00016704(0)		LIPE-related familial partial lipodystrophy;LIPODYSTROPHY FAMILIAL PARTIAL TYPE 6	GO:0005737;GO:0016020;GO:0005829;GO:0016787;GO:0006629;GO:0016042;GO:0008202;GO:0005886;GO:0005901;GO:0008203;GO:0005515;GO:0019433;GO:0016298;GO:0006468;GO:0005811;GO:0033878;GO:0004806;GO:0017171;GO:0019901;GO:0042758;GO:0046340	hydrolase activity;lipid catabolic process;lipase activity;cholesterol metabolic process;cytoplasm;membrane;cytosol;lipid metabolic process;steroid metabolic process;plasma membrane;caveola;protein binding;triglyceride catabolic process;protein phosphorylation;lipid droplet;hormone-sensitive lipase activity;triglyceride lipase activity;serine hydrolase activity;protein kinase binding;long-chain fatty acid catabolic process;diacylglycerol catabolic process	Alternative splicing;Cell membrane;Cholesterol metabolism;Cytoplasm;Diabetes mellitus;Hydrolase;Lipid degradation;Lipid metabolism;Membrane;Obesity;Phosphoprotein;Polymorphism;Reference proteome;Steroid metabolism;Sterol metabolism	R-HSA-1430728;R-HSA-556833;R-HSA-163560;R-HSA-8979227	Metabolism;Metabolism of lipids;Triglyceride catabolism;Triglyceride metabolism
COQ8B	positive	SLC8B1	ENSG00000089060	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00003571;WBGene00003572;WBGene00003573;WBGene00003574;WBGene00003575	WBGene00003571(0);WBGene00003572(0);WBGene00003573(0);WBGene00003574(0)			GO:0016020;GO:0016021;GO:0055085;GO:0005743;GO:0005739;GO:0006811;GO:0015297;GO:0006814;GO:0006816;GO:0050896;GO:0005886;GO:0042803;GO:0086036;GO:0050796;GO:0042593;GO:0006851;GO:0051560;GO:0099093;GO:0051480;GO:0005432;GO:0032592;GO:2001256;GO:0015368;GO:0042802;GO:0086038;GO:0035725;GO:0070588;GO:1901623;GO:0030061;GO:0042383	integral component of membrane;transmembrane transport;cell;membrane;mitochondrial inner membrane;mitochondrion;ion transport;antiporter activity;sodium ion transport;calcium ion transport;response to stimulus;plasma membrane;protein homodimerization activity;regulation of cardiac muscle cell membrane potential;regulation of insulin secretion;glucose homeostasis;mitochondrial calcium ion transmembrane transport;mitochondrial calcium ion homeostasis;calcium export from the mitochondrion;regulation of cytosolic calcium ion concentration;calcium:sodium antiporter activity;integral component of mitochondrial membrane;regulation of store-operated calcium entry;calcium:cation antiporter activity;identical protein binding;calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential;sodium ion transmembrane transport;calcium ion transmembrane transport;regulation of lymphocyte chemotaxis;mitochondrial crista;sarcolemma	Alternative splicing;Antiport;Calcium;Calcium transport;Glycoprotein;Ion transport;Lithium;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Polymorphism;Reference proteome;Sensory transduction;Sodium;Sodium transport;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-425407;R-HSA-425393;R-HSA-425561;R-HSA-8949215	Transport of small molecules;SLC-mediated transmembrane transport;Transport of inorganic cations/anions and amino acids/oligopeptides;Sodium/Calcium exchangers;Mitochondrial calcium ion transport
COQ8B	positive	CERS4	ENSG00000090661	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00002043;WBGene00002044	WBGene00002043(0);WBGene00002044(0)			GO:0005634;GO:0016020;GO:0016021;GO:0003677;GO:0016740;GO:0005783;GO:0005789;GO:0006629;GO:0006665;GO:0030148;GO:0046513;GO:0050291	DNA binding;integral component of membrane;nucleus;membrane;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;lipid metabolic process;sphingolipid metabolic process;sphingolipid biosynthetic process;ceramide biosynthetic process;N-acyltransferase activity;sphingosine N-acyltransferase activity	Endoplasmic reticulum;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-428157;R-HSA-556833;R-HSA-1660661	Metabolism;Sphingolipid metabolism;Metabolism of lipids;Sphingolipid de novo biosynthesis
COQ8B	positive	AAAS	ENSG00000094914	COQ8B	1	COQ8B	1	0.00679015613713607				Triple A syndrome;Achalasia-Addisonianism-Alacrima syndrome;Achalasia-Addisonianism-Alacrima syndrome	GO:0005515;GO:0051028;GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0005813;GO:0005829;GO:0005654;GO:0031965;GO:0005856;GO:0005643;GO:0000922;GO:0003674;GO:0001578;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0072686;GO:0090307;GO:0046822;GO:0006913;GO:0007612;GO:0009566	protein binding;mRNA transport;nucleus;cytoplasm;membrane;protein transport;nucleoplasm;cytosol;cytoskeleton;nuclear membrane;centrosome;nuclear pore;spindle pole;molecular_function;microtubule bundle formation;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;mitotic spindle;mitotic spindle assembly;regulation of nucleocytoplasmic transport;nucleocytoplasmic transport;learning;fertilization	Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Disease mutation;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Translocation;Transport;WD repeat;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
COQ8B	positive	GCAT	ENSG00000100116	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00012007	WBGene00012007(0)			GO:0005634;GO:0016607;GO:0016740;GO:0005654;GO:0005739;GO:0003824;GO:0016746;GO:0009058;GO:0030170;GO:0005743;GO:0006520;GO:0008890;GO:0006567;GO:0019518	catalytic activity;pyridoxal phosphate binding;biosynthetic process;transferase activity;glycine C-acetyltransferase activity;threonine catabolic process;nucleus;nuclear speck;nucleoplasm;mitochondrion;transferase activity, transferring acyl groups;mitochondrial inner membrane;cellular amino acid metabolic process;L-threonine catabolic process to glycine	Acetylation;Acyltransferase;Alternative splicing;Mitochondrion;Nucleus;Polymorphism;Pyridoxal phosphate;Reference proteome;Transferase;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-8849175	Metabolism;Metabolism of amino acids and derivatives;Threonine catabolism
COQ8B	positive	RHBDD3	ENSG00000100263	COQ8B	1	COQ8B	1	0.00679015613713607					GO:0016020;GO:0016021;GO:0004252;GO:0000165;GO:0001889;GO:0002673;GO:0006508;GO:0009410;GO:0032815;GO:0045732;GO:0050708;GO:0005515	integral component of membrane;protein binding;serine-type endopeptidase activity;membrane;MAPK cascade;liver development;regulation of acute inflammatory response;proteolysis;response to xenobiotic stimulus;negative regulation of natural killer cell activation;positive regulation of protein catabolic process;regulation of protein secretion	Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	positive	SYNGR1	ENSG00000100321	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00004912	WBGene00004912(1)			GO:0016020;GO:0016021;GO:0005515;GO:0042470;GO:0030054;GO:0031410;GO:0045202;GO:0005886;GO:0048172;GO:0043312;GO:0030672;GO:0035577;GO:0031594;GO:0045055;GO:0048169;GO:0048499;GO:0006605;GO:1990830;GO:0008021;GO:0030285	membrane;integral component of membrane;protein binding;melanosome;cell junction;cytoplasmic vesicle;synapse;plasma membrane;regulation of short-term neuronal synaptic plasticity;neutrophil degranulation;synaptic vesicle membrane;azurophil granule membrane;neuromuscular junction;regulated exocytosis;regulation of long-term neuronal synaptic plasticity;synaptic vesicle membrane organization;protein targeting;cellular response to leukemia inhibitory factor;synaptic vesicle;integral component of synaptic vesicle membrane	Acetylation;Alternative splicing;Cell junction;Cytoplasmic vesicle;Membrane;Polymorphism;Reference proteome;Synapse;Transmembrane;Transmembrane helix	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ8B	positive	COG4	ENSG00000103051	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00021784	WBGene00021784(1)		COG4-CDG;Microcephalic osteodysplastic dysplasia Saul-Wilson type;COG4-CDG;SAUL-WILSON SYNDROME;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIj;SAUL-WILSON SYNDROME	GO:0005737;GO:0016020;GO:0015031;GO:0005794;GO:0005829;GO:0005515;GO:0000139;GO:0017119;GO:0007030;GO:0006890;GO:0032588;GO:0006888;GO:0048213	cytoplasm;membrane;protein transport;Golgi apparatus;cytosol;protein binding;Golgi membrane;Golgi transport complex;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;Golgi organization;trans-Golgi network membrane;endoplasmic reticulum to Golgi vesicle-mediated transport;Golgi vesicle prefusion complex stabilization	3D-structure;Acetylation;Alternative splicing;Congenital disorder of glycosylation;Cytoplasm;Disease mutation;Dwarfism;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811442;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-6811438;R-HSA-6811440	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network
COQ8B	positive	AXIN1	ENSG00000103126	COQ8B	1	COQ8B	1	0.00679015613713607				Adult hepatocellular carcinoma;caudal duplication anomaly;caudal duplication anomaly;Hepatocellular Carcinoma	GO:0048471;GO:0005737;GO:0001934;GO:0090090;GO:0045893;GO:0005634;GO:0016020;GO:0008013;GO:0046330;GO:0042803;GO:0005886;GO:0005515;GO:0006915;GO:0007275;GO:0016055;GO:0042802;GO:0030877;GO:0005829;GO:0090263;GO:0060090;GO:0070016;GO:0031625;GO:0033138;GO:0019899;GO:0031410;GO:0019901;GO:1904886;GO:0070411;GO:0031398;GO:0035591;GO:0046332;GO:0010800;GO:0030111;GO:0032147;GO:0033146;GO:0034622;GO:0045732;GO:0051443;GO:1904885;GO:2000060;GO:0016328;GO:0071944;GO:0007165;GO:0030159	beta-catenin binding;positive regulation of JNK cascade;beta-catenin destruction complex;perinuclear region of cytoplasm;cytoplasm;positive regulation of protein phosphorylation;negative regulation of canonical Wnt signaling pathway;positive regulation of transcription, DNA-templated;nucleus;membrane;protein homodimerization activity;plasma membrane;protein binding;apoptotic process;multicellular organism development;Wnt signaling pathway;identical protein binding;cytosol;positive regulation of canonical Wnt signaling pathway;molecular adaptor activity;armadillo repeat domain binding;ubiquitin protein ligase binding;positive regulation of peptidyl-serine phosphorylation;enzyme binding;cytoplasmic vesicle;protein kinase binding;beta-catenin destruction complex disassembly;I-SMAD binding;positive regulation of protein ubiquitination;signaling adaptor activity;SMAD binding;positive regulation of peptidyl-threonine phosphorylation;regulation of Wnt signaling pathway;activation of protein kinase activity;regulation of intracellular estrogen receptor signaling pathway;cellular protein-containing complex assembly;positive regulation of protein catabolic process;positive regulation of ubiquitin-protein transferase activity;beta-catenin destruction complex assembly;positive regulation of ubiquitin-dependent protein catabolic process;lateral plasma membrane;cell periphery	3D-structure;ADP-ribosylation;Alternative splicing;Apoptosis;Cell membrane;Cytoplasm;Developmental protein;Disease mutation;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;Tumor suppressor;Ubl conjugation;Wnt signaling pathway	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-4641257;R-HSA-5663202;R-HSA-5688426;R-HSA-5689880;R-HSA-8878171;R-HSA-8939211;R-HSA-9006931;R-HSA-9018519;R-HSA-4641262;R-HSA-196299;R-HSA-4791275;R-HSA-4839735;R-HSA-4839743;R-HSA-4839744;R-HSA-4839748;R-HSA-5339716;R-HSA-5358747;R-HSA-5358749;R-HSA-5358751;R-HSA-5358752;R-HSA-5467337;R-HSA-5467340;R-HSA-5467348;R-HSA-8931987;R-HSA-8939256	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Degradation of AXIN;Diseases of signal transduction;Deubiquitination;Ub-specific processing proteases;Transcriptional regulation by RUNX1;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Beta-catenin phosphorylation cascade;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;RUNX1 regulates estrogen receptor mediated transcription;RUNX1 regulates transcription of genes involved in WNT signaling
COQ8B	positive	LMF1	ENSG00000103227	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00019657	WBGene00019657(0)		Familial lipase maturation factor 1 deficiency;Lipase deficiency combined	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0051604;GO:0051004;GO:0006641;GO:0006888;GO:0009306;GO:0033578;GO:0034382;GO:0051006;GO:0090181;GO:0090207;GO:0005794	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein maturation;regulation of lipoprotein lipase activity;triglyceride metabolic process;endoplasmic reticulum to Golgi vesicle-mediated transport;protein secretion;protein glycosylation in Golgi;chylomicron remnant clearance;positive regulation of lipoprotein lipase activity;regulation of cholesterol metabolic process;regulation of triglyceride metabolic process;Golgi apparatus	Alternative splicing;Chaperone;Endoplasmic reticulum;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-382551;R-HSA-174824;R-HSA-8963889;R-HSA-8963899	Transport of small molecules;Plasma lipoprotein assembly, remodeling, and clearance;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
COQ8B	positive	MED25	ENSG00000104973	COQ8B	1	COQ8B	1	0.00679015613713607				Autosomal recessive non-syndromic intellectual disability;Charcot-Marie-Tooth disease type 2B2;Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome;Basel-Vanagaite-Smirin-Yosef syndrome;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2B2	GO:0005634;GO:0005654;GO:0005515;GO:0044798;GO:0000122;GO:0045944;GO:0016592;GO:0042974;GO:0008134;GO:0006367;GO:0071158;GO:0046965;GO:0048147;GO:0035563;GO:2001178	nucleus;nucleoplasm;protein binding;nuclear transcription factor complex;negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;mediator complex;retinoic acid receptor binding;transcription factor binding;transcription initiation from RNA polymerase II promoter;positive regulation of cell cycle arrest;transcription coactivator binding;retinoid X receptor binding;negative regulation of fibroblast proliferation;positive regulation of chromatin binding;positive regulation of mediator complex assembly	3D-structure;Activator;Alternative splicing;Charcot-Marie-Tooth disease;Direct protein sequencing;Disease mutation;Mental retardation;Methylation;Neurodegeneration;Neuropathy;Nucleus;Reference proteome;Transcription;Transcription regulation	R-HSA-1266738;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206	Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha
COQ8B	positive	ILVBL	ENSG00000105135	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00020831;WBGene00007143	WBGene00020831(1)			GO:0016020;GO:0016021;GO:0046872;GO:0016740;GO:0000287;GO:0003824;GO:0005515;GO:0030976;GO:0003674;GO:0008150	magnesium ion binding;catalytic activity;thiamine pyrophosphate binding;membrane;integral component of membrane;metal ion binding;transferase activity;endoplasmic reticulum membrane;protein binding;molecular_function;fatty acid alpha-oxidation	Endoplasmic reticulum;Fatty acid metabolism;Lipid metabolism;Lyase;Magnesium;Membrane;Metal-binding;Polymorphism;Reference proteome;Thiamine pyrophosphate;Transmembrane;Transmembrane helix		
COQ8B	positive	MEGF8	ENSG00000105429	COQ8B	1	COQ8B	1	0.00679015613713607				CARPENTER SYNDROME;CARPENTER SYNDROME;CARPENTER SYNDROME 2	GO:0005634;GO:0016020;GO:0016021;GO:0005509;GO:0005515;GO:0009887;GO:0009888;GO:0070062;GO:0035108;GO:0030509;GO:0045879;GO:0048842;GO:0010468;GO:0048704;GO:0097155;GO:0030326;GO:0042074;GO:0097094;GO:0003143;GO:0055113;GO:0060971;GO:0060972;GO:0061371;GO:0071907;GO:0007368;GO:0060976	protein binding;calcium ion binding;nucleus;membrane;integral component of membrane;animal organ morphogenesis;tissue development;extracellular exosome;limb morphogenesis;BMP signaling pathway;negative regulation of smoothened signaling pathway;positive regulation of axon extension involved in axon guidance;regulation of gene expression;embryonic skeletal system morphogenesis;fasciculation of sensory neuron axon;embryonic limb morphogenesis;cell migration involved in gastrulation;craniofacial suture morphogenesis;embryonic heart tube morphogenesis;epiboly involved in gastrulation with mouth forming second;embryonic heart tube left/right pattern formation;left/right pattern formation;determination of heart left/right asymmetry;determination of digestive tract left/right asymmetry;determination of left/right symmetry;coronary vasculature development	Alternative splicing;Calcium;Craniosynostosis;Disease mutation;Disulfide bond;EGF-like domain;Glycoprotein;Kelch repeat;Laminin EGF-like domain;Membrane;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		
COQ8B	positive	ARMC6	ENSG00000105676	COQ8B	1	COQ8B	1	0.00679015613713607					GO:0005829;GO:0002244;GO:0005515	protein binding;cytosol;hematopoietic progenitor cell differentiation	Alternative splicing;Phosphoprotein;Reference proteome;Repeat		
COQ8B	positive	PCOLCE	ENSG00000106333	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00003555;WBGene00020954				GO:0005615;GO:0005515;GO:0005576;GO:0010952;GO:0005518;GO:0008201;GO:0070062;GO:0062023;GO:0016504;GO:0007275;GO:0005201;GO:0006508;GO:1990830	protein binding;extracellular space;heparin binding;peptidase activator activity;collagen binding;extracellular region;positive regulation of peptidase activity;extracellular exosome;collagen-containing extracellular matrix;multicellular organism development;extracellular matrix structural constituent;proteolysis;cellular response to leukemia inhibitory factor	3D-structure;Direct protein sequencing;Disulfide bond;Glycoprotein;Phosphoprotein;Reference proteome;Repeat;Secreted;Signal	R-HSA-1474244;R-HSA-1474290;R-HSA-1650814;R-HSA-2022090;R-HSA-2243919	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils
COQ8B	positive	RECQL5	ENSG00000108469	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00004322;WBGene00001865;WBGene00006944;WBGene00019334	WBGene00004322(0)			GO:0003676;GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0005829;GO:0016787;GO:0051301;GO:0006281;GO:0006974;GO:0007049;GO:0004386;GO:0006260;GO:0003678;GO:0006310;GO:0005654;GO:0032508;GO:0051304;GO:0000278;GO:0000724;GO:0034244;GO:0009378;GO:0006268;GO:0005694;GO:0000993;GO:0006259;GO:0016591;GO:0035690;GO:0072757;GO:1990414;GO:2000042	ATP binding;nucleic acid binding;DNA recombination;helicase activity;nucleus;cytoplasm;nucleotide binding;nucleoplasm;cytosol;hydrolase activity;cell division;DNA repair;cellular response to DNA damage stimulus;cell cycle;DNA replication;DNA helicase activity;chromosome separation;mitotic cell cycle;double-strand break repair via homologous recombination;DNA duplex unwinding;negative regulation of transcription elongation from RNA polymerase II promoter;four-way junction helicase activity;3'-5' DNA helicase activity;DNA unwinding involved in DNA replication;chromosome;RNA polymerase II complex binding;DNA metabolic process;RNA polymerase II, holoenzyme;cellular response to drug;cellular response to camptothecin;replication-born double-strand break repair via sister chromatid exchange;negative regulation of double-strand break repair via homologous recombination	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Cytoplasm;DNA damage;DNA repair;DNA replication;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	KAT2A	ENSG00000108773	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00021636	WBGene00017423(0);WBGene00001470(0)			GO:0005634;GO:0005737;GO:0016740;GO:0006355;GO:0016746;GO:0005694;GO:0005615;GO:0005856;GO:0005515;GO:0004402;GO:0016573;GO:0008080;GO:0003713;GO:0016578;GO:0005813;GO:0005815;GO:0001816;GO:0045944;GO:0005654;GO:0007507;GO:0016579;GO:0003682;GO:0016032;GO:0007616;GO:0045815;GO:0008134;GO:0033276;GO:0006357;GO:0048167;GO:0042826;GO:0043966;GO:0005671;GO:0006338;GO:0060173;GO:0030914;GO:0046600;GO:0018393;GO:0050863;GO:0106077;GO:0045252;GO:0061733;GO:0010484;GO:0016407;GO:0019903;GO:0043997;GO:0106078;GO:0001701;GO:0001756;GO:0001843;GO:0007399;GO:0008283;GO:0014070;GO:0021537;GO:0022037;GO:0030901;GO:0031346;GO:0031647;GO:0031667;GO:0035066;GO:0035264;GO:0035948;GO:0043983;GO:0044154;GO:0045589;GO:0048312;GO:0071356;GO:0071929;GO:1990090;GO:2000727;GO:0000123;GO:0000790;GO:0072686	regulation of transcription, DNA-templated;nucleus;protein binding;N-acetyltransferase activity;histone acetyltransferase activity;histone acetylation;cytoplasm;transferase activity;transferase activity, transferring acyl groups;cytoskeleton;chromosome;extracellular space;transcription coactivator activity;histone deubiquitination;positive regulation of transcription, DNA-templated;centrosome;microtubule organizing center;cytokine production;positive regulation of transcription by RNA polymerase II;nucleoplasm;heart development;protein deubiquitination;regulation of stem cell population maintenance;chromatin binding;viral process;long-term memory;positive regulation of gene expression, epigenetic;transcription factor binding;transcription factor TFTC complex;regulation of transcription by RNA polymerase II;regulation of synaptic plasticity;histone acetyltransferase complex;histone deacetylase binding;histone H3 acetylation;Ada2/Gcn5/Ada3 transcription activator complex;chromatin remodeling;limb development;STAGA complex;negative regulation of centriole replication;internal peptidyl-lysine acetylation;regulation of T cell activation;histone succinylation;oxoglutarate dehydrogenase complex;peptide-lysine-N-acetyltransferase activity;regulation of cartilage development;H3 histone acetyltransferase activity;acetyltransferase activity;protein phosphatase binding;histone acetyltransferase activity (H4-K12 specific);histone succinyltransferase activity;histone glutaryltransferase activity;in utero embryonic development;somitogenesis;neural tube closure;nervous system development;cell population proliferation;response to organic cyclic compound;telencephalon development;metencephalon development;midbrain development;positive regulation of cell projection organization;regulation of protein stability;response to nutrient levels;positive regulation of histone acetylation;multicellular organism growth;histone H4-K12 acetylation;histone H3-K14 acetylation;regulation of regulatory T cell differentiation;positive regulation of gluconeogenesis;intracellular distribution of mitochondria;cellular response to tumor necrosis factor;alpha-tubulin acetylation;peptidyl-lysine glutarylation;regulation of bone development;cellular response to nerve growth factor stimulus;positive regulation of cardiac muscle cell differentiation;nuclear chromatin;mitotic spindle	3D-structure;Acetylation;Acyltransferase;Alternative splicing;Bromodomain;Chromosome;Cytoplasm;Cytoskeleton;Host-virus interaction;Isopeptide bond;Nucleus;Reference proteome;Transcription;Transcription regulation;Transferase;Ubl conjugation	R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-5688426;R-HSA-5689880;R-HSA-157118;R-HSA-1980143;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-9012852;R-HSA-8878159;R-HSA-9013694;R-HSA-212165;R-HSA-3247509;R-HSA-4839726;R-HSA-1912422;R-HSA-1912408;R-HSA-3214847;R-HSA-5250913;R-HSA-5250924;R-HSA-73762;R-HSA-73854;R-HSA-73864;R-HSA-2122947;R-HSA-350054;R-HSA-186712;R-HSA-9013508;R-HSA-210744;R-HSA-9013695;R-HSA-8941856	Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;Diseases of signal transduction;Deubiquitination;Ub-specific processing proteases;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH3;Transcriptional regulation by RUNX3;Signaling by NOTCH4;Epigenetic regulation of gene expression;Chromatin modifying enzymes;Chromatin organization;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;HATs acetylate histones;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;NOTCH1 Intracellular Domain Regulates Transcription;Notch-HLH transcription pathway;Regulation of beta-cell development;NOTCH3 Intracellular Domain Regulates Transcription;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH4 Intracellular Domain Regulates Transcription;RUNX3 regulates NOTCH signaling
COQ8B	positive	NAGLU	ENSG00000108784	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00010722	WBGene00010722(1)		Autosomal dominant Charcot-Marie-Tooth disease type 2V;Sanfilippo syndrome type B;MUCOPOLYSACCHARIDOSIS TYPE 3B;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2V;MUCOPOLYSACCHARIDOSIS TYPE IIIB	GO:0016787;GO:0008152;GO:0016798;GO:0005764;GO:0007040;GO:0021680;GO:0042474;GO:0045475;GO:0046548;GO:0060119;GO:0070062;GO:0007399;GO:0043202;GO:0006027;GO:0004561	hydrolase activity;metabolic process;hydrolase activity, acting on glycosyl bonds;lysosome;lysosome organization;cerebellar Purkinje cell layer development;middle ear morphogenesis;locomotor rhythm;retinal rod cell development;inner ear receptor cell development;extracellular exosome;nervous system development;lysosomal lumen;glycosaminoglycan catabolic process;alpha-N-acetylglucosaminidase activity	3D-structure;Charcot-Marie-Tooth disease;Direct protein sequencing;Disease mutation;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Mucopolysaccharidosis;Neurodegeneration;Neuropathy;Polymorphism;Reference proteome;Signal	R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-1630316;R-HSA-1638091;R-HSA-2024096;R-HSA-5668914;R-HSA-5663084;R-HSA-2206281;R-HSA-2206282	Metabolism;Disease;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG degradation;Diseases of metabolism;Diseases of carbohydrate metabolism;Mucopolysaccharidoses;MPS IIIB - Sanfilippo syndrome B
COQ8B	positive	RAB34	ENSG00000109113	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00016970;WBGene00022177				GO:0003924;GO:0005525;GO:0005737;GO:0016020;GO:0015031;GO:0000166;GO:0005794;GO:0042995;GO:0005515;GO:0048471;GO:0031410;GO:0005795;GO:0006886;GO:0005929;GO:0070062;GO:0030670;GO:0030030;GO:0045880;GO:0032482;GO:0006897;GO:0017160;GO:0030742;GO:0031982;GO:0031985;GO:0072659;GO:0090385;GO:0032418;GO:0045335;GO:0019882;GO:0090382;GO:0043001;GO:0005634;GO:0005730	GTP binding;GTPase activity;cytoplasm;membrane;protein transport;nucleotide binding;Golgi apparatus;cell projection;protein binding;perinuclear region of cytoplasm;cytoplasmic vesicle;Golgi stack;intracellular protein transport;cilium;extracellular exosome;phagocytic vesicle membrane;cell projection organization;positive regulation of smoothened signaling pathway;Rab protein signal transduction;endomembrane system;endocytosis;Ral GTPase binding;GTP-dependent protein binding;vesicle;Golgi cisterna;protein localization to plasma membrane;phagosome-lysosome fusion;lysosome localization;phagocytic vesicle;antigen processing and presentation;phagosome maturation;Golgi to plasma membrane protein transport;nucleus;nucleolus	Alternative splicing;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Acetylation;Alternative splicing;Cell projection;Cilium biogenesis/degradation;Cytoplasm;Cytoplasmic vesicle;GTP-binding;Golgi apparatus;Lipoprotein;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-392499;R-HSA-597592;R-HSA-8873719	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
COQ8B	positive	MVK	ENSG00000110921	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00021534	WBGene00021534(1)		Disseminated superficial actinic porokeratosis;Hyperimmunoglobulinemia D with periodic fever;MEVALONIC ACIDURIA;Porokeratosis of Mibelli;HYPER-IgD SYNDROME;MEVALONIC ACIDURIA;POROKERATOSIS 3 MULTIPLE TYPES	GO:0005524;GO:0016301;GO:0016310;GO:0050728;GO:0005737;GO:0046872;GO:0000166;GO:0016740;GO:0006629;GO:0005829;GO:0006694;GO:0008202;GO:0008299;GO:0016126;GO:0005515;GO:0000287;GO:0008203;GO:0005777;GO:0042802;GO:0004496;GO:0006695;GO:0019287;GO:0045540	ATP binding;intracellular membrane-bounded organelle;cytosol;kinase activity;phosphorylation;cytoplasm;isoprenoid biosynthetic process;mevalonate kinase activity;negative regulation of inflammatory response;metal ion binding;nucleotide binding;transferase activity;lipid metabolic process;steroid biosynthetic process;steroid metabolic process;sterol biosynthetic process;protein binding;identical protein binding;magnesium ion binding;cholesterol metabolic process;peroxisome;cholesterol biosynthetic process;isopentenyl diphosphate biosynthetic process, mevalonate pathway;regulation of cholesterol biosynthetic process	3D-structure;ATP-binding;Cataract;Cholesterol biosynthesis;Cholesterol metabolism;Cytoplasm;Disease mutation;Kinase;Lipid biosynthesis;Lipid metabolism;Magnesium;Metal-binding;Nucleotide-binding;Peroxisome;Polymorphism;Reference proteome;Steroid biosynthesis;Steroid metabolism;Sterol biosynthesis;Sterol metabolism;Transferase	R-HSA-1430728;R-HSA-556833;R-HSA-8957322;R-HSA-1655829;R-HSA-2426168;R-HSA-191273	Metabolism;Metabolism of lipids;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Activation of gene expression by SREBF (SREBP);Cholesterol biosynthesis
COQ8B	positive	MECR	ENSG00000116353	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00012375;WBGene00012970	WBGene00012375(1)		MEPAN syndrome;Childhood-Onset Dystonia and Optic Atrophy;DYSTONIA CHILDHOOD-ONSET WITH OPTIC ATROPHY AND BASAL GANGLIAABNORMALITIES	GO:0005634;GO:0005737;GO:0016491;GO:0055114;GO:0005739;GO:0006629;GO:0006631;GO:0006633;GO:0005759;GO:0006635;GO:0019166	oxidation-reduction process;oxidoreductase activity;nucleus;cytoplasm;mitochondrion;lipid metabolic process;fatty acid metabolic process;fatty acid biosynthetic process;mitochondrial matrix;fatty acid beta-oxidation;trans-2-enoyl-CoA reductase (NADPH) activity	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Disease mutation;Dystonia;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Mitochondrion;NADP;Nucleus;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289;R-HSA-77286;R-HSA-77346	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA
COQ8B	positive	IPO13	ENSG00000117408	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00011807	WBGene00011807(0)			GO:0005634;GO:0005737;GO:0006886;GO:0015031;GO:0005515;GO:0008536;GO:0006606	intracellular protein transport;Ran GTPase binding;nucleus;cytoplasm;protein transport;protein binding;protein import into nucleus	3D-structure;Cytoplasm;Nucleus;Protein transport;Reference proteome;Repeat;Transport		
COQ8B	positive	HDHD3	ENSG00000119431	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00010481	WBGene00010481(1)			GO:0016787;GO:0005515	hydrolase activity;intracellular membrane-bounded organelle;nucleolus;protein binding	3D-structure;Acetylation;Polymorphism;Reference proteome		
COQ8B	positive	NT5C	ENSG00000125458	COQ8B	1	COQ8B	1	0.00679015613713607					GO:0016311;GO:0008253;GO:0009264;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0005829;GO:0016787;GO:0009117;GO:0070062;GO:0006195;GO:0046135;GO:0008252;GO:0019103;GO:0009223;GO:0016791	5'-nucleotidase activity;deoxyribonucleotide catabolic process;dephosphorylation;nucleus;cytoplasm;metal ion binding;nucleotide binding;cytosol;hydrolase activity;nucleotide metabolic process;identical protein binding;extracellular exosome;purine nucleotide catabolic process;pyrimidine nucleoside catabolic process;nucleotidase activity;pyrimidine nucleotide binding;pyrimidine deoxyribonucleotide catabolic process;phosphatase activity	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Hydrolase;Magnesium;Metal-binding;Nucleotide metabolism;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-74259;R-HSA-8956319;R-HSA-73621	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism;Pyrimidine catabolism
COQ8B	positive	CHTF18	ENSG00000127586	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00010676	WBGene00010676(0)			GO:0005634;GO:0016020;GO:0000166;GO:0005524;GO:0005829;GO:0005654;GO:0003677;GO:0032508;GO:0007049;GO:0006260;GO:0005515;GO:0017116;GO:0003689;GO:1900264;GO:0031390	ATP binding;nucleus;membrane;nucleotide binding;nucleoplasm;cytosol;DNA binding;DNA duplex unwinding;cell cycle;DNA replication;protein binding;single-stranded DNA helicase activity;DNA clamp loader activity;positive regulation of DNA-directed DNA polymerase activity;Ctf18 RFC-like complex	ATP-binding;Alternative splicing;Cell cycle;DNA replication;DNA-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	KRI1	ENSG00000129347	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00010044	WBGene00010044(1)			GO:0003723;GO:0005730;GO:0030686;GO:0000447	RNA binding;nucleolus;90S preribosome;endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	positive	ECSIT	ENSG00000130159	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00021202	WBGene00021202(0)			GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005739;GO:0055114;GO:0005515;GO:0002376;GO:0045087;GO:0032981;GO:0005743;GO:0016651;GO:0051341	nucleus;cytoplasm;nucleoplasm;cytosol;mitochondrion;protein binding;immune system process;innate immune response;regulation of protein complex stability;mitochondrial respiratory chain complex I assembly;mitochondrial inner membrane;regulation of oxidoreductase activity	Alternative splicing;Cytoplasm;Immunity;Innate immunity;Mitochondrion;Nucleus;Polymorphism;Reference proteome;Transit peptide	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-166016;R-HSA-166058;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-975138;R-HSA-975155;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-6799198;R-HSA-168142;R-HSA-168176;R-HSA-975871	Innate Immune System;Immune System;Metabolism;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;MyD88 cascade initiated on plasma membrane
COQ8B	positive	MACROD1	ENSG00000133315	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00007106				GO:0005634;GO:0005654;GO:0016787;GO:0005515;GO:0016798;GO:0006974;GO:0019213;GO:0140293;GO:0042278;GO:0051725;GO:0140291	nucleus;nucleoplasm;hydrolase activity;protein binding;hydrolase activity, acting on glycosyl bonds;cellular response to DNA damage stimulus;deacetylase activity;ADP-ribosylglutamate hydrolase activity;purine nucleoside metabolic process;protein de-ADP-ribosylation;peptidyl-glutamate ADP-deribosylation	3D-structure;Acetylation;Chromosomal rearrangement;DNA damage;Hydrolase;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation		
COQ8B	positive	WDR74	ENSG00000133316	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00011538	WBGene00011538(1)			GO:0005634;GO:0005730;GO:0005515;GO:0006364;GO:0030687;GO:0042273;GO:0000176;GO:0016070;GO:0001825	protein binding;nucleolus;ribosomal large subunit biogenesis;nucleus;nucleoplasm;rRNA processing;preribosome, large subunit precursor;nuclear exosome (RNase complex);RNA metabolic process;blastocyst formation	Alternative splicing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat		
COQ8B	positive	KRBA1	ENSG00000133619	COQ8B	1	COQ8B	1	0.00679015613713607					GO:0003676;GO:0006355;GO:0005622;GO:0003674;GO:0008150;GO:0005575	regulation of transcription, DNA-templated;nucleic acid binding;molecular_function;biological_process;cellular_component	Alternative splicing;Coiled coil;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ8B	positive	SLC37A4	ENSG00000137700	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00009811;WBGene00016588	WBGene00010931(0);WBGene00011185(0);WBGene00012443(0);WBGene00019187(0);WBGene00021157(0);WBGene00021158(0);WBGene00019655(0);WBGene00020700(0);WBGene00011556(0);WBGene00010755(0);WBGene00018920(0);WBGene00021226(0);WBGene00018918(0);WBGene00021223(0);WBGene00018429(0);WBGene00001135(0);WBGene00015272(0);WBGene00021220(0);WBGene00008000(0);WBGene00015271(0);WBGene00021219(0);WBGene00020584(0);WBGene00016003(0);WBGene00020583(0);WBGene00008677(0);WBGene00007669(0);WBGene00020697(0);WBGene00020698(0);WBGene00020699(0);WBGene00302978(0)		Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib;GLYCOGEN STORAGE DISEASE Ib;GLYCOGEN STORAGE DISEASE Ic	GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005887;GO:0015152;GO:0001780;GO:0001816;GO:0002318;GO:0005977;GO:0006089;GO:0006641;GO:0006874;GO:0007584;GO:0008202;GO:0009749;GO:0014070;GO:0015760;GO:0030593;GO:0032682;GO:0035166;GO:0042593;GO:0042632;GO:0043085;GO:0045730;GO:0043231	integral component of membrane;transmembrane transporter activity;transmembrane transport;membrane;cell;glucose-6-phosphate transmembrane transporter activity;neutrophil homeostasis;cytokine production;myeloid progenitor cell differentiation;glycogen metabolic process;lactate metabolic process;triglyceride metabolic process;cellular calcium ion homeostasis;response to nutrient;steroid metabolic process;response to glucose;response to organic cyclic compound;glucose-6-phosphate transport;neutrophil chemotaxis;negative regulation of chemokine production;post-embryonic hemopoiesis;glucose homeostasis;cholesterol homeostasis;positive regulation of catalytic activity;respiratory burst;intracellular membrane-bounded organelle			
COQ8B	positive	IMPA2	ENSG00000141401	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00008765				GO:0046854;GO:0046872;GO:0016787;GO:0005515;GO:0008934;GO:0052832;GO:0052833;GO:0052834;GO:0006021;GO:0046855;GO:0007165;GO:0005829;GO:0005737;GO:0006796;GO:0042803;GO:0043647	phosphatidylinositol phosphorylation;inositol phosphate dephosphorylation;inositol monophosphate 1-phosphatase activity;metal ion binding;hydrolase activity;protein binding;inositol monophosphate 3-phosphatase activity;inositol monophosphate 4-phosphatase activity;inositol monophosphate phosphatase activity;inositol biosynthetic process;signal transduction;cytosol;cytoplasm;phosphate-containing compound metabolic process;protein homodimerization activity;inositol metabolic process;inositol phosphate metabolic process	3D-structure;Alternative splicing;Hydrolase;Magnesium;Metal-binding;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-1483249;R-HSA-1855183	Metabolism;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
COQ8B	positive	LMTK3	ENSG00000142235	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00004395				GO:0005524;GO:0006468;GO:0004672;GO:0004713;GO:0016020;GO:0016021;GO:0046872;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0005794;GO:0042995;GO:0005515;GO:0000139;GO:0030425;GO:0030424;GO:0003674;GO:0005575;GO:0010923	ATP binding;protein phosphorylation;protein kinase activity;protein tyrosine kinase activity;membrane;integral component of membrane;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;Golgi apparatus;cell projection;protein binding;Golgi membrane;dendrite;axon;molecular_function;cellular_component;negative regulation of phosphatase activity	ATP-binding;Cell projection;Glycoprotein;Golgi apparatus;Kinase;Magnesium;Membrane;Metal-binding;Methylation;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Signal;Transferase;Transmembrane;Transmembrane helix		
COQ8B	positive	SEMA6C	ENSG00000143434	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00004889;WBGene00004890	WBGene00004889(0)			GO:0016020;GO:0016021;GO:0005886;GO:0007275;GO:0030154;GO:0005615;GO:0030215;GO:0007399;GO:0005887;GO:0007411;GO:0045499;GO:0001755;GO:0030335;GO:0048843;GO:0050919;GO:0071526;GO:0005515	protein binding;semaphorin receptor binding;membrane;integral component of membrane;plasma membrane;multicellular organism development;cell differentiation;extracellular space;nervous system development;integral component of plasma membrane;axon guidance;chemorepellent activity;neural crest cell migration;positive regulation of cell migration;negative regulation of axon extension involved in axon guidance;negative chemotaxis;semaphorin-plexin signaling pathway	Alternative splicing;Cell membrane;Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Membrane;Neurogenesis;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ8B	positive	VPS51	ENSG00000149823	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00015176	WBGene00015176(1)			GO:0016021;GO:0015031;GO:0005794;GO:0005829;GO:0043231;GO:0005730;GO:0006869;GO:0006914;GO:0005768;GO:0007030;GO:0016020;GO:0005515;GO:0003674;GO:0042147;GO:0055037;GO:0032588;GO:0048193;GO:0032456;GO:0000938;GO:1990745;GO:0007041;GO:0005802	integral component of membrane;protein transport;Golgi apparatus;cytosol;intracellular membrane-bounded organelle;nucleolus;endosome;lipid transport;autophagy;protein binding;Golgi organization;membrane;molecular_function;trans-Golgi network;retrograde transport, endosome to Golgi;recycling endosome;trans-Golgi network membrane;Golgi vesicle transport;endocytic recycling;GARP complex;EARP complex;lysosomal transport	3D-structure;Acetylation;Alternative splicing;Coiled coil;Disease mutation;Endosome;Golgi apparatus;Lipid transport;Mental retardation;Phosphoprotein;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-199991;R-HSA-6811442;R-HSA-6811440	Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Retrograde transport at the Trans-Golgi-Network
COQ8B	positive	CFAP410	ENSG00000160226	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00017320	WBGene00017320(0)		Amyotrophic lateral sclerosis;Cone rod dystrophy;Axial Spondylometaphyseal Dysplasia;RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA;Spondylometaphyseal dysplasia axial	GO:0005737;GO:0005739;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0006974;GO:0036064;GO:0003674;GO:0007010;GO:0030030;GO:0060271;GO:0001750;GO:0008360;GO:0032391;GO:0042769	protein binding;cytoplasm;intracellular membrane-bounded organelle;cytosol;mitochondrion;cytoskeleton;plasma membrane;cell projection;cellular response to DNA damage stimulus;ciliary basal body;molecular_function;cytoskeleton organization;cell projection organization;cilium assembly;photoreceptor outer segment;regulation of cell shape;photoreceptor connecting cilium;DNA damage response, detection of DNA damage;cilium organization	Alternative splicing;Cell projection;Ciliopathy;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;DNA damage;Disease mutation;Dwarfism;Leucine-rich repeat;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ8B	positive	NAXE	ENSG00000163382	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00012476	WBGene00012476(0)		Lethal Neurometabolic Disorder of Early Childhood;ENCEPHALOPATHY PROGRESSIVE EARLY-ONSET WITH BRAIN EDEMA AND/ORLEUKOENCEPHALOPATHY 1	GO:0043231;GO:0005829;GO:0005654;GO:0005615;GO:0046872;GO:0000166;GO:0016853;GO:0005739;GO:0005576;GO:0046496;GO:0005515;GO:0070062;GO:0005759;GO:0052856;GO:0052857;GO:0034356;GO:0042802;GO:0005929;GO:0044297	intracellular membrane-bounded organelle;nucleoplasm;cytosol;extracellular space;metal ion binding;nucleotide binding;isomerase activity;mitochondrion;extracellular region;nicotinamide nucleotide metabolic process;protein binding;extracellular exosome;mitochondrial matrix;NADHX epimerase activity;NADPHX epimerase activity;NAD biosynthesis via nicotinamide riboside salvage pathway;identical protein binding;cilium;cell body	Alternative splicing;Disease mutation;Isomerase;Metal-binding;Mitochondrion;NAD;NADP;Neurodegeneration;Nucleotide-binding;Phosphoprotein;Polymorphism;Potassium;Reference proteome;Secreted;Transit peptide	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196807;R-HSA-197264	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Nicotinate metabolism;Nicotinamide salvaging
COQ8B	positive	SLC25A6	ENSG00000169100	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00006439;WBGene00007057;WBGene00010485;WBGene00020140;WBGene00008147;WBGene00011105;WBGene00017770				GO:0005634;GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005739;GO:0005743;GO:0005744;GO:0005515;GO:0006915;GO:0016032;GO:0050796;GO:0015866;GO:0005471;GO:0015867;GO:0006626	transmembrane transporter activity;transmembrane transport;mitochondrial inner membrane;nucleus;membrane;integral component of membrane;mitochondrion;TIM23 mitochondrial import inner membrane translocase complex;protein binding;apoptotic process;viral process;regulation of insulin secretion;ADP transport;ATP:ADP antiporter activity;ATP transport;protein targeting to mitochondrion	Acetylation;Apoptosis;Direct protein sequencing;Host-virus interaction;Membrane;Methylation;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-425407;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-168253;R-HSA-168254;R-HSA-176033;R-HSA-9609507;R-HSA-425397;R-HSA-83936;R-HSA-1268020;R-HSA-168277;R-HSA-180897	Transport of small molecules;SLC-mediated transmembrane transport;Disease;HIV Infection;Infectious disease;Host Interactions of HIV factors;Host Interactions with Influenza Factors;Influenza Infection;Interactions of Vpr with host cellular proteins;Protein localization;Transport of vitamins, nucleosides, and related molecules;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane;Mitochondrial protein import;Influenza Virus Induced Apoptosis;Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
COQ8B	positive	SCAND1	ENSG00000171222	COQ8B	1	COQ8B	1	0.00679015613713607		WBGene00003033(0);WBGene00001824(0);WBGene00012385(0)			GO:0005634;GO:0006355;GO:0003700;GO:1903508;GO:0005515;GO:0042802;GO:0003713	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleus;positive regulation of nucleic acid-templated transcription;protein binding;identical protein binding;transcription coactivator activity	Nucleus;Reference proteome		
COQ8B	positive	ZNF584	ENSG00000171574	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00044651				GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding	DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ8B	positive	THOP1	ENSG00000172009	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00013997	WBGene00013997(0)			GO:0005737;GO:0046872;GO:0016787;GO:0008233;GO:0006508;GO:0004222;GO:0008237;GO:0005829;GO:0000209;GO:0006518;GO:0005758;GO:0042277	proteolysis;metalloendopeptidase activity;metallopeptidase activity;cytoplasm;metal ion binding;hydrolase activity;peptidase activity;cytosol;protein polyubiquitination;peptide metabolic process;mitochondrial intermembrane space;peptide binding	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Hydrolase;Metal-binding;Metalloprotease;Phosphoprotein;Protease;Reference proteome;Zinc	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ8B	positive	CTSF	ENSG00000174080	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00007055;WBGene00000776;WBGene00019986	WBGene00000784(0);WBGene00000785(0);WBGene00013076(0);WBGene00013072(0);WBGene00013764(0);WBGene00009158(0);WBGene00019314(0);WBGene00016306(0);WBGene00016300(0);WBGene00044760(0);WBGene00022189(0);WBGene00019986(0);WBGene00007055(0);WBGene00000782(0);WBGene00000781(0)		CLN13 disease;CEROID LIPOFUSCINOSIS NEURONAL 13	GO:0016787;GO:0008233;GO:0008234;GO:0006508;GO:0005764;GO:0005615;GO:0070062;GO:0004197;GO:0062023;GO:0019886;GO:0043202;GO:1903561;GO:0051603	proteolysis;cysteine-type peptidase activity;hydrolase activity;peptidase activity;lysosome;extracellular space;extracellular exosome;cysteine-type endopeptidase activity;collagen-containing extracellular matrix;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal lumen;extracellular vesicle;proteolysis involved in cellular protein catabolic process	3D-structure;Disease mutation;Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Neurodegeneration;Neuronal ceroid lipofuscinosis;Polymorphism;Protease;Reference proteome;Signal;Thiol protease;Zymogen	R-HSA-1280218;R-HSA-168256;R-HSA-2132295	Adaptive Immune System;Immune System;MHC class II antigen presentation
COQ8B	positive	PELI3	ENSG00000174516	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00017766	WBGene00017766(1)			GO:0016740;GO:0016567;GO:0005515;GO:0061630;GO:0000209;GO:0008063;GO:0008592;GO:0005829;GO:0070498;GO:0070534;GO:0010804;GO:2001237	ubiquitin protein ligase activity;protein polyubiquitination;regulation of Toll signaling pathway;transferase activity;protein ubiquitination;protein binding;Toll signaling pathway;cytosol;interleukin-1-mediated signaling pathway;protein K63-linked ubiquitination;negative regulation of tumor necrosis factor-mediated signaling pathway;negative regulation of extrinsic apoptotic signaling pathway	Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation pathway	R-HSA-168249;R-HSA-168256;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-9020702;R-HSA-166016;R-HSA-166058;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-975138;R-HSA-975155;R-HSA-168142;R-HSA-168176;R-HSA-975871;R-HSA-937039;R-HSA-975144	Innate Immune System;Immune System;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;MyD88 cascade initiated on plasma membrane;IRAK1 recruits IKK complex;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
COQ8B	positive	TP53I11	ENSG00000175274	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00021185	WBGene00021185(0)			GO:0016020;GO:0016021;GO:0008285	membrane;integral component of membrane;negative regulation of cell population proliferation	Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	positive	ACSF3	ENSG00000176715	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00016849;WBGene00018269	WBGene00016849(1);WBGene00018269(0)		Combined malonic and methylmalonic acidemia;Combined malonic and methylmalonic aciduria	GO:0003824;GO:0000166;GO:0005524;GO:0005739;GO:0006629;GO:0006631;GO:0006633;GO:0016874;GO:0035338;GO:0005759;GO:0016878;GO:0031957;GO:0090409;GO:0090410	catalytic activity;nucleotide binding;ATP binding;mitochondrion;lipid metabolic process;fatty acid metabolic process;fatty acid biosynthetic process;ligase activity;long-chain fatty-acyl-CoA biosynthetic process;mitochondrial matrix;acid-thiol ligase activity;very long-chain fatty acid-CoA ligase activity;malonyl-CoA synthetase activity;malonate catabolic process	ATP-binding;Fatty acid metabolism;Ligase;Lipid metabolism;Mitochondrion;Nucleotide-binding;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-75105;R-HSA-75876;R-HSA-8978868	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
COQ8B	positive	SHMT1	ENSG00000176974	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00003214	WBGene00003214(1)			GO:0005737;GO:0005634;GO:0016740;GO:0005829;GO:0003824;GO:0042803;GO:0006730;GO:0005515;GO:0030170;GO:0004372;GO:0019264;GO:0035999;GO:0042802;GO:0070062;GO:0000900;GO:0008270;GO:0051289;GO:0051262;GO:0048027;GO:0046655;GO:0045329;GO:0016597;GO:0017148;GO:0046653;GO:0009113;GO:0006565;GO:0008732;GO:0050897;GO:0070905;GO:0006231;GO:0006544;GO:0006545;GO:0006563;GO:1904482;GO:1990830;GO:0004843;GO:0016579	catalytic activity;pyridoxal phosphate binding;glycine hydroxymethyltransferase activity;glycine biosynthetic process from serine;tetrahydrofolate interconversion;cytoplasm;transferase activity;nucleoplasm;cytosol;protein homodimerization activity;one-carbon metabolic process;protein binding;nucleus;identical protein binding;extracellular exosome;translation repressor activity, mRNA regulatory element binding;zinc ion binding;protein homotetramerization;purine nucleobase biosynthetic process;mRNA 5'-UTR binding;folic acid metabolic process;carnitine biosynthetic process;amino acid binding;negative regulation of translation;tetrahydrofolate metabolic process;L-serine catabolic process;L-allo-threonine aldolase activity;small molecule binding;cobalt ion binding;serine binding;dTMP biosynthetic process;glycine metabolic process;glycine biosynthetic process;L-serine metabolic process;cellular response to tetrahydrofolate;cellular response to leukemia inhibitory factor;thiol-dependent ubiquitin-specific protease activity;protein deubiquitination	3D-structure;Acetylation;Alternative splicing;Cytoplasm;One-carbon metabolism;Polymorphism;Pyridoxal phosphate;Reference proteome;Transferase	R-HSA-1430728;R-HSA-71291;R-HSA-196854;R-HSA-196849;R-HSA-196757;R-HSA-71262	Metabolism;Metabolism of amino acids and derivatives;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Metabolism of folate and pterines;Carnitine synthesis
COQ8B	positive	DMAP1	ENSG00000178028	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00013676	WBGene00013676(1)			GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0006325;GO:0006281;GO:0005515;GO:0045892;GO:0006338;GO:0035267;GO:0043486;GO:0000812;GO:0000122;GO:0003714;GO:0040008;GO:0042307;GO:0043967;GO:0006306;GO:0043968;GO:0001103;GO:0045471;GO:0005657	nucleus;DNA repair;chromatin remodeling;negative regulation of transcription, DNA-templated;NuA4 histone acetyltransferase complex;histone H4 acetylation;histone H2A acetylation;cytoplasm;nucleoplasm;cytosol;chromatin organization;protein binding;histone exchange;Swr1 complex;negative regulation of transcription by RNA polymerase II;transcription corepressor activity;regulation of growth;positive regulation of protein import into nucleus;DNA methylation;RNA polymerase II repressing transcription factor binding;response to ethanol;replication fork	3D-structure;Activator;Chromatin regulator;Coiled coil;Cytoplasm;Direct protein sequencing;Growth regulation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
COQ8B	positive	TSSK6	ENSG00000178093	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00012638;WBGene00015230;WBGene00044388;WBGene00012207;WBGene00017737	WBGene00044388(0);WBGene00012638(0);WBGene00015230(0)			GO:0005634;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005515;GO:0007275;GO:0000287;GO:0030154;GO:0007283;GO:0005737;GO:0035556;GO:0035092;GO:0044877;GO:0018105	nucleus;metal ion binding;nucleotide binding;protein kinase activity;protein serine/threonine kinase activity;ATP binding;kinase activity;transferase activity;protein phosphorylation;phosphorylation;protein binding;multicellular organism development;magnesium ion binding;cell differentiation;spermatogenesis;cytoplasm;intracellular signal transduction;sperm chromatin condensation;protein-containing complex binding;peptidyl-serine phosphorylation	ATP-binding;Developmental protein;Differentiation;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Spermatogenesis;Transferase;Ubl conjugation		
COQ8B	positive	CYC1	ENSG00000179091	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00000869	WBGene00000869(1)		Isolated complex III deficiency;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 6;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 6	GO:0005634;GO:0016020;GO:0016021;GO:0046872;GO:0055114;GO:0005739;GO:0005743;GO:0070469;GO:0020037;GO:0009055;GO:0006122;GO:0005750;GO:0042776;GO:0045153;GO:0045155;GO:0033762	electron transfer activity;heme binding;nucleus;membrane;integral component of membrane;metal ion binding;nucleoplasm;cytosol;oxidation-reduction process;mitochondrion;mitochondrial inner membrane;nuclear body;respirasome;mitochondrial electron transport, ubiquinol to cytochrome c;mitochondrial respiratory chain complex III;mitochondrial ATP synthesis coupled proton transport;electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity;electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity;response to glucagon	3D-structure;Disease mutation;Electron transport;Heme;Iron;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Polymorphism;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transit peptide;Translocase;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-9609507;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-1268020	Metabolism;Protein localization;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Mitochondrial protein import
COQ8B	positive	CUEDC1	ENSG00000180891	COQ8B	1	COQ8B	1	0.00679015613713607		WBGene00009649(0)			GO:0005515	protein binding	3D-structure;Alternative splicing;Polymorphism;Reference proteome		
COQ8B	positive	CCDC159	ENSG00000183401	COQ8B	1	COQ8B	1	0.00679015613713607							Alternative splicing;Coiled coil;Polymorphism;Reference proteome		
COQ8B	positive	TBL3	ENSG00000183751	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00013143	WBGene00013143(1)			GO:0003723;GO:0005634;GO:0005730;GO:0005515;GO:0006364;GO:0032040;GO:0000462;GO:0034388;GO:0005654	protein binding;rRNA processing;small-subunit processome;RNA binding;nucleus;nucleoplasm;nucleolus;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);Pwp2p-containing subcomplex of 90S preribosome;snoRNA binding	Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;WD repeat	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
COQ8B	positive	THAP7	ENSG00000184436	COQ8B	1	COQ8B	1	0.00679015613713607					GO:0003676;GO:0005634;GO:0016607;GO:0043231;GO:0046872;GO:0003677;GO:0031965;GO:0005694;GO:0005515;GO:0042802;GO:0006357;GO:0000981;GO:0000790;GO:0045892;GO:0047485;GO:0070742	nucleic acid binding;nucleus;nuclear speck;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;DNA binding;nuclear membrane;chromosome;protein binding;identical protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;negative regulation of transcription, DNA-templated;protein N-terminus binding;C2H2 zinc finger domain binding	Chromosome;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ8B	positive	HDDC3	ENSG00000184508	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00014148	WBGene00014148(1)			GO:0046872;GO:0016787;GO:0005515;GO:0008893	metal ion binding;hydrolase activity;protein binding;guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity	3D-structure;Acetylation;Alternative splicing;Hydrolase;Manganese;Metal-binding;Reference proteome		
COQ8B	positive	INTS5	ENSG00000185085	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00013075	WBGene00013075(0)			GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0032039;GO:0005515;GO:0005654;GO:0031965;GO:0042795;GO:0034472;GO:0016180	integrator complex;nucleus;cytoplasm;membrane;integral component of membrane;nucleoplasm;cytosol;protein binding;nuclear membrane;snRNA transcription by RNA polymerase II;snRNA 3'-end processing;snRNA processing	Acetylation;Cytoplasm;Membrane;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-73857;R-HSA-74160;R-HSA-6807505	RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes
COQ8B	positive	GNB1L	ENSG00000185838	COQ8B	1	COQ8B	1	0.00679015613713607					GO:0007186;GO:0003674;GO:0009898;GO:0035556;GO:0035176;GO:0005737;GO:0005515	protein binding;G protein-coupled receptor signaling pathway;molecular_function;cytoplasmic side of plasma membrane;intracellular signal transduction;social behavior;cytoplasm	Alternative splicing;Polymorphism;Reference proteome;Repeat;WD repeat		
COQ8B	positive	FIS1	ENSG00000214253	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00001425;WBGene00001424	WBGene00001424(1);WBGene00001425(1)			GO:0016020;GO:0016021;GO:0005739;GO:0005515;GO:0006915;GO:0005741;GO:0005777;GO:0005778;GO:0000422;GO:0090314;GO:0032991;GO:0051260;GO:0000266;GO:0005783;GO:0001836;GO:0010821;GO:0016559;GO:0043653;GO:0070584;GO:2001244;GO:0007204;GO:0043280;GO:0005779;GO:0008053;GO:0035584;GO:0006626;GO:0032471;GO:0051561;GO:0031307;GO:0090141;GO:0044877;GO:0014850;GO:0031667;GO:0043525;GO:0071333;GO:0071396;GO:0097237;GO:1901653;GO:1902617;GO:1904579;GO:1905395;GO:1990910	protein binding;mitochondrial fission;cell;membrane;integral component of membrane;mitochondrion;apoptotic process;identical protein binding;mitochondrial outer membrane;peroxisome;peroxisomal membrane;integral component of mitochondrial outer membrane;autophagy of mitochondrion;positive regulation of protein targeting to membrane;protein-containing complex;endoplasmic reticulum;release of cytochrome c from mitochondria;regulation of mitochondrion organization;peroxisome fission;mitochondrial fragmentation involved in apoptotic process;mitochondrion morphogenesis;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of cytosolic calcium ion concentration;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;integral component of peroxisomal membrane;mitochondrial fusion;calcium-mediated signaling using intracellular calcium source;protein targeting to mitochondrion;negative regulation of endoplasmic reticulum calcium ion concentration;positive regulation of mitochondrial calcium ion concentration;positive regulation of mitochondrial fission;protein-containing complex binding;response to muscle activity;response to nutrient levels;positive regulation of neuron apoptotic process;cellular response to glucose stimulus;cellular response to lipid;cellular response to toxic substance;cellular response to peptide;response to fluoride;cellular response to thapsigargin;response to flavonoid;response to hypobaric hypoxia	3D-structure;Acetylation;Apoptosis;Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion outer membrane;Peroxisome;Phosphoprotein;Reference proteome;TPR repeat;Transmembrane;Transmembrane helix;Ubl conjugation	R-HSA-9609507;R-HSA-9603798	Protein localization;Class I peroxisomal membrane protein import
COQ8B	positive	ZNF324B	ENSG00000249471	COQ8B	1	COQ8B	1	0.00679015613713607	WBGene00016890;WBGene00021931	WBGene00003933(0)			GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding	Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ8B	positive	SPPL2B	ENSG00000005206	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00007979				GO:0016020;GO:0016021;GO:0005813;GO:0005654;GO:0016787;GO:0005794;GO:0005765;GO:0005886;GO:0042803;GO:0015629;GO:0008233;GO:0006508;GO:0000139;GO:0004190;GO:0005764;GO:0031293;GO:0005768;GO:0005515;GO:0010008;GO:0030660;GO:0006509;GO:0010803;GO:0033619;GO:0050776;GO:0042500;GO:0071458;GO:0071556	integral component of membrane;aspartic-type endopeptidase activity;aspartic endopeptidase activity, intramembrane cleaving;membrane protein intracellular domain proteolysis;membrane;nucleoplasm;plasma membrane;hydrolase activity;endosome;Golgi apparatus;lysosomal membrane;centrosome;protein homodimerization activity;actin cytoskeleton;peptidase activity;proteolysis;Golgi membrane;lysosome;protein binding;endosome membrane;Golgi-associated vesicle membrane;membrane protein ectodomain proteolysis;regulation of tumor necrosis factor-mediated signaling pathway;membrane protein proteolysis;regulation of immune response;integral component of cytoplasmic side of endoplasmic reticulum membrane;integral component of lumenal side of endoplasmic reticulum membrane	Alternative splicing;Cell membrane;Endosome;Glycoprotein;Golgi apparatus;Hydrolase;Lysosome;Membrane;Polymorphism;Protease;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-73887;R-HSA-5357905;R-HSA-75893	Signal Transduction;Death Receptor Signalling;Regulation of TNFR1 signaling;TNF signaling
COQ8B	positive	NISCH	ENSG00000010322	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00008750	WBGene00008750(0)			GO:0005737;GO:0016020;GO:0005886;GO:0005515;GO:0006915;GO:0035091;GO:0042802;GO:0005768;GO:0005769;GO:0005178;GO:0019901;GO:0055037;GO:0005829;GO:0006006;GO:0008217;GO:0016601;GO:0030036;GO:0030336;GO:0032228;GO:0048243	protein binding;phosphatidylinositol binding;integrin binding;cytoplasm;membrane;endosome;plasma membrane;apoptotic process;identical protein binding;early endosome;protein kinase binding;recycling endosome;cytosol;glucose metabolic process;regulation of blood pressure;Rac protein signal transduction;actin cytoskeleton organization;negative regulation of cell migration;regulation of synaptic transmission, GABAergic;norepinephrine secretion	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell membrane;Coiled coil;Cytoplasm;Endosome;Leucine-rich repeat;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat		
COQ8B	positive	FUZ	ENSG00000010361	COQ8B	1	COQ8B	1	0.00977635141774491				Arnold-Chiari malformation type II;Caudal regression sequence;Cervical spina bifida aperta;Cervical spina bifida cystica;Cervicothoracic spina bifida aperta;Cervicothoracic spina bifida cystica;Lumbosacral spina bifida aperta;Lumbosacral spina bifida cystica;Thoracolumbosacral spina bifida aperta;Thoracolumbosacral spina bifida cystica;Total spina bifida aperta;Total spina bifida cystica;Upper thoracic spina bifida aperta;Upper thoracic spina bifida cystica;Neural tube defects susceptibility to	GO:0005737;GO:0015031;GO:0005856;GO:0042995;GO:0005515;GO:0007275;GO:0060271;GO:0070062;GO:0030030;GO:0008285;GO:0090090;GO:0001843;GO:0030336;GO:0045724;GO:0001942;GO:0008589;GO:0048704;GO:1905515;GO:0001736;GO:0010172;GO:0090301;GO:2000314	cytoplasm;protein transport;cytoskeleton;cell projection;protein binding;multicellular organism development;cilium assembly;extracellular exosome;cell projection organization;negative regulation of cell population proliferation;negative regulation of canonical Wnt signaling pathway;neural tube closure;negative regulation of cell migration;positive regulation of cilium assembly;hair follicle development;regulation of smoothened signaling pathway;embryonic skeletal system morphogenesis;non-motile cilium assembly;establishment of planar polarity;embryonic body morphogenesis;negative regulation of neural crest formation;negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation	Alternative splicing;Cell projection;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Developmental protein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-162582;R-HSA-5358351;R-HSA-5610787	Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
COQ8B	positive	LYPLA2	ENSG00000011009	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00010564	WBGene00010564(0)			GO:0005737;GO:0016787;GO:0006629;GO:0006631;GO:0008474;GO:0002084;GO:0005795;GO:0005829;GO:0045296;GO:0070062;GO:0007411;GO:0052689	hydrolase activity;cytoplasm;lipid metabolic process;fatty acid metabolic process;palmitoyl-(protein) hydrolase activity;protein depalmitoylation;prostaglandin catabolic process;Golgi stack;cytosol;cadherin binding;extracellular exosome;axon guidance;carboxylic ester hydrolase activity;lysophospholipase activity;acylglycerol catabolic process	3D-structure;Cytoplasm;Fatty acid metabolism;Hydrolase;Lipid metabolism;Lipoprotein;Palmitate;Phosphoprotein;Reference proteome	R-HSA-1266738;R-HSA-373760;R-HSA-422475	Developmental Biology;L1CAM interactions;Axon guidance
COQ8B	positive	TMEM161A	ENSG00000064545	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00013601	WBGene00013601(0)			GO:0016020;GO:0016021;GO:0005515;GO:0032526;GO:1902230;GO:0034644;GO:0034599;GO:0045739	membrane;integral component of membrane;protein binding;response to retinoic acid;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;cellular response to UV;cellular response to oxidative stress;positive regulation of DNA repair	Alternative splicing;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ8B	positive	COQ9	ENSG00000088682	COQ8B	1	COQ8B	1	0.00977635141774491				Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome;Coenzyme Q10 deficiency;COENZYME Q10 DEFICIENCY PRIMARY 5	GO:0005739;GO:0042803;GO:0006744;GO:0005515;GO:0008289;GO:0006120;GO:0005743	lipid binding;ubiquinone biosynthetic process;mitochondrion;protein homodimerization activity;protein binding;mitochondrial electron transport, NADH to ubiquinone;mitochondrial inner membrane	3D-structure;Acetylation;Alternative splicing;Lipid-binding;Mitochondrion;Primary mitochondrial disease;Reference proteome;Transit peptide;Ubiquinone biosynthesis	R-HSA-1430728;R-HSA-196854;R-HSA-2142789;R-HSA-8978934	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
COQ8B	positive	GGA1	ENSG00000100083	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00000166	WBGene00004109(0);WBGene00008402(0)			GO:0016020;GO:0006886;GO:0015031;GO:0016192;GO:0005829;GO:0043231;GO:0005654;GO:0005794;GO:0005515;GO:0005768;GO:0005769;GO:0003674;GO:0044267;GO:0031901;GO:0010008;GO:0042147;GO:0008104;GO:0032991;GO:0034394;GO:0046982;GO:0043001;GO:0030306;GO:0005622;GO:0006893;GO:0045732;GO:1901998;GO:1903441;GO:0005623	intracellular protein transport;vesicle-mediated transport;membrane;protein transport;Golgi apparatus;cytosol;intracellular membrane-bounded organelle;nucleoplasm;endosome;protein binding;early endosome;molecular_function;cellular protein metabolic process;early endosome membrane;endosome membrane;retrograde transport, endosome to Golgi;protein localization;protein-containing complex;protein localization to cell surface;Golgi to plasma membrane protein transport;ADP-ribosylation factor binding;Golgi to plasma membrane transport;positive regulation of protein catabolic process;toxin transport;protein localization to ciliary membrane	3D-structure;Acetylation;Alternative splicing;Endosome;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Ubl conjugation	R-HSA-5653656;R-HSA-392499;R-HSA-977225;R-HSA-199991;R-HSA-9007101;R-HSA-8854214	Vesicle-mediated transport;Metabolism of proteins;Amyloid fiber formation;Membrane Trafficking;Rab regulation of trafficking;TBC/RABGAPs
COQ8B	positive	RAB36	ENSG00000100228	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00016970;WBGene00022177				GO:0016020;GO:0015031;GO:0000166;GO:0003924;GO:0005525;GO:0005794;GO:0000139;GO:0006886;GO:0032482	GTP binding;GTPase activity;membrane;protein transport;nucleotide binding;Golgi apparatus;Golgi membrane;intracellular protein transport;Rab protein signal transduction;endomembrane system	Alternative splicing;GTP-binding;Golgi apparatus;Lipoprotein;Membrane;Nucleotide-binding;Polymorphism;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811442;R-HSA-8873719;R-HSA-6811438	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB geranylgeranylation;Intra-Golgi traffic
COQ8B	positive	ZMAT5	ENSG00000100319	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0006397;GO:0008380;GO:0005634;GO:0008270;GO:0046872;GO:0005654;GO:0005681;GO:0000398;GO:0005689	zinc ion binding;metal ion binding;mRNA processing;RNA splicing;nucleus;nucleoplasm;spliceosomal complex;mRNA splicing, via spliceosome;U12-type spliceosomal complex	Metal-binding;Nucleus;Reference proteome;Spliceosome;Zinc;Zinc-finger;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72172;R-HSA-72165	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing;mRNA Splicing - Minor Pathway
COQ8B	positive	ARFGAP1	ENSG00000101199	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00010500	WBGene00010500(1)			GO:0005737;GO:0015031;GO:0046872;GO:0005794;GO:0005096;GO:0043547;GO:0005515;GO:0016192;GO:0000139;GO:0005829;GO:0006890;GO:0006888;GO:0036498;GO:0030100;GO:0032012;GO:0045202;GO:0014069	GTPase activator activity;cytoplasm;protein transport;metal ion binding;Golgi apparatus;positive regulation of GTPase activity;protein binding;vesicle-mediated transport;Golgi membrane;cytosol;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;endoplasmic reticulum to Golgi vesicle-mediated transport;IRE1-mediated unfolded protein response;regulation of endocytosis;regulation of ARF protein signal transduction;synapse;postsynaptic density	3D-structure;Acetylation;Alternative splicing;Cytoplasm;ER-Golgi transport;GTPase activation;Golgi apparatus;Metal-binding;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Zinc;Zinc-finger	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-8856828;R-HSA-381038;R-HSA-381070;R-HSA-381119	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Clathrin-mediated endocytosis;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
COQ8B	positive	ZNF629	ENSG00000102870	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00021689;WBGene00001223;WBGene00021931				GO:0003676;GO:0005634;GO:0046872;GO:0003677	nucleic acid binding;nucleus;metal ion binding;DNA binding	DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ8B	positive	ANTKMT	ENSG00000103254	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00012658	WBGene00012658(0)			GO:0016020;GO:0016021;GO:0016740;GO:0008168;GO:0032259;GO:0005739;GO:0016279;GO:0031966;GO:0018023;GO:0018022	protein-lysine N-methyltransferase activity;membrane;integral component of membrane;transferase activity;methyltransferase activity;methylation;mitochondrion;mitochondrial membrane;peptidyl-lysine trimethylation;peptidyl-lysine methylation	Membrane;Methyltransferase;Mitochondrion;Reference proteome;S-adenosyl-L-methionine;Transferase;Transmembrane;Transmembrane helix		
COQ8B	positive	PPP1R37	ENSG00000104866	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00009201	WBGene00009201(0)			GO:0005515;GO:0032515;GO:0004864;GO:0010923	protein binding;negative regulation of phosphoprotein phosphatase activity;protein phosphatase inhibitor activity;negative regulation of phosphatase activity	Alternative splicing;Leucine-rich repeat;Phosphoprotein;Protein phosphatase inhibitor;Reference proteome;Repeat		
COQ8B	positive	DBP	ENSG00000105516	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00000469;WBGene00017535;WBGene00013100	WBGene00017535(0);WBGene00011130(0)	ALDOB;CYP3A4;CYP7A1		GO:0045944;GO:0005634;GO:0006355;GO:0006357;GO:0003677;GO:0003700;GO:0007623;GO:0048511;GO:0000977;GO:0000981;GO:0000790;GO:0001228;GO:0001889	regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;regulation of transcription by RNA polymerase II;circadian rhythm;RNA polymerase II regulatory region sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;DNA binding;rhythmic process;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;DNA-binding transcription activator activity, RNA polymerase II-specific;liver development	Activator;Biological rhythms;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	R-HSA-1368108;R-HSA-400253	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock
COQ8B	positive	ATP13A1	ENSG00000105726	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00007514	WBGene00007514(1)			GO:0003674;GO:0008150;GO:0016020;GO:0016021;GO:0046872;GO:0000166;GO:0005524;GO:0005783;GO:0005789;GO:0016787;GO:0006812;GO:0016887;GO:0071421;GO:0034220;GO:0006874;GO:0015410	integral component of membrane;nucleotide binding;cation transport;ATPase activity;molecular_function;biological_process;cell;membrane;metal ion binding;ATP binding;endoplasmic reticulum;endoplasmic reticulum membrane;ion transmembrane transport;manganese ion transmembrane transport;cellular calcium ion homeostasis;manganese transmembrane transporter activity, phosphorylative mechanism	ATP-binding;Acetylation;Alternative splicing;Endoplasmic reticulum;Glycoprotein;Magnesium;Manganese;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport	R-HSA-382551;R-HSA-983712;R-HSA-936837	Transport of small molecules;Ion channel transport;Ion transport by P-type ATPases
COQ8B	positive	BRAT1	ENSG00000106009	COQ8B	1	COQ8B	1	0.00977635141774491				Lethal neonatal spasticity-epileptic encephalopathy syndrome;Lethal neonatal rigidity and seizure syndrome;NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH ORWITHOUT SEIZURES;RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME LETHAL NEONATAL	GO:0005634;GO:0005737;GO:0016020;GO:0005654;GO:0005515;GO:0006974;GO:0006915;GO:0008283;GO:0006006;GO:0001934;GO:0016477;GO:0030307;GO:0010212;GO:0051646	protein binding;cell population proliferation;cellular response to DNA damage stimulus;nucleus;cytoplasm;membrane;nucleoplasm;apoptotic process;glucose metabolic process;positive regulation of protein phosphorylation;cell migration;positive regulation of cell growth;response to ionizing radiation;mitochondrion localization	3D-structure;Alternative splicing;Cytoplasm;DNA damage;Disease mutation;Epilepsy;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation		
COQ8B	positive	NUDT1	ENSG00000106268	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0003723;GO:0005634;GO:0005737;GO:0046872;GO:0005829;GO:0016787;GO:0005739;GO:0005759;GO:0006281;GO:0005515;GO:0003924;GO:0008413;GO:0006979;GO:0034656;GO:0030515;GO:0035539;GO:0036219;GO:0047693;GO:0006195;GO:0006203;GO:0042262;GO:0046061;GO:0007568;GO:0008584;GO:0046686;GO:0001669;GO:0005615;GO:0005886;GO:0031965	hydrolase activity;DNA repair;8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity;RNA binding;nucleus;cytoplasm;metal ion binding;cytosol;mitochondrion;mitochondrial matrix;protein binding;GTPase activity;response to oxidative stress;nucleobase-containing small molecule catabolic process;snoRNA binding;8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity;GTP diphosphatase activity;ATP diphosphatase activity;purine nucleotide catabolic process;dGTP catabolic process;DNA protection;dATP catabolic process;aging;male gonad development;response to cadmium ion;acrosomal vesicle;extracellular space;plasma membrane;nuclear membrane	3D-structure;Alternative initiation;Cytoplasm;Direct protein sequencing;Hydrolase;Magnesium;Metal-binding;Mitochondrion;Nucleus;Polymorphism;RNA-binding;Reference proteome;Transit peptide		
COQ8B	positive	MOSPD3	ENSG00000106330	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00016406				GO:0016020;GO:0016021;GO:0005789;GO:0005886;GO:0033149;GO:0061817;GO:0090158;GO:0007507	endoplasmic reticulum membrane;membrane;integral component of membrane;plasma membrane;FFAT motif binding;endoplasmic reticulum-plasma membrane tethering;endoplasmic reticulum membrane organization;heart development	Alternative splicing;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	positive	GALK1	ENSG00000108479	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00006461			GALACTOKINASE DEFICIENCY;Galactosemia II;GALACTOKINASE DEFICIENCY	GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0016773;GO:0005975;GO:0005829;GO:0006012;GO:0070062;GO:0004335;GO:0005534;GO:0046835;GO:0033499;GO:0019388;GO:0019402;GO:0061623	ATP binding;cytoplasm;phosphotransferase activity, alcohol group as acceptor;galactokinase activity;galactose metabolic process;carbohydrate phosphorylation;kinase activity;galactose binding;membrane;nucleotide binding;transferase activity;phosphorylation;carbohydrate metabolic process;cytosol;extracellular exosome;galactose catabolic process via UDP-galactose;galactose catabolic process;carbohydrate kinase activity;galactitol metabolic process;glycolytic process from galactose	3D-structure;ATP-binding;Alternative splicing;Carbohydrate metabolism;Cataract;Direct protein sequencing;Disease mutation;Galactose metabolism;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-1430728;R-HSA-1643685;R-HSA-3781865;R-HSA-71387;R-HSA-5609975;R-HSA-70370;R-HSA-5609976	Metabolism;Disease;Diseases of glycosylation;Metabolism of carbohydrates;Diseases associated with glycosylation precursor biosynthesis;Galactose catabolism;Defective GALK1 can cause Galactosemia II (GALCT2)
COQ8B	positive	NAT9	ENSG00000109065	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00022055	WBGene00022055(1)			GO:0016740;GO:0016746;GO:0005515;GO:0016747;GO:0008080;GO:0032991;GO:0006473	N-acetyltransferase activity;transferase activity, transferring acyl groups other than amino-acyl groups;transferase activity;transferase activity, transferring acyl groups;protein binding;protein-containing complex;protein acetylation	Acyltransferase;Alternative splicing;Polymorphism;Reference proteome;Transferase		
COQ8B	positive	UNC119	ENSG00000109103	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00006843;WBGene00003966	WBGene00006843(1)		Cone rod dystrophy;Idiopathic CD4 lymphocytopenia;Immunodeficiency 13	GO:0005737;GO:0007399;GO:0015031;GO:0005856;GO:0005515;GO:0008289;GO:0050896;GO:0000922;GO:0005813;GO:0005815;GO:0005819;GO:0006897;GO:0007601;GO:0061098;GO:0051233;GO:0042953;GO:0007268;GO:0007602;GO:0000281;GO:0005829;GO:0045171;GO:1900186;GO:2001287	nervous system development;cytoplasm;protein transport;cytoskeleton;protein binding;synapse;lipid binding;response to stimulus;spindle pole;centrosome;microtubule organizing center;spindle;endocytosis;visual perception;positive regulation of protein tyrosine kinase activity;spindle midzone;lipoprotein transport;chemical synaptic transmission;phototransduction;mitotic cytokinesis;cytosol;intercellular bridge;negative regulation of clathrin-dependent endocytosis;negative regulation of caveolin-mediated endocytosis	3D-structure;Alternative splicing;Cone-rod dystrophy;Cytoplasm;Cytoskeleton;Disease mutation;Endocytosis;Lipid-binding;Phosphoprotein;Protein transport;Reference proteome;Sensory transduction;Transport;Vision		
COQ8B	positive	CEP164	ENSG00000110274	COQ8B	1	COQ8B	1	0.00977635141774491				Senior-Loken syndrome;NEPHRONOPHTHISIS 15	GO:0005515;GO:0005634;GO:0005737;GO:0043231;GO:0005813;GO:0005654;GO:0051301;GO:0005615;GO:0005856;GO:0006281;GO:0006974;GO:0007049;GO:0060271;GO:0005829;GO:0030030;GO:0005814;GO:0000086;GO:0010389;GO:0097711;GO:0097539	protein binding;nucleus;cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;cytoskeleton;cell division;extracellular space;centrosome;DNA repair;cellular response to DNA damage stimulus;cell cycle;cilium assembly;cytosol;cell projection organization;centriole;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;ciliary transition fiber	Alternative splicing;Cell cycle;Cell division;Ciliopathy;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Disease mutation;Mitosis;Nephronophthisis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518	Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2
COQ8B	positive	CYB561D2	ENSG00000114395	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0016020;GO:0016021;GO:0046872;GO:0055114;GO:0005783;GO:0005789;GO:0031410;GO:0030659;GO:0020037;GO:0031982;GO:0004322	membrane;integral component of membrane;metal ion binding;oxidation-reduction process;endoplasmic reticulum;endoplasmic reticulum membrane;cytoplasmic vesicle;cytoplasmic vesicle membrane;heme binding;oxidoreductase activity;vesicle;ferroxidase activity	Cytoplasmic vesicle;Direct protein sequencing;Electron transport;Endoplasmic reticulum;Heme;Iron;Membrane;Metal-binding;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport		
COQ8B	positive	ACTR1B	ENSG00000115073	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00013168				GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0015630;GO:0005856;GO:0005515;GO:0005813;GO:0005815;GO:0005576;GO:0005829;GO:0070062;GO:0043312;GO:0019886;GO:0034774;GO:1904813;GO:0005869;GO:0106006;GO:0000132;GO:0030473;GO:0099738	cell;cytoplasm;membrane;nucleotide binding;ATP binding;cytoskeleton;microtubule cytoskeleton;protein binding;centrosome;microtubule organizing center;extracellular region;cytosol;extracellular exosome;neutrophil degranulation;antigen processing and presentation of exogenous peptide antigen via MHC class II;secretory granule lumen;ficolin-1-rich granule lumen;dynactin complex;microtubule cortical anchor activity;establishment of mitotic spindle orientation;nuclear migration along microtubule;cell cortex region	ATP-binding;Acetylation;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nitration;Nucleotide-binding;Polymorphism;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2132295;R-HSA-6798695	Adaptive Immune System;Innate Immune System;Immune System;MHC class II antigen presentation;Neutrophil degranulation
COQ8B	positive	SNX17	ENSG00000115234	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00008927				GO:0005737;GO:0016020;GO:0006886;GO:0015031;GO:0043231;GO:0005829;GO:0007165;GO:0005794;GO:0005515;GO:0031410;GO:0030659;GO:0035091;GO:0008289;GO:0005768;GO:0005769;GO:0016197;GO:1990126;GO:0032991;GO:0008022;GO:0005102;GO:0032456;GO:0030100;GO:0050750;GO:0010008;GO:0006707;GO:0003279;GO:0006898;GO:0035904;GO:0060976;GO:0005623	signal transduction;intracellular protein transport;phosphatidylinositol binding;cytoplasm;membrane;protein transport;intracellular membrane-bounded organelle;cytosol;endosome;Golgi apparatus;protein binding;cytoplasmic vesicle;cytoplasmic vesicle membrane;lipid binding;early endosome;regulation of endocytosis;endosomal transport;retrograde transport, endosome to plasma membrane;protein-containing complex;protein C-terminus binding;signaling receptor binding;endocytic recycling;low-density lipoprotein particle receptor binding;endosome membrane;cholesterol catabolic process;cardiac septum development;receptor-mediated endocytosis;aorta development;coronary vasculature development	3D-structure;Alternative splicing;Cytoplasm;Cytoplasmic vesicle;Direct protein sequencing;Endosome;Lipid-binding;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport		
COQ8B	positive	OPRL1	ENSG00000125510	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00020086;WBGene00013782	WBGene00016265(0)			GO:0016020;GO:0016021;GO:0004930;GO:0007186;GO:0007193;GO:0005886;GO:0005515;GO:0007165;GO:0031410;GO:0004985;GO:0005887;GO:0001626;GO:0007218;GO:0019233;GO:0007600;GO:0051482;GO:0007610;GO:0042277;GO:0042923;GO:0038003;GO:0008022;GO:0032355;GO:0035810;GO:0042755;GO:0043951;GO:0044849;GO:0045776;GO:0051930;GO:0060454;GO:0106072;GO:1901386;GO:1904058;GO:1904059;GO:1990708	G protein-coupled receptor signaling pathway;integral component of membrane;G protein-coupled receptor activity;opioid receptor activity;nociceptin receptor activity;cell;membrane;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;plasma membrane;protein binding;signal transduction;cytoplasmic vesicle;integral component of plasma membrane;neuron projection;neuropeptide signaling pathway;peptide binding;sensory perception of pain;sensory perception;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;behavior;neuropeptide binding;opioid receptor signaling pathway;protein C-terminus binding;response to estradiol;positive regulation of urine volume;eating behavior;negative regulation of cAMP-mediated signaling;estrous cycle;negative regulation of blood pressure;regulation of sensory perception of pain;positive regulation of gastric acid secretion;negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway;negative regulation of voltage-gated calcium channel activity;positive regulation of sensory perception of pain;regulation of locomotor rhythm;conditioned place preference	3D-structure;Alternative splicing;Behavior;Cell membrane;Cytoplasmic vesicle;Disulfide bond;G-protein coupled receptor;Glycoprotein;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-500792;R-HSA-373076;R-HSA-375276	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors
COQ8B	positive	EML2	ENSG00000125746	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00001248				GO:0016020;GO:0016021;GO:0005515;GO:0005737;GO:0005856;GO:0005874;GO:0008017;GO:0005819;GO:0000226;GO:0072686;GO:0007601;GO:0015631;GO:0005875;GO:0007605;GO:0010968;GO:0031115;GO:0005102;GO:0008022	protein binding;membrane;integral component of membrane;cytoplasm;cytoskeleton;microtubule;microtubule binding;spindle;microtubule cytoskeleton organization;mitotic spindle;visual perception;tubulin binding;microtubule associated complex;sensory perception of sound;regulation of microtubule nucleation;negative regulation of microtubule polymerization;signaling receptor binding;protein C-terminus binding	3D-structure;Alternative splicing;Cytoplasm;Cytoskeleton;Microtubule;Polymorphism;Reference proteome;Repeat;WD repeat		
COQ8B	positive	TMEM175	ENSG00000127419	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0016020;GO:0016021;GO:0071805;GO:0005267;GO:0005765;GO:0006811;GO:0006813;GO:0005764;GO:0005768;GO:0010008;GO:0022841;GO:0035751;GO:0090385	potassium channel activity;membrane;integral component of membrane;potassium ion transmembrane transport;cell;endosome;lysosomal membrane;ion transport;potassium ion transport;lysosome;endosome membrane;potassium ion leak channel activity;regulation of lysosomal lumen pH;phagosome-lysosome fusion	Alternative splicing;Endosome;Ion channel;Ion transport;Lysosome;Membrane;Neurodegeneration;Parkinson disease;Parkinsonism;Phosphoprotein;Polymorphism;Potassium;Potassium channel;Potassium transport;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ8B	positive	PGLS	ENSG00000130313	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00013301	WBGene00013301(1)			GO:0005737;GO:0016787;GO:0005975;GO:0005515;GO:0017057;GO:0006098;GO:0005829;GO:0070062;GO:0009051	carbohydrate metabolic process;pentose-phosphate shunt;6-phosphogluconolactonase activity;cytoplasm;hydrolase activity;protein binding;cytosol;extracellular exosome;pentose-phosphate shunt, oxidative branch	Acetylation;Cytoplasm;Direct protein sequencing;Hydrolase;Phosphoprotein;Reference proteome	R-HSA-1430728;R-HSA-71387;R-HSA-71336	Metabolism;Metabolism of carbohydrates;Pentose phosphate pathway
COQ8B	positive	FCHO1	ENSG00000130475	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00018974	WBGene00018974(0)			GO:0005829;GO:0005654;GO:0005515;GO:0072583;GO:0016020;GO:0005886;GO:0005905;GO:0005737;GO:0006897;GO:0005856;GO:0030136;GO:0048268;GO:0061024;GO:0008092;GO:0035612	clathrin-dependent endocytosis;nucleoplasm;cytosol;protein binding;membrane;plasma membrane;clathrin-coated pit;cytoplasm;endocytosis;cytoskeleton;clathrin coat assembly;membrane organization;cytoskeletal protein binding;AP-2 adaptor complex binding	Alternative splicing;Coated pit;Coiled coil;Endocytosis;Membrane;Phosphoprotein;Reference proteome	R-HSA-5653656;R-HSA-199991;R-HSA-8856828;R-HSA-8856825	Vesicle-mediated transport;Membrane Trafficking;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis
COQ8B	positive	PGPEP1	ENSG00000130517	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00010858;WBGene00010856;WBGene00010857;WBGene00008897;WBGene00018056	WBGene00012252(0);WBGene00018056(0);WBGene00008897(0);WBGene00008894(0);WBGene00010858(1);WBGene00010856(0);WBGene00010857(0);WBGene00018057(0)			GO:0005737;GO:0016787;GO:0005829;GO:0008233;GO:0008234;GO:0006508;GO:0016920	proteolysis;pyroglutamyl-peptidase activity;cytosol;peptidase activity;cytoplasm;hydrolase activity;cysteine-type peptidase activity	Alternative splicing;Cytoplasm;Hydrolase;Protease;Reference proteome;Thiol protease		
COQ8B	positive	ADCK2	ENSG00000133597	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00021315	WBGene00021315(1)			GO:0016020;GO:0016021;GO:0000166;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0006468;GO:0004672	membrane;integral component of membrane;nucleotide binding;protein serine/threonine kinase activity;ATP binding;kinase activity;transferase activity;phosphorylation;protein phosphorylation;protein binding;protein kinase activity	ATP-binding;Kinase;Membrane;Nucleotide-binding;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Transmembrane;Transmembrane helix		
COQ8B	positive	MEN1	ENSG00000133895	COQ8B	1	COQ8B	1	0.00977635141774491			CASP8;CDKN1B	Familial isolated hyperparathyroidism;Insulinoma;Multiple endocrine neoplasia type 1;Null pituitary adenoma;Prolactinoma;Silent pituitary adenoma;MULTIPLE ENDOCRINE NEOPLASIA TYPE I	GO:0005634;GO:0005829;GO:0005654;GO:0005737;GO:0003677;GO:0006325;GO:0005515;GO:0006281;GO:0006974;GO:0018024;GO:0034968;GO:0000122;GO:0035097;GO:0044267;GO:0008285;GO:0043687;GO:0032154;GO:0045786;GO:0032991;GO:0000784;GO:0003690;GO:0044212;GO:0003682;GO:0047485;GO:0000400;GO:0000403;GO:0030674;GO:0070412;GO:0000165;GO:0001933;GO:0002076;GO:0009411;GO:0010332;GO:0030511;GO:0032092;GO:0043433;GO:0045668;GO:0045736;GO:0045892;GO:0045944;GO:0046329;GO:0051974;GO:1904837;GO:0000785;GO:0000790;GO:0005788;GO:0016363;GO:0000278;GO:0003309;GO:0007420;GO:0010812;GO:0032925;GO:0046697;GO:0050680;GO:0061469;GO:0071333;GO:0071375;GO:0071559;GO:1902807	nucleus;nucleoplasm;cytosol;cell;cytoplasm;DNA binding;chromatin organization;protein binding;DNA repair;cellular response to DNA damage stimulus;histone lysine methylation;regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;histone methyltransferase complex;cellular protein metabolic process;negative regulation of cell population proliferation;post-translational protein modification;cleavage furrow;negative regulation of cell cycle;protein-containing complex;nuclear chromosome, telomeric region;double-stranded DNA binding;histone-lysine N-methyltransferase activity;transcription regulatory region DNA binding;chromatin binding;protein N-terminus binding;four-way junction DNA binding;Y-form DNA binding;protein binding, bridging;R-SMAD binding;MAPK cascade;negative regulation of protein phosphorylation;osteoblast development;response to UV;response to gamma radiation;positive regulation of transforming growth factor beta receptor signaling pathway;positive regulation of protein binding;negative regulation of DNA-binding transcription factor activity;negative regulation of osteoblast differentiation;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;negative regulation of JNK cascade;negative regulation of telomerase activity;beta-catenin-TCF complex assembly;chromatin;nuclear chromatin;endoplasmic reticulum lumen;nuclear matrix;mitotic cell cycle;type B pancreatic cell differentiation;brain development;negative regulation of cell-substrate adhesion;regulation of activin receptor signaling pathway;decidualization;negative regulation of epithelial cell proliferation;regulation of type B pancreatic cell proliferation;cellular response to glucose stimulus;cellular response to peptide hormone stimulus;response to transforming growth factor beta;negative regulation of cell cycle G1/S phase transition	3D-structure;Alternative splicing;Chromatin regulator;DNA-binding;Disease mutation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-195721;R-HSA-201681;R-HSA-195258;R-HSA-5626467;R-HSA-9006936;R-HSA-170834;R-HSA-201722;R-HSA-2173793;R-HSA-2173796;R-HSA-3769402;R-HSA-381426;R-HSA-8957275	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Signaling by WNT;TCF dependent signaling in response to WNT;RHO GTPase Effectors;RHO GTPases activate IQGAPs;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Formation of the beta-catenin:TCF transactivating complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Deactivation of the beta-catenin transactivating complex;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation
COQ8B	positive	MMAB	ENSG00000139428	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00016144	WBGene00016144(1)		Vitamin B12-responsive methylmalonic acidemia type cblB;Methylmalonic aciduria type cblB;METHYLMALONIC ACIDURIA cblB TYPE	GO:0000166;GO:0005524;GO:0016740;GO:0005739;GO:0005515;GO:0008817;GO:0009236;GO:0005759;GO:0031419;GO:0009235	nucleotide binding;ATP binding;transferase activity;mitochondrion;protein binding;cob(I)yrinic acid a,c-diamide adenosyltransferase activity;mitochondrial matrix;cobalamin binding;cobalamin metabolic process	3D-structure;ATP-binding;Acetylation;Disease mutation;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Transit peptide	R-HSA-1430728;R-HSA-1643685;R-HSA-196854;R-HSA-196849;R-HSA-196741;R-HSA-3296469;R-HSA-3296482;R-HSA-5668914;R-HSA-3359471	Metabolism;Disease;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Cobalamin (Cbl, vitamin B12) transport and metabolism;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Diseases of metabolism;Defective MMAB causes methylmalonic aciduria type cblB
COQ8B	positive	SNAP47	ENSG00000143740	COQ8B	1	COQ8B	1	0.00977635141774491		WBGene00006454(0)			GO:0005737;GO:0016020;GO:0005515;GO:0048471;GO:0005886;GO:0006887;GO:0012505;GO:0005484;GO:0031201;GO:0006906;GO:0019905;GO:0016082;GO:0031629;GO:0031083;GO:0060291;GO:0098967;GO:0099003;GO:0014069;GO:0030425;GO:0030672;GO:0032279;GO:0043025;GO:0098686;GO:0098978	cytoplasm;membrane;protein binding;perinuclear region of cytoplasm;plasma membrane;exocytosis;endomembrane system;SNAP receptor activity;SNARE complex;vesicle fusion;syntaxin binding;synaptic vesicle priming;synaptic vesicle fusion to presynaptic active zone membrane;BLOC-1 complex;long-term synaptic potentiation;exocytic insertion of neurotransmitter receptor to postsynaptic membrane;vesicle-mediated transport in synapse;postsynaptic density;dendrite;synaptic vesicle membrane;asymmetric synapse;neuronal cell body;hippocampal mossy fiber to CA3 synapse;glutamatergic synapse	Alternative splicing;Coiled coil;Cytoplasm;Membrane;Polymorphism;Reference proteome;Repeat		
COQ8B	positive	SLC12A9	ENSG00000146828	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00020207	WBGene00020207(0)			GO:0016020;GO:0016021;GO:0055085;GO:0022857;GO:0006811;GO:0005886;GO:0015379;GO:0006884;GO:0055064;GO:0055075;GO:1902476;GO:1990573;GO:0070062;GO:0015377;GO:0005215	membrane;transmembrane transport;integral component of membrane;cell;transmembrane transporter activity;ion transport;plasma membrane;potassium:chloride symporter activity;cell volume homeostasis;chloride ion homeostasis;potassium ion homeostasis;chloride transmembrane transport;potassium ion import across plasma membrane;extracellular exosome;cation:chloride symporter activity	Alternative splicing;Cell membrane;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ8B	positive	NAPRT	ENSG00000147813	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00021882	WBGene00021882(0)			GO:0009435;GO:0004514;GO:0016740;GO:0003824;GO:0016757;GO:0016874;GO:0019363;GO:0004516;GO:0019358;GO:0005737;GO:0046872;GO:0005829;GO:0005515;GO:0005576;GO:0070062;GO:0043312;GO:0006979;GO:0035578;GO:0034356;GO:0034355	NAD biosynthetic process;nicotinate-nucleotide diphosphorylase (carboxylating) activity;catalytic activity;nicotinate phosphoribosyltransferase activity;transferase activity;transferase activity, transferring glycosyl groups;ligase activity;pyridine nucleotide biosynthetic process;cytoplasm;metal ion binding;cytosol;protein binding;extracellular region;extracellular exosome;neutrophil degranulation;response to oxidative stress;azurophil granule lumen;NAD biosynthesis via nicotinamide riboside salvage pathway;NAD salvage	3D-structure;Alternative splicing;Cytoplasm;Ligase;Magnesium;Manganese;Metal-binding;Phosphoprotein;Polymorphism;Pyridine nucleotide biosynthesis;Reference proteome;Transferase	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-6798695;R-HSA-196854;R-HSA-196849;R-HSA-196807;R-HSA-197264	Innate Immune System;Immune System;Metabolism;Neutrophil degranulation;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Nicotinate metabolism;Nicotinamide salvaging
COQ8B	positive	NUDT22	ENSG00000149761	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0005654;GO:0046872;GO:0016787;GO:0005515;GO:0008768;GO:0052751	nucleoplasm;metal ion binding;hydrolase activity;protein binding;UDP-sugar diphosphatase activity;GDP-mannose hydrolase activity	3D-structure;Alternative splicing;Hydrolase;Magnesium;Metal-binding;Polymorphism;Reference proteome		
COQ8B	positive	TBX6	ENSG00000149922	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00003376;WBGene00006543	WBGene00006546(0);WBGene00006545(0);WBGene00006556(0);WBGene00006557(0);WBGene00044798(0);WBGene00006559(0);WBGene00004750(0);WBGene00003106(0)		Autosomal dominant spondylocostal dysostosis;Spondylocostal dysostosis 5	GO:0043433;GO:0005634;GO:0006355;GO:0003677;GO:0003700;GO:0005515;GO:0007275;GO:0000977;GO:0001228;GO:0045944;GO:0000122;GO:0000981;GO:0000790;GO:0001708;GO:0001085;GO:0009653;GO:0001102;GO:0001947;GO:0007498;GO:0000980;GO:0001570;GO:0001707;GO:0010977;GO:0014043;GO:0023019;GO:0032525	regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;negative regulation of DNA-binding transcription factor activity;DNA binding;protein binding;multicellular organism development;positive regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;DNA-binding transcription activator activity, RNA polymerase II-specific;cell fate specification;RNA polymerase II transcription factor binding;anatomical structure morphogenesis;RNA polymerase II activating transcription factor binding;heart looping;mesoderm development;RNA polymerase II cis-regulatory region sequence-specific DNA binding;vasculogenesis;mesoderm formation;negative regulation of neuron projection development;negative regulation of neuron maturation;signal transduction involved in regulation of gene expression;somite rostral/caudal axis specification	Alternative splicing;DNA-binding;Developmental protein;Dwarfism;Nucleus;Polymorphism;Reference proteome;Transcription;Transcription regulation		
COQ8B	positive	DUSP23	ENSG00000158716	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00000383				GO:0005634;GO:0005737;GO:0005654;GO:0016787;GO:0005829;GO:0004721;GO:0006470;GO:0005515;GO:0004725;GO:0016311;GO:0035335;GO:0016791;GO:0008138	phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;protein tyrosine/serine/threonine phosphatase activity;dephosphorylation;nucleus;cytoplasm;nucleoplasm;hydrolase activity;cytosol;phosphoprotein phosphatase activity;protein binding;peptidyl-tyrosine dephosphorylation	3D-structure;Cytoplasm;Hydrolase;Nucleus;Polymorphism;Protein phosphatase;Reference proteome		
COQ8B	positive	NLRX1	ENSG00000160703	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0005739;GO:0005886;GO:0030054;GO:0016020;GO:0000166;GO:0005524;GO:0005515;GO:0005741;GO:0002376;GO:0045087;GO:0005737;GO:0035556;GO:0016032;GO:0032480;GO:0043124;GO:0032688;GO:0032715;GO:0039536;GO:0045824;GO:0050728	plasma membrane;mitochondrion;cell junction;protein binding;membrane;nucleotide binding;ATP binding;mitochondrial outer membrane;immune system process;innate immune response;intracellular signal transduction;viral process;negative regulation of type I interferon production;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of interferon-beta production;negative regulation of interleukin-6 production;negative regulation of RIG-I signaling pathway;negative regulation of innate immune response;negative regulation of inflammatory response	3D-structure;ATP-binding;Alternative splicing;Host-virus interaction;Immunity;Innate immunity;Leucine-rich repeat;Membrane;Mitochondrion;Mitochondrion outer membrane;Nucleotide-binding;Polymorphism;Reference proteome;Repeat;Transit peptide	R-HSA-168249;R-HSA-168256;R-HSA-168928;R-HSA-936440	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Negative regulators of DDX58/IFIH1 signaling
COQ8B	positive	RUSC1	ENSG00000160753	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00011058				GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0003779;GO:0009967;GO:0005794;GO:0005886;GO:0005856;GO:0005515;GO:0030054;GO:0031410;GO:0045202;GO:0045211;GO:0005874;GO:0005768;GO:0005769;GO:0015630;GO:0014069;GO:0005070;GO:0000209	protein binding;nucleus;cytoplasm;cytosol;endosome;actin binding;positive regulation of signal transduction;Golgi apparatus;cytoskeleton;cell junction;cytoplasmic vesicle;microtubule;synapse;early endosome;microtubule cytoskeleton;postsynaptic density;SH3/SH2 adaptor activity;protein polyubiquitination	3D-structure;Alternative splicing;Cell junction;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Endosome;Golgi apparatus;Microtubule;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;SH3 domain;Synapse;Ubl conjugation		
COQ8B	positive	LRRC14	ENSG00000160959	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0005737;GO:0032088;GO:0019900;GO:0034122;GO:0005515	protein binding;cytoplasm;negative regulation of NF-kappaB transcription factor activity;kinase binding;negative regulation of toll-like receptor signaling pathway	Cytoplasm;Leucine-rich repeat;Polymorphism;Reference proteome;Repeat		
COQ8B	positive	YDJC	ENSG00000161179	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0046872;GO:0016787;GO:0003824;GO:0005975;GO:0000287;GO:0019213	carbohydrate metabolic process;catalytic activity;metal ion binding;hydrolase activity;magnesium ion binding;deacetylase activity	Alternative splicing;Carbohydrate metabolism;Hydrolase;Magnesium;Metal-binding;Polymorphism;Reference proteome		
COQ8B	positive	FLYWCH2	ENSG00000162076	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0003723;GO:0008150;GO:0005575	RNA binding;biological_process;cellular_component	Phosphoprotein;Reference proteome		
COQ8B	positive	TAF6L	ENSG00000162227	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00006387;WBGene00021363				GO:0005634;GO:0005654;GO:0006357;GO:1903508;GO:0046982;GO:0005515;GO:0004402;GO:0006352;GO:0006367;GO:0000124;GO:0005669;GO:0046695;GO:0003713;GO:0006325;GO:0051123;GO:0070062;GO:0006366;GO:0003677;GO:0006355;GO:0000118;GO:0043966;GO:0006338;GO:0030914;GO:1904672	DNA-templated transcription, initiation;regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;transcription factor TFIID complex;protein heterodimerization activity;SAGA complex;SLIK (SAGA-like) complex;nucleus;nucleoplasm;positive regulation of nucleic acid-templated transcription;protein binding;histone acetyltransferase activity;transcription coactivator activity;chromatin organization;RNA polymerase II preinitiation complex assembly;extracellular exosome;transcription by RNA polymerase II;regulation of transcription, DNA-templated;DNA binding;histone deacetylase complex;histone H3 acetylation;chromatin remodeling;STAGA complex;regulation of somatic stem cell population maintenance	Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
COQ8B	positive	RPS6KA4	ENSG00000162302	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00008311	WBGene00012929(0);WBGene00044281(0)			GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0005654;GO:0000287;GO:0035556;GO:0045944;GO:0005634;GO:0046872;GO:0005515;GO:0006954;GO:0005737;GO:0051092;GO:0006355;GO:0070498;GO:0001818;GO:0016572;GO:0032793;GO:0033129;GO:0035066;GO:0043987;GO:0043988;GO:0004711	ATP binding;magnesium ion binding;protein phosphorylation;intracellular signal transduction;protein serine/threonine kinase activity;protein kinase activity;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytosol;positive regulation of transcription by RNA polymerase II;nucleus;metal ion binding;protein binding;inflammatory response;cytoplasm;regulation of transcription, DNA-templated;positive regulation of NF-kappaB transcription factor activity;interleukin-1-mediated signaling pathway;negative regulation of cytokine production;histone phosphorylation;positive regulation of CREB transcription factor activity;positive regulation of histone phosphorylation;positive regulation of histone acetylation;histone H3-S10 phosphorylation;histone H3-S28 phosphorylation;ribosomal protein S6 kinase activity	ATP-binding;Alternative splicing;Inflammatory response;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine/threonine-protein kinase;Stress response;Transferase	R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239	Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1
COQ8B	positive	ACOT11	ENSG00000162390	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0005737;GO:0005829;GO:0016787;GO:0005739;GO:0005759;GO:0006629;GO:0006631;GO:0008289;GO:0016790;GO:0052689;GO:0070062;GO:0000062;GO:0016290;GO:0036042;GO:0047617;GO:0102991;GO:0006637;GO:0120163;GO:0035556;GO:0009266;GO:0009409	lipid binding;thiolester hydrolase activity;cytoplasm;cytosol;hydrolase activity;mitochondrion;mitochondrial matrix;lipid metabolic process;fatty acid metabolic process;carboxylic ester hydrolase activity;extracellular exosome;fatty-acyl-CoA binding;palmitoyl-CoA hydrolase activity;long-chain fatty acyl-CoA binding;acyl-CoA hydrolase activity;myristoyl-CoA hydrolase activity;acyl-CoA metabolic process;negative regulation of cold-induced thermogenesis;intracellular signal transduction;response to temperature stimulus;response to cold	3D-structure;Alternative splicing;Cytoplasm;Fatty acid metabolism;Hydrolase;Lipid metabolism;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Serine esterase;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation
COQ8B	positive	HDAC11	ENSG00000163517	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00007953	WBGene00007953(1)	TNFSF4		GO:0016787;GO:0005634;GO:0006325;GO:0014003;GO:0005515;GO:0004407;GO:0032041;GO:0070932;GO:0000118;GO:0008134;GO:0005886;GO:0016575	hydrolase activity;nucleus;chromatin organization;protein binding;histone deacetylase activity;NAD-dependent histone deacetylase activity (H3-K14 specific);histone H3 deacetylation;histone deacetylase complex;transcription factor binding;plasma membrane;histone deacetylation;oligodendrocyte development	Alternative splicing;Chromatin regulator;Hydrolase;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-157118;R-HSA-1980143;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-2122947;R-HSA-350054	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;Diseases of signal transduction;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH1 Intracellular Domain Regulates Transcription;Notch-HLH transcription pathway
COQ8B	positive	IL17RC	ENSG00000163702	COQ8B	1	COQ8B	1	0.00977635141774491		WBGene00013415(0)		Chronic mucocutaneous candidiasis;CANDIDIASIS FAMILIAL 9	GO:0016020;GO:0016021;GO:0005886;GO:0030368;GO:0097400;GO:0019221;GO:0005102;GO:0050832;GO:0071621;GO:1900017;GO:2000778;GO:0009986	interleukin-17 receptor activity;membrane;integral component of membrane;plasma membrane;interleukin-17-mediated signaling pathway;cytokine-mediated signaling pathway;signaling receptor binding;defense response to fungus;granulocyte chemotaxis;positive regulation of cytokine production involved in inflammatory response;positive regulation of interleukin-6 secretion;cell surface	Alternative splicing;Cell membrane;Direct protein sequencing;Glycoprotein;Membrane;Polymorphism;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-168256;R-HSA-1280215;R-HSA-449147;R-HSA-448424	Immune System;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-17 signaling
COQ8B	positive	ST5	ENSG00000166444	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00003477				GO:0005737;GO:0016020;GO:0005886;GO:0005085;GO:0005768;GO:0017112;GO:0005938;GO:0055037	cytoplasm;membrane;endosome;plasma membrane;guanyl-nucleotide exchange factor activity;Rab guanyl-nucleotide exchange factor activity;cell cortex;recycling endosome	Alternative promoter usage;Alternative splicing;Cell membrane;Cytoplasm;Endosome;Guanine-nucleotide releasing factor;Membrane;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-5653656;R-HSA-199991;R-HSA-8876198;R-HSA-9007101	Vesicle-mediated transport;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
COQ8B	positive	PHB	ENSG00000167085	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00004014	WBGene00004014(1)		Breast Cancer	GO:0008285;GO:0005737;GO:0005634;GO:0044212;GO:0016020;GO:0005743;GO:0005739;GO:0005886;GO:0005515;GO:0007165;GO:0009986;GO:0045893;GO:0005654;GO:0005769;GO:0071897;GO:0007005;GO:0070062;GO:0050821;GO:0070374;GO:0008022;GO:0042981;GO:0006355;GO:0000122;GO:0045892;GO:0042177;GO:0019899;GO:0070373;GO:0010944;GO:0042826;GO:0005887;GO:0030308;GO:0010942;GO:0001649;GO:0060766;GO:0010628;GO:0006851;GO:0045745;GO:0050847;GO:0001851;GO:0071354;GO:0001850;GO:0031871;GO:0016575;GO:0045917;GO:2000323	membrane;negative regulation of cell population proliferation;cytoplasm;nucleus;transcription regulatory region DNA binding;mitochondrial inner membrane;mitochondrion;plasma membrane;protein binding;signal transduction;cell surface;positive regulation of transcription, DNA-templated;nucleoplasm;early endosome;DNA biosynthetic process;mitochondrion organization;extracellular exosome;protein stabilization;positive regulation of ERK1 and ERK2 cascade;protein C-terminus binding;regulation of transcription, DNA-templated;regulation of apoptotic process;negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;negative regulation of protein catabolic process;enzyme binding;negative regulation of ERK1 and ERK2 cascade;negative regulation of transcription by competitive promoter binding;histone deacetylase binding;integral component of plasma membrane;negative regulation of cell growth;positive regulation of cell death;osteoblast differentiation;negative regulation of androgen receptor signaling pathway;positive regulation of gene expression;mitochondrial calcium ion transmembrane transport;positive regulation of G protein-coupled receptor signaling pathway;progesterone receptor signaling pathway;complement component C3b binding;cellular response to interleukin-6;complement component C3a binding;proteinase activated receptor binding;histone deacetylation;positive regulation of complement activation;negative regulation of glucocorticoid receptor signaling pathway	3D-structure;Acetylation;Alternative splicing;Coiled coil;DNA synthesis;Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome	R-HSA-168256;R-HSA-382551;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-6802957;R-HSA-6802949;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-8949215;R-HSA-8949664	Immune System;Transport of small molecules;Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Oncogenic MAPK signaling;Signaling by RAS mutants;RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Mitochondrial calcium ion transport;Processing of SMDT1
COQ8B	positive	TP53I13	ENSG00000167543	COQ8B	1	COQ8B	1	0.00977635141774491		WBGene00012755(0)			GO:0016020;GO:0016021;GO:0005737;GO:0005886;GO:0003674;GO:0009411;GO:0045786;GO:0042493;GO:0014070	membrane;integral component of membrane;cytoplasm;plasma membrane;molecular_function;response to UV;negative regulation of cell cycle;response to drug;response to organic cyclic compound	Cell membrane;Cytoplasm;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ8B	positive	NCKAP5L	ENSG00000167566	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0005737;GO:0005856;GO:0005874;GO:0005813;GO:0005815;GO:0005515;GO:0001578;GO:0007019;GO:0035371	cytoplasm;cytoskeleton;microtubule;centrosome;microtubule organizing center;protein binding;microtubule bundle formation;microtubule depolymerization;microtubule plus-end	Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Phosphoprotein;Reference proteome		
COQ8B	positive	CCDC88B	ENSG00000168071	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00013082	WBGene00013082(0);WBGene00006997(0)			GO:0005737;GO:0016020;GO:0005783;GO:0005794;GO:0005856;GO:0005813;GO:0008017;GO:0051959;GO:0001819;GO:0030705;GO:0031122;GO:0042102;GO:0042832;GO:0050870	cytoplasm;membrane;endoplasmic reticulum;Golgi apparatus;cytoskeleton;centrosome;microtubule binding;dynein light intermediate chain binding;positive regulation of cytokine production;cytoskeleton-dependent intracellular transport;cytoplasmic microtubule organization;positive regulation of T cell proliferation;defense response to protozoan;positive regulation of T cell activation	Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Endoplasmic reticulum;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Stress response		
COQ8B	positive	COG7	ENSG00000168434	COQ8B	1	COQ8B	1	0.00977635141774491				COG7-CDG;COG7-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIe	GO:0016020;GO:0006886;GO:0015031;GO:0005794;GO:0005730;GO:0005515;GO:0000139;GO:0006486;GO:0017119;GO:0007030;GO:0050821;GO:0006890;GO:0032588;GO:0006888;GO:0034067;GO:0033365	intracellular protein transport;Golgi transport complex;membrane;protein transport;Golgi apparatus;intracellular membrane-bounded organelle;nucleolus;protein binding;protein glycosylation;Golgi membrane;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;Golgi organization;protein stabilization;trans-Golgi network membrane;endoplasmic reticulum to Golgi vesicle-mediated transport;protein localization to Golgi apparatus;protein localization to organelle	Congenital disorder of glycosylation;Golgi apparatus;Membrane;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811442;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-6811438;R-HSA-6811440	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network
COQ8B	positive	RGS14	ENSG00000169220	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00004347;WBGene00004350;WBGene00004349				GO:0005634;GO:0005737;GO:0016020;GO:0035556;GO:0007165;GO:0009967;GO:0051301;GO:0005886;GO:0030695;GO:0005096;GO:0005856;GO:0042995;GO:0005515;GO:0007049;GO:0008277;GO:0008017;GO:0030054;GO:0045202;GO:0045211;GO:0005874;GO:0030425;GO:0000922;GO:0005813;GO:0005815;GO:0005819;GO:0007051;GO:0007059;GO:0005092;GO:0050769;GO:0014069;GO:0043197;GO:0007186;GO:0016605;GO:0001965;GO:0007616;GO:0006979;GO:0048008;GO:0007612;GO:0009968;GO:0070373;GO:0003924;GO:0006913;GO:0019901;GO:0030159;GO:0032794;GO:0000278;GO:0008542;GO:0010070;GO:0031914;GO:0043407;GO:0043547;GO:0043620;GO:0045744;GO:0050804;GO:0060291;GO:0016604;GO:0098978;GO:0050790	signal transduction;GTPase activator activity;intracellular signal transduction;microtubule binding;GTPase regulator activity;regulation of G protein-coupled receptor signaling pathway;cell division;GDP-dissociation inhibitor activity;spindle organization;G-protein alpha-subunit binding;nucleus;cytoplasm;membrane;positive regulation of signal transduction;cytoskeleton;plasma membrane;cell projection;protein binding;cell cycle;cell junction;microtubule;positive regulation of neurogenesis;synapse;dendrite;spindle pole;centrosome;microtubule organizing center;spindle;chromosome segregation;PML body;postsynaptic density;dendritic spine;G protein-coupled receptor signaling pathway;long-term memory;response to oxidative stress;platelet-derived growth factor receptor signaling pathway;learning;negative regulation of signal transduction;negative regulation of ERK1 and ERK2 cascade;GTPase activity;nucleocytoplasmic transport;protein kinase binding;receptor signaling complex adaptor activity;GTPase activating protein binding;mitotic cell cycle;visual learning;zygote asymmetric cell division;negative regulation of synaptic plasticity;negative regulation of MAP kinase activity;positive regulation of GTPase activity;regulation of DNA-templated transcription in response to stress;negative regulation of G protein-coupled receptor signaling pathway;modulation of chemical synaptic transmission;long-term synaptic potentiation;nuclear body;glutamatergic synapse;regulation of catalytic activity	3D-structure;Alternative splicing;Cell cycle;Cell division;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;GTPase activation;Membrane;Microtubule;Nucleus;Phosphoprotein;Reference proteome;Repeat;Signal transduction inhibitor;Synapse	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
COQ8B	positive	IRF2BP1	ENSG00000170604	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00010867	WBGene00010867(0);WBGene00009939(0)			GO:0005634;GO:0046872;GO:0016740;GO:0005654;GO:0005515;GO:0045944;GO:0000977;GO:0001228;GO:0000122;GO:0003714;GO:0008134;GO:0061630;GO:0000209	metal ion binding;nucleus;transferase activity;nucleoplasm;protein binding;regulation of transcription by RNA polymerase II;transcription corepressor activity;ubiquitin protein ligase activity;negative regulation of transcription by RNA polymerase II;transcription factor binding;protein polyubiquitination	Coiled coil;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger		
COQ8B	positive	ATP6V0E2	ENSG00000171130	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00009882	WBGene00009882(0)			GO:0016020;GO:0016021;GO:1902600;GO:0015078;GO:0033179;GO:0016787;GO:0006811;GO:0046961;GO:0034220;GO:0010008;GO:0055085;GO:0030670;GO:0042625;GO:0007035;GO:0008286;GO:0016241;GO:0033572;GO:0090383	proton transmembrane transporter activity;proton transmembrane transport;proton-transporting V-type ATPase, V0 domain;membrane;integral component of membrane;cell;hydrolase activity;ion transport;proton-transporting ATPase activity, rotational mechanism;ion transmembrane transport;endosome membrane;transmembrane transport;phagocytic vesicle membrane;ATPase-coupled ion transmembrane transporter activity;vacuolar acidification;insulin receptor signaling pathway;regulation of macroautophagy;transferrin transport;phagosome acidification	Alternative splicing;Hydrogen ion transport;Hydrolase;Ion transport;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-168249;R-HSA-168256;R-HSA-382551;R-HSA-162582;R-HSA-983712;R-HSA-9006934;R-HSA-74752;R-HSA-1222556;R-HSA-77387;R-HSA-917937;R-HSA-917977	Innate Immune System;Immune System;Transport of small molecules;Signal Transduction;Ion channel transport;Signaling by Receptor Tyrosine Kinases;Signaling by Insulin receptor;ROS and RNS production in phagocytes;Insulin receptor recycling;Iron uptake and transport;Transferrin endocytosis and recycling
COQ8B	positive	GAA	ENSG00000171298	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00017071;WBGene00019895	WBGene00019895(0);WBGene00018682(0)		Glycogen storage disease due to acid maltase deficiency infantile onset;Glycogen storage disease due to acid maltase deficiency late-onset;GLYCOGEN STORAGE DISEASE TYPE II;GLYCOGEN STORAGE DISEASE II	GO:0016020;GO:0016021;GO:0030246;GO:0003824;GO:0005975;GO:0016787;GO:0005765;GO:0008152;GO:0004553;GO:0016798;GO:0005764;GO:0005886;GO:0070062;GO:0043312;GO:0070821;GO:0035577;GO:0043202;GO:0060048;GO:0101003;GO:0004558;GO:0032450;GO:0090599;GO:0007040;GO:0005980;GO:0000023;GO:0002086;GO:0005985;GO:0006006;GO:0043181;GO:0002026;GO:0003007;GO:0005977;GO:0006941;GO:0007626;GO:0009888;GO:0046716;GO:0050884;GO:0050885	carbohydrate metabolic process;catalytic activity;carbohydrate binding;membrane;integral component of membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;cell;hydrolase activity;lysosomal membrane;metabolic process;hydrolase activity, acting on glycosyl bonds;lysosome;plasma membrane;extracellular exosome;neutrophil degranulation;tertiary granule membrane;azurophil granule membrane;lysosomal lumen;cardiac muscle contraction;ficolin-1-rich granule membrane;alpha-1,4-glucosidase activity;maltose alpha-glucosidase activity;alpha-glucosidase activity;lysosome organization;glycogen catabolic process;maltose metabolic process;diaphragm contraction;sucrose metabolic process;glucose metabolic process;vacuolar sequestering;regulation of the force of heart contraction;heart morphogenesis;glycogen metabolic process;striated muscle contraction;locomotory behavior;tissue development;muscle cell cellular homeostasis;neuromuscular process controlling posture;neuromuscular process controlling balance	3D-structure;Direct protein sequencing;Disease mutation;Disulfide bond;Glycogen storage disease;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Signal	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-6798695;R-HSA-5668914;R-HSA-3229121;R-HSA-5663084;R-HSA-70221;R-HSA-8982491;R-HSA-5357609	Innate Immune System;Immune System;Metabolism;Disease;Metabolism of carbohydrates;Neutrophil degranulation;Diseases of metabolism;Glycogen storage diseases;Diseases of carbohydrate metabolism;Glycogen breakdown (glycogenolysis);Glycogen metabolism;Glycogen storage disease type II (GAA)
COQ8B	positive	QARS	ENSG00000172053	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00001336			Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome;Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome;Microcephaly progressive seizures and cerebral and cerebellar atrophy;Microcephaly progressive with seizures and cerebral and cerebellar atrophy	GO:0005737;GO:0006412;GO:0000166;GO:0005524;GO:0005829;GO:0016874;GO:0004812;GO:0006418;GO:0043039;GO:0005515;GO:0004819;GO:0006425;GO:0005759;GO:0032991;GO:0007420;GO:0017101;GO:0045892;GO:0019901;GO:0006469;GO:0004860;GO:0032873;GO:2001234;GO:0016020;GO:0016021	translation;ATP binding;cytoplasm;aminoacyl-tRNA ligase activity;tRNA aminoacylation for protein translation;nucleotide binding;tRNA aminoacylation;cytosol;ligase activity;glutamine-tRNA ligase activity;glutaminyl-tRNA aminoacylation;protein binding;mitochondrial matrix;protein-containing complex;brain development;aminoacyl-tRNA synthetase multienzyme complex;negative regulation of transcription, DNA-templated;protein kinase binding;negative regulation of protein kinase activity;protein kinase inhibitor activity;negative regulation of stress-activated MAPK cascade;negative regulation of apoptotic signaling pathway;membrane;integral component of membrane	3D-structure;ATP-binding;Acetylation;Alternative splicing;Aminoacyl-tRNA synthetase;Cytoplasm;Direct protein sequencing;Disease mutation;Epilepsy;Ligase;Nucleotide-binding;Phosphoprotein;Primary microcephaly;Protein biosynthesis;Reference proteome	R-HSA-392499;R-HSA-1430728;R-HSA-71291;R-HSA-72766;R-HSA-2408522;R-HSA-379716;R-HSA-379724;R-HSA-379726	Metabolism of proteins;Metabolism;Metabolism of amino acids and derivatives;Translation;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation
COQ8B	positive	SNX33	ENSG00000173548	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00003086	WBGene00013354(0);WBGene00004927(0)			GO:0005737;GO:0016020;GO:0006886;GO:0015031;GO:0006897;GO:0051301;GO:0005829;GO:0005515;GO:0007049;GO:0031410;GO:0030659;GO:0035091;GO:0042802;GO:0000281;GO:0000278;GO:0016197;GO:0019898;GO:2000009;GO:2000010;GO:0007032;GO:0097320;GO:0045806;GO:0044351;GO:0036089;GO:0051044;GO:0017038	protein binding;intracellular protein transport;protein transport;phosphatidylinositol binding;endocytosis;mitotic cell cycle;mitotic cytokinesis;extrinsic component of membrane;cytoplasmic vesicle;cytoplasm;membrane;cell division;cytosol;cell cycle;cytoplasmic vesicle membrane;identical protein binding;endosomal transport;negative regulation of protein localization to cell surface;positive regulation of protein localization to cell surface;endosome organization;plasma membrane tubulation;negative regulation of endocytosis;macropinocytosis;cleavage furrow formation;positive regulation of membrane protein ectodomain proteolysis;protein import	3D-structure;Cell cycle;Cell division;Cytoplasm;Cytoplasmic vesicle;Endocytosis;Membrane;Mitosis;Phosphoprotein;Protein transport;Reference proteome;SH3 domain;Transport		
COQ8B	positive	TTLL11	ENSG00000175764	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00019230	WBGene00019230(1)			GO:0006464;GO:0005737;GO:0000166;GO:0005524;GO:0005856;GO:0042995;GO:0016874;GO:0005874;GO:0005929;GO:0005829;GO:0018095;GO:0051013	cellular protein modification process;ATP binding;cytoplasm;nucleotide binding;cytoskeleton;cell projection;ligase activity;microtubule;cilium;cytosol;protein polyglutamylation;microtubule severing;ciliary basal body	ATP-binding;Alternative splicing;Cell projection;Cilium;Cytoplasm;Cytoskeleton;Ligase;Microtubule;Nucleotide-binding;Reference proteome	R-HSA-392499;R-HSA-597592;R-HSA-8955332	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
COQ8B	positive	CRACR2B	ENSG00000177685	COQ8B	1	COQ8B	1	0.00977635141774491					GO:0005509;GO:0005515;GO:0002115;GO:0034613;GO:2001256;GO:0005737	calcium ion binding;protein binding;store-operated calcium entry;cellular protein localization;regulation of store-operated calcium entry;cytoplasm	Alternative splicing;Coiled coil;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ8B	positive	SH2B1	ENSG00000178188	COQ8B	1	COQ8B	1	0.00977635141774491				Distal 16p11.2 microdeletion syndrome;Proximal 16p11.2 microdeletion syndrome;Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency	GO:0007165;GO:0035591;GO:0009967;GO:0005634;GO:0005737;GO:0016020;GO:0030032;GO:0045840;GO:2000278;GO:0005515;GO:0035556;GO:0005886;GO:0005829;GO:0007596;GO:0007169;GO:0005068	signal transduction;signaling adaptor activity;positive regulation of signal transduction;nucleus;cytoplasm;membrane;lamellipodium assembly;positive regulation of mitotic nuclear division;regulation of DNA biosynthetic process;protein binding;plasma membrane;intracellular signal transduction;cytosol;blood coagulation;positive regulation of SMAD protein signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;transmembrane receptor protein tyrosine kinase adaptor activity	3D-structure;Alternative splicing;Cytoplasm;Membrane;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;SH2 domain	R-HSA-109582;R-HSA-983231	Hemostasis;Factors involved in megakaryocyte development and platelet production
COQ8B	positive	DNAH2	ENSG00000183914	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00000485;WBGene00000962				GO:0005737;GO:0000166;GO:0005524;GO:0003774;GO:0003777;GO:0005856;GO:0042995;GO:0005874;GO:0007018;GO:0030286;GO:0005929;GO:0051959;GO:0031514;GO:0005930;GO:0045505;GO:0060285;GO:0008569;GO:0005858	ATP binding;dynein complex;microtubule motor activity;microtubule-based movement;cytoplasm;nucleotide binding;motile cilium;motor activity;cytoskeleton;cell projection;microtubule;cilium;axoneme;dynein light intermediate chain binding;sperm flagellum;dynein intermediate chain binding;cilium-dependent cell motility;ATP-dependent microtubule motor activity, minus-end-directed;axonemal dynein complex	ATP-binding;Alternative splicing;Cell projection;Cilium;Coiled coil;Cytoplasm;Cytoskeleton;Dynein;Flagellum;Microtubule;Motor protein;Nucleotide-binding;Polymorphism;RNA editing;Reference proteome;Repeat;TPR repeat		
COQ8B	positive	TMEM173	ENSG00000184584	COQ8B	1	COQ8B	1	0.00977635141774491				Familial Chilblain lupus;STING-associated vasculopathy with onset in infancy;Sting-associated vasculopathy infantile-onset	GO:0051091;GO:0045944;GO:0005737;GO:0016020;GO:0016021;GO:0000166;GO:0005783;GO:0005789;GO:0005739;GO:0042803;GO:0005886;GO:0005515;GO:0048471;GO:0031410;GO:0005741;GO:0006914;GO:0002376;GO:0045087;GO:0042802;GO:0051607;GO:0005768;GO:0005776;GO:0002218;GO:0032481;GO:0035438;GO:0019901;GO:0000045;GO:0000421;GO:0016032;GO:0043312;GO:0030667;GO:0051259;GO:0032092;GO:0033116;GO:0030659;GO:0008134;GO:0016239;GO:0071407;GO:0071360;GO:0032479;GO:0002230;GO:0061507;GO:0032608;GO:0039528;GO:0061709;GO:0030176;GO:1990701	activation of innate immune response;positive regulation of type I interferon production;cyclic-di-GMP binding;positive regulation of DNA-binding transcription factor activity;positive regulation of transcription by RNA polymerase II;cytoplasm;membrane;integral component of membrane;nucleotide binding;nucleoplasm;cytosol;endoplasmic reticulum;endoplasmic reticulum membrane;endosome;mitochondrion;protein homodimerization activity;plasma membrane;protein binding;perinuclear region of cytoplasm;cytoplasmic vesicle;mitochondrial outer membrane;autophagy;immune system process;innate immune response;identical protein binding;defense response to virus;autophagosome;protein kinase binding;autophagosome assembly;autophagosome membrane;viral process;neutrophil degranulation;secretory granule membrane;protein complex oligomerization;endoplasmic reticulum-Golgi intermediate compartment membrane;positive regulation of protein binding;cytoplasmic vesicle membrane;transcription factor binding;positive regulation of macroautophagy;cellular response to organic cyclic compound;cellular response to exogenous dsRNA;regulation of type I interferon production;positive regulation of defense response to virus by host;cyclic-GMP-AMP binding;interferon-beta production;reticulophagy;integral component of endoplasmic reticulum membrane;integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;ubiquitin protein ligase binding;regulation of gene expression;regulation of cellular metabolic process;cellular response to interferon-beta;regulation of inflammatory response;peroxisome;Golgi apparatus	3D-structure;Autophagy;Cell membrane;Cytoplasm;Cytoplasmic vesicle;Disease mutation;Endoplasmic reticulum;Host-virus interaction;Immunity;Innate immunity;Isopeptide bond;Membrane;Mitochondrion;Mitochondrion outer membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-6798695;R-HSA-1834949;R-HSA-3134975;R-HSA-1834941;R-HSA-3270619;R-HSA-3249367	Innate Immune System;Immune System;Neutrophil degranulation;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA;STING mediated induction of host immune responses;IRF3-mediated induction of type I IFN;STAT6-mediated induction of chemokines
COQ8B	positive	CCDC157	ENSG00000187860	COQ8B	1	COQ8B	1	0.00977635141774491		WBGene00004873(0);WBGene00012198(0);WBGene00019087(0)					Coiled coil;Polymorphism;Reference proteome		
COQ8B	positive	NAA80	ENSG00000243477	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00016983	WBGene00016983(0)			GO:0005737;GO:0016740;GO:0016746;GO:0005829;GO:0008080;GO:0006473;GO:0004596;GO:0030047;GO:1905502;GO:0008064;GO:0017190;GO:0018002	N-acetyltransferase activity;cytoplasm;transferase activity;transferase activity, transferring acyl groups;cytosol;actin modification;protein acetylation;peptide alpha-N-acetyltransferase activity;acetyl-CoA binding;regulation of actin polymerization or depolymerization;N-terminal peptidyl-aspartic acid acetylation;N-terminal peptidyl-glutamic acid acetylation	Acyltransferase;Alternative splicing;Cytoplasm;Polymorphism;Reference proteome;Transferase;Tumor suppressor		
COQ8B	positive	CORO7	ENSG00000262246	COQ8B	1	COQ8B	1	0.00977635141774491	WBGene00004075	WBGene00004075(0)			GO:0005737;GO:0016020;GO:0016021;GO:0015031;GO:0003779;GO:0005794;GO:0005829;GO:0005515;GO:0000139;GO:0031410;GO:0051015;GO:0005802;GO:0030041;GO:0006895;GO:0007015	protein binding;Golgi apparatus;cytoplasm;membrane;integral component of membrane;protein transport;actin binding;cytosol;cytoplasmic vesicle;Golgi membrane;actin filament binding;trans-Golgi network;actin filament organization;actin filament polymerization;Golgi to endosome transport	Actin-binding;Alternative splicing;Cytoplasm;Cytoplasmic vesicle;Golgi apparatus;Isopeptide bond;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Transport;Ubl conjugation;WD repeat		
COQ8B	negative	LRP12	ENSG00000147650	COQ8B	1	COQ8B	1	0.000245053625954284	WBGene00003075;WBGene00004374;WBGene00008609;WBGene00015083;WBGene00019756;WBGene00019811				GO:0005515;GO:0016020;GO:0016021;GO:0007165;GO:0005905;GO:0005887;GO:0006897;GO:0040008;GO:0031175;GO:0005041;GO:0001764	protein binding;membrane;integral component of membrane;signal transduction;clathrin-coated pit;endocytosis;integral component of plasma membrane;regulation of growth;neuron projection development;low-density lipoprotein particle receptor activity;neuron migration	Alternative splicing;Coated pit;Disulfide bond;Endocytosis;Glycoprotein;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-196854;R-HSA-2187338;R-HSA-6806667;R-HSA-975634	Metabolism;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of vitamins and cofactors;Visual phototransduction;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
COQ8B	negative	PHF20L1	ENSG00000129292	COQ8B	1	COQ8B	1	0.000379804268474282					GO:0005634;GO:0006355;GO:0046872;GO:0005515	regulation of transcription, DNA-templated;nucleus;metal ion binding;protein binding	3D-structure;Acetylation;Alternative splicing;Isopeptide bond;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger		
COQ8B	negative	THOC2	ENSG00000125676	COQ8B	1	COQ8B	1	0.000580870008103696	WBGene00015813	WBGene00015813(0)		X-linked intellectual disability-short stature-overweight syndrome;MENTAL RETARDATION X-LINKED 12;MENTAL RETARDATION X-LINKED 12	GO:0006397;GO:0006406;GO:0000347;GO:0003723;GO:0008380;GO:0051028;GO:0005634;GO:0016607;GO:0005515;GO:0048666;GO:0003729;GO:0005654;GO:0000784;GO:0006405;GO:0031124;GO:0048699;GO:0016973;GO:0000346;GO:0046784;GO:0000445	mRNA processing;mRNA export from nucleus;THO complex;RNA binding;RNA splicing;mRNA transport;nucleus;nuclear speck;protein binding;neuron development;mRNA binding;nucleoplasm;nuclear chromosome, telomeric region;RNA export from nucleus;mRNA 3'-end processing;generation of neurons;poly(A)+ mRNA export from nucleus;transcription export complex;viral mRNA export from host cell nucleus;THO complex part of transcription export complex;cell morphogenesis;blastocyst development;regulation of gene expression;regulation of mRNA export from nucleus;negative regulation of neuron projection development;stem cell division	Alternative splicing;Coiled coil;Disease mutation;Mental retardation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transport;mRNA processing;mRNA splicing;mRNA transport	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination
COQ8B	negative	RP2	ENSG00000102218	COQ8B	1	COQ8B	1	0.000876673110756343	WBGene00019536	WBGene00019536(1)		Retinitis pigmentosa;RETINITIS PIGMENTOSA 2	GO:0005737;GO:0016020;GO:0015031;GO:0000166;GO:0005654;GO:0005886;GO:0005525;GO:0005096;GO:0043547;GO:0042995;GO:0005515;GO:0016604;GO:0000287;GO:0000902;GO:0005929;GO:0036064;GO:0005794;GO:0005814;GO:1990075;GO:0070062;GO:0007601;GO:0006457;GO:0031410;GO:0051082;GO:0006892	GTPase activator activity;cell morphogenesis;cytoplasm;membrane;protein transport;nucleotide binding;nucleoplasm;plasma membrane;GTP binding;positive regulation of GTPase activity;cell projection;protein binding;nuclear body;magnesium ion binding;cilium;ciliary basal body;Golgi apparatus;centriole;periciliary membrane compartment;extracellular exosome;visual perception;protein folding;cytoplasmic vesicle;unfolded protein binding;post-Golgi vesicle-mediated transport	3D-structure;Cell membrane;Cell projection;Cilium;Disease mutation;GTP-binding;GTPase activation;Lipoprotein;Membrane;Myristate;Nucleotide-binding;Palmitate;Polymorphism;Protein transport;Reference proteome;Retinitis pigmentosa;Transport	R-HSA-1852241;R-HSA-5617833;R-HSA-5620920;R-HSA-5624138	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;Trafficking of myristoylated proteins to the cilium
COQ8B	negative	USP12	ENSG00000152484	COQ8B	1	COQ8B	1	0.000876673110756343	WBGene00011216	WBGene00011216(0)			GO:0046872;GO:0016579;GO:0016787;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0006511;GO:0036459;GO:0004843;GO:0005654;GO:0005575;GO:0004197;GO:0101005	ubiquitin-dependent protein catabolic process;thiol-dependent ubiquitinyl hydrolase activity;protein deubiquitination;metal ion binding;hydrolase activity;protein binding;peptidase activity;cysteine-type peptidase activity;proteolysis;thiol-dependent ubiquitin-specific protease activity;nucleoplasm;cellular_component;cysteine-type endopeptidase activity;ubiquitinyl hydrolase activity	3D-structure;Hydrolase;Metal-binding;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway;Zinc	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689880	Metabolism of proteins;Post-translational protein modification;Deubiquitination;Ub-specific processing proteases
COQ8B	negative	VPS37A	ENSG00000155975	COQ8B	1	COQ8B	1	0.000876673110756343	WBGene00016990	WBGene00016990(0)		Autosomal recessive spastic paraplegia type 53;SPASTIC PARAPLEGIA 53 AUTOSOMAL RECESSIVE	GO:0005634;GO:0016020;GO:0015031;GO:0043231;GO:0005813;GO:0005829;GO:0005654;GO:0005515;GO:0000813;GO:0032509;GO:0005768;GO:0031902;GO:0006612;GO:0006623;GO:0016197;GO:0016236;GO:0019058;GO:0036258;GO:0039702;GO:0043162;GO:0075733;GO:0010008;GO:0043657	endosome transport via multivesicular body sorting pathway;ESCRT I complex;nucleus;membrane;protein transport;intracellular membrane-bounded organelle;nucleoplasm;cytosol;endosome;centrosome;protein binding;late endosome membrane;protein targeting to membrane;protein targeting to vacuole;endosomal transport;macroautophagy;viral life cycle;multivesicular body assembly;viral budding via host ESCRT complex;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;intracellular transport of virus;endosome membrane;host cell	Alternative splicing;Disease mutation;Endosome;Hereditary spastic paraplegia;Membrane;Neurodegeneration;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-199991;R-HSA-1643685;R-HSA-162587;R-HSA-162588;R-HSA-162599;R-HSA-162906;R-HSA-174490;R-HSA-174495;R-HSA-175474;R-HSA-5663205;R-HSA-917729;R-HSA-9612973;R-HSA-9615710	Vesicle-mediated transport;Membrane Trafficking;Disease;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);Autophagy;Late endosomal microautophagy
COQ8B	negative	ZNF24	ENSG00000172466	COQ8B	1	COQ8B	1	0.000876673110756343	WBGene00013970		CCND1;CTNNB1		GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0008270;GO:0003677;GO:0003700;GO:0005515;GO:0043565;GO:0000981;GO:0001228;GO:0045944;GO:0045892;GO:0042552	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;zinc ion binding;DNA binding;protein binding;sequence-specific DNA binding;identical protein binding;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;myelination	3D-structure;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ8B	negative	ROCK2	ENSG00000134318	COQ8B	1	COQ8B	1	0.00130573979694815	WBGene00002694;WBGene00011992	WBGene00002694(1)			GO:0010629;GO:0030335;GO:0045019;GO:0043410;GO:0010628;GO:1902004;GO:1900037;GO:0002931;GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0035556;GO:0005886;GO:0030036;GO:0005856;GO:0005515;GO:0048511;GO:0007266;GO:0005813;GO:0005815;GO:0032956;GO:0017048;GO:0017049;GO:0006939;GO:0010825;GO:2000114;GO:0001934;GO:0031032;GO:0030155;GO:0007186;GO:0018107;GO:0048013;GO:0048010;GO:0048156;GO:0005198;GO:0016525;GO:0042752;GO:0036464;GO:0000281;GO:0030866;GO:0010595;GO:0072659;GO:0051496;GO:0007249;GO:0035509;GO:1903140;GO:1903347;GO:0039694;GO:0018105;GO:0051893;GO:2000145;GO:0051298;GO:0003180;GO:0050321;GO:0072518;GO:0010613;GO:0031644;GO:0032723;GO:0045616;GO:0048598;GO:0051246;GO:0051492;GO:0061157;GO:0070168;GO:0071394;GO:0071559;GO:0090271;GO:0097746;GO:0110061;GO:0150033;GO:1901888;GO:1902961;GO:1902966;GO:1902993;GO:1905145;GO:1905205;GO:1990776	ATP binding;protein phosphorylation;Rho protein signal transduction;smooth muscle contraction;intracellular signal transduction;protein serine/threonine kinase activity;protein kinase activity;actin cytoskeleton organization;Rho GTPase binding;regulation of actin cytoskeleton organization;positive regulation of centrosome duplication;negative regulation of gene expression;positive regulation of cell migration;negative regulation of nitric oxide biosynthetic process;positive regulation of MAPK cascade;positive regulation of gene expression;positive regulation of amyloid-beta formation;regulation of cellular response to hypoxia;response to ischemia;RNA binding;nucleus;cytoplasm;membrane;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytosol;cytoskeleton;plasma membrane;protein binding;rhythmic process;centrosome;microtubule organizing center;GTP-Rho binding;regulation of establishment of cell polarity;positive regulation of protein phosphorylation;actomyosin structure organization;regulation of cell adhesion;G protein-coupled receptor signaling pathway;peptidyl-threonine phosphorylation;ephrin receptor signaling pathway;vascular endothelial growth factor receptor signaling pathway;tau protein binding;structural molecule activity;negative regulation of angiogenesis;regulation of circadian rhythm;cytoplasmic ribonucleoprotein granule;mitotic cytokinesis;cortical actin cytoskeleton organization;positive regulation of endothelial cell migration;protein localization to plasma membrane;positive regulation of stress fiber assembly;I-kappaB kinase/NF-kappaB signaling;negative regulation of myosin-light-chain-phosphatase activity;regulation of establishment of endothelial barrier;negative regulation of bicellular tight junction assembly;viral RNA genome replication;peptidyl-serine phosphorylation;regulation of focal adhesion assembly;regulation of cell motility;centrosome duplication;aortic valve morphogenesis;tau-protein kinase activity;Rho-dependent protein serine/threonine kinase activity;positive regulation of cardiac muscle hypertrophy;regulation of nervous system process;positive regulation of connective tissue growth factor production;regulation of keratinocyte differentiation;embryonic morphogenesis;regulation of protein metabolic process;regulation of stress fiber assembly;mRNA destabilization;negative regulation of biomineral tissue development;cellular response to testosterone stimulus;response to transforming growth factor beta;positive regulation of fibroblast growth factor production;regulation of blood vessel diameter;regulation of angiotensin-activated signaling pathway;negative regulation of protein localization to lysosome;regulation of cell junction assembly;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;positive regulation of protein localization to early endosome;positive regulation of amyloid precursor protein catabolic process;cellular response to acetylcholine;positive regulation of connective tissue replacement;response to angiotensin	3D-structure;ATP-binding;Biological rhythms;Cell membrane;Coiled coil;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Zinc;Zinc-finger	R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-194315;R-HSA-372790;R-HSA-388396;R-HSA-416482;R-HSA-195258;R-HSA-9006934;R-HSA-2682334;R-HSA-3928662;R-HSA-194138;R-HSA-4420097;R-HSA-373755;R-HSA-3928663;R-HSA-400685;R-HSA-416572;R-HSA-5627117	Developmental Biology;Axon guidance;Signal Transduction;Signaling by Rho GTPases;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;RHO GTPase Effectors;Signaling by Receptor Tyrosine Kinases;EPH-Ephrin signaling;EPHB-mediated forward signaling;Signaling by VEGF;VEGFA-VEGFR2 Pathway;Semaphorin interactions;EPHA-mediated growth cone collapse;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;RHO GTPases Activate ROCKs
COQ8B	negative	MIER1	ENSG00000198160	COQ8B	1	COQ8B	1	0.00130573979694815	WBGene00017352;WBGene00020320	WBGene00020320(0);WBGene00017352(0)			GO:0005634;GO:0005737;GO:0005654;GO:0006355;GO:0003677;GO:0005515;GO:0017053;GO:0042826;GO:0000122;GO:0000981;GO:0003714;GO:0004407;GO:0032991;GO:0043123;GO:0016575;GO:0001103;GO:0031937	DNA binding;regulation of transcription, DNA-templated;transcriptional repressor complex;histone deacetylase binding;nucleus;cytoplasm;nucleoplasm;protein binding;negative regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor activity;histone deacetylase activity;protein-containing complex;positive regulation of I-kappaB kinase/NF-kappaB signaling;histone deacetylation;RNA polymerase II repressing transcription factor binding;positive regulation of chromatin silencing	Alternative splicing;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation		
COQ8B	negative	BIRC2	ENSG00000110330	COQ8B	1	COQ8B	1	0.00191936656024005		WBGene00000250(0)			GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0043066;GO:0008270;GO:0042981;GO:1903508;GO:0005515;GO:0004842;GO:0006915;GO:0003713;GO:0042802;GO:0061630;GO:0005829;GO:0016579;GO:0033209;GO:0043123;GO:0042127;GO:0051726;GO:0047485;GO:0002756;GO:0007249;GO:0035666;GO:0007166;GO:0043161;GO:0009898;GO:0035631;GO:0051087;GO:0010803;GO:0043027;GO:0043154;GO:0060544;GO:0045595;GO:0000209;GO:0050727;GO:1902527;GO:0045088;GO:2000116;GO:0043130;GO:0031398;GO:0070424;GO:1990001;GO:0098770;GO:0034121;GO:0038061;GO:0039535;GO:0060546;GO:1902523;GO:1902524;GO:0001666;GO:0001890;GO:0010243;GO:0014070;GO:0045471;GO:0051291;GO:0051591;GO:0070266;GO:0071356;GO:1901222;GO:1902443;GO:1902916;GO:2000377;GO:0001741;GO:0032991;GO:0045121	regulation of apoptotic process;nucleus;cytoplasm;metal ion binding;transferase activity;negative regulation of apoptotic process;zinc ion binding;positive regulation of nucleic acid-templated transcription;protein binding;ubiquitin-protein transferase activity;apoptotic process;regulation of innate immune response;transcription coactivator activity;identical protein binding;ubiquitin protein ligase activity;cytosol;protein deubiquitination;tumor necrosis factor-mediated signaling pathway;regulation of cell cycle;positive regulation of I-kappaB kinase/NF-kappaB signaling;regulation of cell population proliferation;protein N-terminus binding;MyD88-independent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;TRIF-dependent toll-like receptor signaling pathway;cell surface receptor signaling pathway;proteasome-mediated ubiquitin-dependent protein catabolic process;cytoplasmic side of plasma membrane;CD40 receptor complex;positive regulation of protein K63-linked ubiquitination;chaperone binding;regulation of tumor necrosis factor-mediated signaling pathway;regulation of inflammatory response;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;regulation of necroptotic process;regulation of cell differentiation;protein polyubiquitination;positive regulation of protein monoubiquitination;regulation of cysteine-type endopeptidase activity;ubiquitin binding;positive regulation of protein ubiquitination;regulation of nucleotide-binding oligomerization domain containing signaling pathway;inhibition of cysteine-type endopeptidase activity involved in apoptotic process;FBXO family protein binding;regulation of toll-like receptor signaling pathway;NIK/NF-kappaB signaling;regulation of RIG-I signaling pathway;negative regulation of necroptotic process;positive regulation of protein K48-linked ubiquitination;protein-containing complex binding;response to hypoxia;placenta development;response to organonitrogen compound;response to organic cyclic compound;response to ethanol;response to cAMP;necroptotic process;cellular response to tumor necrosis factor;regulation of NIK/NF-kappaB signaling;negative regulation of ripoptosome assembly involved in necroptotic process;positive regulation of protein polyubiquitination;regulation of reactive oxygen species metabolic process;XY body;protein-containing complex;membrane raft	3D-structure;Activator;Alternative splicing;Apoptosis;Cytoplasm;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-109581;R-HSA-162582;R-HSA-5357801;R-HSA-73887;R-HSA-1280215;R-HSA-5668541;R-HSA-5688426;R-HSA-5689880;R-HSA-166016;R-HSA-166166;R-HSA-168898;R-HSA-937041;R-HSA-937061;R-HSA-5213460;R-HSA-5218859;R-HSA-5675482;R-HSA-75153;R-HSA-168164;R-HSA-5676594;R-HSA-168643;R-HSA-168638;R-HSA-168927;R-HSA-5357905;R-HSA-5357956;R-HSA-75893;R-HSA-111465	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Apoptosis;Signal Transduction;Programmed Cell Death;Death Receptor Signalling;Cytokine Signaling in Immune system;TNFR2 non-canonical NF-kB pathway;Deubiquitination;Ub-specific processing proteases;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll-like Receptor Cascades;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;RIPK1-mediated regulated necrosis;Regulated Necrosis;Regulation of necroptotic cell death;Apoptotic execution phase;Toll Like Receptor 3 (TLR3) Cascade;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;NOD1/2 Signaling Pathway;TICAM1, RIP1-mediated IKK complex recruitment;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNF signaling;Apoptotic cleavage of cellular proteins
COQ8B	negative	ATF2	ENSG00000115966	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00000793;WBGene00000223	WBGene00000223(0)	APOC3;ATF3;CCND1;IFNB1;IFNG;INS;JUN;MMP2;PCK1;PLAT;POLB;RELA;RETN;ST3GAL5;TNF		GO:0010628;GO:0016525;GO:0005634;GO:0003676;GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0005654;GO:0006355;GO:0006357;GO:0003677;GO:0003700;GO:0005739;GO:0005515;GO:0006974;GO:0005741;GO:0004402;GO:0000981;GO:0000790;GO:0019901;GO:0001228;GO:0035861;GO:0045944;GO:0016573;GO:0000980;GO:0051091;GO:0000977;GO:0001102;GO:0006970;GO:0110024;GO:0001158;GO:0051090;GO:0035497;GO:0003682;GO:0008134;GO:0008140;GO:0043565;GO:0046982;GO:0000122;GO:0003151;GO:0009414;GO:0031573;GO:0032915;GO:0043525;GO:0045444;GO:0050680;GO:0060612;GO:0097186;GO:1902110	regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;nucleic acid binding;regulation of transcription by RNA polymerase II;positive regulation of gene expression;negative regulation of angiogenesis;cytoplasm;membrane;metal ion binding;transferase activity;nucleoplasm;DNA binding;mitochondrion;protein binding;cellular response to DNA damage stimulus;mitochondrial outer membrane;histone acetyltransferase activity;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;cis-regulatory region sequence-specific DNA binding;protein kinase binding;DNA-binding transcription activator activity, RNA polymerase II-specific;site of double-strand break;positive regulation of transcription by RNA polymerase II;histone acetylation;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of DNA-binding transcription factor activity;RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II activating transcription factor binding;response to osmotic stress;positive regulation of cardiac muscle myoblast proliferation;regulation of DNA-binding transcription factor activity;cAMP response element binding;chromatin binding;transcription factor binding;cAMP response element binding protein binding;sequence-specific DNA binding;protein-containing complex binding;negative regulation of transcription by RNA polymerase II;outflow tract morphogenesis;response to water deprivation;intra-S DNA damage checkpoint;positive regulation of transforming growth factor beta2 production;positive regulation of neuron apoptotic process;fat cell differentiation;negative regulation of epithelial cell proliferation;adipose tissue development;amelogenesis;positive regulation of mitochondrial membrane permeability involved in apoptotic process	3D-structure;Acetylation;Activator;Alternative splicing;Cytoplasm;DNA damage;DNA-binding;Membrane;Metal-binding;Mitochondrion;Mitochondrion outer membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Transferase;Zinc;Zinc-finger	R-HSA-168249;R-HSA-168256;R-HSA-1852241;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1257604;R-HSA-1280215;R-HSA-449147;R-HSA-6807070;R-HSA-9006925;R-HSA-6796648;R-HSA-8939211;R-HSA-9006931;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-8943724;R-HSA-400253;R-HSA-1592230;R-HSA-2151201;R-HSA-3247509;R-HSA-4839726;R-HSA-9018519;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-975871;R-HSA-3214847;R-HSA-450282;R-HSA-450341	Innate Immune System;Immune System;Organelle biogenesis and maintenance;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signaling by Interleukins;PTEN Regulation;Intracellular signaling by second messengers;TP53 Regulates Transcription of DNA Repair Genes;ESR-mediated signaling;Signaling by Nuclear Receptors;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Regulation of PTEN gene transcription;Circadian Clock;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;Chromatin modifying enzymes;Chromatin organization;Estrogen-dependent gene expression;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;MyD88 cascade initiated on plasma membrane;HATs acetylate histones;MAPK targets/ Nuclear events mediated by MAP kinases;Activation of the AP-1 family of transcription factors
COQ8B	negative	TRAK2	ENSG00000115993	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00020838				GO:0005737;GO:0032839;GO:0005739;GO:1904115;GO:0005886;GO:0005768;GO:0005769;GO:0047496;GO:0005515;GO:0050811;GO:0030425;GO:0031410;GO:0005102;GO:0022008;GO:0008104;GO:0017022;GO:0019894;GO:0019899;GO:0030911;GO:0006357;GO:0006493;GO:0006605;GO:0008089;GO:0008333;GO:0048311;GO:0048813;GO:0050771;GO:0098939;GO:0098957;GO:0098972;GO:0005634;GO:0043005;GO:0043025;GO:0044295	cell;cytoplasm;endosome;dendrite cytoplasm;mitochondrion;axon cytoplasm;plasma membrane;early endosome;vesicle transport along microtubule;protein binding;GABA receptor binding;dendrite;cytoplasmic vesicle;signaling receptor binding;neurogenesis;protein localization;myosin binding;kinesin binding;enzyme binding;TPR domain binding;regulation of transcription by RNA polymerase II;protein O-linked glycosylation;protein targeting;anterograde axonal transport;endosome to lysosome transport;mitochondrion distribution;dendrite morphogenesis;negative regulation of axonogenesis;dendritic transport of mitochondrion;anterograde axonal transport of mitochondrion;anterograde dendritic transport of mitochondrion;nucleus;neuron projection;neuronal cell body;axonal growth cone	Alternative splicing;Coiled coil;Cytoplasm;Endosome;Glycoprotein;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Transport		
COQ8B	negative	RO60	ENSG00000116747	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00004405	WBGene00004405(1)			GO:0003723;GO:0005737;GO:0046872;GO:0005829;GO:0005654;GO:0030030;GO:1990904;GO:0010468;GO:0006383;GO:0035457;GO:0030620;GO:0002520;GO:0007224;GO:0009411;GO:0060271;GO:0005634	RNA binding;cytoplasm;metal ion binding;nucleoplasm;cytosol;cell projection organization;ribonucleoprotein complex;regulation of gene expression;transcription by RNA polymerase III;cellular response to interferon-alpha;U2 snRNA binding;immune system development;smoothened signaling pathway;response to UV;cilium assembly;nucleus	Acetylation;Alternative splicing;Cilium biogenesis/degradation;Cytoplasm;Direct protein sequencing;Metal-binding;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein		
COQ8B	negative	RBBP6	ENSG00000122257	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00009477				GO:0003676;GO:0008270;GO:0004842;GO:0006397;GO:0016567;GO:0061630;GO:0003723;GO:0005634;GO:0005737;GO:0016607;GO:0046872;GO:0016740;GO:0005694;GO:0005856;GO:0005515;GO:0006974;GO:0006511;GO:0006260;GO:0005730;GO:0005813;GO:0005815;GO:0005829;GO:0019901;GO:0000209;GO:0032991;GO:0006275;GO:0001701;GO:0035264;GO:0048568;GO:0061053	zinc ion binding;nucleic acid binding;ubiquitin-protein transferase activity;mRNA processing;protein ubiquitination;ubiquitin protein ligase activity;RNA binding;nucleus;cytoplasm;nuclear speck;metal ion binding;transferase activity;cytoskeleton;chromosome;protein binding;cellular response to DNA damage stimulus;ubiquitin-dependent protein catabolic process;DNA replication;nucleolus;centrosome;microtubule organizing center;cytosol;protein kinase binding;protein polyubiquitination;protein-containing complex;regulation of DNA replication;in utero embryonic development;multicellular organism growth;embryonic organ development;somite development	3D-structure;Acetylation;Alternative splicing;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA replication;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ8B	negative	ACTR2	ENSG00000138071	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00000200	WBGene00000200(1)			GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0007015;GO:0003779;GO:0005856;GO:0042995;GO:0034314;GO:0005885;GO:0005925;GO:0038096;GO:0005576;GO:0051015;GO:0045944;GO:0005829;GO:0070062;GO:0030479;GO:0035861;GO:0043312;GO:1904813;GO:0061024;GO:0048013;GO:0035578;GO:0060271;GO:0015629;GO:0005200;GO:1905168;GO:0008092;GO:0007163;GO:0008306;GO:0008356;GO:0016344;GO:0016482;GO:0030036;GO:0033206;GO:0035902;GO:0035984;GO:0045471;GO:0051321;GO:0051653;GO:0061003;GO:0071346;GO:0005938;GO:0014069;GO:0030027;GO:0030478;GO:0061825;GO:0071437;GO:0098794	ATP binding;cytoskeleton;actin filament organization;Arp2/3 complex-mediated actin nucleation;Arp2/3 protein complex;cell;nucleus;cytoplasm;membrane;nucleotide binding;actin binding;focal adhesion;cell projection;Fc-gamma receptor signaling pathway involved in phagocytosis;extracellular region;protein binding;actin filament binding;positive regulation of transcription by RNA polymerase II;cytosol;extracellular exosome;site of double-strand break;neutrophil degranulation;ficolin-1-rich granule lumen;membrane organization;ephrin receptor signaling pathway;azurophil granule lumen;cilium assembly;positive regulation of lamellipodium assembly;actin cytoskeleton;structural constituent of cytoskeleton;positive regulation of double-strand break repair via homologous recombination;cytoskeletal protein binding;establishment or maintenance of cell polarity;associative learning;asymmetric cell division;meiotic chromosome movement towards spindle pole;cytosolic transport;actin cytoskeleton organization;meiotic cytokinesis;response to immobilization stress;cellular response to trichostatin A;response to ethanol;meiotic cell cycle;spindle localization;positive regulation of dendritic spine morphogenesis;cellular response to interferon-gamma;cell cortex;postsynaptic density;lamellipodium;actin cap;podosome core;invadopodium;postsynapse	ATP-binding;Acetylation;Actin-binding;Alternative splicing;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleotide-binding;Nucleus;Reference proteome	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029482;R-HSA-5653656;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-194315;R-HSA-199991;R-HSA-195258;R-HSA-5663213;R-HSA-6798695;R-HSA-8856828;R-HSA-2682334;R-HSA-3928662	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Vesicle-mediated transport;Developmental Biology;Axon guidance;Signal Transduction;Signaling by Rho GTPases;Membrane Trafficking;RHO GTPase Effectors;RHO GTPases Activate WASPs and WAVEs;Neutrophil degranulation;Clathrin-mediated endocytosis;EPH-Ephrin signaling;EPHB-mediated forward signaling
COQ8B	negative	TP53BP2	ENSG00000143514	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00000146	WBGene00000146(0)			GO:0048471;GO:0005737;GO:0005739;GO:0005634;GO:0005829;GO:0030054;GO:0005515;GO:0007049;GO:0006915;GO:0042802;GO:0005654;GO:0017124;GO:0007165;GO:0042981;GO:0045786;GO:1901796;GO:0005070;GO:1900740;GO:0051059;GO:0072332;GO:1900119;GO:0002039;GO:1901216	protein binding;perinuclear region of cytoplasm;cytoplasm;mitochondrion;nucleus;cytosol;cell junction;cell cycle;apoptotic process;identical protein binding;nucleoplasm;SH3 domain binding;signal transduction;regulation of apoptotic process;negative regulation of cell cycle;regulation of signal transduction by p53 class mediator;SH3/SH2 adaptor activity;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;NF-kappaB binding;intrinsic apoptotic signaling pathway by p53 class mediator;positive regulation of execution phase of apoptosis;p53 binding;positive regulation of neuron death	3D-structure;ANK repeat;Alternative splicing;Apoptosis;Cell cycle;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat;SH3 domain;SH3-binding	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-109581;R-HSA-5357801;R-HSA-5633007;R-HSA-5633008;R-HSA-6803211;R-HSA-109606;R-HSA-114452;R-HSA-139915;R-HSA-6803204;R-HSA-6803205;R-HSA-6804759	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptosis;Programmed Cell Death;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Death Receptors and Ligands;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Regulation of TP53 Activity through Association with Co-factors
COQ8B	negative	NEK7	ENSG00000151414	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00008956	WBGene00008956(1)			GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0005856;GO:0005874;GO:0000922;GO:0005815;GO:0005515;GO:0007346;GO:0032212;GO:0051973;GO:1904355;GO:0051225	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytoskeleton;microtubule;spindle pole;microtubule organizing center;protein binding;regulation of mitotic cell cycle;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;positive regulation of telomere capping;spindle assembly	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Metal-binding;Microtubule;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-2980766;R-HSA-3301854;R-HSA-68875;R-HSA-2980767	Cell Cycle;M Phase;Cell Cycle, Mitotic;Nuclear Envelope Breakdown;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Activation of NIMA Kinases NEK9, NEK6, NEK7
COQ8B	negative	PEA15	ENSG00000162734	COQ8B	1	COQ8B	1	0.00191936656024005					GO:0005737;GO:0005634;GO:0005829;GO:0042981;GO:0000077;GO:0005515;GO:0006915;GO:0008643;GO:0005875;GO:0000165;GO:0000187;GO:0046325;GO:1902042;GO:0043278;GO:1902043	protein binding;regulation of apoptotic process;DNA damage checkpoint;cytoplasm;nucleoplasm;cytosol;apoptotic process;carbohydrate transport;microtubule associated complex;MAPK cascade;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;activation of MAPK activity;negative regulation of glucose import;response to morphine;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	3D-structure;Alternative splicing;Apoptosis;Cytoplasm;Direct protein sequencing;Phosphoprotein;Reference proteome;Sugar transport;Transport	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-112409	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;RAF-independent MAPK1/3 activation
COQ8B	negative	CNST	ENSG00000162852	COQ8B	1	COQ8B	1	0.00191936656024005					GO:0016020;GO:0016021;GO:0043231;GO:0005794;GO:0005886;GO:0005515;GO:0005802;GO:0031410;GO:0019902;GO:0010923;GO:0071253;GO:0030133;GO:0042998;GO:0032991	trans-Golgi network;connexin binding;positive regulation of Golgi to plasma membrane protein transport;membrane;integral component of membrane;intracellular membrane-bounded organelle;Golgi apparatus;plasma membrane;protein binding;cytoplasmic vesicle;phosphatase binding;negative regulation of phosphatase activity;transport vesicle;protein-containing complex	Alternative splicing;Cell membrane;Cytoplasmic vesicle;Golgi apparatus;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	negative	OSGIN2	ENSG00000164823	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00017934	WBGene00017934(0)			GO:0007165;GO:0051321;GO:0003674;GO:0005575;GO:0008083;GO:0030308	signal transduction;meiotic cell cycle;molecular_function;cellular_component;growth factor activity;negative regulation of cell growth	Alternative splicing;Meiosis;Polymorphism;Reference proteome		
COQ8B	negative	SESTD1	ENSG00000187231	COQ8B	1	COQ8B	1	0.00191936656024005	WBGene00010111				GO:0045111;GO:0005515;GO:0010314;GO:0032266;GO:0080025;GO:0005546;GO:0043325;GO:0070300;GO:0070273;GO:0034704;GO:1904878	intermediate filament cytoskeleton;protein binding;phosphatidylinositol-5-phosphate binding;phosphatidylinositol-3-phosphate binding;phosphatidylinositol-3,5-bisphosphate binding;phosphatidylinositol-4,5-bisphosphate binding;phosphatidylinositol-3,4-bisphosphate binding;phosphatidic acid binding;phosphatidylinositol-4-phosphate binding;calcium channel complex;negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	Polymorphism;Reference proteome;Repeat		
COQ8B	negative	C11orf58	ENSG00000110696	COQ8B	1	COQ8B	1	0.00278461578616818					GO:0003674;GO:0008150;GO:0005575	molecular_function;biological_process;cellular_component	Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ubl conjugation		
COQ8B	negative	EHBP1	ENSG00000115504	COQ8B	1	COQ8B	1	0.00278461578616818	WBGene00009098			PROSTATE CANCER HEREDITARY 12	GO:0005737;GO:0016020;GO:0015031;GO:0005829;GO:0005886;GO:0005768;GO:0006897;GO:0005815;GO:0030036;GO:0031941;GO:0005515	protein binding;cytoplasm;membrane;protein transport;nucleoplasm;cytosol;plasma membrane;endosome;endocytosis;microtubule organizing center;actin cytoskeleton organization;filamentous actin	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Endocytosis;Endosome;Lipoprotein;Membrane;Phosphoprotein;Polymorphism;Prenylation;Protein transport;Reference proteome;Transport		
COQ8B	negative	BLZF1	ENSG00000117475	COQ8B	1	COQ8B	1	0.00278461578616818	WBGene00020018	WBGene00020018(0)			GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0005794;GO:0003677;GO:0003700;GO:0005515;GO:0000139;GO:0006355;GO:0007030;GO:0043001;GO:0016192;GO:0031625;GO:0001558;GO:0019899	Golgi organization;Golgi to plasma membrane protein transport;nucleus;cytoplasm;membrane;protein transport;Golgi apparatus;nucleoplasm;DNA binding;DNA-binding transcription factor activity;protein binding;regulation of transcription, DNA-templated;Golgi membrane;vesicle-mediated transport;ubiquitin protein ligase binding;regulation of cell growth;enzyme binding	ADP-ribosylation;Alternative splicing;Coiled coil;Cytoplasm;ER-Golgi transport;Golgi apparatus;Membrane;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Ubl conjugation	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68875;R-HSA-162658	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prophase;Golgi Cisternae Pericentriolar Stack Reorganization
COQ8B	negative	RNF11	ENSG00000123091	COQ8B	1	COQ8B	1	0.00278461578616818	WBGene00007226	WBGene00007226(1)			GO:0005634;GO:0005737;GO:0046872;GO:0005515;GO:0006511;GO:0005768;GO:0005769;GO:0070062;GO:0055037;GO:0003677;GO:0004842;GO:0051865;GO:0000151;GO:0008270	nucleus;cytoplasm;metal ion binding;endosome;protein binding;ubiquitin-dependent protein catabolic process;early endosome;extracellular exosome;recycling endosome;DNA binding;protein autoubiquitination;ubiquitin ligase complex;zinc ion binding;ubiquitin protein ligase activity	Cytoplasm;Direct protein sequencing;Endosome;Lipoprotein;Metal-binding;Myristate;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger		
COQ8B	negative	NCOA3	ENSG00000124151	COQ8B	1	COQ8B	1	0.00278461578616818			BCL2;EPO;MMP10;MMP7		GO:0005634;GO:0005737;GO:0016740;GO:0005829;GO:0005654;GO:0003713;GO:0046983;GO:0006355;GO:0016746;GO:0005515;GO:0004402;GO:0045893;GO:0045944;GO:0000981;GO:0000790;GO:0070062;GO:0010628;GO:0016573;GO:0030374;GO:0035257;GO:0047485;GO:0032991;GO:0030521;GO:0046982;GO:0050681;GO:0032870;GO:0045618;GO:0016922;GO:0046966;GO:2000035;GO:0097718;GO:0000993;GO:0043697;GO:1902459;GO:0071392;GO:2001141;GO:0035624	regulation of transcription, DNA-templated;nucleus;protein dimerization activity;transcription coactivator activity;nuclear hormone receptor binding;nuclear receptor transcription coactivator activity;cytoplasm;transferase activity;nucleoplasm;cytosol;transferase activity, transferring acyl groups;protein binding;histone acetyltransferase activity;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;extracellular exosome;positive regulation of gene expression;histone acetylation;protein N-terminus binding;protein-containing complex;androgen receptor signaling pathway;androgen receptor binding;cellular response to hormone stimulus;positive regulation of keratinocyte differentiation;nuclear receptor binding;thyroid hormone receptor binding;regulation of stem cell division;disordered domain specific binding;RNA polymerase II complex binding;cell dedifferentiation;positive regulation of stem cell population maintenance;cellular response to estradiol stimulus;regulation of RNA biosynthetic process	3D-structure;Acetylation;Activator;Acyltransferase;Alternative splicing;Cytoplasm;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase	R-HSA-1266738;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206;R-HSA-162582;R-HSA-5683057;R-HSA-5687128;R-HSA-8939211;R-HSA-9006931;R-HSA-5617472;R-HSA-5619507;R-HSA-9018519	Developmental Biology;Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling;ESR-mediated signaling;Signaling by Nuclear Receptors;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Estrogen-dependent gene expression
COQ8B	negative	ASAP1	ENSG00000153317	COQ8B	1	COQ8B	1	0.00278461578616818					GO:0005096;GO:0043547;GO:0005515;GO:0005737;GO:0016020;GO:0046872;GO:0060271;GO:0005829;GO:0045296;GO:0030030;GO:0031253;GO:1903527;GO:0002102;GO:0001786;GO:0005546;GO:0005547;GO:0061000;GO:0071803;GO:0043197	protein binding;GTPase activator activity;positive regulation of GTPase activity;cytoplasm;membrane;metal ion binding;cilium assembly;cytosol;cadherin binding;cell projection organization;cell projection membrane;positive regulation of membrane tubulation;podosome;phosphatidylserine binding;phosphatidylinositol-4,5-bisphosphate binding;phosphatidylinositol-3,4,5-trisphosphate binding;negative regulation of dendritic spine development;positive regulation of podosome assembly;dendritic spine	3D-structure;ANK repeat;Alternative splicing;Cilium biogenesis/degradation;Cytoplasm;GTPase activation;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH3 domain;Zinc;Zinc-finger	R-HSA-1852241;R-HSA-5617833;R-HSA-5620920;R-HSA-5620916	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;VxPx cargo-targeting to cilium
COQ8B	negative	UBXN2A	ENSG00000173960	COQ8B	1	COQ8B	1	0.00278461578616818	WBGene00022381				GO:0005515;GO:0007030;GO:0005829;GO:0043161;GO:0000045;GO:0043130;GO:0061025;GO:0031468;GO:0033130;GO:0010468;GO:0031396;GO:0042176;GO:1990830;GO:0005783;GO:0005801	protein binding;nucleus;cytosol;Golgi organization;membrane fusion;proteasome-mediated ubiquitin-dependent protein catabolic process;autophagosome assembly;ubiquitin binding;nuclear envelope reassembly;acetylcholine receptor binding;regulation of gene expression;regulation of protein ubiquitination;regulation of protein catabolic process;cellular response to leukemia inhibitory factor;endoplasmic reticulum;cis-Golgi network	Alternative splicing;Reference proteome		
COQ8B	negative	AP1S2	ENSG00000182287	COQ8B	1	COQ8B	1	0.00278461578616818	WBGene00000159	WBGene00000159(0)		Fried syndrome;X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome;X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome;MENTAL RETARDATION X-LINKED TYPE 59;PETTIGREW SYNDROME	GO:0006886;GO:0016192;GO:0030117;GO:0015031;GO:0016020;GO:0005794;GO:0043231;GO:0005515;GO:0031410;GO:0030659;GO:0005905;GO:0005829;GO:0019886;GO:0032588;GO:0000139;GO:0005765;GO:0050690;GO:0030119	intracellular protein transport;vesicle-mediated transport;membrane coat;protein transport;membrane;Golgi apparatus;intracellular membrane-bounded organelle;protein binding;cytoplasmic vesicle;cytoplasmic vesicle membrane;clathrin-coated pit;cytosol;antigen processing and presentation of exogenous peptide antigen via MHC class II;trans-Golgi network membrane;Golgi membrane;lysosomal membrane;regulation of defense response to virus by virus;AP-type membrane coat adaptor complex	Alternative splicing;Coated pit;Cytoplasmic vesicle;Golgi apparatus;Membrane;Mental retardation;Protein transport;Reference proteome;Transport	R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-199991;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-2132295;R-HSA-199992;R-HSA-432720;R-HSA-432722;R-HSA-164938;R-HSA-164940;R-HSA-164952	Adaptive Immune System;Immune System;Vesicle-mediated transport;Membrane Trafficking;Disease;HIV Infection;Infectious disease;Host Interactions of HIV factors;MHC class II antigen presentation;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis
COQ8B	negative	ATL3	ENSG00000184743	COQ8B	1	COQ8B	1	0.00278461578616818	WBGene00021868;WBGene00012763	WBGene00021868(1)		Hereditary sensory and autonomic neuropathy type 1;NEUROPATHY HEREDITARY SENSORY TYPE IF	GO:0016020;GO:0016021;GO:0000166;GO:0005783;GO:0005789;GO:0016787;GO:0003924;GO:0005525;GO:0005515;GO:0051260;GO:0042802;GO:0007029;GO:0007030;GO:0071782;GO:1903373;GO:0098826	GTP binding;GTPase activity;membrane;integral component of membrane;nucleotide binding;endoplasmic reticulum;endoplasmic reticulum membrane;hydrolase activity;identical protein binding;protein binding;protein homooligomerization;endoplasmic reticulum organization;Golgi organization;endoplasmic reticulum tubular network;positive regulation of endoplasmic reticulum tubular network organization;endoplasmic reticulum tubular network membrane	3D-structure;Acetylation;Coiled coil;Disease mutation;Endoplasmic reticulum;GTP-binding;Hydrolase;Membrane;Neuropathy;Nucleotide-binding;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
COQ8B	negative	ZNF267	ENSG00000185947	COQ8B	1	COQ8B	1	0.00278461578616818	WBGene00021931;WBGene00001223				GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0006357;GO:0000981;GO:0007275;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding;DNA-binding transcription factor activity;multicellular organism development	DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ8B	negative	CDC27	ENSG00000004897	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00003132	WBGene00003132(1)			GO:0005634;GO:0005654;GO:0016567;GO:0005515;GO:0005737;GO:0005829;GO:0031145;GO:1901990;GO:0006511;GO:0070979;GO:0005680;GO:0019903;GO:0005813;GO:0005876;GO:0007091;GO:0016020;GO:0016021;GO:0051301	protein binding;nucleus;nucleoplasm;protein ubiquitination;cytoplasm;ubiquitin protein ligase activity;cytosol;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;ubiquitin-dependent protein catabolic process;protein K11-linked ubiquitination;anaphase-promoting complex;protein phosphatase binding;centrosome;spindle microtubule;metaphase/anaphase transition of mitotic cell cycle;positive regulation of mitotic metaphase/anaphase transition;cell division;membrane;integral component of membrane	3D-structure;Alternative splicing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;TPR repeat;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169;R-HSA-1640170;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69620;R-HSA-8953897;R-HSA-69618;R-HSA-174084;R-HSA-2559583;R-HSA-141405;R-HSA-141430;R-HSA-174048;R-HSA-176407;R-HSA-176412;R-HSA-179409;R-HSA-2559582	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Cell Cycle Checkpoints;Cellular responses to external stimuli;Mitotic Spindle Checkpoint;Autodegradation of Cdh1 by Cdh1:APC/C;Cellular Senescence;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;APC/C:Cdc20 mediated degradation of Cyclin B;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Phosphorylation of the APC/C;APC-Cdc20 mediated degradation of Nek2A;Senescence-Associated Secretory Phenotype (SASP)
COQ8B	negative	TNPO1	ENSG00000083312	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00002076				GO:0003723;GO:0005634;GO:0005737;GO:0006886;GO:0015031;GO:0005515;GO:0008536;GO:0006606;GO:0035735;GO:0005929;GO:0005829;GO:0070062;GO:0043488;GO:0016032;GO:0008139;GO:0061608;GO:0005623	intracellular protein transport;Ran GTPase binding;protein import into nucleus;RNA binding;nucleus;cytoplasm;protein transport;protein binding;intraciliary transport involved in cilium assembly;cilium;cytosol;extracellular exosome;regulation of mRNA stability;viral process;nuclear localization sequence binding;nuclear import signal receptor activity	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Host-virus interaction;Nucleus;Protein transport;Reference proteome;Repeat;Transport	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-8953854;R-HSA-450531;R-HSA-450513	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
COQ8B	negative	EPS15	ENSG00000085832	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00001224	WBGene00001224(0);WBGene00006405(0)			GO:0043231;GO:0005829;GO:0005509;GO:0005515;GO:0005737;GO:0016020;GO:0015031;GO:0046872;GO:0005886;GO:0005905;GO:0005768;GO:0098794;GO:0045296;GO:0006897;GO:0031901;GO:0016032;GO:0017124;GO:0006895;GO:0061024;GO:0042059;GO:0046718;GO:0016235;GO:0031593;GO:0042802;GO:0001921;GO:0016050;GO:0019065;GO:0032456;GO:0042127;GO:0048268;GO:0098884;GO:0005769;GO:0009925;GO:0016324;GO:0030122;GO:0030132;GO:0030136;GO:0045202;GO:0060170;GO:0098978	protein binding;calcium ion binding;intracellular membrane-bounded organelle;cytosol;cytoplasm;membrane;protein transport;metal ion binding;endosome;plasma membrane;clathrin-coated pit;endocytosis;postsynapse;cadherin binding;early endosome membrane;viral process;SH3 domain binding;Golgi to endosome transport;membrane organization;negative regulation of epidermal growth factor receptor signaling pathway;viral entry into host cell;aggresome;polyubiquitin modification-dependent protein binding;identical protein binding;positive regulation of receptor recycling;vesicle organization;receptor-mediated endocytosis of virus by host cell;endocytic recycling;regulation of cell population proliferation;clathrin coat assembly;postsynaptic neurotransmitter receptor internalization;early endosome;basal plasma membrane;apical plasma membrane;AP-2 adaptor complex;clathrin coat of coated pit;clathrin-coated vesicle;synapse;ciliary membrane;glutamatergic synapse	3D-structure;Acetylation;Alternative splicing;Calcium;Cell membrane;Chromosomal rearrangement;Coated pit;Cytoplasm;Endocytosis;Endosome;Host-virus interaction;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Protein transport;Proto-oncogene;Reference proteome;Repeat;SH3-binding;Transport;Ubl conjugation	R-HSA-5653656;R-HSA-162582;R-HSA-199991;R-HSA-1643685;R-HSA-5663205;R-HSA-9006934;R-HSA-8856828;R-HSA-8856825;R-HSA-177929;R-HSA-182971;R-HSA-6806834;R-HSA-6807004;R-HSA-8875360;R-HSA-8876384	Vesicle-mediated transport;Signal Transduction;Membrane Trafficking;Disease;Infectious disease;Signaling by Receptor Tyrosine Kinases;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Signaling by EGFR;EGFR downregulation;Signaling by MET;Negative regulation of MET activity;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
COQ8B	negative	ALG13	ENSG00000101901	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00011193			ALG13-CDG;X-linked non-syndromic intellectual disability;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Is;epileptic encephalopathies;Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 36	GO:0016758;GO:0006488;GO:0003723;GO:0016740;GO:0005783;GO:0016787;GO:0016757;GO:0003824;GO:0008152;GO:0008233;GO:0008234;GO:0006508;GO:0036459;GO:0005789;GO:0004577	transferase activity, transferring hexosyl groups;dolichol-linked oligosaccharide biosynthetic process;RNA binding;transferase activity;endoplasmic reticulum;hydrolase activity;transferase activity, transferring glycosyl groups;catalytic activity;metabolic process;peptidase activity;cysteine-type peptidase activity;proteolysis;thiol-dependent ubiquitinyl hydrolase activity;endoplasmic reticulum membrane;N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity	Alternative splicing;Congenital disorder of glycosylation;Disease mutation;Endoplasmic reticulum;Epilepsy;Glycosyltransferase;Hydrolase;Multifunctional enzyme;Polymorphism;Protease;Reference proteome;Thiol protease;Transferase;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-446193;R-HSA-446203;R-HSA-1643685;R-HSA-3781865;R-HSA-3781860;R-HSA-5633231	Metabolism of proteins;Post-translational protein modification;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Disease;Diseases of glycosylation;Diseases associated with N-glycosylation of proteins;Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
COQ8B	negative	MED13	ENSG00000108510	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00002295	WBGene00002295(0)		MED13 - Neurodevelopment disorder	GO:0005634;GO:0016020;GO:0003712;GO:0006357;GO:0042632;GO:0043433;GO:0070328;GO:0016592;GO:0030374;GO:0045893;GO:0006367;GO:0005654;GO:0003713;GO:0045944;GO:0042809;GO:0046966	transcription coregulator activity;regulation of transcription by RNA polymerase II;mediator complex;nucleus;membrane;nucleoplasm;cholesterol homeostasis;negative regulation of DNA-binding transcription factor activity;triglyceride homeostasis;nuclear receptor transcription coactivator activity;positive regulation of transcription, DNA-templated;transcription initiation from RNA polymerase II promoter;transcription coactivator activity;positive regulation of transcription by RNA polymerase II;vitamin D receptor binding;thyroid hormone receptor binding	Activator;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation	R-HSA-1266738;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206	Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha
COQ8B	negative	ERBIN	ENSG00000112851	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00002632				GO:0005634;GO:0005737;GO:0016607;GO:0016020;GO:0007165;GO:0007155;GO:0005886;GO:0030054;GO:0005515;GO:0007229;GO:0005200;GO:0071356;GO:0005176;GO:0016323;GO:0032496;GO:0032088;GO:0031965;GO:0005102;GO:0009925;GO:0007173;GO:0038128;GO:0045104;GO:0005604;GO:0030056;GO:0045197;GO:0032495;GO:0045175;GO:0070433;GO:0006605;GO:0071638;GO:0099072;GO:0098794;GO:0098978	protein binding;signal transduction;negative regulation of NF-kappaB transcription factor activity;ErbB-2 class receptor binding;nucleus;cytoplasm;nuclear speck;membrane;plasma membrane;cell adhesion;cell junction;integrin-mediated signaling pathway;structural constituent of cytoskeleton;cellular response to tumor necrosis factor;basolateral plasma membrane;response to lipopolysaccharide;nuclear membrane;signaling receptor binding;basal plasma membrane;epidermal growth factor receptor signaling pathway;ERBB2 signaling pathway;intermediate filament cytoskeleton organization;basement membrane;hemidesmosome;establishment or maintenance of epithelial cell apical/basal polarity;response to muramyl dipeptide;basal protein localization;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;protein targeting;negative regulation of monocyte chemotactic protein-1 production;regulation of postsynaptic membrane neurotransmitter receptor levels;postsynapse;glutamatergic synapse	3D-structure;Alternative splicing;Cell junction;Cell membrane;Leucine-rich repeat;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-162582;R-HSA-9006934;R-HSA-1227986;R-HSA-8863795	Signal Transduction;Signaling by Receptor Tyrosine Kinases;Signaling by ERBB2;Downregulation of ERBB2 signaling
COQ8B	negative	STXBP3	ENSG00000116266	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00006757				GO:0005737;GO:0016020;GO:0015031;GO:0016192;GO:0005829;GO:0005886;GO:0006904;GO:0005515;GO:0070062;GO:0019905;GO:0042581;GO:0017075;GO:0001678;GO:0006887;GO:0007420;GO:0022615;GO:0030073;GO:0032868;GO:0043312;GO:0045955;GO:0046325;GO:0051291;GO:0070527;GO:0071346;GO:0016323;GO:0016324;GO:0031091;GO:0045335;GO:0070820;GO:0098793	vesicle-mediated transport;vesicle docking involved in exocytosis;cell;cytoplasm;membrane;protein transport;cytosol;plasma membrane;protein binding;extracellular exosome;syntaxin binding;specific granule;syntaxin-1 binding;protein-containing complex binding;cellular glucose homeostasis;exocytosis;brain development;protein to membrane docking;insulin secretion;response to insulin;neutrophil degranulation;negative regulation of calcium ion-dependent exocytosis;negative regulation of glucose import;platelet aggregation;cellular response to interferon-gamma;basolateral plasma membrane;apical plasma membrane;platelet alpha granule;phagocytic vesicle;tertiary granule;presynapse	Cell membrane;Cytoplasm;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-109582;R-HSA-5653656;R-HSA-199991;R-HSA-1445148;R-HSA-76002;R-HSA-114516;R-HSA-76005	Hemostasis;Vesicle-mediated transport;Membrane Trafficking;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Platelet activation, signaling and aggregation;Disinhibition of SNARE formation;Response to elevated platelet cytosolic Ca2+
COQ8B	negative	LGALSL	ENSG00000119862	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00002264;WBGene00002265;WBGene00002266;WBGene00002267;WBGene00002268;WBGene00008284	WBGene00002266(0);WBGene00002264(0);WBGene00002269(0);WBGene00002270(0);WBGene00002271(0);WBGene00018255(0);WBGene00004165(0)			GO:0030246;GO:0005515;GO:0005737;GO:0005622	carbohydrate binding;protein binding;cytoplasm;intracellular	3D-structure;Acetylation;Lectin;Phosphoprotein;Reference proteome		
COQ8B	negative	WDR44	ENSG00000131725	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00006369	WBGene00006369(1)			GO:0005737;GO:0016020;GO:0005794;GO:0005829;GO:0048471;GO:0017137;GO:0005768;GO:0010008;GO:0005515	protein binding;cytoplasm;membrane;Golgi apparatus;endosome;cytosol;perinuclear region of cytoplasm;Rab GTPase binding;endosome membrane	Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Endosome;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat		
COQ8B	negative	RDX	ENSG00000137710	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00001333			Autosomal recessive non-syndromic sensorineural deafness type DFNB;Deafness autosomal recessive 24	GO:0003779;GO:0005856;GO:0008092;GO:0003723;GO:0005737;GO:0016020;GO:0005886;GO:0005615;GO:0042803;GO:0051693;GO:0042995;GO:0005515;GO:0005925;GO:0045296;GO:0030027;GO:0030175;GO:0070062;GO:0010628;GO:0071944;GO:0032154;GO:0030335;GO:0005902;GO:0016324;GO:0008360;GO:0061028;GO:0030864;GO:1900087;GO:0043087;GO:0008361;GO:0072659;GO:0051018;GO:0045184;GO:0051117;GO:1902966;GO:0097067;GO:0010737;GO:1902115;GO:1903364;GO:2000643;GO:0032231;GO:0032487;GO:0034111;GO:0034260;GO:0045792;GO:1900027;GO:1903392;GO:0019904;GO:0030033;GO:0036120;GO:0045176;GO:0051016;GO:0001726;GO:0005913;GO:0030315;GO:0030496;GO:0032420;GO:0045177;GO:0051286	actin binding;cytoskeleton;cytoskeletal protein binding;RNA binding;cytoplasm;membrane;plasma membrane;focal adhesion;extracellular space;cell projection;protein binding;actin filament capping;cadherin binding;lamellipodium;filopodium;extracellular exosome;positive regulation of gene expression;cell periphery;cleavage furrow;positive regulation of cell migration;microvillus;apical plasma membrane;regulation of cell shape;establishment of endothelial barrier;cortical actin cytoskeleton;positive regulation of G1/S transition of mitotic cell cycle;regulation of GTPase activity;regulation of cell size;protein localization to plasma membrane;protein kinase A binding;establishment of protein localization;ATPase binding;positive regulation of protein localization to early endosome;cellular response to thyroid hormone stimulus;protein kinase A signaling;regulation of organelle assembly;positive regulation of cellular protein catabolic process;positive regulation of early endosome to late endosome transport;regulation of actin filament bundle assembly;regulation of Rap protein signal transduction;negative regulation of homotypic cell-cell adhesion;negative regulation of GTPase activity;negative regulation of cell size;regulation of ruffle assembly;negative regulation of adherens junction organization;protein domain specific binding;microvillus assembly;cellular response to platelet-derived growth factor stimulus;apical protein localization;barbed-end actin filament capping;ruffle;T-tubule;midbody;stereocilium;apical part of cell;cell tip	Actin capping;Actin-binding;Alternative splicing;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Deafness;Disease mutation;Membrane;Non-syndromic deafness;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239	Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1
COQ8B	negative	FNBP1L	ENSG00000137942	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00017298;WBGene00010663	WBGene00017298(1);WBGene00010663(0)			GO:0005829;GO:0006897;GO:0005515;GO:0005737;GO:0016020;GO:0005886;GO:0005856;GO:0031410;GO:0006914;GO:0008289;GO:0045296;GO:0005938;GO:0061024;GO:0006900;GO:0016050;GO:0030050;GO:0051491;GO:0060271;GO:0051020;GO:0072583;GO:0010324;GO:0097320	protein binding;endocytosis;cytosol;cell;cytoplasm;membrane;cytoskeleton;plasma membrane;cytoplasmic vesicle;autophagy;lipid binding;cadherin binding;cell cortex;membrane organization;vesicle budding from membrane;vesicle organization;vesicle transport along actin filament;positive regulation of filopodium assembly;cilium assembly;GTPase binding;clathrin-dependent endocytosis;membrane invagination;plasma membrane tubulation	Alternative splicing;Autophagy;Cell membrane;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Endocytosis;Lipid-binding;Membrane;Phosphoprotein;Reference proteome;SH3 domain	R-HSA-5653656;R-HSA-199991;R-HSA-8856828	Vesicle-mediated transport;Membrane Trafficking;Clathrin-mediated endocytosis
COQ8B	negative	CCDC82	ENSG00000149231	COQ8B	1	COQ8B	1	0.00398753255402307							Alternative splicing;Coiled coil;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	negative	CLIC4	ENSG00000169504	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00001371;WBGene00001365	WBGene00001371(0);WBGene00001365(0);WBGene00001791(0);WBGene00021817(0)			GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0034220;GO:0005739;GO:0005829;GO:0005244;GO:0006811;GO:0034765;GO:0005886;GO:0005856;GO:0005515;GO:0048471;GO:0030054;GO:0031410;GO:0030659;GO:0030154;GO:0005254;GO:0006821;GO:0034707;GO:0009986;GO:1902476;GO:0005813;GO:0005815;GO:0030496;GO:0015630;GO:0070062;GO:0005902;GO:0016363;GO:0005911;GO:0015629;GO:0030216;GO:0030336;GO:0005622;GO:0051493;GO:0071277;GO:0001525;GO:0045177;GO:0035088	cell;nucleus;cytoplasm;membrane;integral component of membrane;ion transmembrane transport;mitochondrion;cytoskeleton;cytosol;voltage-gated ion channel activity;ion transport;regulation of ion transmembrane transport;plasma membrane;protein binding;perinuclear region of cytoplasm;cell junction;cytoplasmic vesicle;cytoplasmic vesicle membrane;cell differentiation;chloride channel activity;chloride transport;chloride channel complex;cell surface;chloride transmembrane transport;centrosome;microtubule organizing center;midbody;microtubule cytoskeleton;extracellular exosome;microvillus;nuclear matrix;cell-cell junction;actin cytoskeleton;keratinocyte differentiation;negative regulation of cell migration;intracellular;regulation of cytoskeleton organization;cellular response to calcium ion;angiogenesis;apical part of cell;endothelial cell morphogenesis;vacuolar acidification;fertilization;multicellular organism growth;branching morphogenesis of an epithelial tube;retina vasculature morphogenesis in camera-type eye;establishment or maintenance of apical/basal cell polarity	3D-structure;Acetylation;Cell junction;Cell membrane;Chloride;Chloride channel;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Direct protein sequencing;Ion channel;Ion transport;Membrane;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel		
COQ8B	negative	USP47	ENSG00000170242	COQ8B	1	COQ8B	1	0.00398753255402307	WBGene00011507	WBGene00011507(1)			GO:0005737;GO:0043066;GO:0016579;GO:0016787;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0006281;GO:0006974;GO:0006511;GO:0036459;GO:0004843;GO:0005654;GO:0004197;GO:0006284;GO:0045892;GO:0030307;GO:0043154;GO:0034644;GO:0090263;GO:0010972;GO:0042493;GO:0035520;GO:0019005;GO:0071987;GO:0101005;GO:1902230	ubiquitin-dependent protein catabolic process;thiol-dependent ubiquitinyl hydrolase activity;protein deubiquitination;cytoplasm;negative regulation of apoptotic process;hydrolase activity;protein binding;peptidase activity;cysteine-type peptidase activity;proteolysis;DNA repair;cellular response to DNA damage stimulus;thiol-dependent ubiquitin-specific protease activity;nucleoplasm;cysteine-type endopeptidase activity;base-excision repair;negative regulation of transcription, DNA-templated;positive regulation of cell growth;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to UV;positive regulation of canonical Wnt signaling pathway;negative regulation of G2/M transition of mitotic cell cycle;response to drug;monoubiquitinated protein deubiquitination;SCF ubiquitin ligase complex;WD40-repeat domain binding;ubiquitinyl hydrolase activity;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA repair;Hydrolase;Phosphoprotein;Polymorphism;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689880	Metabolism of proteins;Post-translational protein modification;Deubiquitination;Ub-specific processing proteases
COQ8B	negative	AIDA	ENSG00000186063	COQ8B	1	COQ8B	1	0.00398753255402307					GO:0005515;GO:0007275;GO:0016020;GO:0035091;GO:0005575;GO:0046329;GO:0009953;GO:0043496;GO:0019904;GO:0043254;GO:0043508;GO:0048264;GO:0005737	protein binding;multicellular organism development;membrane;phosphatidylinositol binding;cellular_component;negative regulation of JNK cascade;negative regulation of protein-containing complex assembly;dorsal/ventral pattern formation;protein domain specific binding;regulation of protein-containing complex assembly;negative regulation of JUN kinase activity;determination of ventral identity;cytoplasm	Alternative splicing;Coiled coil;Developmental protein;Phosphoprotein;Reference proteome		
COQ8B	negative	CSDE1	ENSG00000009307	COQ8B	1	COQ8B	1	0.00563640619057682					GO:0003676;GO:0003723;GO:0005737;GO:0005794;GO:0005829;GO:0005886;GO:0005515;GO:0008584;GO:0070937;GO:0070966	nucleic acid binding;RNA binding;cytoplasm;Golgi apparatus;cytosol;plasma membrane;protein binding;male gonad development;CRD-mediated mRNA stability complex;nuclear-transcribed mRNA catabolic process, no-go decay	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation		
COQ8B	negative	VRK2	ENSG00000028116	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00017895	WBGene00008088(0);WBGene00010692(0);WBGene00008883(0);WBGene00017725(0);WBGene00013868(0);WBGene00008464(0);WBGene00010719(0);WBGene00013744(0);WBGene00020071(0);WBGene00018122(0);WBGene00009402(0);WBGene00010874(0);WBGene00012169(0);WBGene00016673(0);WBGene00022705(0);WBGene00022032(0);WBGene00022102(0);WBGene00017895(0);WBGene00013979(0);WBGene00013978(0);WBGene00016541(0);WBGene00012637(0);WBGene00007791(0);WBGene00019556(0);WBGene00016513(0);WBGene00016765(0);WBGene00022108(0);WBGene00007335(0);WBGene00017050(0);WBGene00021639(0);WBGene00008423(0);WBGene00014007(0);WBGene00007448(0);WBGene00016946(0);WBGene00020381(0);WBGene00008662(0);WBGene00018839(0);WBGene00016963(0);WBGene00018202(0);WBGene00018203(0);WBGene00017714(0);WBGene00010555(0);WBGene00019642(0);WBGene00015893(0);WBGene00016111(0);WBGene00019119(0);WBGene00020580(0);WBGene00007269(0);WBGene00019561(0);WBGene00019562(0);WBGene00011283(0);WBGene00022707(0);WBGene00017803(0);WBGene00018123(0);WBGene00020072(0);WBGene00012731(0);WBGene00018745(0);WBGene00007777(0);WBGene00007049(0);WBGene00019459(0);WBGene00019086(0);WBGene00020223(0);WBGene00016388(0);WBGene00018004(0);WBGene00007305(0);WBGene00009324(0);WBGene00021109(0);WBGene00019769(0)			GO:0005634;GO:0005737;GO:0016020;GO:0016021;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005783;GO:0005789;GO:0005739;GO:0005515;GO:0031966;GO:0016032;GO:0032991;GO:0018105;GO:0034599;GO:0046777;GO:0005635;GO:0043408;GO:0019901;GO:0019904;GO:2000659	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;membrane;integral component of membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;endoplasmic reticulum;endoplasmic reticulum membrane;mitochondrion;protein binding;mitochondrial membrane;viral process;protein-containing complex;peptidyl-serine phosphorylation;cellular response to oxidative stress;protein autophosphorylation;Wnt signaling pathway;nuclear envelope;regulation of MAPK cascade;protein kinase binding;protein domain specific binding;regulation of interleukin-1-mediated signaling pathway	3D-structure;ATP-binding;Alternative splicing;Cytoplasm;Endoplasmic reticulum;Host-virus interaction;Kinase;Membrane;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Transmembrane;Transmembrane helix		
COQ8B	negative	PPP1R12A	ENSG00000058272	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00003196				GO:0005737;GO:0005829;GO:0007165;GO:0015629;GO:0005856;GO:0005515;GO:0019901;GO:0005925;GO:0005813;GO:0000776;GO:0045944;GO:0005654;GO:0030155;GO:0000086;GO:0043292;GO:0007098;GO:0006470;GO:0019208;GO:0030018;GO:0000278;GO:0004857;GO:0071889;GO:0035507;GO:0035508;GO:0035690;GO:0043086;GO:0046822;GO:0031672;GO:0072357;GO:0050790	protein binding;signal transduction;protein kinase binding;phosphatase regulator activity;cytoplasm;nucleolus;cytosol;plasma membrane;cytoskeleton;focal adhesion;actin cytoskeleton;centrosome;kinetochore;positive regulation of transcription by RNA polymerase II;nucleoplasm;regulation of cell adhesion;G2/M transition of mitotic cell cycle;contractile fiber;centrosome cycle;protein dephosphorylation;Z disc;mitotic cell cycle;enzyme inhibitor activity;14-3-3 protein binding;regulation of myosin-light-chain-phosphatase activity;positive regulation of myosin-light-chain-phosphatase activity;cellular response to drug;negative regulation of catalytic activity;regulation of nucleocytoplasmic transport;A band;PTW/PP1 phosphatase complex;regulation of catalytic activity	3D-structure;ANK repeat;Alternative splicing;Cytoplasm;Cytoskeleton;Direct protein sequencing;Hydroxylation;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-195258;R-HSA-2565942;R-HSA-5625900;R-HSA-5625740;R-HSA-5627117;R-HSA-5627123	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;RHO GTPase Effectors;Regulation of PLK1 Activity at G2/M Transition;RHO GTPases activate CIT;RHO GTPases activate PKNs;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs
COQ8B	negative	DNM1L	ENSG00000087470	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00001093;WBGene00001130			Autosomal dominant optic atrophy classic form;DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect;ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1;OPTIC ATROPHY 5	GO:0005737;GO:0016020;GO:0043231;GO:0000166;GO:0005829;GO:0016787;GO:0003924;GO:0005525;GO:0005794;GO:0005739;GO:0042803;GO:0043547;GO:0005515;GO:0048511;GO:0048471;GO:0030054;GO:0031410;GO:0045202;GO:0005741;GO:0016559;GO:0005905;GO:0008289;GO:0005777;GO:0010821;GO:0005783;GO:0006897;GO:0008017;GO:0012505;GO:0032991;GO:0043065;GO:0031625;GO:0000266;GO:0001836;GO:1903146;GO:0030742;GO:0051259;GO:0005874;GO:0099073;GO:0005096;GO:0017137;GO:0003374;GO:0007005;GO:0008637;GO:0012501;GO:0032459;GO:0043653;GO:0048312;GO:0050714;GO:0051289;GO:0061025;GO:0070266;GO:0070584;GO:0090141;GO:0090149;GO:0090200;GO:0097194;GO:1900063;GO:2001244;GO:0005789;GO:0030672;GO:0030276;GO:0044877;GO:0051433;GO:0006816;GO:0010468;GO:0010637;GO:0036466;GO:0048488;GO:0051260;GO:0060047;GO:0061003;GO:0070585;GO:0071396;GO:0090650;GO:1900244;GO:1903578;GO:1904579;GO:1904666;GO:1905395;GO:1990910;GO:2000302;GO:0000139;GO:0005903;GO:0031966;GO:0098835;GO:0099503	GTP binding;GTPase activity;peroxisome fission;mitochondrial fission;cytoplasm;membrane;intracellular membrane-bounded organelle;nucleotide binding;cytosol;hydrolase activity;Golgi apparatus;mitochondrion;protein homodimerization activity;positive regulation of GTPase activity;protein binding;rhythmic process;perinuclear region of cytoplasm;cell junction;cytoplasmic vesicle;identical protein binding;mitochondrial outer membrane;lipid binding;clathrin-coated pit;synapse;peroxisome;endocytosis;regulation of mitochondrion organization;endoplasmic reticulum;microtubule binding;endomembrane system;protein-containing complex;positive regulation of apoptotic process;ubiquitin protein ligase binding;release of cytochrome c from mitochondria;regulation of autophagy of mitochondrion;GTP-dependent protein binding;protein-containing complex assembly;microtubule;mitochondrion-derived vesicle;GTPase activator activity;Rab GTPase binding;dynamin family protein polymerization involved in mitochondrial fission;mitochondrion organization;apoptotic mitochondrial changes;programmed cell death;mitochondrial fragmentation involved in apoptotic process;organelle fission;intracellular distribution of mitochondria;positive regulation of protein secretion;protein complex oligomerization;membrane fusion;necroptotic process;mitochondrion morphogenesis;positive regulation of neutrophil chemotaxis;positive regulation of mitochondrial fission;mitochondrial membrane fission;positive regulation of release of cytochrome c from mitochondria;execution phase of apoptosis;regulation of peroxisome organization;positive regulation of intrinsic apoptotic signaling pathway;endoplasmic reticulum membrane;synaptic vesicle membrane;clathrin binding;protein-containing complex binding;BH2 domain binding;calcium ion transport;regulation of gene expression;negative regulation of mitochondrial fusion;synaptic vesicle recycling via endosome;synaptic vesicle endocytosis;heart contraction;positive regulation of dendritic spine morphogenesis;protein localization to mitochondrion;cellular response to lipid;cellular response to oxygen-glucose deprivation;positive regulation of synaptic vesicle endocytosis;regulation of ATP metabolic process;cellular response to thapsigargin;regulation of ubiquitin protein ligase activity;response to flavonoid;response to hypobaric hypoxia;positive regulation of synaptic vesicle exocytosis;Golgi membrane;brush border;mitochondrial membrane;presynaptic endocytic zone membrane;secretory vesicle	3D-structure;Acetylation;Alternative splicing;Biological rhythms;Cell junction;Coated pit;Cytoplasm;Cytoplasmic vesicle;Disease mutation;Endocytosis;GTP-binding;Glycoprotein;Golgi apparatus;Hydrolase;Isopeptide bond;Lipid-binding;Membrane;Mitochondrion;Mitochondrion outer membrane;Necrosis;Nucleotide-binding;Peroxisome;Phosphoprotein;Polymorphism;Reference proteome;S-nitrosylation;Synapse;Ubl conjugation	R-HSA-109581;R-HSA-5357801;R-HSA-75153	Apoptosis;Programmed Cell Death;Apoptotic execution phase
COQ8B	negative	ARCN1	ENSG00000095139	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00015734	WBGene00015734(1)		Microcephalic dwarfism;SHORT STATURE RHIZOMELIC WITH MICROCEPHALY MICROGNATHIA AND DEVELOPMENTAL DELAY	GO:0003723;GO:0005737;GO:0016020;GO:0015031;GO:0005794;GO:0000139;GO:0006890;GO:0031410;GO:0030126;GO:0016192;GO:0006888;GO:0005829;GO:0030663;GO:0005789;GO:0006886;GO:0030133;GO:0051645;GO:0030137;GO:0008344;GO:0021691;GO:0043473;GO:0048193;GO:0005783	retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;COPI vesicle coat;RNA binding;cytoplasm;membrane;protein transport;Golgi apparatus;cytoplasmic vesicle;Golgi membrane;vesicle-mediated transport;COPI-coated vesicle membrane;cytosol;endoplasmic reticulum to Golgi vesicle-mediated transport;endoplasmic reticulum membrane;intracellular protein transport;transport vesicle;Golgi localization;COPI-coated vesicle;adult locomotory behavior;cerebellar Purkinje cell layer maturation;pigmentation;Golgi vesicle transport;endoplasmic reticulum	Acetylation;Alternative splicing;Cytoplasm;Cytoplasmic vesicle;Dwarfism;ER-Golgi transport;Golgi apparatus;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification
COQ8B	negative	RBX1	ENSG00000100387	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00004320	WBGene00004320(1)			GO:0005634;GO:0005737;GO:0008270;GO:0046872;GO:0016740;GO:0005654;GO:0016567;GO:0005829;GO:0005515;GO:0004842;GO:0006281;GO:0006974;GO:0006511;GO:0061630;GO:0000165;GO:0000209;GO:0010972;GO:0031146;GO:0043687;GO:0061418;GO:0070498;GO:0090090;GO:0031462;GO:0016032;GO:0031625;GO:0080008;GO:0008134;GO:0043161;GO:0016055;GO:0031463;GO:0006283;GO:0006513;GO:0097602;GO:0032436;GO:0042769;GO:0031466;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0070911;GO:0000715;GO:0000717;GO:0006294;GO:0019005;GO:0019788;GO:0045116;GO:0034450;GO:0044877;GO:0061663;GO:0010265;GO:0030163;GO:0030891;GO:0031461;GO:0031464;GO:0031465;GO:0031467;GO:0043224	zinc ion binding;nucleus;cytoplasm;metal ion binding;transferase activity;nucleoplasm;protein ubiquitination;cytosol;protein binding;ubiquitin-protein transferase activity;DNA repair;cellular response to DNA damage stimulus;ubiquitin-dependent protein catabolic process;ubiquitin protein ligase activity;MAPK cascade;protein polyubiquitination;negative regulation of G2/M transition of mitotic cell cycle;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;Cul4-RING E3 ubiquitin ligase complex;Cul2-RING ubiquitin ligase complex;viral process;ubiquitin protein ligase binding;transcription factor binding;proteasome-mediated ubiquitin-dependent protein catabolic process;Wnt signaling pathway;Cul3-RING ubiquitin ligase complex;transcription-coupled nucleotide-excision repair;protein monoubiquitination;cullin family protein binding;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, detection of DNA damage;Cul5-RING ubiquitin ligase complex;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;global genome nucleotide-excision repair;nucleotide-excision repair, DNA damage recognition;nucleotide-excision repair, DNA duplex unwinding;nucleotide-excision repair, preincision complex assembly;SCF ubiquitin ligase complex;NEDD8 transferase activity;protein neddylation;ubiquitin-ubiquitin ligase activity;protein-containing complex binding;NEDD8 ligase activity;SCF complex assembly;protein catabolic process;positive regulation of protein autoubiquitination;VCB complex;cullin-RING ubiquitin ligase complex;Cul4A-RING E3 ubiquitin ligase complex;Cul4B-RING E3 ubiquitin ligase complex;Cul7-RING ubiquitin ligase complex;nuclear SCF ubiquitin ligase complex	3D-structure;Acetylation;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Host-virus interaction;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-422475;R-HSA-162582;R-HSA-1640170;R-HSA-1643685;R-HSA-73894;R-HSA-162906;R-HSA-5663205;R-HSA-1234174;R-HSA-1234176;R-HSA-1280215;R-HSA-162909;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-2262752;R-HSA-376176;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-453274;R-HSA-4641258;R-HSA-5358351;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-68949;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-8854050;R-HSA-8878166;R-HSA-8939902;R-HSA-8951664;R-HSA-8953897;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-1980143;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-9013694;R-HSA-9604323;R-HSA-73893;R-HSA-2122947;R-HSA-5696398;R-HSA-6781823;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-1170546;R-HSA-5696395;R-HSA-5696399;R-HSA-110314;R-HSA-5696394;R-HSA-5696400;R-HSA-2644605;R-HSA-2644607	Adaptive Immune System;Immune System;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Axon guidance;Signal Transduction;Cell Cycle;Disease;DNA Repair;HIV Infection;Infectious disease;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Cellular responses to stress;Signaling by ROBO receptors;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;Mitotic G2-G2/M phases;Degradation of DVL;Signaling by Hedgehog;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Orc1 removal from chromatin;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Neddylation;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling;DNA Damage Bypass;NOTCH1 Intracellular Domain Regulates Transcription;Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Prolactin receptor signaling;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;DNA Damage Recognition in GG-NER;Dual Incision in GG-NER;FBXW7 Mutants and NOTCH1 in Cancer;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
COQ8B	negative	PLS3	ENSG00000102024	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00022425;WBGene00022223	WBGene00022425(1);WBGene00022223(0)		X-linked osteoporosis with fractures;BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	GO:0005829;GO:0005886;GO:0005737;GO:0046872;GO:0005509;GO:0003779;GO:0051015;GO:0051017;GO:0060348;GO:0005884;GO:0051639;GO:0032432;GO:0005515	cytosol;plasma membrane;protein binding;calcium ion binding;actin filament binding;actin filament bundle assembly;cytoplasm;metal ion binding;actin binding;bone development;actin filament;actin filament network formation;actin filament bundle	3D-structure;Actin-binding;Alternative splicing;Calcium;Cytoplasm;Direct protein sequencing;Disease mutation;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
COQ8B	negative	PPP2CB	ENSG00000104695	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00002363;WBGene00004083	WBGene00002363(1)			GO:0005634;GO:0005737;GO:0046872;GO:0016787;GO:0005694;GO:0004721;GO:0005856;GO:0005515;GO:0000159;GO:0000922;GO:0000775;GO:0004722;GO:0008022;GO:0006470;GO:0008637;GO:0010288;GO:0010468;GO:0034976;GO:0042542;GO:0043161;GO:0046580;GO:0046677;GO:1904528;GO:0005829;GO:0048156;GO:0035970;GO:0070262	hydrolase activity;nucleus;cytoplasm;metal ion binding;cytoskeleton;chromosome;phosphoprotein phosphatase activity;protein binding;protein phosphatase type 2A complex;spindle pole;chromosome, centromeric region;protein serine/threonine phosphatase activity;protein C-terminus binding;protein dephosphorylation;apoptotic mitochondrial changes;response to lead ion;regulation of gene expression;response to endoplasmic reticulum stress;response to hydrogen peroxide;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of Ras protein signal transduction;response to antibiotic;positive regulation of microtubule binding;cytosol;tau protein binding;peptidyl-threonine dephosphorylation;peptidyl-serine dephosphorylation	Centromere;Chromosome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Hydrolase;Manganese;Metal-binding;Methylation;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-388841;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-162582;R-HSA-194315;R-HSA-372790;R-HSA-388396;R-HSA-1640170;R-HSA-1643685;R-HSA-1257604;R-HSA-1280215;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-2467813;R-HSA-2555396;R-HSA-449147;R-HSA-449836;R-HSA-453274;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-68882;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-69620;R-HSA-9006925;R-HSA-9607240;R-HSA-418594;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-9006934;R-HSA-68875;R-HSA-111885;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-5633007;R-HSA-6804757;R-HSA-6806003;R-HSA-166016;R-HSA-166058;R-HSA-166166;R-HSA-168138;R-HSA-168179;R-HSA-168181;R-HSA-168188;R-HSA-168898;R-HSA-181438;R-HSA-937061;R-HSA-975138;R-HSA-975155;R-HSA-453279;R-HSA-69206;R-HSA-199418;R-HSA-6811558;R-HSA-418346;R-HSA-163685;R-HSA-166520;R-HSA-187037;R-HSA-69231;R-HSA-69236;R-HSA-4641262;R-HSA-168142;R-HSA-168164;R-HSA-168176;R-HSA-448424;R-HSA-450294;R-HSA-975871;R-HSA-69273;R-HSA-196299;R-HSA-4791275;R-HSA-4839735;R-HSA-4839743;R-HSA-4839744;R-HSA-4839748;R-HSA-5339716;R-HSA-5358747;R-HSA-5358749;R-HSA-5358751;R-HSA-5358752;R-HSA-5467337;R-HSA-5467340;R-HSA-5467348;R-HSA-190236;R-HSA-5654738;R-HSA-5654726;R-HSA-5654727;R-HSA-5654736;R-HSA-5654732;R-HSA-5654733;R-HSA-5654741;R-HSA-5654743;R-HSA-1295596;R-HSA-2465910;R-HSA-113510;R-HSA-5673000;R-HSA-9634600;R-HSA-198725;R-HSA-198753;R-HSA-450282;R-HSA-5675221;R-HSA-432142;R-HSA-389513;R-HSA-113501;R-HSA-180024;R-HSA-163767;R-HSA-202670	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Costimulation by the CD28 family;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Signal Transduction;Signaling by Rho GTPases;Signaling by GPCR;GPCR downstream signalling;Cell Cycle;Disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Signaling by Interleukins;Other interleukin signaling;Mitotic G2-G2/M phases;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Cell Cycle Checkpoints;Intracellular signaling by second messengers;FLT3 Signaling;G alpha (i) signalling events;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Signaling by Receptor Tyrosine Kinases;Mitotic Prophase;Opioid Signalling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Mitotic G1 phase and G1/S transition;G1/S Transition;Negative regulation of the PI3K/AKT network;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet homeostasis;Integration of energy metabolism;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Cyclin D associated events in G1;G1 Phase;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Interleukin-17 signaling;MAP kinase activation;MyD88 cascade initiated on plasma membrane;Cyclin A/B1/B2 associated events during G2/M transition;Beta-catenin phosphorylation cascade;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Signaling by FGFR;Signaling by FGFR2;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR1;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR3;Signaling by FGFR4;Spry regulation of FGF signaling;MASTL Facilitates Mitotic Progression;E2F mediated regulation of DNA replication;RAF activation;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;MAPK targets/ Nuclear events mediated by MAP kinases;Negative regulation of MAPK pathway;Platelet sensitization by LDL;CTLA4 inhibitory signaling;Inhibition of replication initiation of damaged DNA by RB1/E2F1;DARPP-32 events;PP2A-mediated dephosphorylation of key metabolic factors;ERKs are inactivated
COQ8B	negative	KCTD9	ENSG00000104756	COQ8B	1	COQ8B	1	0.00563640619057682					GO:0016567;GO:0035556;GO:0051260;GO:0005515;GO:0042802;GO:0043621;GO:0097602	protein binding;intracellular signal transduction;protein homooligomerization;protein ubiquitination;identical protein binding;protein self-association;cullin family protein binding	3D-structure;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation pathway		
COQ8B	negative	MOB1A	ENSG00000114978	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00020447				GO:0046872;GO:0005634;GO:0005730;GO:0005829;GO:0005515;GO:0035329;GO:0070062	metal ion binding;nucleoplasm;nucleolus;cytosol;protein binding;hippo signaling;extracellular exosome	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Metal-binding;Phosphoprotein;Reference proteome;Zinc	R-HSA-162582;R-HSA-2028269	Signal Transduction;Signaling by Hippo
COQ8B	negative	STRN	ENSG00000115808	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00010631	WBGene00010631(0)			GO:0005737;GO:0016020;GO:0042995;GO:0005515;GO:0016055;GO:0045211;GO:0005516;GO:0005923;GO:0051721;GO:0008285;GO:0030331;GO:0014069;GO:0043197;GO:0030425;GO:0016358;GO:0044877;GO:0070830;GO:0070016;GO:0007626;GO:0043025;GO:0090443	protein binding;cytoplasm;membrane;cell projection;Wnt signaling pathway;cell junction;synapse;postsynaptic membrane;calmodulin binding;bicellular tight junction;protein phosphatase 2A binding;negative regulation of cell population proliferation;estrogen receptor binding;postsynaptic density;dendritic spine;dendrite;dendrite development;protein-containing complex binding;bicellular tight junction assembly;armadillo repeat domain binding;locomotory behavior;neuronal cell body;FAR/SIN/STRIPAK complex	Alternative splicing;Calmodulin-binding;Cell junction;Cell projection;Coiled coil;Cytoplasm;Membrane;Phosphoprotein;Reference proteome;Repeat;Synapse;WD repeat	R-HSA-162582;R-HSA-1643685;R-HSA-1257604;R-HSA-5663202;R-HSA-9006925;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-2219528;R-HSA-199418;R-HSA-2219530;R-HSA-6811558	Signal Transduction;Disease;PIP3 activates AKT signaling;Diseases of signal transduction;Intracellular signaling by second messengers;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;PI3K/AKT Signaling in Cancer;Negative regulation of the PI3K/AKT network;Constitutive Signaling by Aberrant PI3K in Cancer;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
COQ8B	negative	SENP5	ENSG00000119231	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00006736				GO:0005634;GO:0016787;GO:0051301;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0007049;GO:0005730;GO:0016926;GO:0005654;GO:0016925;GO:0019783	proteolysis;cysteine-type peptidase activity;nucleolus;ubiquitin-like protein-specific protease activity;protein desumoylation;nucleus;plasma membrane;hydrolase activity;cell division;protein binding;peptidase activity;cell cycle;nucleoplasm;protein sumoylation	Alternative splicing;Cell cycle;Cell division;Hydrolase;Nucleus;Polymorphism;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-2990846;R-HSA-3065679;R-HSA-3215018	Metabolism of proteins;Post-translational protein modification;SUMOylation;SUMO is proteolytically processed;Processing and activation of SUMO
COQ8B	negative	ELF1	ENSG00000120690	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00016029		CD68;FLI1;MEIS1;TEK		GO:0005634;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0045893;GO:0000978;GO:0001228;GO:0001817;GO:0045944;GO:0050860;GO:0000981;GO:0030154;GO:0006357;GO:0000790;GO:0005654;GO:0001959;GO:0050855	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;sequence-specific DNA binding;nucleus;DNA binding;protein binding;positive regulation of transcription, DNA-templated;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;regulation of cytokine production;positive regulation of transcription by RNA polymerase II;negative regulation of T cell receptor signaling pathway;DNA-binding transcription factor activity, RNA polymerase II-specific;cell differentiation;regulation of transcription by RNA polymerase II;nuclear chromatin;nucleoplasm;regulation of cytokine-mediated signaling pathway;regulation of B cell receptor signaling pathway	Activator;Alternative splicing;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8878171;R-HSA-8939247;R-HSA-8939245	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in interleukin signaling;RUNX1 regulates transcription of genes involved in BCR signaling
COQ8B	negative	ZC3H7A	ENSG00000122299	COQ8B	1	COQ8B	1	0.00563640619057682					GO:0003723;GO:0005634;GO:0046872;GO:0035198;GO:0010608;GO:0035196;GO:0005515	metal ion binding;protein binding;miRNA binding;RNA binding;nucleus;posttranscriptional regulation of gene expression;production of miRNAs involved in gene silencing by miRNA	3D-structure;Alternative splicing;Coiled coil;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Repeat;TPR repeat;Zinc;Zinc-finger		
COQ8B	negative	ZNF644	ENSG00000122482	COQ8B	1	COQ8B	1	0.00563640619057682				MYOPIA 21 AUTOSOMAL DOMINANT	GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0006357;GO:0003700;GO:0006355;GO:0000981	nucleic acid binding;nucleus;metal ion binding;DNA binding;DNA-binding transcription factor activity;regulation of transcription, DNA-templated	Alternative splicing;DNA-binding;Disease mutation;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ8B	negative	USP9X	ENSG00000124486	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00011980			X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability;X-linked non-syndromic intellectual disability;Mental retardation X-linked 99;Mental retardation X-linked 99;MENTAL RETARDATION X-LINKED 99 SYNDROMIC FEMALE-RESTRICTED	GO:0005737;GO:0016020;GO:0016579;GO:0016787;GO:0051301;GO:0005829;GO:0042995;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0007049;GO:0048511;GO:0006511;GO:0036459;GO:0007059;GO:0016567;GO:0030426;GO:0050821;GO:0044267;GO:0004197;GO:0004843;GO:0030509;GO:1990380;GO:0006625;GO:0071108;GO:0007179;GO:0070410;GO:0042752;GO:0001764;GO:0007292;GO:0000122;GO:0048675;GO:1901537;GO:0071947;GO:0101005	ubiquitin-dependent protein catabolic process;thiol-dependent ubiquitinyl hydrolase activity;protein deubiquitination;cytoplasm;membrane;hydrolase activity;cell division;cytosol;cell projection;protein binding;peptidase activity;cysteine-type peptidase activity;proteolysis;cell cycle;rhythmic process;chromosome segregation;protein ubiquitination;growth cone;protein stabilization;cellular protein metabolic process;cell migration;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;BMP signaling pathway;Lys48-specific deubiquitinase activity;protein targeting to peroxisome;protein K48-linked deubiquitination;transforming growth factor beta receptor signaling pathway;co-SMAD binding;regulation of circadian rhythm;neuron migration;female gamete generation;negative regulation of transcription by RNA polymerase II;positive regulation of DNA demethylation;axon extension;protein deubiquitination involved in ubiquitin-dependent protein catabolic process;ubiquitinyl hydrolase activity	3D-structure;Alternative splicing;Biological rhythms;Cell cycle;Cell division;Cell projection;Chromosome partition;Cytoplasm;Disease mutation;Hydrolase;Mental retardation;Mitosis;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8866652;R-HSA-162582;R-HSA-977225;R-HSA-5688426;R-HSA-5689880;R-HSA-9033241;R-HSA-9609507;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-2173795	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Signal Transduction;Amyloid fiber formation;Deubiquitination;Ub-specific processing proteases;Peroxisomal protein import;Protein localization;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity
COQ8B	negative	TBC1D20	ENSG00000125875	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00013196	WBGene00013196(1)		Micro syndrome;Warburg micro syndrome 4;Warburg micro syndrome 4	GO:0016020;GO:0016021;GO:0005789;GO:0005515;GO:0005783;GO:0005096;GO:0017137;GO:0006888;GO:0043547;GO:0030173;GO:0016032;GO:0031965;GO:0048208;GO:0033116;GO:0007030;GO:0090110;GO:0046726;GO:0044829;GO:0019068;GO:1902953;GO:0001675;GO:0002088;GO:0007283;GO:0008584;GO:0034389;GO:0043010;GO:0070309;GO:0072520	membrane;integral component of membrane;endoplasmic reticulum membrane;protein binding;endoplasmic reticulum;GTPase activator activity;Rab GTPase binding;endoplasmic reticulum to Golgi vesicle-mediated transport;positive regulation of GTPase activity;integral component of Golgi membrane;viral process;nuclear membrane;COPII vesicle coating;endoplasmic reticulum-Golgi intermediate compartment membrane;Golgi organization;COPII-coated vesicle cargo loading;positive regulation by virus of viral protein levels in host cell;positive regulation by host of viral genome replication;virion assembly;positive regulation of ER to Golgi vesicle-mediated transport;acrosome assembly;lens development in camera-type eye;spermatogenesis;male gonad development;lipid droplet organization;camera-type eye development;lens fiber cell morphogenesis;seminiferous tubule development	3D-structure;Alternative splicing;GTPase activation;Host-virus interaction;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-9007101;R-HSA-446203;R-HSA-199977;R-HSA-948021;R-HSA-204005;R-HSA-8854214	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Rab regulation of trafficking;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport;TBC/RABGAPs
COQ8B	negative	SPCS3	ENSG00000129128	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00019679	WBGene00019679(0)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0031090;GO:0043231;GO:0016787;GO:0008233;GO:0006508;GO:0006465;GO:0005787;GO:0045047;GO:0019082	integral component of membrane;peptidase activity;signal peptide processing;signal peptidase complex;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle;hydrolase activity;proteolysis;protein targeting to ER;viral protein processing	Endoplasmic reticulum;Glycoprotein;Hydrolase;Membrane;Microsome;Protease;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-2980736;R-HSA-381771;R-HSA-400508;R-HSA-72766;R-HSA-400511;R-HSA-422085;R-HSA-1799339	Metabolism of proteins;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Incretin synthesis, secretion, and inactivation;Translation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Synthesis, secretion, and deacylation of Ghrelin;SRP-dependent cotranslational protein targeting to membrane
COQ8B	negative	CLIP1	ENSG00000130779	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00010796			Autosomal recessive non-syndromic intellectual disability	GO:0005737;GO:0016020;GO:0046872;GO:0008270;GO:0042803;GO:0005856;GO:0042995;GO:0005515;GO:0031410;GO:0005874;GO:0030659;GO:0008017;GO:0005813;GO:0000776;GO:0005829;GO:0015630;GO:0001578;GO:0001726;GO:0015631;GO:0000278;GO:0005768;GO:0051010;GO:0005882;GO:0031116;GO:0035371;GO:0044354;GO:0044861;GO:0005635;GO:0005881	cytoplasm;membrane;metal ion binding;zinc ion binding;cytoskeleton;cell projection;protein binding;cytoplasmic vesicle;microtubule;cytoplasmic vesicle membrane;microtubule binding;centrosome;kinetochore;cytosol;microtubule cytoskeleton;microtubule bundle formation;ruffle;tubulin binding;mitotic cell cycle;microtubule plus-end binding;intermediate filament;positive regulation of microtubule polymerization;microtubule plus-end;macropinosome;protein transport into plasma membrane raft;nuclear envelope;cytoplasmic microtubule	3D-structure;Alternative splicing;Cell projection;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Membrane;Metal-binding;Microtubule;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transport;Zinc;Zinc-finger	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5626467;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases activate IQGAPs;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ8B	negative	TPP2	ENSG00000134900	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00017686	WBGene00017686(1)		Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome	GO:0005829;GO:0005654;GO:0006508;GO:0004252;GO:0016604;GO:0008240;GO:0042277;GO:0005634;GO:0005737;GO:0016787;GO:0005515;GO:0008233;GO:0004177;GO:0008236;GO:0042802;GO:0000209;GO:0004175	proteolysis;serine-type endopeptidase activity;tripeptidyl-peptidase activity;nucleoplasm;cytosol;nuclear body;peptide binding;nucleus;cytoplasm;hydrolase activity;protein binding;peptidase activity;serine-type peptidase activity;aminopeptidase activity;identical protein binding;protein polyubiquitination;endopeptidase activity	Acetylation;Aminopeptidase;Cytoplasm;Direct protein sequencing;Hydrolase;Nucleus;Phosphoprotein;Protease;Reference proteome;Serine protease	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ8B	negative	RMC1	ENSG00000141452	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00021738	WBGene00021738(1)			GO:0016020;GO:0005765;GO:0010506;GO:0006914;GO:0005764;GO:0005768;GO:0031902;GO:0035658;GO:0005515	protein binding;Mon1-Ccz1 complex;regulation of autophagy;membrane;endosome;lysosomal membrane;autophagy;lysosome;late endosome membrane	Autophagy;Endosome;Lysosome;Membrane;Reference proteome		
COQ8B	negative	RABL3	ENSG00000144840	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00013790				GO:0005623;GO:0000166;GO:0005525;GO:0006886;GO:0003924;GO:0032482	nucleotide binding;GTP binding;intracellular protein transport;GTPase activity;Rab protein signal transduction;endomembrane system	GTP-binding;Nucleotide-binding;Reference proteome		
COQ8B	negative	LPP	ENSG00000145012	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00006999			LEUKEMIA ACUTE MYELOID	GO:0005829;GO:0005925;GO:0046872;GO:0005634;GO:0005737;GO:0016020;GO:0007155;GO:0005886;GO:0005515;GO:0030054;GO:0008150;GO:0001725;GO:0098609	cytosol;focal adhesion;metal ion binding;nucleus;cytoplasm;membrane;cell adhesion;plasma membrane;protein binding;cell junction;biological_process;stress fiber;cell-cell adhesion	Acetylation;Activator;Cell adhesion;Cell junction;Cell membrane;Chromosomal rearrangement;Cytoplasm;Isopeptide bond;LIM domain;Membrane;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Zinc		
COQ8B	negative	FIP1L1	ENSG00000145216	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00017988			ACUTE PROMYELOCYTIC LEUKEMIA;Chronic eosinophilic leukemia;Primary hypereosinophilic syndrome	GO:0003723;GO:0006397;GO:0005634;GO:0005654;GO:0005515;GO:0005847;GO:0006378;GO:0098789;GO:0006406;GO:0031124;GO:0000398;GO:0006369	mRNA cleavage and polyadenylation specificity factor complex;pre-mRNA cleavage required for polyadenylation;RNA binding;mRNA processing;nucleus;nucleoplasm;protein binding;mRNA polyadenylation;mRNA export from nucleus;mRNA 3'-end processing;mRNA splicing, via spliceosome;termination of RNA polymerase II transcription	Alternative splicing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159231;R-HSA-159234;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-75067;R-HSA-77595	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs
COQ8B	negative	CD226	ENSG00000150637	COQ8B	1	COQ8B	1	0.00563640619057682					GO:0016020;GO:0016021;GO:0007155;GO:0005886;GO:0005515;GO:0009897;GO:0050776;GO:0050862;GO:0009986;GO:0005887;GO:0007165;GO:0019901;GO:0008037;GO:0045954;GO:0045121;GO:0001816;GO:0050839;GO:0005178;GO:0032729;GO:0002860;GO:0002891;GO:0002729;GO:0033005;GO:0060369	positive regulation of natural killer cell cytokine production;membrane;integral component of membrane;cell adhesion;plasma membrane;protein binding;external side of plasma membrane;regulation of immune response;positive regulation of T cell receptor signaling pathway;cell surface;integral component of plasma membrane;signal transduction;protein kinase binding;cell recognition;positive regulation of natural killer cell mediated cytotoxicity;membrane raft;cytokine production;cell adhesion molecule binding;integrin binding;positive regulation of interferon-gamma production;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;positive regulation of immunoglobulin mediated immune response;positive regulation of mast cell activation;positive regulation of Fc receptor mediated stimulatory signaling pathway	3D-structure;Cell adhesion;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1280218;R-HSA-168256;R-HSA-198933	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
COQ8B	negative	NEXN	ENSG00000162614	COQ8B	1	COQ8B	1	0.00563640619057682				Familial isolated dilated cardiomyopathy;CARDIOMYOPATHY DILATED 1CC;Cardiomyopathy familial hypertrophic 20	GO:0005737;GO:0003779;GO:0005856;GO:0030054;GO:0005925;GO:0007411;GO:0005886;GO:0051015;GO:0005912;GO:0030424;GO:0030334;GO:0030018;GO:0008307;GO:0051493;GO:0098632;GO:0007156;GO:0070593;GO:0009617	cytoplasm;actin binding;cytoskeleton;focal adhesion;actin cytoskeleton;cell junction;plasma membrane;axon guidance;actin filament binding;adherens junction;axon;regulation of cell migration;Z disc;structural constituent of muscle;regulation of cytoskeleton organization;cell-cell adhesion mediator activity;homophilic cell adhesion via plasma membrane adhesion molecules;dendrite self-avoidance;response to bacterium	Actin-binding;Alternative splicing;Cardiomyopathy;Cell junction;Cytoplasm;Cytoskeleton;Disease mutation;Immunoglobulin domain;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	negative	SEPTIN2	ENSG00000168385	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00006793				GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0031514;GO:0005525;GO:0051301;GO:0005694;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0007049;GO:0030154;GO:0007283;GO:0005819;GO:0030496;GO:0000775;GO:0000776;GO:0000777;GO:0005929;GO:0007224;GO:0060271;GO:0045296;GO:0070062;GO:0003924;GO:0005938;GO:0097730;GO:0032154;GO:0015630;GO:0060170;GO:0061640;GO:0005940;GO:0031105;GO:0005930;GO:0097227;GO:0032391;GO:0031175;GO:0000145;GO:0048471	GTP binding;cell division;nucleus;cytoplasm;membrane;nucleotide binding;nucleoplasm;plasma membrane;motile cilium;intercellular bridge;cytoskeleton;chromosome;actin cytoskeleton;cell projection;protein binding;cell cycle;cell differentiation;spermatogenesis;spindle;midbody;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cilium;smoothened signaling pathway;cilium assembly;cadherin binding;extracellular exosome;GTPase activity;cell cortex;non-motile cilium;cleavage furrow;molecular adaptor activity;ciliary membrane;cellular protein localization;cytoskeleton-dependent cytokinesis;septin ring;microtubule cytoskeleton;septin complex;cell division site;axoneme;sperm annulus;photoreceptor connecting cilium;neuron projection development;exocyst;perinuclear region of cytoplasm	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Cell membrane;Cell projection;Centromere;Chromosome;Cilium;Cytoplasm;Cytoskeleton;Differentiation;Direct protein sequencing;Flagellum;GTP-binding;Kinetochore;Membrane;Mitosis;Nucleotide-binding;Phosphoprotein;Reference proteome;Spermatogenesis	R-HSA-1852241;R-HSA-5617833;R-HSA-5620912	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
COQ8B	negative	UGP2	ENSG00000169764	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00010665	WBGene00010665(1)			GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0005515;GO:0016779;GO:0042802;GO:0003983;GO:0070569;GO:0006011;GO:0005829;GO:0070062;GO:0005978;GO:0006065;GO:0005977;GO:0005536;GO:0032557;GO:0019255	uridylyltransferase activity;UTP:glucose-1-phosphate uridylyltransferase activity;UDP-glucose metabolic process;nucleus;cytoplasm;metal ion binding;transferase activity;protein binding;nucleotidyltransferase activity;identical protein binding;cytosol;extracellular exosome;glycogen biosynthetic process;UDP-glucuronate biosynthetic process;glycogen metabolic process;glucose binding;pyrimidine ribonucleotide binding;glucose 1-phosphate metabolic process	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Magnesium;Metal-binding;Nucleotidyltransferase;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-1430728;R-HSA-71387;R-HSA-156580;R-HSA-211859;R-HSA-3322077;R-HSA-8982491;R-HSA-156588;R-HSA-173599	Metabolism;Metabolism of carbohydrates;Phase II - Conjugation of compounds;Biological oxidations;Glycogen synthesis;Glycogen metabolism;Glucuronidation;Formation of the active cofactor, UDP-glucuronate
COQ8B	negative	ANO6	ENSG00000177119	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00010138			SCOTT SYNDROME;SCOTT SYNDROME	GO:1903766;GO:0016020;GO:0016021;GO:0046872;GO:0005829;GO:0046983;GO:0005886;GO:0005244;GO:0006811;GO:0034765;GO:0006869;GO:0007596;GO:0005254;GO:0006821;GO:0034707;GO:0009986;GO:0070588;GO:1902476;GO:0005247;GO:0005515;GO:0061588;GO:0070062;GO:0005229;GO:0034220;GO:0043065;GO:0043312;GO:0035579;GO:0070821;GO:0030501;GO:0035725;GO:0046931;GO:0017121;GO:0090026;GO:2000353;GO:0006812;GO:0032060;GO:0060100;GO:0045794;GO:0005227;GO:0002407;GO:0002543;GO:0034767;GO:0035590;GO:0097045;GO:0017128;GO:0042803;GO:0035630;GO:0045332;GO:0061589;GO:0061590;GO:0061591;GO:0005887	blood coagulation;protein dimerization activity;chloride transmembrane transport;calcium activated phospholipid scrambling;dendritic cell chemotaxis;positive regulation of bone mineralization;positive regulation of ion transmembrane transport;cell;positive regulation of potassium ion export across plasma membrane;membrane;integral component of membrane;metal ion binding;cytosol;plasma membrane;voltage-gated ion channel activity;ion transport;regulation of ion transmembrane transport;lipid transport;chloride channel activity;chloride transport;chloride channel complex;cell surface;calcium ion transmembrane transport;protein binding;voltage-gated chloride channel activity;extracellular exosome;intracellular calcium activated chloride channel activity;ion transmembrane transport;positive regulation of apoptotic process;neutrophil degranulation;specific granule membrane;tertiary granule membrane;sodium ion transmembrane transport;pore complex assembly;plasma membrane phospholipid scrambling;positive regulation of monocyte chemotaxis;positive regulation of endothelial cell apoptotic process;cation transport;bleb assembly;positive regulation of phagocytosis, engulfment;negative regulation of cell volume;calcium activated cation channel activity;activation of blood coagulation via clotting cascade;purinergic nucleotide receptor signaling pathway;phosphatidylserine exposure on blood platelet;phospholipid scramblase activity;identical protein binding;protein homodimerization activity;bone mineralization involved in bone maturation;phospholipid translocation;calcium activated phosphatidylserine scrambling;calcium activated phosphatidylcholine scrambling;calcium activated galactosylceramide scrambling;integral component of plasma membrane	Alternative splicing;Calcium;Cell membrane;Chloride;Chloride channel;Disulfide bond;Glycoprotein;Ion channel;Ion transport;Lipid transport;Membrane;Metal-binding;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel	R-HSA-168249;R-HSA-168256;R-HSA-382551;R-HSA-2672351;R-HSA-983712;R-HSA-6798695	Innate Immune System;Immune System;Transport of small molecules;Stimuli-sensing channels;Ion channel transport;Neutrophil degranulation
COQ8B	negative	NRIP1	ENSG00000180530	COQ8B	1	COQ8B	1	0.00563640619057682			SLC7A1	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3	GO:0005634;GO:0005102;GO:0005730;GO:0003712;GO:0006357;GO:0005515;GO:0007623;GO:0048511;GO:0032922;GO:0003713;GO:0045893;GO:0000122;GO:0045944;GO:0003714;GO:0005654;GO:0030331;GO:0000790;GO:0000978;GO:0030521;GO:0035257;GO:0050681;GO:0035259;GO:0071392;GO:0046965;GO:0042826;GO:0042974;GO:0001543;GO:0019915;GO:0030728;GO:0000118;GO:0016607	nucleus;transcription coregulator activity;regulation of transcription by RNA polymerase II;signaling receptor binding;nucleoplasm;nucleolus;cytosol;fibrillar center;protein binding;circadian rhythm;rhythmic process;circadian regulation of gene expression;transcription coactivator activity;positive regulation of transcription, DNA-templated;negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;transcription corepressor activity;estrogen receptor binding;nuclear chromatin;RNA polymerase II cis-regulatory region sequence-specific DNA binding;androgen receptor signaling pathway;nuclear hormone receptor binding;androgen receptor binding;glucocorticoid receptor binding;cellular response to estradiol stimulus;retinoid X receptor binding;histone deacetylase binding;retinoic acid receptor binding;ovarian follicle rupture;lipid storage;ovulation;histone deacetylase complex;nuclear speck	3D-structure;Acetylation;Activator;Biological rhythms;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-2990846;R-HSA-3108232;R-HSA-8939211;R-HSA-9006931;R-HSA-3899300;R-HSA-400253;R-HSA-9018519	Metabolism of proteins;Post-translational protein modification;Signal Transduction;SUMOylation;SUMO E3 ligases SUMOylate target proteins;ESR-mediated signaling;Signaling by Nuclear Receptors;SUMOylation of transcription cofactors;Circadian Clock;Estrogen-dependent gene expression
COQ8B	negative	TRAPPC6B	ENSG00000182400	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00010699	WBGene00010699(1)		NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY EPILEPSY AND BRAIN ATROPHY	GO:0005783;GO:0005794;GO:0005515;GO:0043087;GO:0048193;GO:0007399;GO:0006888;GO:0000139;GO:0005801;GO:0005829;GO:0005802;GO:0048208	regulation of GTPase activity;Golgi vesicle transport;endoplasmic reticulum;Golgi apparatus;protein binding;nervous system development;endoplasmic reticulum to Golgi vesicle-mediated transport;Golgi membrane;cis-Golgi network;cytosol;trans-Golgi network;COPII vesicle coating;TRAPP complex	3D-structure;Alternative splicing;Disease mutation;Endoplasmic reticulum;Epilepsy;Golgi apparatus;Mental retardation;Neurogenesis;Reference proteome	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-446203;R-HSA-199977;R-HSA-948021;R-HSA-204005	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport
COQ8B	negative	CA13	ENSG00000185015	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00000283;WBGene00000281;WBGene00000282	WBGene00000279(0);WBGene00000284(0);WBGene00000283(0)			GO:0008270;GO:0046872;GO:0016829;GO:0004089;GO:0005829;GO:0015701;GO:0043209;GO:0043231	zinc ion binding;carbonate dehydratase activity;metal ion binding;lyase activity;cytosol;bicarbonate transport;myelin sheath;intracellular membrane-bounded organelle	3D-structure;Lyase;Metal-binding;Polymorphism;Reference proteome;Zinc	R-HSA-1430728;R-HSA-1475029	Metabolism;Reversible hydration of carbon dioxide
COQ8B	negative	NRAS	ENSG00000213281	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00002335;WBGene00004310			Differentiated thyroid carcinoma;Juvenile myelomonocytic leukemia;Large congenital melanocytic nevus;Linear nevus sebaceus syndrome;Noonan Syndrome;RAS-associated autoimmune leukoproliferative disease;Selection of therapeutic option in colorectal cancer;Noonan syndrome type 6;Colorectal Cancer;Melanocytic nevus syndrome congenital;Melanosis neurocutaneous;NEVUS EPIDERMAL;NOONAN SYNDROME 6;RAS-associated autoimmune leukoproliferative disorder;SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME;THYROID CANCER NONMEDULLARY 2	GO:0016020;GO:0000166;GO:0007165;GO:0003924;GO:0005525;GO:0005794;GO:0005886;GO:0005515;GO:0000139;GO:0007265;GO:0070062;GO:0000165;GO:0002223;GO:0043312;GO:0070821;GO:0001938;GO:0044877;GO:0019003	signal transduction;membrane;GTP binding;GTPase activity;nucleotide binding;Golgi apparatus;plasma membrane;protein binding;Golgi membrane;Ras protein signal transduction;extracellular exosome;MAPK cascade;stimulatory C-type lectin receptor signaling pathway;neutrophil degranulation;tertiary granule membrane;positive regulation of endothelial cell proliferation;protein-containing complex binding;GDP binding	3D-structure;Acetylation;Cell membrane;Disease mutation;GTP-binding;Golgi apparatus;Isopeptide bond;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Palmitate;Phosphoprotein;Prenylation;Proto-oncogene;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-202733;R-HSA-2454202;R-HSA-2871796;R-HSA-983705;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-1643685;R-HSA-1168372;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5621481;R-HSA-5658442;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-416476;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-438064;R-HSA-442755;R-HSA-2172127;R-HSA-186797;R-HSA-375165;R-HSA-9006934;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-6798695;R-HSA-6802952;R-HSA-6802957;R-HSA-9006335;R-HSA-112399;R-HSA-1433557;R-HSA-166520;R-HSA-186763;R-HSA-187037;R-HSA-194138;R-HSA-210993;R-HSA-2404192;R-HSA-2424491;R-HSA-2428924;R-HSA-2428928;R-HSA-4420097;R-HSA-74751;R-HSA-74752;R-HSA-1227986;R-HSA-1236394;R-HSA-1250196;R-HSA-1250347;R-HSA-1963640;R-HSA-8848021;R-HSA-9006927;R-HSA-177929;R-HSA-442742;R-HSA-442982;R-HSA-1643713;R-HSA-179812;R-HSA-180336;R-HSA-6806834;R-HSA-1226099;R-HSA-5655302;R-HSA-167044;R-HSA-171007;R-HSA-187687;R-HSA-190236;R-HSA-5654738;R-HSA-5655253;R-HSA-5654687;R-HSA-5654688;R-HSA-5654693;R-HSA-5654696;R-HSA-5654699;R-HSA-5654700;R-HSA-5654736;R-HSA-5218921;R-HSA-9634635;R-HSA-5654704;R-HSA-5654706;R-HSA-5654708;R-HSA-5654712;R-HSA-5654716;R-HSA-5654719;R-HSA-5654741;R-HSA-5654743;R-HSA-5655332;R-HSA-8853338;R-HSA-6802949;R-HSA-9006115;R-HSA-9028731;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-9027284;R-HSA-5621575;R-HSA-1169092;R-HSA-1236382;R-HSA-2179392;R-HSA-5637810;R-HSA-5637812;R-HSA-5637815;R-HSA-881907;R-HSA-112412;R-HSA-2428933;R-HSA-5655291;R-HSA-5674135;R-HSA-5675221;R-HSA-6802948;R-HSA-6802953;R-HSA-8849471;R-HSA-8851805;R-HSA-8853334;R-HSA-9026519;R-HSA-9034015;R-HSA-9034864	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;Signaling by the B Cell Receptor (BCR);Developmental Biology;Axon guidance;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Disease;Downstream signaling events of B Cell Receptor (BCR);Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;C-type lectin receptors (CLRs);Regulation of RAS by GAPs;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;G alpha (q) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;DAP12 interactions;Signaling by PDGF;NCAM signaling for neurite out-growth;Signaling by Receptor Tyrosine Kinases;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Neutrophil degranulation;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Signaling by Erythropoietin;IRS-mediated signalling;Signaling by SCF-KIT;Signaling by NTRKs;Downstream signal transduction;Signaling by NTRK1 (TRKA);Signaling by VEGF;Tie2 Signaling;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;VEGFA-VEGFR2 Pathway;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by ERBB2;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;GRB2 events in ERBB2 signaling;Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;Signaling by EGFR;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Ras activation upon Ca2+ influx through NMDA receptor;Signaling by EGFR in Cancer;GRB2 events in EGFR signaling;SHC1 events in EGFR signaling;Signaling by MET;Signaling by FGFR in disease;Signaling by FGFR1 in disease;Signalling to RAS;p38MAPK events;Signalling to ERKs;Signaling by FGFR;Signaling by FGFR2;Signaling by FGFR2 in disease;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;FRS-mediated FGFR1 signaling;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Signaling by FGFR1;VEGFR2 mediated cell proliferation;Estrogen-stimulated signaling through PRKCZ;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR3 in disease;Signaling by FGFR3 point mutants in cancer;Signaling by RAS mutants;Signaling by NTRK2 (TRKB);Activated NTRK2 signals through FRS2 and FRS3;RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Erythropoietin activates RAS;CD209 (DC-SIGN) signaling;Activation of RAS in B cells;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;EGFR Transactivation by Gastrin;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Gastrin-CREB signalling pathway via PKC and MAPK;SOS-mediated signalling;SHC-related events triggered by IGF1R;Signaling by FGFR4 in disease;MAP2K and MAPK activation;Negative regulation of MAPK pathway;Signaling by high-kinase activity BRAF mutants;RAS signaling downstream of NF1 loss-of-function variants;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;MET activates RAS signaling;Signaling by FGFR3 fusions in cancer;Activated NTRK2 signals through RAS;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS
COQ8B	negative	LSM14A	ENSG00000257103	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00012484	WBGene00012484(0)			GO:0003723;GO:0005737;GO:0005829;GO:0007275;GO:0036464;GO:0000932;GO:0006417;GO:0010494;GO:0033962;GO:0003690;GO:0003725;GO:0003727;GO:0039529;GO:0051607;GO:0060340	RNA binding;cytoplasm;cytosol;multicellular organism development;cytoplasmic ribonucleoprotein granule;P-body;regulation of translation;cytoplasmic stress granule;cytoplasmic mRNA processing body assembly;double-stranded DNA binding;double-stranded RNA binding;single-stranded RNA binding;RIG-I signaling pathway;defense response to virus;positive regulation of type I interferon-mediated signaling pathway	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Developmental protein;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Ribonucleoprotein;Translation regulation		
COQ8B	negative	RNF115	ENSG00000265491	COQ8B	1	COQ8B	1	0.00563640619057682	WBGene00021842				GO:0005737;GO:0046872;GO:0016740;GO:0016567;GO:0005829;GO:0005515;GO:0004842;GO:0051865;GO:0061630;GO:0070936;GO:0000209;GO:0070534;GO:0043162;GO:0042059	cytoplasm;metal ion binding;transferase activity;protein ubiquitination;cytosol;protein binding;ubiquitin-protein transferase activity;protein autoubiquitination;ubiquitin protein ligase activity;protein K48-linked ubiquitination;protein polyubiquitination;protein K63-linked ubiquitination;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;negative regulation of epidermal growth factor receptor signaling pathway	Acetylation;Cytoplasm;Metal-binding;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ8B	negative	PAFAH1B1	ENSG00000007168	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00003047	WBGene00003047(1)		17p13.3 microduplication syndrome;Lissencephaly due to LIS1 mutation;Miller-Dieker syndrome;Subcortical band heterotopia;LISSENCEPHALY TYPE 1;Subcortical band heterotopia;LISSENCEPHALY 1	GO:0005515;GO:0048471;GO:0030036;GO:0005634;GO:0005737;GO:0016020;GO:0005813;GO:0006629;GO:0016042;GO:0051301;GO:1904115;GO:0005856;GO:0007049;GO:0007275;GO:0005874;GO:0030154;GO:0005815;GO:0005819;GO:0000776;GO:0007399;GO:0043005;GO:0005829;GO:0005875;GO:0070062;GO:0047496;GO:0005938;GO:0070840;GO:0005635;GO:0043025;GO:0031965;GO:0000086;GO:0010389;GO:0097711;GO:0005881;GO:0042803;GO:0000132;GO:0001764;GO:0007268;GO:0021987;GO:0043274;GO:0008201;GO:0031023;GO:0031514;GO:0008017;GO:0008090;GO:0019226;GO:0008344;GO:0048854;GO:0051219;GO:0007611;GO:0031252;GO:0034452;GO:0044877;GO:0045505;GO:0051010;GO:0000226;GO:0001667;GO:0001675;GO:0001961;GO:0007017;GO:0007097;GO:0007405;GO:0007420;GO:0009306;GO:0010977;GO:0016477;GO:0017145;GO:0021540;GO:0021766;GO:0021819;GO:0021895;GO:0036035;GO:0040019;GO:0042249;GO:0043087;GO:0043622;GO:0045773;GO:0045931;GO:0046329;GO:0046469;GO:0050885;GO:0051012;GO:0051081;GO:0051130;GO:0051660;GO:0051661;GO:0060117;GO:0061003;GO:0070507;GO:0090102;GO:0090176;GO:0000235;GO:0005871;GO:0015630;GO:0030424;GO:0030426;GO:0031982;GO:0032420;GO:0090724	protein binding;perinuclear region of cytoplasm;cell;actin cytoskeleton organization;nucleus;cytoplasm;membrane;cytoskeleton;lipid metabolic process;lipid catabolic process;cell division;axon cytoplasm;centrosome;cell cycle;synapse;multicellular organism development;microtubule;cell differentiation;microtubule organizing center;spindle;kinetochore;nervous system development;neuron projection;cytosol;microtubule associated complex;extracellular exosome;vesicle transport along microtubule;cell cortex;dynein complex binding;nuclear envelope;neuronal cell body;nuclear membrane;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;cytoplasmic microtubule;identical protein binding;establishment of mitotic spindle orientation;neuron migration;chemical synaptic transmission;cerebral cortex development;phospholipase binding;heparin binding;microtubule organizing center organization;motile cilium;microtubule binding;retrograde axonal transport;transmission of nerve impulse;adult locomotory behavior;brain morphogenesis;phosphoprotein binding;learning or memory;cell leading edge;dynactin binding;protein-containing complex binding;dynein intermediate chain binding;microtubule plus-end binding;microtubule cytoskeleton organization;ameboidal-type cell migration;acrosome assembly;positive regulation of cytokine-mediated signaling pathway;microtubule-based process;nuclear migration;germ cell development;neuroblast proliferation;brain development;protein secretion;negative regulation of neuron projection development;cell migration;stem cell division;corpus callosum morphogenesis;hippocampus development;layer formation in cerebral cortex;cerebral cortex neuron differentiation;osteoclast development;positive regulation of embryonic development;establishment of planar polarity of embryonic epithelium;regulation of GTPase activity;cortical microtubule organization;positive regulation of axon extension;positive regulation of mitotic cell cycle;negative regulation of JNK cascade;platelet activating factor metabolic process;neuromuscular process controlling balance;microtubule sliding;nuclear envelope disassembly;positive regulation of cellular component organization;establishment of centrosome localization;maintenance of centrosome location;auditory receptor cell development;positive regulation of dendritic spine morphogenesis;regulation of microtubule cytoskeleton organization;cochlea development;microtubule cytoskeleton organization involved in establishment of planar polarity;regulation of microtubule motor activity;astral microtubule;kinesin complex;microtubule cytoskeleton;axon;growth cone;vesicle;stereocilium;central region of growth cone	Acetylation;Alternative splicing;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Developmental protein;Differentiation;Disease mutation;Lipid degradation;Lipid metabolism;Lissencephaly;Membrane;Microtubule;Mitosis;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transport;WD repeat	R-HSA-5653656;R-HSA-1852241;R-HSA-5617833;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811442;R-HSA-8856688;R-HSA-2467813;R-HSA-2555396;R-HSA-453274;R-HSA-68882;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-380320;R-HSA-5663220;R-HSA-6811436;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518;R-HSA-141424;R-HSA-141444;R-HSA-69618	Vesicle-mediated transport;Organelle biogenesis and maintenance;Cilium Assembly;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic G2-G2/M phases;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;Recruitment of NuMA to mitotic centrosomes;RHO GTPases Activate Formins;COPI-independent Golgi-to-ER retrograde traffic;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ8B	negative	VTA1	ENSG00000009844	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00011972				GO:0005737;GO:0016020;GO:0015031;GO:0043231;GO:0005829;GO:0005654;GO:0005515;GO:0005768;GO:0070062;GO:0016197;GO:0016236;GO:0019058;GO:0036258;GO:0010008;GO:0008022;GO:0071985;GO:1904903;GO:0046755	cytoplasm;membrane;protein transport;intracellular membrane-bounded organelle;nucleoplasm;cytosol;endosome;protein binding;extracellular exosome;endosomal transport;macroautophagy;viral life cycle;multivesicular body assembly;endosome membrane;protein C-terminus binding;multivesicular body sorting pathway;late endosome to vacuole transport via multivesicular body sorting pathway;ESCRT III complex disassembly;multivesicular body;viral budding	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Endosome;Membrane;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-199991;R-HSA-1643685;R-HSA-162587;R-HSA-162588;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-917729	Vesicle-mediated transport;Membrane Trafficking;Disease;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT)
COQ8B	negative	ZNF207	ENSG00000010244	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00007105	WBGene00007105(1)			GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0046872;GO:0005730;GO:0005654;GO:0008270;GO:0003677;GO:0003700;GO:0051301;GO:0005694;GO:0005856;GO:0007049;GO:0005874;GO:0008017;GO:0005819;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0005515;GO:0050821;GO:0001578;GO:0007094;GO:0090307;GO:0006355;GO:0008608;GO:0008201;GO:0000070;GO:0046785;GO:0051983;GO:1990047	nucleic acid binding;RNA binding;nucleus;cytoplasm;metal ion binding;nucleoplasm;nucleolus;zinc ion binding;DNA binding;DNA-binding transcription factor activity;cytoskeleton;cell division;chromosome;cell cycle;microtubule;microtubule binding;spindle;protein binding;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;protein stabilization;microtubule bundle formation;regulation of transcription, DNA-templated;mitotic spindle assembly checkpoint;mitotic spindle assembly;attachment of spindle microtubules to kinetochore;heparin binding;mitotic sister chromatid segregation;microtubule polymerization;regulation of chromosome segregation;spindle matrix	Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;Cytoskeleton;DNA-binding;Kinetochore;Metal-binding;Microtubule;Mitosis;Nucleus;Polymorphism;Reference proteome;Repeat;Zinc;Zinc-finger		
COQ8B	negative	DCUN1D1	ENSG00000043093	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00010428	WBGene00010428(0)			GO:0005634;GO:0005829;GO:0005515;GO:0000151;GO:0043687;GO:0031624;GO:0097602;GO:0045116;GO:0032182;GO:0051443;GO:2000436	protein binding;nucleus;nucleoplasm;cytosol;ubiquitin ligase complex;post-translational protein modification;ubiquitin conjugating enzyme binding;cullin family protein binding;protein neddylation;ubiquitin-like protein binding;positive regulation of ubiquitin-protein transferase activity;positive regulation of protein neddylation	3D-structure;Acetylation;Nucleus;Proto-oncogene;Reference proteome;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-8951664	Metabolism of proteins;Post-translational protein modification;Neddylation
COQ8B	negative	TRAM1	ENSG00000067167	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00007696	WBGene00007696(1)			GO:0005623;GO:0016020;GO:0016021;GO:0006616;GO:0015031;GO:0005783;GO:0005789;GO:0005515;GO:0016032;GO:0030176;GO:0038023;GO:0005791;GO:0006613	integral component of membrane;SRP-dependent cotranslational protein targeting to membrane, translocation;membrane;protein transport;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;viral process;integral component of endoplasmic reticulum membrane;signaling receptor activity;rough endoplasmic reticulum;cotranslational protein targeting to membrane	Alternative splicing;Endoplasmic reticulum;Glycoprotein;Host-virus interaction;Membrane;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport	R-HSA-392499;R-HSA-72766;R-HSA-1799339	Metabolism of proteins;Translation;SRP-dependent cotranslational protein targeting to membrane
COQ8B	negative	CDC42	ENSG00000070831	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00000390	WBGene00000390(1)		Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome;Takenouchi-Kosaki syndrome	GO:0005737;GO:0016020;GO:0000166;GO:0016787;GO:0003924;GO:0005525;GO:0051301;GO:0007264;GO:0016567;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0030154;GO:0019901;GO:0030742;GO:0031435;GO:0002040;GO:0003161;GO:0006897;GO:0007015;GO:0007030;GO:0007088;GO:0007097;GO:0032488;GO:0034332;GO:0034613;GO:0035088;GO:0036336;GO:0043085;GO:0043393;GO:0043410;GO:0043525;GO:0043552;GO:0045740;GO:0046330;GO:0046847;GO:0048664;GO:0051491;GO:0051647;GO:0051683;GO:0051835;GO:0060047;GO:0060501;GO:0060661;GO:0060997;GO:0071346;GO:0072384;GO:0090135;GO:0090316;GO:0099159;GO:0099563;GO:0000139;GO:0000322;GO:0005829;GO:0005911;GO:0030141;GO:0031256;GO:0045177;GO:0045335;GO:0071944;GO:0098685;GO:0005925;GO:0030425;GO:0005813;GO:0005815;GO:0005819;GO:0030496;GO:0038096;GO:0042802;GO:0007399;GO:0043005;GO:0005789;GO:0030175;GO:0070062;GO:0051056;GO:0032991;GO:0051233;GO:0005938;GO:0031274;GO:0007266;GO:0008360;GO:0030036;GO:0034329;GO:0045198;GO:0021762;GO:0072686;GO:2000251;GO:0035722;GO:0032956;GO:0048013;GO:0048010;GO:0031996;GO:0031333;GO:0036464;GO:0032467;GO:0060071;GO:0007229;GO:0038189;GO:0051496;GO:0007163;GO:0042059;GO:0039694;GO:0007596;GO:0031295;GO:0051149;GO:0043197;GO:0043025;GO:0051489;GO:1900026;GO:0034191;GO:0006911;GO:0030225;GO:0030031;GO:0051988;GO:0010591;GO:0051492;GO:0032427;GO:0061630;GO:0010592;GO:0030307;GO:0017119;GO:0005622	GTP binding;GTPase activity;small GTPase mediated signal transduction;cell;protein binding;cytoplasm;membrane;nucleotide binding;hydrolase activity;cytoskeleton;focal adhesion;protein ubiquitination;plasma membrane;cell projection;cell differentiation;dendrite;centrosome;microtubule organizing center;spindle;midbody;Fc-gamma receptor signaling pathway involved in phagocytosis;identical protein binding;intracellular membrane-bounded organelle;nervous system development;neuron projection;endoplasmic reticulum membrane;cytosol;filopodium;extracellular exosome;regulation of small GTPase mediated signal transduction;protein kinase binding;cell migration;actin filament organization;endocytosis;regulation of cell shape;protein-containing complex;spindle midzone;cell cortex;positive regulation of pseudopodium assembly;Rho protein signal transduction;actin cytoskeleton organization;cell junction assembly;establishment of epithelial cell apical/basal polarity;substantia nigra development;cytoplasmic vesicle;mitotic spindle;positive regulation of actin cytoskeleton reorganization;interleukin-12-mediated signaling pathway;establishment or maintenance of cell polarity;regulation of actin cytoskeleton organization;ephrin receptor signaling pathway;positive regulation of filopodium assembly;dendritic spine morphogenesis;vascular endothelial growth factor receptor signaling pathway;thioesterase binding;negative regulation of protein-containing complex assembly;cytoplasmic ribonucleoprotein granule;positive regulation of cytokinesis;Wnt signaling pathway, planar cell polarity pathway;integrin-mediated signaling pathway;neuropilin signaling pathway;positive regulation of stress fiber assembly;negative regulation of epidermal growth factor receptor signaling pathway;viral RNA genome replication;blood coagulation;T cell costimulation;positive regulation of muscle cell differentiation;dendritic spine;neuronal cell body;regulation of filopodium assembly;cortical cytoskeleton organization;positive regulation of substrate adhesion-dependent cell spreading;Golgi membrane;apolipoprotein A-I receptor binding;phagocytosis, engulfment;macrophage differentiation;cell projection assembly;regulation of attachment of spindle microtubules to kinetochore;regulation of lamellipodium assembly;regulation of stress fiber assembly;positive regulation of pinocytosis;GTP-dependent protein binding;mitogen-activated protein kinase kinase kinase binding;GBD domain binding;ubiquitin protein ligase activity;sprouting angiogenesis;cardiac conduction system development;Golgi organization;regulation of mitotic nuclear division;nuclear migration;positive regulation of lamellipodium assembly;positive regulation of cell growth;Cdc42 protein signal transduction;adherens junction organization;cellular protein localization;establishment or maintenance of apical/basal cell polarity;dendritic cell migration;positive regulation of catalytic activity;regulation of protein binding;positive regulation of MAPK cascade;positive regulation of neuron apoptotic process;positive regulation of phosphatidylinositol 3-kinase activity;positive regulation of DNA replication;positive regulation of JNK cascade;filopodium assembly;neuron fate determination;nucleus localization;establishment of Golgi localization;positive regulation of synapse structural plasticity;heart contraction;positive regulation of epithelial cell proliferation involved in lung morphogenesis;submandibular salivary gland formation;cellular response to interferon-gamma;organelle transport along microtubule;actin filament branching;positive regulation of intracellular protein transport;regulation of modification of postsynaptic structure;modification of synaptic structure;storage vacuole;cell-cell junction;Golgi transport complex;secretory granule;leading edge membrane;apical part of cell;phagocytic vesicle;cell periphery;Schaffer collateral - CA1 synapse;cell division	3D-structure;Alternative splicing;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Differentiation;Direct protein sequencing;Disease mutation;GTP-binding;Glycoprotein;Hydrolase;Lipoprotein;Membrane;Mental retardation;Methylation;Neurogenesis;Nucleotide-binding;Phosphoprotein;Prenylation;Reference proteome	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029482;R-HSA-388841;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-372790;R-HSA-388396;R-HSA-1280215;R-HSA-376176;R-HSA-449147;R-HSA-5683057;R-HSA-5687128;R-HSA-195258;R-HSA-5663213;R-HSA-5626467;R-HSA-5663220;R-HSA-983231;R-HSA-9006934;R-HSA-76002;R-HSA-447115;R-HSA-8950505;R-HSA-9020591;R-HSA-2682334;R-HSA-373752;R-HSA-3928662;R-HSA-418885;R-HSA-114604;R-HSA-194138;R-HSA-389356;R-HSA-4420097;R-HSA-525793;R-HSA-397795;R-HSA-8964616;R-HSA-177929;R-HSA-182971;R-HSA-5627123;R-HSA-428543;R-HSA-389359;R-HSA-5625970	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Costimulation by the CD28 family;Developmental Biology;Axon guidance;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by GPCR;GPCR downstream signalling;Cytokine Signaling in Immune system;Signaling by ROBO receptors;Signaling by Interleukins;MAPK family signaling cascades;MAPK6/MAPK4 signaling;RHO GTPase Effectors;RHO GTPases Activate WASPs and WAVEs;RHO GTPases activate IQGAPs;RHO GTPases Activate Formins;Factors involved in megakaryocyte development and platelet production;Signaling by Receptor Tyrosine Kinases;Platelet activation, signaling and aggregation;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;EPH-Ephrin signaling;Netrin-1 signaling;EPHB-mediated forward signaling;DCC mediated attractive signaling;GPVI-mediated activation cascade;Signaling by VEGF;CD28 co-stimulation;VEGFA-VEGFR2 Pathway;Myogenesis;G-protein beta:gamma signalling;G beta:gamma signalling through CDC42;Signaling by EGFR;EGFR downregulation;RHO GTPases activate PAKs;Inactivation of CDC42 and RAC1;CD28 dependent Vav1 pathway;RHO GTPases activate KTN1
COQ8B	negative	RAB21	ENSG00000080371	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00004279	WBGene00004279(1)			GO:0016020;GO:0015031;GO:0000166;GO:0005783;GO:0005789;GO:0007165;GO:0003924;GO:0005525;GO:0005794;GO:1904115;GO:0032482;GO:0005515;GO:0000139;GO:0031410;GO:0030659;GO:0005925;GO:0008089;GO:0030516;GO:0050775;GO:0043005;GO:0045202;GO:0006886;GO:0005768;GO:0032580;GO:0005829;GO:0070062;GO:0005802;GO:0031901;GO:0032154;GO:0005769;GO:0019003;GO:0048260;GO:0009898;GO:0017157;GO:0012506;GO:2000643;GO:0098559	signal transduction;membrane;GTP binding;GTPase activity;Rab protein signal transduction;protein transport;nucleotide binding;endoplasmic reticulum;endoplasmic reticulum membrane;endosome;Golgi apparatus;focal adhesion;axon cytoplasm;cell projection;protein binding;cytoplasmic vesicle;cytoplasmic vesicle membrane;Golgi membrane;anterograde axonal transport;regulation of axon extension;positive regulation of dendrite morphogenesis;neuron projection;synapse;intracellular protein transport;Golgi cisterna membrane;cytosol;extracellular exosome;trans-Golgi network;early endosome membrane;endomembrane system;cleavage furrow;early endosome;GDP binding;positive regulation of receptor-mediated endocytosis;cytoplasmic side of plasma membrane;regulation of exocytosis;vesicle membrane;positive regulation of early endosome to late endosome transport;cytoplasmic side of early endosome membrane	3D-structure;Acetylation;Cell projection;Cytoplasmic vesicle;Direct protein sequencing;Endoplasmic reticulum;Endosome;GTP-binding;Golgi apparatus;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-8873719	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;RAB geranylgeranylation
COQ8B	negative	EIF5	ENSG00000100664	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00016496	WBGene00016496(1)			GO:0003723;GO:0005737;GO:0003743;GO:0006412;GO:0006413;GO:0000166;GO:0005829;GO:0005886;GO:0005525;GO:0005515;GO:0045296;GO:0003924;GO:0008135;GO:0006446;GO:0001731;GO:0001732;GO:0005092;GO:0071074	protein binding;translation initiation factor activity;translational initiation;RNA binding;cytoplasm;translation;nucleotide binding;cytosol;plasma membrane;GTP binding;eukaryotic initiation factor eIF2 binding;formation of translation preinitiation complex;activation of GTPase activity;cadherin binding;formation of cytoplasmic translation initiation complex;regulation of translational initiation;GDP-dissociation inhibitor activity	3D-structure;GTP-binding;Initiation factor;Isopeptide bond;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-72613;R-HSA-72702;R-HSA-72706;R-HSA-72737;R-HSA-72766	Metabolism of proteins;Eukaryotic Translation Initiation;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
COQ8B	negative	TSC22D1	ENSG00000102804	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00011824;WBGene00016269;WBGene00019273	WBGene00011824(0);WBGene00012994(0)	CNP		GO:0005634;GO:0005737;GO:0006355;GO:0003700;GO:0005515;GO:0006357;GO:0000981;GO:0006366	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleus;cytoplasm;protein binding;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription by RNA polymerase II	Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ8B	negative	CMC2	ENSG00000103121	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00016452	WBGene00016452(1)			GO:0005739	mitochondrion	Disulfide bond;Mitochondrion;Polymorphism;Reference proteome	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
COQ8B	negative	PHACTR2	ENSG00000112419	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00009174;WBGene00004212	WBGene00009174(0)			GO:0003779;GO:0032515;GO:0004864;GO:0016020;GO:0005515;GO:0005886;GO:0002576;GO:0031092	actin binding;negative regulation of phosphoprotein phosphatase activity;protein phosphatase inhibitor activity;membrane;protein binding;plasma membrane;platelet degranulation;platelet alpha granule membrane	Actin-binding;Alternative splicing;Lipoprotein;Membrane;Myristate;Phosphoprotein;Polymorphism;Protein phosphatase inhibitor;Reference proteome;Repeat	R-HSA-109582;R-HSA-76002;R-HSA-76005;R-HSA-114608	Hemostasis;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation 
COQ8B	negative	QKI	ENSG00000112531	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00006423;WBGene00001595			Angiocentric glioma;Intellectual disability	GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0051028;GO:0005634;GO:0005737;GO:0005515;GO:0007275;GO:0030154;GO:0003729;GO:0006417;GO:0017124;GO:0001570;GO:0007286;GO:0008366;GO:0010628;GO:0042552;GO:0042692;GO:0042759;GO:0045202	nucleic acid binding;RNA binding;mRNA processing;RNA splicing;mRNA transport;nucleus;cytoplasm;protein binding;multicellular organism development;cell differentiation;mRNA binding;regulation of translation;SH3 domain binding;vasculogenesis;spermatid development;axon ensheathment;positive regulation of gene expression;myelination;muscle cell differentiation;long-chain fatty acid biosynthetic process;synapse	3D-structure;Alternative splicing;Cytoplasm;Developmental protein;Differentiation;Methylation;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;SH3-binding;Translation regulation;Transport;mRNA processing;mRNA splicing;mRNA transport	R-HSA-1643685;R-HSA-5663202;R-HSA-6802952;R-HSA-6802957	Disease;Diseases of signal transduction;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
COQ8B	negative	UXS1	ENSG00000115652	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00005019	WBGene00005019(1)			GO:0016020;GO:0016021;GO:0016829;GO:0005794;GO:0070403;GO:0042803;GO:0016831;GO:0005737;GO:0032580;GO:0070062;GO:0048040;GO:0051262;GO:0033320;GO:0003824;GO:0050662	UDP-glucuronate decarboxylase activity;membrane;integral component of membrane;lyase activity;Golgi apparatus;NAD+ binding;protein homodimerization activity;carboxy-lyase activity;identical protein binding;cytoplasm;Golgi cisterna membrane;extracellular exosome;catalytic complex;UDP-D-xylose biosynthetic process;catalytic activity;coenzyme binding	3D-structure;Acetylation;Alternative splicing;Decarboxylase;Glycoprotein;Golgi apparatus;Lyase;Membrane;NAD;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix		
COQ8B	negative	FAM20B	ENSG00000116199	COQ8B	1	COQ8B	1	0.00786482394138022					GO:0016020;GO:0016021;GO:0005794;GO:0046872;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005654;GO:0005515;GO:0000139;GO:0030166;GO:0016773	membrane;integral component of membrane;Golgi apparatus;metal ion binding;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;protein binding;Golgi membrane;phosphotransferase activity, alcohol group as acceptor;proteoglycan biosynthetic process	ATP-binding;Disulfide bond;Glycoprotein;Golgi apparatus;Kinase;Manganese;Membrane;Metal-binding;Nucleotide-binding;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix		
COQ8B	negative	CAPZA1	ENSG00000116489	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00000292	WBGene00000292(0)			GO:0005737;GO:0003779;GO:0051016;GO:0051693;GO:0008290;GO:0005856;GO:0005515;GO:0005576;GO:0051015;GO:0005829;GO:0045296;GO:0070062;GO:0030479;GO:0071203;GO:0045087;GO:0030036;GO:0034329;GO:0019886;GO:0035722;GO:0006888;GO:0065003;GO:0015629;GO:0007596	barbed-end actin filament capping;F-actin capping protein complex;cytoplasm;actin binding;cytoskeleton;protein binding;extracellular region;actin filament capping;actin filament binding;cytosol;cadherin binding;extracellular exosome;WASH complex;innate immune response;actin cytoskeleton organization;cell junction assembly;antigen processing and presentation of exogenous peptide antigen via MHC class II;interleukin-12-mediated signaling pathway;endoplasmic reticulum to Golgi vesicle-mediated transport;protein-containing complex assembly;actin cytoskeleton;blood coagulation	3D-structure;Acetylation;Actin capping;Actin-binding;Cytoplasm;Cytoskeleton;Direct protein sequencing;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-8953897;R-HSA-199977;R-HSA-2132295;R-HSA-3371497;R-HSA-6807878;R-HSA-6811436;R-HSA-948021;R-HSA-983231;R-HSA-447115;R-HSA-8950505;R-HSA-9020591;R-HSA-879415	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Cellular responses to external stimuli;ER to Golgi Anterograde Transport;MHC class II antigen presentation;HSP90 chaperone cycle for steroid hormone receptors (SHR);COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Transport to the Golgi and subsequent modification;Factors involved in megakaryocyte development and platelet production;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Advanced glycosylation endproduct receptor signaling
COQ8B	negative	GNA13	ENSG00000120063	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00001674	WBGene00001664(0);WBGene00001675(0);WBGene00001665(0);WBGene00001678(0);WBGene00001666(0);WBGene00001745(0);WBGene00001670(0);WBGene00001671(0);WBGene00001674(0);WBGene00001673(0);WBGene00001668(0);WBGene00001676(0);WBGene00001667(0)			GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0007186;GO:0005829;GO:0007165;GO:0003924;GO:0005525;GO:0005886;GO:0001664;GO:0005515;GO:0005834;GO:0042470;GO:0019001;GO:0031683;GO:0031752;GO:0001525;GO:0001569;GO:0001701;GO:0007188;GO:0007189;GO:0007204;GO:0007266;GO:0008360;GO:0030154;GO:0030168;GO:0030334;GO:0031584;GO:0035556;GO:0031526;GO:0005925;GO:0070062;GO:0051056;GO:0043065	G protein-coupled receptor signaling pathway;signal transduction;GTPase activity;G-protein beta/gamma-subunit complex binding;G protein-coupled receptor binding;Rho protein signal transduction;guanyl nucleotide binding;cell;nucleus;cytoplasm;membrane;metal ion binding;nucleotide binding;cytosol;focal adhesion;GTP binding;plasma membrane;protein binding;heterotrimeric G-protein complex;melanosome;D5 dopamine receptor binding;angiogenesis;branching involved in blood vessel morphogenesis;in utero embryonic development;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;regulation of cell shape;cell differentiation;platelet activation;regulation of cell migration;activation of phospholipase D activity;intracellular signal transduction;brush border membrane;extracellular exosome;regulation of small GTPase mediated signal transduction;positive regulation of apoptotic process	Alternative splicing;Cell membrane;Cytoplasm;GTP-binding;Lipoprotein;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Nucleus;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;Transducer	R-HSA-109582;R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-193648;R-HSA-193704;R-HSA-204998;R-HSA-372790;R-HSA-388396;R-HSA-416482;R-HSA-73887;R-HSA-392518;R-HSA-76002;R-HSA-456926;R-HSA-428930	Hemostasis;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling;Signal amplification;Platelet activation, signaling and aggregation;Thrombin signalling through proteinase activated receptors (PARs);Thromboxane signalling through TP receptor
COQ8B	negative	CCDC18	ENSG00000122483	COQ8B	1	COQ8B	1	0.00786482394138022							Alternative splicing;Coiled coil;Phosphoprotein;Reference proteome		
COQ8B	negative	GNG11	ENSG00000127920	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00001681				GO:0016020;GO:0007186;GO:0003924;GO:0005886;GO:0005515;GO:0007165;GO:0005834;GO:0031681;GO:0031680	G protein-coupled receptor signaling pathway;GTPase activity;heterotrimeric G-protein complex;membrane;plasma membrane;protein binding;signal transduction;G-protein beta-subunit binding;G-protein beta/gamma-subunit complex	Cell membrane;Lipoprotein;Membrane;Methylation;Prenylation;Reference proteome;Transducer	R-HSA-109582;R-HSA-392499;R-HSA-1430728;R-HSA-382551;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416482;R-HSA-418555;R-HSA-195721;R-HSA-3858494;R-HSA-416476;R-HSA-418594;R-HSA-418597;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-390466;R-HSA-391251;R-HSA-111885;R-HSA-202040;R-HSA-392170;R-HSA-392518;R-HSA-6814122;R-HSA-76002;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-373080;R-HSA-500792;R-HSA-456926;R-HSA-418346;R-HSA-163685;R-HSA-422356;R-HSA-445717;R-HSA-381676;R-HSA-392451;R-HSA-392851;R-HSA-397795;R-HSA-400042;R-HSA-4086398;R-HSA-418217;R-HSA-418592;R-HSA-420092;R-HSA-428930;R-HSA-432040;R-HSA-451326;R-HSA-500657;R-HSA-8964315;R-HSA-8964616;R-HSA-163359	Hemostasis;Metabolism of proteins;Metabolism;Transport of small molecules;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;G alpha (s) signalling events;Signaling by WNT;Beta-catenin independent WNT signaling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Chaperonin-mediated protein folding;Protein folding;Opioid Signalling;G-protein activation;ADP signalling through P2Y purinoceptor 12;Signal amplification;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Class B/2 (Secretin family receptors);GPCR ligand binding;Thrombin signalling through proteinase activated receptors (PARs);Platelet homeostasis;Integration of energy metabolism;Regulation of insulin secretion;Aquaporin-mediated transport;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;G beta:gamma signalling through PI3Kgamma;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G beta:gamma signalling through PLC beta;ADP signalling through P2Y purinoceptor 1;Glucagon-type ligand receptors;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Activation of kainate receptors upon glutamate binding;Presynaptic function of Kainate receptors;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Glucagon signaling in metabolic regulation
COQ8B	negative	PTPN12	ENSG00000127947	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00021507;WBGene00008661;WBGene00009129;WBGene00009492;WBGene00010636;WBGene00011918;WBGene00012138;WBGene00015026;WBGene00015331;WBGene00015929;WBGene00016382;WBGene00016942;WBGene00017647;WBGene00018124;WBGene00018525;WBGene00018530;WBGene00018531;WBGene00018895;WBGene00019773;WBGene00020841;WBGene00021435;WBGene00021702;WBGene00022709;WBGene00022753;WBGene00235383				GO:0005737;GO:0016787;GO:0004721;GO:0006470;GO:0042995;GO:0005515;GO:0004725;GO:0016311;GO:0016791;GO:0030054;GO:0005925;GO:0005654;GO:0005829;GO:0002102;GO:0035335;GO:0017124;GO:0038128;GO:0071364;GO:0071345;GO:1901185;GO:0042058;GO:0004726;GO:0042246;GO:2000587	phosphatase activity;protein tyrosine phosphatase activity;protein dephosphorylation;dephosphorylation;cytoplasm;hydrolase activity;focal adhesion;phosphoprotein phosphatase activity;cell projection;protein binding;cell junction;nucleus;nucleoplasm;cytosol;podosome;peptidyl-tyrosine dephosphorylation;SH3 domain binding;ERBB2 signaling pathway;cellular response to epidermal growth factor stimulus;cellular response to cytokine stimulus;negative regulation of ERBB signaling pathway;regulation of epidermal growth factor receptor signaling pathway;non-membrane spanning protein tyrosine phosphatase activity;tissue regeneration;negative regulation of platelet-derived growth factor receptor-beta signaling pathway	3D-structure;Acetylation;Alternative splicing;Cell junction;Cell projection;Cytoplasm;Direct protein sequencing;Disease mutation;Hydrolase;Phosphoprotein;Polymorphism;Protein phosphatase;Reference proteome	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-446652;R-HSA-449147;R-HSA-186797;R-HSA-9006934;R-HSA-1227986;R-HSA-1250196;R-HSA-8863795;R-HSA-177929;R-HSA-182971;R-HSA-9008059	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Interleukin-1 family signaling;Signaling by Interleukins;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases;Signaling by ERBB2;SHC1 events in ERBB2 signaling;Downregulation of ERBB2 signaling;Signaling by EGFR;EGFR downregulation;Interleukin-37 signaling
COQ8B	negative	CALU	ENSG00000128595	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00019760	WBGene00019760(0)			GO:0016020;GO:0046872;GO:0005783;GO:0005789;GO:0005509;GO:0005794;GO:0005515;GO:0005576;GO:0042470;GO:0008150;GO:0044267;GO:0016529;GO:0043687;GO:0005788;GO:0033018	calcium ion binding;membrane;metal ion binding;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;protein binding;extracellular region;melanosome;biological_process;cellular protein metabolic process;sarcoplasmic reticulum;post-translational protein modification;endoplasmic reticulum lumen;sarcoplasmic reticulum lumen	Acetylation;Alternative splicing;Calcium;Direct protein sequencing;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Sarcoplasmic reticulum;Secreted;Signal	R-HSA-109582;R-HSA-392499;R-HSA-597592;R-HSA-76002;R-HSA-76005;R-HSA-114608;R-HSA-381426;R-HSA-8957275	Hemostasis;Metabolism of proteins;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet degranulation ;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation
COQ8B	negative	PPFIA1	ENSG00000131626	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00006364	WBGene00006364(0)			GO:0005737;GO:0005829;GO:0005925;GO:0005515;GO:0007165;GO:0014047;GO:0007269;GO:0048786;GO:0007160;GO:0051497;GO:1903077;GO:0016020;GO:0016021	protein binding;cytoplasm;cytosol;focal adhesion;signal transduction;glutamate secretion;neurotransmitter secretion;presynaptic active zone;cell-matrix adhesion;synapse organization;negative regulation of stress fiber assembly;negative regulation of protein localization to plasma membrane;membrane;integral component of membrane	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-112315;R-HSA-112316;R-HSA-112310;R-HSA-210500;R-HSA-6794362;R-HSA-181429;R-HSA-181430;R-HSA-212676;R-HSA-264642;R-HSA-388844	Transmission across Chemical Synapses;Neuronal System;Neurotransmitter release cycle;Glutamate Neurotransmitter Release Cycle;Protein-protein interactions at synapses;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases
COQ8B	negative	EFR3A	ENSG00000132294	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00016311	WBGene00016311(1)			GO:0005737;GO:0016020;GO:0005829;GO:0005886;GO:0072659;GO:0046854	cytoplasm;membrane;cytosol;plasma membrane;protein localization to plasma membrane;phosphatidylinositol phosphorylation	Alternative splicing;Autism;Autism spectrum disorder;Cell membrane;Cytoplasm;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Polymorphism;Reference proteome		
COQ8B	negative	FOPNL	ENSG00000133393	COQ8B	1	COQ8B	1	0.00786482394138022					GO:0005634;GO:0005813;GO:0031514;GO:0036064;GO:0005515;GO:0005815;GO:0034453;GO:0005737;GO:0005856;GO:0042995;GO:0005929;GO:0060271;GO:0030030;GO:0005814;GO:0034451	protein binding;nucleoplasm;centrosome;motile cilium;ciliary basal body;microtubule organizing center;microtubule anchoring;cytoplasm;cytoskeleton;cell projection;cilium;cilium assembly;cell projection organization;centriole;centriolar satellite	Alternative splicing;Cell projection;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Phosphoprotein;Reference proteome		
COQ8B	negative	NAPG	ENSG00000134265	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00013345;WBGene00044794	WBGene00013345(1);WBGene00044794(0)			GO:0016020;GO:0006886;GO:0015031;GO:0005739;GO:0005765;GO:0016192;GO:0005515;GO:0070062;GO:0050821;GO:0031201;GO:0019905;GO:0005774;GO:0061025;GO:0065003;GO:0006891;GO:0005483;GO:0045202;GO:0005623	protein binding;intracellular protein transport;membrane;protein transport;mitochondrion;lysosomal membrane;vesicle-mediated transport;extracellular exosome;protein stabilization;SNARE complex;syntaxin binding;vacuolar membrane;membrane fusion;protein-containing complex assembly;intra-Golgi vesicle-mediated transport;soluble NSF attachment protein activity;synapse	Alternative splicing;ER-Golgi transport;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-6811438;R-HSA-204005;R-HSA-6811440	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Intra-Golgi traffic;COPII-mediated vesicle transport;Retrograde transport at the Trans-Golgi-Network
COQ8B	negative	KIDINS220	ENSG00000134313	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00006490			Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome;SPASTIC PARAPLEGIA INTELLECTUAL DISABILITY NYSTAGMUS AND OBESITY;SPASTIC PARAPLEGIA INTELLECTUAL DISABILITY NYSTAGMUS AND OBESITY	GO:0016020;GO:0016021;GO:0005515;GO:0005768;GO:0007399;GO:0005829;GO:0032991;GO:0030165;GO:0005770;GO:0038180;GO:0010976;GO:0019887;GO:0000186;GO:1990090;GO:0001701;GO:0048813	membrane;integral component of membrane;protein binding;endosome;nervous system development;cytosol;protein-containing complex;PDZ domain binding;late endosome;nerve growth factor signaling pathway;positive regulation of neuron projection development;protein kinase regulator activity;activation of MAPKK activity;cellular response to nerve growth factor stimulus;in utero embryonic development;dendrite morphogenesis	ANK repeat;Alternative splicing;Disease mutation;Endosome;Hereditary spastic paraplegia;Membrane;Mental retardation;Neurodegeneration;Neurogenesis;Obesity;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-9006934;R-HSA-166520;R-HSA-187037;R-HSA-187687;R-HSA-169893;R-HSA-170984	Signal Transduction;Signaling by Receptor Tyrosine Kinases;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Signalling to ERKs;Prolonged ERK activation events;ARMS-mediated activation
COQ8B	negative	IL6ST	ENSG00000134352	COQ8B	1	COQ8B	1	0.00786482394138022					GO:0008284;GO:0042531;GO:0043066;GO:0010613;GO:0002675;GO:0045669;GO:0016020;GO:0016021;GO:0005886;GO:0005515;GO:0005576;GO:0004896;GO:0009897;GO:0042802;GO:0043235;GO:0070062;GO:0016032;GO:0042803;GO:0019221;GO:0070102;GO:0019838;GO:0070106;GO:0070757;GO:0005127;GO:0019955;GO:0010575;GO:0042102;GO:0005138;GO:0005896;GO:0004897;GO:0004915;GO:0019981;GO:0034097;GO:0070120;GO:0070110;GO:0038165;GO:0048861;GO:0004923;GO:0004924;GO:0004921;GO:0019970;GO:0045509;GO:0002821;GO:0005977;GO:0007165;GO:0008593;GO:0038154;GO:0048711;GO:0005900;GO:0030425;GO:0043025;GO:0044297	protein binding;membrane;cytokine receptor activity;positive regulation of cell population proliferation;positive regulation of tyrosine phosphorylation of STAT protein;negative regulation of apoptotic process;positive regulation of cardiac muscle hypertrophy;positive regulation of acute inflammatory response;positive regulation of osteoblast differentiation;integral component of membrane;plasma membrane;extracellular region;external side of plasma membrane;identical protein binding;receptor complex;extracellular exosome;viral process;cytokine-mediated signaling pathway;interleukin-6-mediated signaling pathway;growth factor binding;interleukin-27-mediated signaling pathway;interleukin-35-mediated signaling pathway;ciliary neurotrophic factor receptor binding;cytokine binding;positive regulation of vascular endothelial growth factor production;positive regulation of T cell proliferation;interleukin-6 receptor binding;interleukin-6 receptor complex;ciliary neurotrophic factor receptor activity;interleukin-6 receptor activity;interleukin-6 binding;response to cytokine;ciliary neurotrophic factor-mediated signaling pathway;ciliary neurotrophic factor receptor complex;oncostatin-M-mediated signaling pathway;leukemia inhibitory factor signaling pathway;leukemia inhibitory factor receptor activity;oncostatin-M receptor activity;interleukin-11 receptor activity;interleukin-11 binding;interleukin-27 receptor activity;positive regulation of adaptive immune response;glycogen metabolic process;signal transduction;regulation of Notch signaling pathway;interleukin-11-mediated signaling pathway;positive regulation of astrocyte differentiation;oncostatin-M receptor complex;dendrite;neuronal cell body;cell body	3D-structure;Alternative splicing;Cell membrane;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Host-virus interaction;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix	R-HSA-168256;R-HSA-1280215;R-HSA-449147;R-HSA-447115;R-HSA-1059683;R-HSA-6783589;R-HSA-6788467;R-HSA-8984722;R-HSA-9020956	Immune System;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-12 family signaling;Interleukin-6 signaling;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions;Interleukin-35 Signalling;Interleukin-27 signaling
COQ8B	negative	TMOD3	ENSG00000138594	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00006823;WBGene00006582	WBGene00006823(0)			GO:0030036;GO:0048821;GO:0005523;GO:0051694;GO:0005737;GO:0003779;GO:0005856;GO:0098641;GO:0098609;GO:0005913;GO:0006936;GO:0030239;GO:0005865;GO:0030016;GO:1901992	tropomyosin binding;pointed-end actin filament capping;actin cytoskeleton organization;erythrocyte development;cytoplasm;actin binding;cytoskeleton;actin filament organization;cadherin binding involved in cell-cell adhesion;cell-cell adhesion;adherens junction;muscle contraction;myofibril assembly;striated muscle thin filament;myofibril;positive regulation of mitotic cell cycle phase transition	Actin-binding;Cytoplasm;Cytoskeleton;Direct protein sequencing;Phosphoprotein;Reference proteome	R-HSA-397014;R-HSA-390522	Muscle contraction;Striated Muscle Contraction
COQ8B	negative	NCOR1	ENSG00000141027	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00001565	WBGene00001565(0)	AR		GO:0005634;GO:0044212;GO:0016020;GO:0005829;GO:0005654;GO:0003677;GO:0006325;GO:0005515;GO:0048511;GO:0043565;GO:0000790;GO:0000122;GO:0003714;GO:0042826;GO:0000118;GO:0003682;GO:0072686;GO:0045892;GO:0046329;GO:0006366;GO:0007623;GO:0001102;GO:0019216;GO:0051225;GO:0017053;GO:0035257;GO:0016580;GO:0001012;GO:0046966;GO:0045475;GO:0060766;GO:0072362;GO:0072368;GO:1903799;GO:2000191	DNA binding;nucleus;transcription regulatory region DNA binding;membrane;nucleoplasm;cytosol;chromatin organization;protein binding;rhythmic process;sequence-specific DNA binding;nuclear chromatin;negative regulation of transcription by RNA polymerase II;transcription corepressor activity;histone deacetylase binding;histone deacetylase complex;chromatin binding;mitotic spindle;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;transcription by RNA polymerase II;circadian rhythm;RNA polymerase II activating transcription factor binding;regulation of lipid metabolic process;spindle assembly;transcriptional repressor complex;nuclear hormone receptor binding;Sin3 complex;RNA polymerase II regulatory region DNA binding;thyroid hormone receptor binding;locomotor rhythm;negative regulation of glycolytic process;negative regulation of fatty acid metabolic process;negative regulation of androgen receptor signaling pathway;negative regulation of production of miRNAs involved in gene silencing by miRNA	3D-structure;Acetylation;Alternative splicing;Biological rhythms;Chromatin regulator;Coiled coil;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-1266738;R-HSA-1852241;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206;R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-9006934;R-HSA-157118;R-HSA-1980143;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-8986944;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-400253;R-HSA-1592230;R-HSA-2151201;R-HSA-3214815;R-HSA-3247509;R-HSA-4839726;R-HSA-5617472;R-HSA-5619507;R-HSA-1236394;R-HSA-1251985;R-HSA-1368071;R-HSA-2122947;R-HSA-350054;R-HSA-9005891;R-HSA-9005895;R-HSA-9022537;R-HSA-9022692;R-HSA-2173795;R-HSA-383280	Developmental Biology;Organelle biogenesis and maintenance;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Signal Transduction;Disease;Diseases of signal transduction;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Transcriptional Regulation by MECP2;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Circadian Clock;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by ERBB4;Nuclear signaling by ERBB4;NR1D1 (REV-ERBA) represses gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Notch-HLH transcription pathway;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Loss of MECP2 binding ability to the NCoR/SMRT complex;Regulation of MECP2 expression and activity;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Nuclear Receptor transcription pathway
COQ8B	negative	POGK	ENSG00000143157	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00020959;WBGene00021679				GO:0003676;GO:0006355;GO:0005622;GO:0005634;GO:0003677;GO:0005515;GO:0007275	regulation of transcription, DNA-templated;nucleic acid binding;DNA binding;nucleus;protein binding;multicellular organism development	Coiled coil;DNA-binding;Developmental protein;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation		
COQ8B	negative	CREG1	ENSG00000143162	COQ8B	1	COQ8B	1	0.00786482394138022					GO:0005576;GO:0048037;GO:0005615;GO:1903507;GO:0070062;GO:0040008;GO:0043312;GO:0007275;GO:0003714;GO:0006357;GO:0035578;GO:0008134;GO:0006355;GO:0005667	cofactor binding;extracellular region;extracellular space;negative regulation of nucleic acid-templated transcription;extracellular exosome;regulation of growth;neutrophil degranulation;multicellular organism development;transcription corepressor activity;regulation of transcription by RNA polymerase II;azurophil granule lumen;transcription factor binding;regulation of transcription, DNA-templated;transcription factor complex	3D-structure;Direct protein sequencing;Glycoprotein;Growth regulation;Reference proteome;Secreted;Signal	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ8B	negative	LIN7C	ENSG00000148943	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00002996	WBGene00002996(1)			GO:0005737;GO:0016020;GO:0015031;GO:0098793;GO:0006887;GO:0005886;GO:0005515;GO:0030054;GO:0045202;GO:0045211;GO:0005923;GO:0019904;GO:0016323;GO:0005911;GO:0014069;GO:0043005;GO:0008092;GO:0007269;GO:0097016;GO:0045199;GO:1903361;GO:0097025;GO:0002011;GO:0030165;GO:0098978	protein binding;cytoplasm;membrane;protein transport;exocytosis;plasma membrane;cell junction;synapse;postsynaptic membrane;presynapse;bicellular tight junction;protein domain specific binding;basolateral plasma membrane;cell-cell junction;postsynaptic density membrane;cytoskeletal protein binding;neurotransmitter secretion;L27 domain binding;maintenance of epithelial cell apical/basal polarity;protein localization to basolateral plasma membrane;MPP7-DLG1-LIN7 complex;morphogenesis of an epithelial sheet;PDZ domain binding;glutamatergic synapse	3D-structure;Acetylation;Cell junction;Cell membrane;Direct protein sequencing;Exocytosis;Membrane;Postsynaptic cell membrane;Protein transport;Reference proteome;Synapse;Tight junction;Transport	R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-442755;R-HSA-9609736;R-HSA-112310;R-HSA-6794361;R-HSA-6794362;R-HSA-212676	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of NMDA receptors and postsynaptic events;Assembly and cell surface presentation of NMDA receptors;Neurotransmitter release cycle;Neurexins and neuroligins;Protein-protein interactions at synapses;Dopamine Neurotransmitter Release Cycle
COQ8B	negative	MAP3K7CL	ENSG00000156265	COQ8B	1	COQ8B	1	0.00786482394138022					GO:0005634;GO:0005829;GO:0005515	nucleus;cytosol;protein binding	Alternative splicing;Polymorphism;Reference proteome		
COQ8B	negative	TAOK1	ENSG00000160551	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00002201				GO:0004672;GO:0005524;GO:0006468;GO:0005737;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0006281;GO:0006974;GO:0006915;GO:0005634;GO:0005829;GO:0070062;GO:0000226;GO:0007095;GO:0005515;GO:0048156;GO:0023014;GO:0032147;GO:0032874;GO:0046330;GO:0051493;GO:0004709;GO:0007257;GO:0097194;GO:0050321;GO:0000186;GO:0048487;GO:0070050;GO:0048471;GO:0043014;GO:0070507;GO:0015630;GO:0007026;GO:0043539;GO:0000187;GO:0032956;GO:0046777;GO:1901985	ATP binding;protein phosphorylation;protein kinase activity;cell;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;DNA repair;cellular response to DNA damage stimulus;apoptotic process;cytosol;extracellular exosome;microtubule cytoskeleton organization;mitotic G2 DNA damage checkpoint;protein binding;tau protein binding;regulation of mitotic cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;positive regulation of stress-activated MAPK cascade;positive regulation of JNK cascade;regulation of cytoskeleton organization;MAP kinase kinase kinase activity;activation of JUN kinase activity;execution phase of apoptosis;tau-protein kinase activity;activation of MAPKK activity;beta-tubulin binding;perinuclear region of cytoplasm;neuron cellular homeostasis;alpha-tubulin binding;regulation of microtubule cytoskeleton organization;microtubule cytoskeleton;negative regulation of microtubule depolymerization;protein serine/threonine kinase activator activity;activation of MAPK activity;regulation of actin cytoskeleton organization;protein autophosphorylation;positive regulation of protein acetylation	ATP-binding;Alternative splicing;Apoptosis;Coiled coil;Cytoplasm;DNA damage;DNA repair;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ8B	negative	WDR26	ENSG00000162923	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00021482			Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome;Intellectual Disability Seizures Abnormal Gait and Distinctive Facial Features;SKRABAN-DEARDORFF SYNDROME	GO:0005515;GO:0005829;GO:0005654;GO:0005634;GO:0005737;GO:0005739;GO:0000151	protein binding;nucleoplasm;cytosol;nucleus;cytoplasm;mitochondrion;ubiquitin ligase complex	Alternative splicing;Cytoplasm;Disease mutation;Mental retardation;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat		
COQ8B	negative	MOB1B	ENSG00000173542	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00020447				GO:0005634;GO:0005730;GO:0005829;GO:0005737;GO:0046872;GO:0005515;GO:0035329;GO:0070062;GO:0019900;GO:0019209;GO:0033674;GO:0031952	nucleoplasm;nucleolus;cytosol;nucleus;cytoplasm;metal ion binding;protein binding;hippo signaling;extracellular exosome;kinase binding;kinase activator activity;positive regulation of kinase activity;regulation of protein autophosphorylation	Acetylation;Alternative splicing;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc	R-HSA-162582;R-HSA-2028269	Signal Transduction;Signaling by Hippo
COQ8B	negative	SRSF10	ENSG00000188529	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00004701				GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0016607;GO:0005829;GO:0005654;GO:0000398;GO:0043484;GO:0000381;GO:0005515;GO:0006355;GO:0048025;GO:0000375;GO:0051082;GO:0045292;GO:0000244;GO:0006376;GO:0050733;GO:0048024;GO:0016482	nucleic acid binding;regulation of RNA splicing;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nuclear speck;cytosol;nucleoplasm;mRNA splicing, via spliceosome;protein binding;regulation of alternative mRNA splicing, via spliceosome;regulation of transcription, DNA-templated;negative regulation of mRNA splicing, via spliceosome;RNA splicing, via transesterification reactions;unfolded protein binding;mRNA cis splicing, via spliceosome;spliceosomal tri-snRNP complex assembly;mRNA splice site selection;RS domain binding;regulation of mRNA splicing, via spliceosome;cytosolic transport	Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
COQ8B	negative	TRAPPC2	ENSG00000196459	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00021046			SPONDYLOEPIPHYSEAL DYSPLASIA TARDA;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA X-LINKED	GO:0048471;GO:0005634;GO:0005737;GO:0043231;GO:0005783;GO:0005654;GO:0006888;GO:0005515;GO:0016192;GO:0000139;GO:0005829;GO:0001501;GO:0044325;GO:0008134;GO:0006355;GO:0048208;GO:0005793;GO:0030008;GO:0005622	endoplasmic reticulum to Golgi vesicle-mediated transport;perinuclear region of cytoplasm;nucleus;cytoplasm;intracellular membrane-bounded organelle;endoplasmic reticulum;nucleoplasm;protein binding;vesicle-mediated transport;Golgi membrane;cytosol;skeletal system development;regulation of transcription, DNA-templated;TRAPP complex;ion channel binding;transcription factor binding;COPII vesicle coating;endoplasmic reticulum-Golgi intermediate compartment	Alternative splicing;Cytoplasm;Disease mutation;ER-Golgi transport;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-446203;R-HSA-199977;R-HSA-948021;R-HSA-204005	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport
COQ8B	negative	OPA1	ENSG00000198836	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00001134	WBGene00001134(1)		Autosomal dominant optic atrophy plus syndrome;Autosomal dominant optic atrophy classic form;Behr syndrome;GLAUCOMA NORMAL TENSION SUSCEPTIBILITY TO;MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHICTYPE);OPTIC ATROPHY 1;OPTIC ATROPHY WITH OR WITHOUT DEAFNESS OPHTHALMOPLEGIA MYOPATHY ATAXIA AND NEUROPATHY	GO:0016020;GO:0016021;GO:0000166;GO:0043066;GO:0005829;GO:0005654;GO:0016787;GO:0005739;GO:0005743;GO:0003924;GO:0005525;GO:1904115;GO:0006915;GO:0005515;GO:0000287;GO:0005741;GO:0007005;GO:0008289;GO:0050896;GO:0030425;GO:0005737;GO:0031966;GO:0005886;GO:0005758;GO:0008017;GO:0007601;GO:0031410;GO:0046039;GO:0051259;GO:0000266;GO:0090398;GO:0090201;GO:1902236;GO:0070300;GO:1901612;GO:0000002;GO:0007007;GO:0008053;GO:0019896;GO:0097749;GO:0030061;GO:0019900;GO:0007568;GO:0010636;GO:0014042;GO:0014850;GO:0031667;GO:0036444;GO:0046628;GO:0048312;GO:0051602;GO:0060041;GO:0061003;GO:0070584;GO:0071333;GO:0071456;GO:0090102;GO:1900006;GO:1900078;GO:1904643;GO:1905232;GO:0031314	GTP binding;GTPase activity;mitochondrion;apoptotic process;mitochondrion organization;cell;membrane;integral component of membrane;nucleotide binding;negative regulation of apoptotic process;nucleoplasm;cytosol;hydrolase activity;mitochondrial inner membrane;axon cytoplasm;protein binding;mitochondrial outer membrane;magnesium ion binding;lipid binding;response to stimulus;dendrite;plasma membrane;cytoplasm;mitochondrial intermembrane space;mitochondrial membrane;membrane fusion;inner mitochondrial membrane organization;microtubule binding;visual perception;microtubule cytoskeleton;cytoplasmic vesicle;GTP metabolic process;mitochondrial fission;organelle fission;protein complex oligomerization;cellular senescence;negative regulation of release of cytochrome c from mitochondria;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;phosphatidic acid binding;cardiolipin binding;mitochondrial genome maintenance;mitochondrial fusion;axonal transport of mitochondrion;membrane tubulation;mitochondrial crista;kinase binding;protein-containing complex binding;aging;positive regulation of mitochondrial fusion;positive regulation of neuron maturation;response to muscle activity;response to nutrient levels;calcium import into the mitochondrion;positive regulation of insulin receptor signaling pathway;intracellular distribution of mitochondria;response to electrical stimulus;retina development in camera-type eye;positive regulation of dendritic spine morphogenesis;mitochondrion morphogenesis;cellular response to glucose stimulus;cellular response to hypoxia;cochlea development;positive regulation of dendrite development;positive regulation of cellular response to insulin stimulus;response to curcumin;cellular response to L-glutamate;extrinsic component of mitochondrial inner membrane	Acetylation;Alternative splicing;Apoptosis;Cardiomyopathy;Coiled coil;Deafness;Disease mutation;GTP-binding;Hydrolase;Lipid-binding;Membrane;Mitochondrion;Mitochondrion inner membrane;Neurodegeneration;Nucleotide-binding;Polymorphism;Primary mitochondrial disease;Reference proteome;Sensory transduction;Transit peptide;Transmembrane;Transmembrane helix;Vision	R-HSA-109581;R-HSA-169911;R-HSA-5357801	Apoptosis;Regulation of Apoptosis;Programmed Cell Death
COQ8B	negative	TMEM167B	ENSG00000215717	COQ8B	1	COQ8B	1	0.00786482394138022	WBGene00010639	WBGene00303023(1)			GO:0016020;GO:0016021;GO:0005794;GO:0000139	membrane;integral component of membrane;Golgi apparatus;Golgi membrane;molecular_function;constitutive secretory pathway	Golgi apparatus;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix		
